data_2lcz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lcz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.328 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.9 m 60.32 101.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.563 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.5 m-80 -91.0 -51.44 0.31 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.08 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 61.5 Cg_endo -106.52 21.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.501 3.467 . . . . 0.0 112.406 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -118.8 51.18 1.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.436 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -105.59 -67.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.079 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.612 ' HA ' ' CG2' ' A' ' 519' ' ' THR . 6.0 p-80 -161.51 -57.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.193 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.605 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -55.94 -9.61 0.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.698 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -123.23 -44.31 2.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.581 0.705 . . . . 0.0 110.563 -176.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.612 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 12.1 t -63.15 -28.78 70.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.467 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.491 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.8 OUTLIER -84.57 -65.69 0.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.764 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.491 ' N ' ' CG2' ' A' ' 520' ' ' THR . 3.5 pt20 -99.99 -157.64 0.62 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.2 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.62 36.64 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.233 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.694 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 8.3 mt-10 52.28 34.88 15.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.034 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.418 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 89.26 33.35 9.55 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.571 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -119.95 -5.47 10.07 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -90.79 15.69 10.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.795 0.331 . . . . 0.0 111.72 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.415 HG12 ' CZ2' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -129.65 -44.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.432 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 134.28 -17.63 4.27 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 2.9 tp 78.0 -51.61 0.5 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.67 47.13 0.71 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.107 0.48 . . . . 0.0 112.241 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.568 ' CE2' HD11 ' A' ' 532' ' ' ILE . 3.9 p-90 -122.5 -16.53 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.632 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.601 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -116.17 166.29 12.82 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.856 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.41 ' CD ' ' HB ' ' A' ' 532' ' ' ILE . 83.1 Cg_endo -94.04 2.39 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.835 2.357 . . . . 0.0 113.563 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.424 ' HA ' ' HB2' ' A' ' 538' ' ' ALA . 9.8 p90 -177.16 -21.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.601 ' HD1' ' HB ' ' A' ' 532' ' ' ILE . 60.9 m-85 -59.5 -30.93 68.91 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.91 -0.494 . . . . 0.0 111.67 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.571 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -111.37 -69.07 0.56 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.938 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -49.01 -40.22 40.83 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.603 2.202 . . . . 0.0 112.022 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 534' ' ' TYR . . . -81.91 -31.6 31.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 543' ' ' TYR . . . -52.82 158.09 1.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -141.57 -41.64 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -111.31 34.15 5.45 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.443 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.26 -35.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.101 0.476 . . . . 0.0 109.962 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.735 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -99.68 -29.13 12.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.182 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.52 ' N ' ' CD1' ' A' ' 543' ' ' TYR . 2.5 mp 30.84 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.916 0.886 . . . . 0.0 112.95 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.735 ' N ' ' O ' ' A' ' 543' ' ' TYR . 7.4 mt-10 69.63 91.85 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.116 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 150.13 -9.6 0.84 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.875 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.443 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.7 pt? -128.14 -11.36 5.27 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.477 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -63.13 80.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.911 0.386 . . . . 0.0 110.7 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.443 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 4.1 m170 -133.15 29.7 4.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.424 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 52.32 55.79 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.41 172.21 8.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.819 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.1 t70 179.17 31.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -134.87 -37.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.698 ' HG ' HD11 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -77.8 -3.89 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.616 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.698 HD11 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -144.03 -42.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.32 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.525 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t . . . . . 0 N--CA 1.449 -0.493 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.378 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.826 0.346 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.6 m 51.32 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.54 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.8 m-80 -93.52 -49.53 0.27 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.854 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.678 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 50.4 Cg_endo -102.69 17.42 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 124.339 3.359 . . . . 0.0 112.658 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -123.32 59.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.319 0.58 . . . . 0.0 109.914 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -117.18 -72.83 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.05 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 22.9 p-80 -147.62 -56.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.767 ' C ' ' HD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -65.91 179.51 0.88 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.767 ' HD1' ' C ' ' A' ' 517' ' ' TYR . 0.1 OUTLIER 62.79 -44.99 0.2 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.239 0.472 . . . . 0.0 110.945 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 517' ' ' TYR . 8.9 t -94.37 -19.86 20.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.258 0.551 . . . . 0.0 109.829 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.481 HG23 ' N ' ' A' ' 521' ' ' GLN . 1.2 m -85.16 -78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.391 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.526 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -100.51 -161.88 0.9 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.162 -179.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 525' ' ' ALA . 1.1 t0 -93.19 22.36 5.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.942 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.57 ' HG3' ' HA ' ' A' ' 518' ' ' TRP . 9.3 mt-10 48.31 75.84 0.13 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.546 0.689 . . . . 0.0 110.369 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.45 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 52.47 20.29 7.21 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.391 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 522' ' ' ASP . . . -106.69 -22.83 12.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.302 0.551 . . . . 0.0 111.832 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.408 ' N ' ' HB3' ' A' ' 522' ' ' ASP . . . -87.3 20.98 2.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.974 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.517 HG13 ' CZ2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -133.81 -48.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.476 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 136.98 -11.95 3.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.108 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.526 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 3.2 mt 70.04 -56.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.88 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 46.23 0.73 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.412 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.526 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 3.4 p-90 -120.56 -18.29 7.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.664 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.517 HD12 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.1 160.37 30.26 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.259 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 27.1 Cg_endo -62.2 -47.1 10.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.875 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -155.33 6.26 0.23 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.9 OUTLIER -71.65 -26.48 62.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.044 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.491 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.47 -63.41 0.56 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.674 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.09 -41.88 39.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 111.661 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -78.02 -23.03 48.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.585 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.429 ' HB3' ' CD1' ' A' ' 543' ' ' TYR . . . -51.59 161.64 0.48 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -163.69 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.575 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.01 29.59 9.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.875 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.42 -29.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 110.792 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.693 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.8 OUTLIER -98.68 -47.92 5.15 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.5 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 2.0 mp 36.85 -74.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.377 0.671 . . . . 0.0 112.442 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.693 ' N ' ' O ' ' A' ' 543' ' ' TYR . 22.6 mt-10 68.32 85.82 0.14 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.003 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 162.96 -17.32 0.14 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.551 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.435 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.9 pt? -134.68 -12.57 2.3 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -70.17 64.42 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.129 0.49 . . . . 0.0 111.473 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -116.36 -74.63 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.002 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.7 t30 175.47 73.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.417 ' NE2' HD13 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -99.11 -78.25 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.603 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 6.7 t70 66.08 12.59 8.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.683 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.9 -31.77 1.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.711 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.613 ' HG ' HD12 ' A' ' 555' ' ' ILE . 1.5 pp -93.15 9.4 36.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.613 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.3 -42.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.468 -178.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.462 ' N ' HG12 ' A' ' 555' ' ' ILE . 5.2 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.351 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.715 0.293 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 12.4 m 61.76 114.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.408 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.554 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.7 m-80 -94.09 -50.83 0.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.76 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 86.5 Cg_endo -109.64 16.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.267 3.311 . . . . 0.0 113.32 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -118.62 53.18 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.17 0.51 . . . . 0.0 110.171 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.452 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -121.98 -62.73 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.956 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.637 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 7.9 p-80 -171.18 -56.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.578 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.637 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.53 -10.61 0.27 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.76 ' CE3' ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -123.61 -33.33 3.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.21 0.529 . . . . 0.0 110.462 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.621 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 8.9 t -82.87 -16.1 48.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.505 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.533 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -87.07 -56.8 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.716 0.294 . . . . 0.0 111.38 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.54 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 5.6 pt20 -100.45 -157.58 0.62 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.146 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 521' ' ' GLN . 5.3 m-20 -102.73 32.55 3.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.26 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.54 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.5 mt-10 45.33 69.69 0.42 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.907 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.401 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 93.59 -26.94 13.52 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 52.89 11.0 0.17 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.69 16.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.377 . . . . 0.0 110.769 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.456 ' H ' ' C ' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -56.08 -22.23 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.275 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 163.63 -34.01 0.29 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.805 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 2.0 mt 67.91 -53.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.28 -21.68 60.54 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.601 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.9 p-90 -43.61 -29.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.016 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.549 HG22 ' CD2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -103.71 152.09 38.87 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.574 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.56 -50.51 13.8 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.618 2.212 . . . . 0.0 112.281 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -157.97 6.45 0.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.495 ' CD2' ' HB ' ' A' ' 532' ' ' ILE . 1.0 OUTLIER -62.59 -27.1 68.96 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.831 0.348 . . . . 0.0 110.766 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -107.84 -56.65 0.59 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.838 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 46.6 Cg_exo -56.27 -41.27 78.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.481 2.12 . . . . 0.0 111.937 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -93.24 -7.92 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.219 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 542' ' ' ILE . . . -53.1 -75.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 75.87 -43.59 0.49 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.464 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -112.33 35.08 4.83 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.745 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.49 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -151.09 -33.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.992 0.425 . . . . 0.0 110.513 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.697 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.6 OUTLIER -94.96 -45.75 7.13 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.037 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.4 mp 36.47 -73.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.627 0.771 . . . . 0.0 112.404 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 543' ' ' TYR . 19.9 mt-10 67.49 32.24 5.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.732 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.424 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -137.88 -7.86 1.31 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.87 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.487 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.3 pt? -137.67 -8.57 1.65 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.444 ' HE2' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -70.49 65.66 0.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 110.761 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.487 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.7 OUTLIER -111.49 -65.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.611 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 168.59 63.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.422 ' HB3' ' CD2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -115.61 -178.84 3.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.238 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 556' ' ' CYS . 2.9 p30 -179.2 -22.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.187 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -88.33 -29.05 20.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.309 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.617 ' HG ' HD12 ' A' ' 555' ' ' ILE . 1.2 pp -82.42 -2.77 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.669 0.271 . . . . 0.0 111.45 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.617 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.99 -41.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.996 0.427 . . . . 0.0 111.04 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.481 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.186 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.761 0.315 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.67 90.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.53 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 6.0 m-80 -87.39 -49.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.75 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.624 ' HD2' HG13 ' A' ' 555' ' ' ILE . 39.3 Cg_endo -102.08 16.7 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 124.195 3.263 . . . . 0.0 112.525 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -123.82 60.2 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -111.46 -46.15 3.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.31 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.9 p-80 -177.59 -56.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.665 0.269 . . . . 0.0 111.514 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.626 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -56.18 -20.16 16.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.735 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.83 -44.03 2.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.186 0.517 . . . . 0.0 110.761 -177.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.561 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.3 t -53.84 -31.34 49.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.288 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.19 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.163 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.503 ' N ' ' CG2' ' A' ' 520' ' ' THR . 0.0 OUTLIER -99.64 -169.99 1.83 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.467 -178.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.19 21.39 2.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.9 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.502 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 34.2 mt-10 69.11 4.51 4.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.934 0.397 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.459 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 130.96 20.23 1.19 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.16 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.21 -25.26 15.35 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -84.45 23.19 1.15 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 111.412 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.502 HG13 ' CZ2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -131.67 -46.57 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.587 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 138.72 -12.9 3.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.04 -46.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -75.85 -20.25 58.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.532 ' CE2' HD12 ' A' ' 532' ' ' ILE . 2.0 p-90 -47.55 -26.13 1.34 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.953 0.406 . . . . 0.0 111.074 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.562 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 0.3 OUTLIER -114.63 157.75 42.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -91.09 -23.69 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.991 2.461 . . . . 0.0 114.023 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -154.34 6.65 0.3 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.562 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 2.9 m-85 -78.93 -43.08 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.224 0.535 . . . . 0.0 110.705 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.545 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.41 -58.06 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.622 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.68 -42.05 44.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.322 2.014 . . . . 0.0 111.583 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.75 -29.79 32.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.591 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.435 ' HB3' ' HA2' ' A' ' 536' ' ' GLY . . . -58.18 148.11 28.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.223 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -129.16 -35.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.594 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.421 ' O ' ' HZ2' ' A' ' 518' ' ' TRP . . . -114.76 27.57 8.66 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -142.35 -6.19 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.72 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -127.42 -41.99 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 120.368 0.128 . . . . 0.0 111.085 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.488 ' HB ' ' OE1' ' A' ' 523' ' ' GLU . 3.2 mp 34.45 -72.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.549 0.74 . . . . 0.0 112.551 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.72 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.5 mt-10 68.4 90.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.148 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.415 ' H ' ' HE2' ' A' ' 548' ' ' MET . . . 155.51 -15.33 0.47 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.182 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -129.4 -3.17 4.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.786 0.327 . . . . 0.0 111.684 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.461 ' HE1' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -81.08 80.37 7.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.173 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.457 ' CD2' ' HE1' ' A' ' 548' ' ' MET . 1.2 m170 -133.19 -68.7 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.589 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 167.44 66.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.405 ' CG ' HD22 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -88.7 -74.67 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.19 -179.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.93 20.61 9.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.93 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -122.99 -38.15 0.58 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.647 ' HG ' HD11 ' A' ' 555' ' ' ILE . 2.4 pp -83.15 -1.16 52.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.647 HD11 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.31 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.709 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.481 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.93 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.842 0.353 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.7 m 63.41 122.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.557 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.4 m-80 -104.67 -52.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.875 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 512' ' ' ASN . 39.7 Cg_endo -104.02 5.71 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.019 3.146 . . . . 0.0 113.162 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.414 ' N ' HD12 ' A' ' 515' ' ' LEU . 19.4 m-80 -115.53 57.61 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.195 0.521 . . . . 0.0 109.791 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.445 HD22 ' CD2' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -121.73 -38.21 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.736 ' O ' ' O ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -164.23 -84.63 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.768 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.992 ' O ' ' N ' ' A' ' 519' ' ' THR . 1.4 m-85 -52.21 -137.79 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.69 ' HA ' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER 26.14 -63.17 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.992 ' N ' ' O ' ' A' ' 517' ' ' TYR . 9.2 t -70.13 -25.35 63.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.066 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.587 ' HB ' ' O ' ' A' ' 516' ' ' HIS . 0.4 OUTLIER -78.64 -63.93 1.29 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.554 ' N ' ' CG2' ' A' ' 520' ' ' THR . 7.6 pt20 -100.79 -153.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.83 31.75 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.69 ' HG3' ' HA ' ' A' ' 518' ' ' TRP . 1.7 mt-10 46.96 70.72 0.37 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.824 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 90.97 -25.15 14.84 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.895 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 52.47 11.95 0.21 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.55 16.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.749 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.467 ' H ' ' C ' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -57.88 -20.25 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.319 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 160.61 -46.0 0.4 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.924 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 3.4 mp 71.15 -34.79 0.31 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.18 -22.94 44.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.46 ' CE3' HG21 ' A' ' 532' ' ' ILE . 2.4 p-90 -47.63 -26.73 1.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.631 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -116.03 167.45 10.27 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.713 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.418 ' CD ' ' HB ' ' A' ' 532' ' ' ILE . 92.7 Cg_endo -95.39 -5.92 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.13 2.553 . . . . 0.0 113.812 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.52 ' CZ ' ' CE1' ' A' ' 535' ' ' PHE . 17.9 p90 -159.0 -28.95 0.07 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.631 ' HD1' ' HB ' ' A' ' 532' ' ' ILE . 16.4 m-85 -59.44 -26.14 64.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.72 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.424 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -115.53 -55.28 0.36 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.223 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 17.9 Cg_exo -67.33 -31.92 33.97 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.701 2.267 . . . . 0.0 112.224 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -93.31 -25.93 17.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.43 ' O ' ' CD1' ' A' ' 543' ' ' TYR . . . -64.63 131.35 46.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.63 -25.07 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.925 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.559 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.25 35.24 4.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.777 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.458 HG22 ' CG ' ' A' ' 517' ' ' TYR . 0.2 OUTLIER -148.36 -28.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -103.85 -43.97 5.17 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.594 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 34.44 -72.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.613 0.765 . . . . 0.0 112.497 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 18.2 mt-10 71.87 34.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.032 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.472 ' N ' ' HE2' ' A' ' 548' ' ' MET . . . -139.44 -3.62 1.58 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.016 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.476 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.4 pt? -143.04 -4.11 0.93 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.494 ' HB3' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -75.81 73.74 2.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.01 0.433 . . . . 0.0 111.602 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -132.78 27.79 4.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.229 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.56 101.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.626 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.404 ' NE2' HD13 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -133.43 -76.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.117 0.484 . . . . 0.0 110.721 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 11.9 t70 60.24 18.53 8.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.427 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -125.63 -34.61 0.64 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 555' ' ' ILE . 1.6 pp -88.24 6.19 38.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 0.0 111.045 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.592 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.56 -42.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.266 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.461 ' N ' HG12 ' A' ' 555' ' ' ILE . 4.8 t . . . . . 0 N--CA 1.449 -0.481 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.352 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 9.1 mttm . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.792 0.33 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.72 111.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.548 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.5 m-80 -103.88 -51.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.759 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.619 ' HD2' HG13 ' A' ' 555' ' ' ILE . 46.6 Cg_endo -105.41 14.97 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.241 3.294 . . . . 0.0 113.033 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -126.33 58.13 1.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.229 0.538 . . . . 0.0 109.899 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.433 ' N ' ' CD2' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -119.31 -54.37 2.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.858 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.632 ' HA ' ' CG2' ' A' ' 519' ' ' THR . 7.4 p-80 -174.75 -54.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.619 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.46 -10.85 0.45 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.694 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.85 -49.69 1.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.517 0.675 . . . . 0.0 109.869 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.632 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 14.7 t -60.35 -23.29 64.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.48 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -85.02 -56.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.629 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 4.2 pt20 -100.44 -161.31 0.86 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.043 0.449 . . . . 0.0 111.166 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.454 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -102.92 31.85 3.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.607 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.629 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.9 mp0 45.21 74.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.5 0.667 . . . . 0.0 109.933 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 91.38 -25.74 14.14 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.412 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 52.03 10.28 0.11 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.6 16.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.922 0.392 . . . . 0.0 110.54 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -55.65 -22.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.301 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 156.32 -38.08 0.59 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.266 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.543 ' O ' ' HD3' ' A' ' 537' ' ' PRO . 4.4 mp 70.39 -38.48 0.42 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.02 -24.62 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.498 ' CD1' HD13 ' A' ' 532' ' ' ILE . 1.9 p-90 -45.98 -27.47 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.564 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.498 HD13 ' CD1' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -113.04 165.71 12.6 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.917 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.08 -41.09 0.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.06 2.506 . . . . 0.0 113.232 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -156.31 6.08 0.19 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.4 OUTLIER -73.95 -26.97 60.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.051 0.453 . . . . 0.0 110.597 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -108.49 -55.09 0.59 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.785 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 23.9 Cg_exo -64.33 -37.98 37.09 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.621 2.214 . . . . 0.0 111.788 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -93.25 -5.47 49.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.163 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.435 ' CB ' HD12 ' A' ' 542' ' ' ILE . . . -51.73 -72.02 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.772 0.32 . . . . 0.0 110.963 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 70.89 -48.23 0.66 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.409 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -108.41 29.55 9.9 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.968 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.453 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -146.62 -33.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.436 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.701 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -95.36 -43.07 8.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.526 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.512 HD13 ' CH2' ' A' ' 518' ' ' TRP . 1.6 mp 37.77 -73.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.545 0.738 . . . . 0.0 112.345 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.701 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.9 mt-10 66.86 85.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.261 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 165.02 -22.13 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.91 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.471 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.3 pt? -133.87 -8.38 2.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.426 ' CE ' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -67.85 64.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 111.811 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.471 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.27 46.68 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.568 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 2.4 m-80 68.7 -66.29 0.25 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.53 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.901 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.7 m-20 59.89 20.06 9.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.187 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -133.17 -34.12 0.34 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.422 ' HG ' HD11 ' A' ' 555' ' ' ILE . 3.0 pp -86.96 8.32 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.326 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.619 HG13 ' HD2' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -143.91 -42.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.159 0.504 . . . . 0.0 111.087 -178.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.491 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.19 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.787 0.327 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 95.1 m 61.72 101.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.554 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.4 m-80 -99.04 -50.31 0.21 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.763 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.65 ' HB3' ' CZ3' ' A' ' 518' ' ' TRP . 38.3 Cg_endo -101.54 16.17 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.048 3.166 . . . . 0.0 112.593 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.418 ' HA ' ' HB ' ' A' ' 519' ' ' THR . 5.8 m-80 -119.91 54.4 1.02 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -99.11 -47.74 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.415 -178.23 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 11.1 p-80 -175.61 -52.76 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.586 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -61.55 -24.5 66.69 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.732 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -116.61 -39.8 3.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.181 0.515 . . . . 0.0 110.838 -177.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.545 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 5.5 t -57.89 -21.47 43.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.527 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.492 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -105.15 -67.12 0.93 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.087 0.47 . . . . 0.0 111.225 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.492 ' N ' ' CG2' ' A' ' 520' ' ' THR . 1.3 pt20 -99.88 -160.84 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.782 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -94.73 34.7 1.3 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.31 -179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 16.1 mt-10 60.69 20.09 10.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 98.38 32.84 5.89 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.165 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.488 ' HA ' HD12 ' A' ' 529' ' ' LEU . . . -117.34 3.63 12.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -92.29 18.3 8.5 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.901 0.381 . . . . 0.0 111.146 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.401 ' HB ' ' NE1' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -124.75 -53.4 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.658 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 150.52 -19.96 1.03 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.794 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 7.1 mp 72.98 -20.74 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.22 -20.93 47.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.175 0.512 . . . . 0.0 111.268 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.465 ' CD2' HG23 ' A' ' 532' ' ' ILE . 7.3 p-90 -69.07 -13.7 62.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.774 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 0.8 OUTLIER -126.26 142.74 43.64 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.063 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.92 -21.6 2.06 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.712 2.274 . . . . 0.0 113.935 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.428 ' HA ' ' CB ' ' A' ' 538' ' ' ALA . 9.7 p90 -150.82 6.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.559 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 22.7 m-85 -82.3 -39.54 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -112.55 -61.44 0.44 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.452 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.53 -39.69 74.17 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.392 2.062 . . . . 0.0 111.903 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -85.02 -37.12 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.285 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 543' ' ' TYR . . . -46.25 164.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.518 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -147.11 -43.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.55 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.99 23.25 21.77 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' A' ' 523' ' ' GLU . 0.1 OUTLIER -139.99 -18.52 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.463 0.173 . . . . 0.0 111.046 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.818 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -122.85 -3.08 8.69 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.533 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.691 ' O ' ' HG3' ' A' ' 545' ' ' GLU . 1.5 mp 4.69 -51.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.805 1.242 . . . . 0.0 114.044 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.818 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.6 pt-20 44.44 79.18 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 549' ' ' HIS . . . 172.79 -25.61 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.839 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.453 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.6 pt? -125.78 -12.23 6.57 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 71.94 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 111.174 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.453 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.8 OUTLIER -124.94 26.35 7.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.708 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 59.23 61.58 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -70.94 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.578 . . . . 0.0 110.64 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 556' ' ' CYS . 1.1 m-20 63.2 19.28 11.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.092 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.52 -30.62 1.37 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.883 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.665 ' HG ' HD13 ' A' ' 555' ' ' ILE . 1.9 pp -88.79 2.23 53.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.756 0.313 . . . . 0.0 111.119 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.665 HD13 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -147.52 -40.95 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.293 0.568 . . . . 0.0 110.658 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.474 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.6 m . . . . . 0 N--CA 1.449 -0.486 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.176 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.825 0.345 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.66 98.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.559 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.551 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 3.5 m-80 -95.66 -50.58 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.878 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.584 ' HD2' HG13 ' A' ' 555' ' ' ILE . 57.7 Cg_endo -105.45 16.39 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.224 3.282 . . . . 0.0 113.04 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -123.76 57.91 1.17 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.561 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -117.43 -52.82 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.99 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.655 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 5.1 p-80 -176.97 -56.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.332 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.655 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.41 -13.52 0.6 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.716 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.07 -43.84 2.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.372 0.606 . . . . 0.0 110.037 -177.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.577 HG22 ' HA ' ' A' ' 516' ' ' HIS . 6.7 t -70.96 -22.06 62.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.804 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.34 -56.15 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.822 0.344 . . . . 0.0 111.601 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.547 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 6.2 pt20 -100.46 -157.85 0.63 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.445 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -102.67 32.72 3.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.317 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.547 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 4.3 mt-10 44.75 74.02 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.949 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.13 -24.81 20.07 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 54.1 9.99 0.26 Allowed 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.98 16.48 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 110.614 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.53 -24.24 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.296 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 158.55 -52.49 0.39 Allowed Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.176 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 3.4 mp 75.28 -21.4 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.799 0.44 . . . . 0.0 112.048 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.41 -26.42 41.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.241 0.543 . . . . 0.0 110.922 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.469 ' CD2' HG21 ' A' ' 532' ' ' ILE . 4.7 p-90 -63.03 -16.52 60.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.715 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.555 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 1.3 pt -126.06 135.69 27.45 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.022 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 1.2 Cg_endo -84.48 -20.43 3.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.957 2.438 . . . . 0.0 113.889 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.508 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 9.0 p90 -146.65 6.34 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.555 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 15.1 m-85 -87.72 -39.91 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.033 0.444 . . . . 0.0 110.793 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.464 ' N ' HD11 ' A' ' 532' ' ' ILE . . . -110.44 -60.54 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.506 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.94 -37.2 85.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.41 2.073 . . . . 0.0 111.576 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -93.18 -17.21 23.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.25 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.439 ' CB ' HD11 ' A' ' 542' ' ' ILE . . . -48.84 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.606 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 21.0 mt-10 76.72 -44.96 0.48 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.462 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -110.14 33.44 6.0 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.478 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -151.06 -33.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.138 0.494 . . . . 0.0 110.416 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.708 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -97.6 -37.75 9.81 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.162 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.545 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.0 OUTLIER 37.53 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.436 0.694 . . . . 0.0 112.567 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.708 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.1 mt-10 66.05 86.09 0.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.025 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 159.24 -16.7 0.24 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.369 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.446 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.3 pt? -129.6 -13.28 4.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.46 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -69.11 69.16 0.19 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.137 0.494 . . . . 0.0 111.299 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.446 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.8 OUTLIER -120.74 -53.18 2.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.71 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 551' ' ' GLN . 22.8 t-20 -179.11 -57.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.425 ' NE2' HD13 ' A' ' 555' ' ' ILE . 0.0 OUTLIER 27.12 -91.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.408 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.95 15.72 9.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.035 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -127.51 -29.35 0.84 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.946 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.616 ' HG ' HD12 ' A' ' 555' ' ' ILE . 2.2 pp -80.97 1.65 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.616 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -141.49 -42.62 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.769 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.48 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.53 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.199 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.726 0.298 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.3 m 60.78 107.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.167 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.557 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.3 m-80 -90.9 -51.08 0.32 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.733 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.654 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 74.5 Cg_endo -105.92 20.94 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.315 3.343 . . . . 0.0 112.623 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -118.35 51.99 1.05 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.501 0.667 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -109.35 -56.75 2.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.133 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 7.5 p-80 -174.93 -57.14 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.712 0.291 . . . . 0.0 111.366 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.629 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -56.23 -15.63 4.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.08 -29.82 4.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.021 0.439 . . . . 0.0 111.325 -177.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 3.0 t -77.5 -20.43 54.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.288 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.84 -67.65 0.84 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.483 ' N ' ' CG2' ' A' ' 520' ' ' THR . 4.3 pt20 -99.9 -156.82 0.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.554 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 521' ' ' GLN . 0.7 OUTLIER -98.35 34.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.404 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.771 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 62.2 mt-10 56.93 34.08 24.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.547 0.689 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.402 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 80.14 32.36 35.79 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.311 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 522' ' ' ASP . . . -117.88 1.96 12.13 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -91.56 19.49 6.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.449 HG12 ' CZ2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -124.27 -52.7 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.642 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.89 -18.45 1.09 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.986 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 6.8 mp 73.21 -25.6 0.19 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.27 -24.65 42.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.234 0.54 . . . . 0.0 111.433 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.512 ' CD2' HG22 ' A' ' 532' ' ' ILE . 5.9 p-90 -62.53 -16.02 53.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.852 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.575 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 1.1 pt -125.91 140.99 38.14 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.362 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -89.3 -18.88 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.867 2.378 . . . . 0.0 113.826 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.97 6.14 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.575 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 13.9 m-85 -86.03 -40.34 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.014 0.435 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.455 ' N ' HD12 ' A' ' 532' ' ' ILE . . . -112.96 -62.17 0.44 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.443 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -50.16 -38.88 51.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.211 1.94 . . . . 0.0 111.686 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -86.34 -31.24 21.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 543' ' ' TYR . . . -51.07 169.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.447 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -153.5 -41.01 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -113.25 33.37 5.6 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -149.66 -31.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.771 ' HA ' ' O ' ' A' ' 523' ' ' GLU . 0.3 OUTLIER -103.02 -44.77 5.13 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.451 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.516 HG12 ' CZ3' ' A' ' 518' ' ' TRP . 1.2 mp 42.09 -72.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 112.666 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.669 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.0 mm-40 69.34 29.08 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.406 ' N ' ' HE1' ' A' ' 548' ' ' MET . . . -139.6 -1.93 1.81 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.798 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.451 HD22 ' CG2' ' A' ' 544' ' ' ILE . 1.5 pt? -139.88 -10.17 1.17 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.428 ' HE3' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -70.19 66.58 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -119.31 24.49 10.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.388 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 65.35 64.29 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.65 -177.63 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.802 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -179.43 -22.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.346 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.4 32.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.411 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -85.53 -0.99 56.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.6 0.238 . . . . 0.0 111.526 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.646 HD11 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.28 -40.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 111.342 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.479 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.1 t . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.304 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.87 0.367 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 99.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.55 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.4 m-80 -100.8 -51.28 0.18 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.67 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.622 ' HD2' HG13 ' A' ' 555' ' ' ILE . 56.2 Cg_endo -104.46 17.84 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.293 3.329 . . . . 0.0 112.548 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.401 HD21 HG13 ' A' ' 555' ' ' ILE . 4.8 m-80 -121.24 57.46 1.0 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.446 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.3 -51.36 2.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.27 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.627 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.0 p-80 -176.89 -56.67 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.627 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -55.09 -16.17 2.75 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.731 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.29 -41.05 2.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.599 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.1 t -62.61 -27.62 69.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.463 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -88.33 -62.83 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.048 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.575 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 2.1 pt20 -99.84 -165.08 1.18 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.405 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . 2.9 m-20 -103.11 34.87 2.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.603 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.575 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 13.5 mt-10 45.56 31.5 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.534 0.683 . . . . 0.0 110.301 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 161.73 -30.32 0.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 57.54 12.6 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.88 15.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -70.55 -13.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.654 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 158.2 -57.36 0.35 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.863 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.458 HD21 ' HD3' ' A' ' 537' ' ' PRO . 0.1 OUTLIER 79.81 -27.91 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.96 -3.86 47.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.466 ' CE3' HG23 ' A' ' 532' ' ' ILE . 10.9 p-90 -81.75 -4.36 56.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.881 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.545 ' O ' ' HD2' ' A' ' 537' ' ' PRO . 1.0 OUTLIER -132.61 61.59 57.71 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.069 -177.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -37.44 -47.14 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.471 2.78 . . . . 0.0 114.075 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -113.73 6.31 16.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.519 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 11.3 t80 -114.06 -19.73 11.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.704 0.288 . . . . 0.0 111.532 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.5 ' HA3' HG13 ' A' ' 532' ' ' ILE . . . -113.49 -74.42 0.65 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.271 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.545 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 33.4 Cg_exo -61.73 -32.81 86.54 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.57 2.18 . . . . 0.0 111.209 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -90.72 -16.26 28.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.62 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.446 ' CB ' ' CD1' ' A' ' 542' ' ' ILE . . . -51.95 -58.41 6.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 70.78 -53.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -106.03 32.7 7.11 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.819 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.508 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -150.74 -30.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.678 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -100.48 -44.78 5.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.519 HD11 ' CH2' ' A' ' 518' ' ' TRP . 1.2 mp 40.65 -72.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.493 0.717 . . . . 0.0 112.62 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.8 mt-10 69.6 33.99 2.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.141 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.431 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -142.17 2.1 1.77 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.002 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.431 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.1 pt? -143.49 -8.89 0.75 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.463 ' HE2' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -76.95 74.39 3.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.075 0.464 . . . . 0.0 111.232 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.463 ' CD2' ' HE2' ' A' ' 548' ' ' MET . 0.0 OUTLIER -134.25 27.98 3.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.082 179.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.49 87.16 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.43 ' NE2' HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -115.71 -77.13 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.778 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.62 24.77 14.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.91 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.19 -34.47 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.919 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.591 ' HG ' HD11 ' A' ' 555' ' ' ILE . 2.3 pp -85.57 2.64 44.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 111.307 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.622 HG13 ' HD2' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -142.53 -42.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.481 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.057 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.83 0.348 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 59.27 92.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.56 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 2.7 m-80 -91.96 -50.88 0.3 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.457 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.628 ' HD2' HG13 ' A' ' 555' ' ' ILE . 57.6 Cg_endo -104.45 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.402 3.402 . . . . 0.0 112.397 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.413 HD21 HG13 ' A' ' 555' ' ' ILE . 3.9 m-80 -121.84 57.98 1.03 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.38 -48.31 3.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.307 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.638 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.4 p-80 -178.48 -56.94 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.797 0.332 . . . . 0.0 111.408 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.638 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -56.93 -16.33 6.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.711 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -124.23 -38.17 2.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.122 0.486 . . . . 0.0 110.639 -177.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.554 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.6 t -65.75 -24.52 66.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.298 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.573 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -90.29 -60.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.683 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 0.4 OUTLIER -100.39 -168.31 1.56 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 548' ' ' MET . 1.1 m-20 -103.25 31.4 4.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.393 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.683 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 4.1 mt-10 45.5 29.02 0.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 110.333 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.532 ' O ' HD13 ' A' ' 527' ' ' ILE . . . 152.96 -23.55 0.8 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.58 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.696 ' CB ' HD13 ' A' ' 527' ' ' ILE . . . 32.24 26.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.06 16.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.789 0.328 . . . . 0.0 111.544 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.696 HD13 ' CB ' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.17 -33.73 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.315 0.579 . . . . 0.0 110.034 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 166.66 -39.82 0.25 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.763 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 3.3 mp 72.23 -18.01 0.34 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.15 -19.2 51.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.293 0.568 . . . . 0.0 110.876 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.424 ' CD2' HG21 ' A' ' 532' ' ' ILE . 8.6 p-90 -74.96 -10.43 59.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.517 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -125.28 59.52 24.88 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.58 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -42.58 -41.6 8.1 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.071 2.514 . . . . 0.0 113.559 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -115.45 6.25 14.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.56 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 10.3 t80 -114.79 -24.36 8.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.443 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.446 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -112.39 -90.98 1.95 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.623 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 83.6 Cg_exo -42.93 -43.65 9.28 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.674 2.249 . . . . 0.0 112.017 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.3 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.48 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.415 ' O ' ' CD1' ' A' ' 543' ' ' TYR . . . -65.8 150.66 48.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.283 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -133.37 -32.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -117.25 30.5 6.23 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.414 HG23 ' CD2' ' A' ' 517' ' ' TYR . 0.1 OUTLIER -142.42 -31.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -105.5 -31.76 8.84 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.902 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.49 ' N ' ' CD1' ' A' ' 543' ' ' TYR . 2.5 mp 33.27 -71.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.637 0.775 . . . . 0.0 112.699 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 32.6 mt-10 70.8 35.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.256 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.446 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -141.1 0.3 1.78 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.727 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.457 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.5 pt? -146.92 -5.52 0.52 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.446 ' HE3' ' N ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -78.63 76.55 5.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.457 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -134.5 28.47 3.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.073 179.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.79 89.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.434 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.453 ' NE2' HD13 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -119.52 -78.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 67.43 23.41 9.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.632 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.47 -34.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.994 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.594 ' HG ' HD12 ' A' ' 555' ' ' ILE . 2.1 pp -81.99 1.24 36.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.628 HG13 ' HD2' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -140.69 -42.61 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.067 0.461 . . . . 0.0 110.816 -179.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.499 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.114 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.763 0.316 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 40.1 m 60.76 117.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.554 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 0.7 OUTLIER -106.78 -52.49 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.465 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.581 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 57.5 Cg_endo -106.51 16.93 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 124.304 3.336 . . . . 0.0 112.448 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -122.56 53.78 1.24 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.318 0.58 . . . . 0.0 109.812 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.437 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.54 -69.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.858 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.635 ' HA ' ' CG2' ' A' ' 519' ' ' THR . 8.5 p-80 -159.64 -55.2 0.06 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.369 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.602 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.92 -8.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -124.82 -44.47 1.94 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.548 0.689 . . . . 0.0 110.51 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.635 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 13.1 t -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.7 OUTLIER -82.51 -64.79 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.846 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.567 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 2.6 pt20 -99.89 -160.37 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.357 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.04 34.48 2.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.478 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.567 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.2 mt-10 44.55 34.46 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 140.66 -40.34 1.38 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.223 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 57.28 8.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.43 15.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 110.792 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.454 HD13 ' CZ2' ' A' ' 531' ' ' TRP . 0.3 OUTLIER -54.55 -24.54 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.539 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.589 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 172.52 -51.67 0.17 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 3.5 mp 77.99 -18.4 0.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.776 0.43 . . . . 0.0 111.986 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.8 45.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.417 0.627 . . . . 0.0 110.164 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.471 ' CD1' HG12 ' A' ' 532' ' ' ILE . 1.8 p-90 -66.07 -15.72 63.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.742 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.625 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -124.01 64.07 33.13 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.39 -36.56 17.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.897 2.398 . . . . 0.0 113.503 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -121.27 6.19 10.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.625 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 8.1 t80 -112.19 -26.46 8.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.648 0.261 . . . . 0.0 111.406 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.459 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -111.84 -90.88 1.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.585 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 82.0 Cg_exo -40.45 -44.01 4.22 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.915 2.41 . . . . 0.0 112.095 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -73.39 -35.3 65.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.425 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 543' ' ' TYR . . . -58.15 157.18 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.989 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.31 -34.08 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.478 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -117.67 36.73 3.56 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.69 -36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.226 0.536 . . . . 0.0 109.849 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.689 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -100.09 -33.94 10.26 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.21 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.506 ' CD1' ' CZ3' ' A' ' 518' ' ' TRP . 1.6 mp 32.31 -72.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.913 0.885 . . . . 0.0 113.025 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 543' ' ' TYR . 20.0 mt-10 68.85 96.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.176 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 140.93 -9.36 2.79 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.844 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.468 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.5 pt? -129.93 -1.66 4.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.516 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -72.62 85.26 1.17 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.468 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 1.6 m170 -130.79 -48.83 1.04 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.417 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 167.73 -73.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' A' ' 552' ' ' ASP . 0.0 OUTLIER 57.04 -152.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 551' ' ' GLN . 13.0 t70 110.49 21.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.105 0.962 . . . . 0.0 110.527 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -141.34 0.14 1.7 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.489 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.599 ' HG ' HD12 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -127.12 2.46 6.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.995 0.518 . . . . 0.0 110.332 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.599 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -147.1 -41.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.629 -178.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.6 t . . . . . 0 N--CA 1.449 -0.507 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.971 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.646 0.26 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 57.94 98.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.327 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.556 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.2 m-80 -101.83 -51.28 0.16 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.576 ' HB3' ' CZ3' ' A' ' 518' ' ' TRP . 48.4 Cg_endo -104.03 15.41 0.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.052 3.168 . . . . 0.0 113.122 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -125.61 59.16 1.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.237 0.542 . . . . 0.0 109.608 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.444 ' N ' ' CD2' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -119.45 -52.06 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.032 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.635 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.9 p-80 -176.63 -55.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.324 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.635 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.44 -13.54 0.96 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.74 -45.64 2.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.449 0.643 . . . . 0.0 110.156 -177.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 2.1 t -65.64 -25.84 67.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.656 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -80.94 -56.97 3.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.251 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.542 ' N ' ' CG2' ' A' ' 520' ' ' THR . 4.3 pt20 -100.68 -162.32 0.93 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.144 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.42 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -103.05 35.96 2.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.496 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.535 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 26.3 mt-10 43.9 73.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.097 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.501 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.73 -21.65 35.04 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.989 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 53.77 11.08 0.29 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.11 16.23 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.481 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 524' ' ' GLY . 0.5 OUTLIER -55.01 -22.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.261 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 157.61 -34.72 0.54 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.354 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 3.6 mt 69.29 -56.87 0.54 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 111.586 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.74 46.16 0.75 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.363 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.548 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 2.9 p-90 -120.28 -18.82 7.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.519 ' CD1' ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -108.63 159.47 30.79 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.055 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 18.5 Cg_endo -59.37 -48.57 13.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.6 2.2 . . . . 0.0 112.868 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -156.58 6.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.5 OUTLIER -72.5 -26.42 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.88 0.371 . . . . 0.0 111.081 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.472 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -108.4 -58.84 0.55 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.878 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.44 -35.6 76.34 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.389 2.059 . . . . 0.0 111.71 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -92.52 -12.14 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.381 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 543' ' ' TYR . . . -75.28 122.51 23.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.366 . . . . 0.0 111.503 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -124.18 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.499 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -120.08 35.27 3.85 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -146.99 -33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.074 0.464 . . . . 0.0 110.333 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.714 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -97.3 -40.02 8.95 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.733 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.5 mp 36.96 -72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.466 0.707 . . . . 0.0 112.364 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.714 ' N ' ' O ' ' A' ' 543' ' ' TYR . 25.1 mt-10 66.21 94.8 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.54 -4.75 1.51 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.998 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.447 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.4 pt? -128.59 -10.25 5.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.336 0.568 . . . . 0.0 112.369 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.487 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.73 78.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.908 0.385 . . . . 0.0 111.032 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 2.0 m170 -133.72 27.13 4.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.638 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 1.3 m120 54.21 63.74 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.355 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -79.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.043 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.71 12.86 7.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.265 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -118.37 -34.61 1.09 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.592 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.647 ' HG ' HD12 ' A' ' 555' ' ' ILE . 2.1 pp -87.48 2.93 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.647 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.64 -40.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.275 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.473 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.973 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.844 0.354 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.4 m 60.1 86.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.007 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.535 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 5.5 m-80 -83.37 -49.22 0.73 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.623 ' HD2' HG13 ' A' ' 555' ' ' ILE . 36.8 Cg_endo -102.2 16.05 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.256 3.304 . . . . 0.0 112.098 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -120.42 56.64 0.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -105.77 -48.0 3.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.302 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.625 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.2 p-80 -177.62 -56.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.353 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.625 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -57.11 -20.44 25.56 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -120.75 -41.23 2.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 0.0 110.999 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.585 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 7.4 t -57.2 -30.15 64.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.18 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.51 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -94.42 -70.11 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.891 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.521 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -99.75 -168.18 1.57 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.451 -178.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.93 22.17 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.904 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.521 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.9 mt-10 69.94 5.51 5.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.983 0.421 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.457 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 128.63 17.16 1.94 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.066 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -99.64 -6.1 27.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -89.17 18.99 4.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.821 0.343 . . . . 0.0 111.413 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.463 ' CD1' ' N ' ' A' ' 527' ' ' ILE . 0.0 OUTLIER -136.09 -50.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 -179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 159.92 -27.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.755 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.432 HD21 ' HD3' ' A' ' 537' ' ' PRO . 0.0 OUTLIER 81.01 -28.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.8 -21.29 48.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.849 0.357 . . . . 0.0 111.869 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.489 ' CE3' HG22 ' A' ' 532' ' ' ILE . 3.0 p-90 -53.61 -24.59 14.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 110.587 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 536' ' ' GLY . 0.3 OUTLIER -115.52 119.34 38.11 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.271 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.442 ' HG2' ' CE2' ' A' ' 534' ' ' TYR . 74.9 Cg_endo -90.12 31.97 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.715 2.276 . . . . 0.0 114.19 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 8.1 p90 172.2 -34.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 111.044 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 534' ' ' TYR . 2.3 t80 -71.89 -21.15 61.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.67 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -116.69 -71.46 0.45 Allowed Glycine 0 C--N 1.32 -0.344 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.34 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.432 ' HD3' HD21 ' A' ' 529' ' ' LEU . 51.2 Cg_exo -52.5 -39.46 74.42 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.485 2.123 . . . . 0.0 111.581 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 534' ' ' TYR . . . -91.84 -17.35 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.117 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.517 ' CB ' HD11 ' A' ' 542' ' ' ILE . . . -45.25 -52.01 10.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.873 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 2.0 mt-10 71.85 -58.91 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -103.96 26.13 24.16 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.348 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -149.05 1.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 O-C-N 122.778 -0.248 . . . . 0.0 111.664 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.712 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.8 OUTLIER -129.33 -42.95 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.482 0.182 . . . . 0.0 110.725 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.454 HD11 ' N ' ' A' ' 544' ' ' ILE . 3.3 mp 34.34 -73.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.444 0.698 . . . . 0.0 112.554 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.712 ' N ' ' O ' ' A' ' 543' ' ' TYR . 20.8 mt-10 64.02 34.98 10.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.356 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -147.17 13.43 1.45 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.54 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -157.87 -17.86 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.407 ' HE1' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -70.07 63.14 0.22 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.407 ' CD2' ' HE1' ' A' ' 548' ' ' MET . 0.3 OUTLIER -113.78 -43.03 3.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.649 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 552' ' ' ASP . 0.9 OUTLIER 172.89 -75.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.403 ' HG2' HD23 ' A' ' 554' ' ' LEU . 0.0 OUTLIER 41.19 -85.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.368 179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.3 OUTLIER 63.65 18.27 10.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -123.79 -31.44 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.187 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.599 ' HG ' HD11 ' A' ' 555' ' ' ILE . 1.6 pp -77.52 -2.55 36.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.611 0.243 . . . . 0.0 111.305 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.623 HG13 ' HD2' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -141.91 -39.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.104 0.478 . . . . 0.0 110.897 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.509 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.417 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.877 0.37 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 97.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.556 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 2.9 m-80 -94.84 -50.37 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.683 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 555' ' ' ILE . 74.4 Cg_endo -107.13 16.88 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.374 3.383 . . . . 0.0 112.902 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.402 HD21 HG13 ' A' ' 555' ' ' ILE . 4.7 m-80 -119.22 56.62 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.676 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.87 -58.7 1.99 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.104 -179.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.649 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.5 p-80 -173.85 -56.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.482 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.649 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.18 -12.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.708 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -122.49 -40.57 2.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -177.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.598 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.0 t -74.4 -21.11 59.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.648 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.49 -56.5 3.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 0.0 111.538 -179.009 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.544 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 6.2 pt20 -100.45 -158.13 0.65 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.449 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 9.0 m-20 -102.72 32.84 3.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.544 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 4.7 mt-10 44.67 73.99 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.963 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.12 -24.58 21.16 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 54.28 10.0 0.28 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.03 16.52 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.416 . . . . 0.0 110.539 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.467 ' H ' ' C ' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.97 -24.13 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.343 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 158.19 -52.68 0.4 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.328 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 3.8 mp 75.07 -22.18 0.27 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.868 0.467 . . . . 0.0 112.115 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.29 -24.82 42.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.162 0.506 . . . . 0.0 111.135 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.481 ' CD2' HG23 ' A' ' 532' ' ' ILE . 6.2 p-90 -64.27 -15.23 59.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.757 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.555 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 1.0 OUTLIER -126.31 139.27 34.12 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.191 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.91 -20.2 2.42 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.777 2.318 . . . . 0.0 113.892 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.0 p90 -148.21 6.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.555 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 18.6 m-85 -86.63 -40.49 15.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.027 0.441 . . . . 0.0 110.701 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.471 ' N ' HD11 ' A' ' 532' ' ' ILE . . . -110.3 -60.4 0.5 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.367 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.76 -37.55 84.52 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.346 2.031 . . . . 0.0 111.551 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -92.65 -17.54 24.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.174 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.432 ' CB ' ' CD1' ' A' ' 542' ' ' ILE . . . -49.29 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.517 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 22.8 mt-10 76.15 -44.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.441 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -110.2 32.41 6.69 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.655 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.475 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -149.95 -32.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.065 0.46 . . . . 0.0 110.543 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.728 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -98.2 -39.86 8.66 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.0 OUTLIER 36.14 -72.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.396 0.679 . . . . 0.0 112.538 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.728 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.9 mt-10 67.0 33.38 5.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.042 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -138.5 -3.75 1.79 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.886 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.503 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.7 pt? -144.72 -8.24 0.65 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.441 ' HE3' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -70.46 68.14 0.36 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.957 0.408 . . . . 0.0 111.859 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.503 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -133.16 34.04 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 43.9 t30 55.67 95.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.424 ' NE2' HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -125.45 -76.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.27 24.76 7.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.884 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.94 -35.75 0.38 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.057 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.593 ' HG ' HD11 ' A' ' 555' ' ' ILE . 2.5 pp -82.3 1.67 35.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 111.261 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.608 HG13 ' HD2' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -140.59 -42.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 110.872 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.496 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.994 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.845 0.355 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.507 ' HA ' HD11 ' A' ' 555' ' ' ILE . 0.6 OUTLIER 63.62 98.36 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.556 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 2.6 m-80 -97.5 -50.8 0.22 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.604 ' HB3' ' CZ3' ' A' ' 518' ' ' TRP . 36.3 Cg_endo -101.93 16.37 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.921 3.08 . . . . 0.0 112.319 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 519' ' ' THR . 5.4 m-80 -119.61 52.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -98.98 -48.63 4.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.354 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 8.5 p-80 -177.04 -53.04 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.586 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -60.17 -23.03 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.733 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -118.01 -39.48 3.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.0 110.959 -177.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.56 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 5.2 t -58.52 -27.78 64.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.542 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.496 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -97.8 -67.59 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.465 -179.135 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.496 ' N ' ' CG2' ' A' ' 520' ' ' THR . 0.0 OUTLIER -99.52 -168.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.771 -178.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.425 ' HB3' ' CB ' ' A' ' 525' ' ' ALA . 0.1 OUTLIER -87.23 24.26 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.883 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 16.9 mt-10 68.57 4.87 4.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.06 0.457 . . . . 0.0 111.073 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.413 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 123.7 22.62 2.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.966 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 522' ' ' ASP . . . -110.28 4.4 20.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -93.16 12.67 23.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.859 0.361 . . . . 0.0 111.657 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.7 -45.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.292 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 150.85 -17.2 0.94 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.467 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.492 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.6 OUTLIER 73.72 -51.53 0.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 45.1 0.64 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.384 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 3.2 p-90 -119.87 -16.92 8.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.577 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.475 HD11 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.24 159.93 32.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.699 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 37.6 Cg_endo -66.3 -45.2 5.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.3 2.0 . . . . 0.0 112.491 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 533' ' ' PRO . 18.5 p90 -161.57 6.68 0.07 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.415 ' CE1' ' HG2' ' A' ' 533' ' ' PRO . 1.1 m-85 -66.0 -26.85 67.73 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.118 -0.364 . . . . 0.0 111.4 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.48 -63.5 0.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.609 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.409 ' HD3' HD22 ' A' ' 529' ' ' LEU . 51.2 Cg_exo -53.07 -39.3 80.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.356 2.038 . . . . 0.0 111.835 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -95.3 -4.58 45.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.533 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 542' ' ' ILE . . . -54.15 -61.73 2.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 32.4 mt-10 72.61 -58.26 0.6 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -102.91 22.59 36.44 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.312 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -144.66 -5.84 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.711 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -125.53 -37.17 2.37 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.47 0.176 . . . . 0.0 111.131 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.485 HD13 ' CZ3' ' A' ' 518' ' ' TRP . 2.1 mp 36.7 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.471 0.708 . . . . 0.0 112.582 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 543' ' ' TYR . 36.9 mt-10 65.47 96.92 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.976 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.39 -8.27 1.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.709 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.408 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.1 pt? -128.15 -9.38 5.33 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.404 ' HG2' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -66.44 76.3 0.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 1.5 m170 -134.62 36.16 3.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.101 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.5 m-20 70.38 -64.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.151 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 42.66 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.963 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.1 OUTLIER 59.63 16.53 5.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -115.17 -34.79 1.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.69 -3.85 52.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.847 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.555 HD13 ' HD2' ' A' ' 513' ' ' PRO . 2.9 pp -145.19 -29.95 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.485 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.512 ' HB2' ' CD1' ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.145 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.902 0.382 . . . . 0.0 110.602 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.74 109.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.551 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 2.3 m-80 -97.03 -50.35 0.23 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.958 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.688 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 23.9 Cg_endo -99.86 -1.67 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.791 2.994 . . . . 0.0 113.208 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.592 ' N ' HD11 ' A' ' 515' ' ' LEU . 18.1 m-80 -106.06 66.2 0.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.592 HD11 ' N ' ' A' ' 514' ' ' ASN . 0.0 OUTLIER -133.27 -30.46 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.616 ' CD2' ' CD1' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -173.0 -78.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.616 ' CD1' ' CD2' ' A' ' 516' ' ' HIS . 0.4 OUTLIER -67.4 12.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -177.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.697 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -139.26 -39.57 0.48 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.305 0.574 . . . . 0.0 109.66 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 516' ' ' HIS . 0.8 OUTLIER -78.62 -13.17 59.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.379 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.5 OUTLIER -95.84 -59.76 1.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.626 0.251 . . . . 0.0 110.873 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.547 ' N ' ' CG2' ' A' ' 520' ' ' THR . 6.4 pt20 -100.7 -158.02 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.301 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.403 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 2.4 m-20 -103.02 34.27 2.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.857 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.487 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 20.9 mt-10 47.07 71.95 0.28 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 110.269 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.552 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.6 -19.47 47.62 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.117 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.457 ' C ' ' N ' ' A' ' 527' ' ' ILE . . . 54.24 11.35 0.38 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.55 16.2 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.023 0.44 . . . . 0.0 110.507 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 524' ' ' GLY . 0.3 OUTLIER -54.17 -22.96 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.482 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 162.15 -53.31 0.31 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.245 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 2.8 mp 75.51 -20.06 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.6 0.36 . . . . 0.0 111.813 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.5 -24.17 42.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.175 0.512 . . . . 0.0 111.106 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.49 ' CD2' HG22 ' A' ' 532' ' ' ILE . 7.1 p-90 -63.84 -14.37 52.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.846 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 0.9 OUTLIER -125.62 140.23 35.98 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.164 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -87.42 -20.06 2.21 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.763 2.308 . . . . 0.0 113.982 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.505 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.56 6.24 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.55 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 18.6 m-85 -86.64 -38.49 17.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 110.93 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -113.73 -60.66 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.595 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.88 -40.07 76.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.434 2.089 . . . . 0.0 111.609 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -84.54 -27.71 27.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.727 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . . . . . . . . . . . -58.07 158.82 6.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.492 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -151.32 -34.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.307 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.54 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -115.44 34.72 4.66 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.489 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.448 HG23 ' CG ' ' A' ' 517' ' ' TYR . 0.3 OUTLIER -149.92 -33.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.044 0.45 . . . . 0.0 110.163 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -103.33 -44.68 5.09 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.235 -178.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.57 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 0.9 OUTLIER 42.4 -72.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.56 0.744 . . . . 0.0 112.755 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.665 ' N ' ' O ' ' A' ' 543' ' ' TYR . 0.4 OUTLIER 69.31 29.91 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.431 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -139.36 -5.7 1.28 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.092 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.462 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.3 pt? -138.94 -6.56 1.44 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -72.36 63.1 0.53 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 111.615 -178.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.462 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -119.08 26.04 9.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.466 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 58.9 80.98 0.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.427 ' NE2' HD13 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -108.57 -77.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 14.8 t70 63.24 15.27 8.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.358 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -121.89 -33.46 0.92 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.61 ' HG ' HD12 ' A' ' 555' ' ' ILE . 1.8 pp -87.84 5.49 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.61 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -146.35 -41.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.114 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.684 0.278 . . . . 0.0 110.566 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.84 100.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.552 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.5 m-80 -103.19 -51.23 0.14 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.947 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.766 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 22.2 Cg_endo -100.11 -1.85 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.777 2.985 . . . . 0.0 113.259 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . 0.632 ' N ' HD11 ' A' ' 515' ' ' LEU . 13.1 m-80 -103.44 65.66 0.85 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.632 HD11 ' N ' ' A' ' 514' ' ' ASN . 0.0 OUTLIER -132.16 -22.64 2.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -178.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.606 ' CD2' ' CD1' ' A' ' 517' ' ' TYR . 0.0 OUTLIER 179.83 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.606 ' CD1' ' CD2' ' A' ' 516' ' ' HIS . 0.5 OUTLIER -62.48 7.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.296 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.766 ' HB2' ' O ' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -135.57 -40.23 0.71 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.369 0.604 . . . . 0.0 109.775 -178.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 7.2 t -80.17 -12.54 59.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.945 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.572 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -97.76 -62.38 1.26 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.685 0.278 . . . . 0.0 111.361 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.572 ' N ' ' CG2' ' A' ' 520' ' ' THR . 2.0 pt20 -100.45 -163.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.995 0.426 . . . . 0.0 111.208 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -102.89 32.32 3.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.44 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 518' ' ' TRP . 3.9 mt-10 41.61 79.56 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.352 0.596 . . . . 0.0 110.097 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 526' ' ' ALA . . . 93.49 -14.93 64.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.934 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.677 ' CB ' HD11 ' A' ' 527' ' ' ILE . . . 28.66 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.56 16.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.677 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.22 -35.6 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 173.99 -38.58 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.134 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.32 -46.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -76.88 -20.04 56.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.3 p-90 -43.69 -29.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 0.0 111.083 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.514 HG22 ' CD2' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -104.71 157.56 33.89 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.319 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.434 ' HG2' ' CE1' ' A' ' 535' ' ' PHE . 36.4 Cg_endo -65.11 -44.09 10.21 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.426 2.084 . . . . 0.0 112.363 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -161.9 6.56 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.468 ' CD2' ' HB ' ' A' ' 532' ' ' ILE . 0.8 OUTLIER -63.98 -28.51 69.86 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.086 -0.384 . . . . 0.0 110.982 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.444 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -110.2 -57.83 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.988 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 75.8 Cg_exo -50.33 -46.71 27.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.47 2.114 . . . . 0.0 112.023 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -79.05 -25.8 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.462 ' O ' ' CD1' ' A' ' 543' ' ' TYR . . . -59.95 141.62 55.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -129.97 -26.13 2.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.56 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.28 38.26 2.96 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 544' ' ' ILE . 0.3 OUTLIER -150.26 -35.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.312 0.577 . . . . 0.0 109.951 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.682 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -103.29 -30.33 10.7 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.089 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.4 mp 33.95 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.789 0.835 . . . . 0.0 112.907 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 543' ' ' TYR . 29.1 mt-10 69.13 87.4 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.934 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 157.29 -19.73 0.4 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.152 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.417 ' HA ' ' NE2' ' A' ' 549' ' ' HIS . 1.4 pt? -127.7 -18.61 4.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 111.68 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.423 ' C ' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -58.36 102.85 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.172 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.423 ' CD2' ' C ' ' A' ' 548' ' ' MET . 0.4 OUTLIER -179.75 -64.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 178.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 175.33 108.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.823 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 -72.6 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.822 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 45.5 28.46 0.5 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.11 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.33 -35.33 0.42 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.639 ' HG ' HD11 ' A' ' 555' ' ' ILE . 1.5 pp -89.65 -4.54 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.735 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.639 HD11 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.74 -42.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.294 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.519 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.334 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.727 0.299 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 64.84 88.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.535 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 5.8 m-80 -87.74 -49.63 0.44 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.6 ' HD2' HG13 ' A' ' 555' ' ' ILE . 38.6 Cg_endo -102.67 17.51 0.24 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 124.229 3.286 . . . . 0.0 112.232 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -122.74 57.77 1.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.402 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.99 -52.42 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.357 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.652 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.4 p-80 -175.76 -56.36 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.054 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.652 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.35 -14.83 1.32 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -179.155 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.37 -47.45 2.0 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.406 0.622 . . . . 0.0 110.04 -177.205 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.4 t -63.79 -26.15 68.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -81.43 -56.5 4.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.56 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.566 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 4.7 pt20 -100.54 -161.92 0.9 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.038 0.447 . . . . 0.0 111.283 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.427 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.2 m-20 -102.95 34.37 2.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.569 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.566 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 20.1 mt-10 43.56 77.28 0.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.854 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.47 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 93.72 -23.44 30.64 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.463 ' C ' ' N ' ' A' ' 527' ' ' ILE . . . 54.0 10.68 0.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.13 15.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.01 0.433 . . . . 0.0 110.644 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 524' ' ' GLY . 0.4 OUTLIER -55.21 -22.35 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.366 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 155.45 -48.36 0.49 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.999 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.1 mp 74.68 -47.02 0.62 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.833 0.453 . . . . 0.0 111.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.54 43.98 0.59 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.529 ' CE2' HD13 ' A' ' 532' ' ' ILE . 4.3 p-90 -121.87 -13.9 8.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.829 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.607 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -117.64 169.67 7.23 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.882 -179.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.481 ' CD ' ' HB ' ' A' ' 532' ' ' ILE . 75.9 Cg_endo -92.73 6.16 3.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.746 2.297 . . . . 0.0 113.318 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.503 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 28.3 p90 -176.83 -27.28 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.607 ' HD1' ' HB ' ' A' ' 532' ' ' ILE . 48.8 m-85 -59.48 -26.49 65.31 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.85 -0.531 . . . . 0.0 111.453 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.468 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -110.8 -65.6 0.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.059 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 42.3 Cg_exo -57.27 -39.0 93.29 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.587 2.191 . . . . 0.0 111.943 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -86.03 -18.38 32.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . . . . . . . . . . . -58.31 150.16 22.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.87 0.367 . . . . 0.0 111.184 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -157.71 -36.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -114.63 31.66 6.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.025 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.429 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -146.57 -33.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.084 0.468 . . . . 0.0 110.366 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -99.56 -36.4 9.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.044 -179.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.4 mp 37.0 -73.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.465 0.706 . . . . 0.0 112.496 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.706 ' N ' ' O ' ' A' ' 543' ' ' TYR . 31.9 mt-10 65.85 36.82 5.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . 0.415 ' N ' ' HE1' ' A' ' 548' ' ' MET . . . -148.69 14.32 1.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.363 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.481 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.2 pt? -160.53 -14.91 0.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.488 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.86 64.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.416 . . . . 0.0 111.759 -178.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.62 33.07 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.437 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 58.15 86.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.449 ' NE2' HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -112.23 -77.84 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.037 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.78 11.5 8.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -117.29 -32.89 1.42 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.973 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.62 ' HG ' HD11 ' A' ' 555' ' ' ILE . 1.6 pp -82.76 -0.81 49.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.796 0.331 . . . . 0.0 111.238 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.62 HD11 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.94 -40.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.876 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.488 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.298 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 556' ' ' CYS . 5.5 mptt . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.646 0.26 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 42.91 61.32 2.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.179 0.514 . . . . 0.0 110.927 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.518 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 2.8 m-80 -89.55 -48.75 0.39 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.503 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.602 ' HD2' HG13 ' A' ' 555' ' ' ILE . 59.9 Cg_endo -103.67 20.59 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.245 3.297 . . . . 0.0 112.314 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -115.46 48.16 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -100.27 -55.24 2.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.256 -178.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.63 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.3 p-80 -175.48 -56.43 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.669 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.63 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -57.21 -20.18 25.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -119.05 -27.68 5.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.424 -177.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.549 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 1.6 t -76.97 -20.09 56.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.5 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -98.55 -70.87 0.71 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 110.539 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.581 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 0.7 OUTLIER -99.93 -160.98 0.83 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.095 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.19 30.83 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.218 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 20.3 mt-10 63.04 14.4 7.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.891 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 113.93 22.68 5.23 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.911 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.83 -3.62 38.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -84.86 22.42 1.37 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 110.968 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.497 HG13 ' CZ2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -132.73 -60.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.1 -21.8 1.25 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.41 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.9 mp 75.2 -20.31 0.35 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.06 -25.09 43.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.331 0.586 . . . . 0.0 111.023 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.498 ' CD2' HG21 ' A' ' 532' ' ' ILE . 7.2 p-90 -65.72 -18.51 65.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.029 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.498 HG21 ' CD2' ' A' ' 531' ' ' TRP . 1.6 pt -123.42 135.61 26.25 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.037 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.415 ' HG2' ' CD2' ' A' ' 534' ' ' TYR . 98.2 Cg_endo -87.63 -17.73 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.71 2.273 . . . . 0.0 113.604 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.61 ' O ' ' HB1' ' A' ' 538' ' ' ALA . 26.6 p90 -138.14 -26.08 0.94 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . 0.501 ' CE2' ' CZ ' ' A' ' 534' ' ' TYR . 98.3 m-85 -59.97 -43.14 95.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.986 -0.446 . . . . 0.0 111.564 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.462 ' N ' HD11 ' A' ' 532' ' ' ILE . . . -109.25 -60.92 0.52 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.987 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.426 ' HG2' ' O ' ' A' ' 532' ' ' ILE . 54.3 Cg_exo -51.7 -41.99 58.97 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.388 2.059 . . . . 0.0 111.813 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 534' ' ' TYR . . . -81.93 -31.08 31.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.633 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 543' ' ' TYR . . . -49.36 159.37 0.32 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -149.28 -44.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.72 25.18 17.76 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.095 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.486 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -145.06 -4.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 -179.389 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.677 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.5 OUTLIER -129.57 -42.73 1.29 Allowed 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.316 -178.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' ILE . . . . . 0.477 HD12 ' CE3' ' A' ' 518' ' ' TRP . 3.4 mp 38.89 -73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 123.54 0.736 . . . . 0.0 112.712 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.677 ' N ' ' O ' ' A' ' 543' ' ' TYR . 2.0 mm-40 73.65 29.77 1.49 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.314 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.93 4.72 2.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.648 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.457 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.7 pt? -149.88 -16.22 0.26 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.479 ' HE3' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -69.46 65.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.938 0.399 . . . . 0.0 111.836 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.479 ' CD2' ' HE3' ' A' ' 548' ' ' MET . 0.0 OUTLIER -132.23 35.73 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.404 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 93.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.333 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -120.72 -76.44 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.216 0.531 . . . . 0.0 111.116 -179.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 3.5 t70 63.7 17.17 10.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.678 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -123.77 -31.91 0.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.891 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.614 ' HG ' HD13 ' A' ' 555' ' ' ILE . 2.7 pp -90.03 8.38 32.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.088 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.614 HD13 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.1 -44.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.545 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.48 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.234 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.404 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -171.12 64.24 0.41 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 35.0 Cg_exo -59.79 173.36 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.592 2.194 . . . . 0.0 112.445 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.01 118.76 25.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.626 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.9 m 60.32 101.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.563 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.5 m-80 -91.0 -51.44 0.31 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.08 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 61.5 Cg_endo -106.52 21.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.501 3.467 . . . . 0.0 112.406 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -118.8 51.18 1.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.436 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -105.59 -67.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.079 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.612 ' HA ' ' CG2' ' A' ' 519' ' ' THR . 6.0 p-80 -161.51 -57.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.193 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.605 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -55.94 -9.61 0.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.698 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -123.23 -44.31 2.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.581 0.705 . . . . 0.0 110.563 -176.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.612 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 12.1 t -63.15 -28.78 70.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.467 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.491 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.8 OUTLIER -84.57 -65.69 0.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.764 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.491 ' N ' ' CG2' ' A' ' 520' ' ' THR . 3.5 pt20 -99.99 -157.64 0.62 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.2 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.62 36.64 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.233 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.694 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 8.3 mt-10 52.28 34.88 15.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.034 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.418 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 89.26 33.35 9.55 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.571 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -119.95 -5.47 10.07 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -90.79 15.69 10.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.795 0.331 . . . . 0.0 111.72 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.415 HG12 ' CZ2' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -129.65 -44.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.432 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 134.28 -17.63 4.27 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 2.9 tp 78.0 -51.61 0.5 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.67 47.13 0.71 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.107 0.48 . . . . 0.0 112.241 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.568 ' CE2' HD11 ' A' ' 532' ' ' ILE . 3.9 p-90 -122.5 -16.53 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.632 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.601 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -116.17 166.29 12.82 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.856 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.41 ' CD ' ' HB ' ' A' ' 532' ' ' ILE . 83.1 Cg_endo -94.04 2.39 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.835 2.357 . . . . 0.0 113.563 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.424 ' HA ' ' HB2' ' A' ' 538' ' ' ALA . 9.8 p90 -177.16 -21.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.601 ' HD1' ' HB ' ' A' ' 532' ' ' ILE . 60.9 m-85 -59.5 -30.93 68.91 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.91 -0.494 . . . . 0.0 111.67 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.571 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -111.37 -69.07 0.56 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.938 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -49.01 -40.22 40.83 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.603 2.202 . . . . 0.0 112.022 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.424 ' HB2' ' HA ' ' A' ' 534' ' ' TYR . . . -81.91 -31.6 31.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 543' ' ' TYR . . . -52.82 158.09 1.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -141.57 -41.64 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -111.31 34.15 5.45 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.443 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.26 -35.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.101 0.476 . . . . 0.0 109.962 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.735 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -99.68 -29.13 12.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.182 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.52 ' N ' ' CD1' ' A' ' 543' ' ' TYR . 2.5 mp 30.84 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.916 0.886 . . . . 0.0 112.95 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.735 ' N ' ' O ' ' A' ' 543' ' ' TYR . 7.4 mt-10 69.63 91.85 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.116 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 150.13 -9.6 0.84 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.875 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.443 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.7 pt? -128.14 -11.36 5.27 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.477 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -63.13 80.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.911 0.386 . . . . 0.0 110.7 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.443 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 4.1 m170 -133.15 29.7 4.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.424 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 52.32 55.79 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.41 172.21 8.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.819 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.1 t70 179.17 31.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -134.87 -37.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.698 ' HG ' HD11 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -77.8 -3.89 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.616 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.698 HD11 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -144.03 -42.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.32 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.525 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t -113.61 60.55 0.66 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.378 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -99.65 -58.47 0.89 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.244 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.483 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 2.5 pt? -146.38 -46.07 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.463 0.173 . . . . 0.0 110.939 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.483 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 175.59 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 111.542 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.432 ' NE2' HD22 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.906 0.384 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 5.2 pt20 -165.68 53.97 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 84.3 Cg_endo -78.23 138.6 16.13 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.19 124.29 37.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.08 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.6 m 51.32 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.54 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.8 m-80 -93.52 -49.53 0.27 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.854 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.678 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 50.4 Cg_endo -102.69 17.42 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 124.339 3.359 . . . . 0.0 112.658 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -123.32 59.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.319 0.58 . . . . 0.0 109.914 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -117.18 -72.83 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.05 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 22.9 p-80 -147.62 -56.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.767 ' C ' ' HD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -65.91 179.51 0.88 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.767 ' HD1' ' C ' ' A' ' 517' ' ' TYR . 0.1 OUTLIER 62.79 -44.99 0.2 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.239 0.472 . . . . 0.0 110.945 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 517' ' ' TYR . 8.9 t -94.37 -19.86 20.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.258 0.551 . . . . 0.0 109.829 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.481 HG23 ' N ' ' A' ' 521' ' ' GLN . 1.2 m -85.16 -78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.391 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.526 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -100.51 -161.88 0.9 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.162 -179.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 525' ' ' ALA . 1.1 t0 -93.19 22.36 5.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.942 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.57 ' HG3' ' HA ' ' A' ' 518' ' ' TRP . 9.3 mt-10 48.31 75.84 0.13 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.546 0.689 . . . . 0.0 110.369 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.45 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 52.47 20.29 7.21 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.391 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' A' ' 522' ' ' ASP . . . -106.69 -22.83 12.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.302 0.551 . . . . 0.0 111.832 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.408 ' N ' ' HB3' ' A' ' 522' ' ' ASP . . . -87.3 20.98 2.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.974 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.517 HG13 ' CZ2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -133.81 -48.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.476 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 136.98 -11.95 3.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.108 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.526 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 3.2 mt 70.04 -56.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.88 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 46.23 0.73 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.412 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.526 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 3.4 p-90 -120.56 -18.29 7.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.664 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.517 HD12 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.1 160.37 30.26 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.259 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.483 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 27.1 Cg_endo -62.2 -47.1 10.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.875 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -155.33 6.26 0.23 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.9 OUTLIER -71.65 -26.48 62.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.044 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.491 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.47 -63.41 0.56 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.674 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.09 -41.88 39.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 111.661 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -78.02 -23.03 48.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.585 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.429 ' HB3' ' CD1' ' A' ' 543' ' ' TYR . . . -51.59 161.64 0.48 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -163.69 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.575 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.01 29.59 9.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.875 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.465 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.42 -29.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 110.792 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.693 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.8 OUTLIER -98.68 -47.92 5.15 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.5 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 2.0 mp 36.85 -74.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.377 0.671 . . . . 0.0 112.442 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.693 ' N ' ' O ' ' A' ' 543' ' ' TYR . 22.6 mt-10 68.32 85.82 0.14 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.003 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 162.96 -17.32 0.14 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.551 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.435 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.9 pt? -134.68 -12.57 2.3 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -70.17 64.42 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.129 0.49 . . . . 0.0 111.473 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -116.36 -74.63 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.002 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.7 t30 175.47 73.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.417 ' NE2' HD13 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -99.11 -78.25 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.603 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 6.7 t70 66.08 12.59 8.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.683 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.9 -31.77 1.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.711 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.613 ' HG ' HD12 ' A' ' 555' ' ' ILE . 1.5 pp -93.15 9.4 36.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.613 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.3 -42.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.468 -178.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.462 ' N ' HG12 ' A' ' 555' ' ' ILE . 5.2 t -105.43 114.46 28.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.351 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -160.22 -73.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.087 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.435 ' HG ' ' HG3' ' A' ' 559' ' ' ARG . 1.2 pt? -141.67 -40.47 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 111.205 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.435 ' HG3' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 173.74 32.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.294 0.569 . . . . 0.0 110.893 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.488 ' NE2' ' H ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.063 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.808 0.337 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -172.38 56.49 0.22 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.04 147.84 24.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.588 2.192 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -72.89 116.75 13.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.655 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 12.4 m 61.76 114.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.408 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.554 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.7 m-80 -94.09 -50.83 0.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.76 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 86.5 Cg_endo -109.64 16.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.267 3.311 . . . . 0.0 113.32 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -118.62 53.18 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.17 0.51 . . . . 0.0 110.171 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.452 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -121.98 -62.73 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.956 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.637 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 7.9 p-80 -171.18 -56.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.578 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.637 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.53 -10.61 0.27 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.76 ' CE3' ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -123.61 -33.33 3.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.21 0.529 . . . . 0.0 110.462 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.621 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 8.9 t -82.87 -16.1 48.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.505 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.533 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -87.07 -56.8 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.716 0.294 . . . . 0.0 111.38 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.54 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 5.6 pt20 -100.45 -157.58 0.62 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.146 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.422 ' N ' ' HG3' ' A' ' 521' ' ' GLN . 5.3 m-20 -102.73 32.55 3.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.26 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.54 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.5 mt-10 45.33 69.69 0.42 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.907 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.401 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 93.59 -26.94 13.52 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 52.89 11.0 0.17 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.69 16.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.377 . . . . 0.0 110.769 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.456 ' H ' ' C ' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -56.08 -22.23 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.275 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 163.63 -34.01 0.29 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.805 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.601 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 2.0 mt 67.91 -53.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.28 -21.68 60.54 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.601 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.9 p-90 -43.61 -29.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.016 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.549 HG22 ' CD2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -103.71 152.09 38.87 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.574 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.56 -50.51 13.8 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.618 2.212 . . . . 0.0 112.281 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -157.97 6.45 0.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.495 ' CD2' ' HB ' ' A' ' 532' ' ' ILE . 1.0 OUTLIER -62.59 -27.1 68.96 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.831 0.348 . . . . 0.0 110.766 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -107.84 -56.65 0.59 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.838 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 46.6 Cg_exo -56.27 -41.27 78.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.481 2.12 . . . . 0.0 111.937 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -93.24 -7.92 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.219 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.436 ' CB ' HD13 ' A' ' 542' ' ' ILE . . . -53.1 -75.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 75.87 -43.59 0.49 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.464 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -112.33 35.08 4.83 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.745 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.49 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -151.09 -33.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.992 0.425 . . . . 0.0 110.513 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.697 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.6 OUTLIER -94.96 -45.75 7.13 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.037 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.4 mp 36.47 -73.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.627 0.771 . . . . 0.0 112.404 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 543' ' ' TYR . 19.9 mt-10 67.49 32.24 5.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.732 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.424 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -137.88 -7.86 1.31 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.87 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.487 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.3 pt? -137.67 -8.57 1.65 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.444 ' HE2' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -70.49 65.66 0.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 110.761 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.487 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.7 OUTLIER -111.49 -65.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.611 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 168.59 63.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.422 ' HB3' ' CD2' ' A' ' 554' ' ' LEU . 0.0 OUTLIER -115.61 -178.84 3.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.238 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 556' ' ' CYS . 2.9 p30 -179.2 -22.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.187 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -88.33 -29.05 20.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.309 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.617 ' HG ' HD12 ' A' ' 555' ' ' ILE . 1.2 pp -82.42 -2.77 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.669 0.271 . . . . 0.0 111.45 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.617 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.99 -41.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.996 0.427 . . . . 0.0 111.04 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.481 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER -101.41 72.16 1.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.186 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -124.5 -67.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.541 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 2.2 pt? -134.32 -48.16 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.522 0.201 . . . . 0.0 111.051 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.1 OUTLIER 178.81 37.7 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.032 0.444 . . . . 0.0 111.421 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.013 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.832 0.348 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -169.87 56.09 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.727 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.87 -165.94 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.815 2.343 . . . . 0.0 112.496 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.8 118.4 15.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.67 90.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.53 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 6.0 m-80 -87.39 -49.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.75 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.624 ' HD2' HG13 ' A' ' 555' ' ' ILE . 39.3 Cg_endo -102.08 16.7 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 124.195 3.263 . . . . 0.0 112.525 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -123.82 60.2 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -111.46 -46.15 3.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.31 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.9 p-80 -177.59 -56.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.665 0.269 . . . . 0.0 111.514 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.626 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -56.18 -20.16 16.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.735 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.83 -44.03 2.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.186 0.517 . . . . 0.0 110.761 -177.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.561 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.3 t -53.84 -31.34 49.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.288 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.19 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.163 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.503 ' N ' ' CG2' ' A' ' 520' ' ' THR . 0.0 OUTLIER -99.64 -169.99 1.83 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.467 -178.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -88.19 21.39 2.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.9 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.502 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 34.2 mt-10 69.11 4.51 4.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.934 0.397 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.459 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 130.96 20.23 1.19 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.16 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.21 -25.26 15.35 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -84.45 23.19 1.15 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 111.412 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.502 HG13 ' CZ2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -131.67 -46.57 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.587 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 138.72 -12.9 3.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.04 -46.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -75.85 -20.25 58.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.532 ' CE2' HD12 ' A' ' 532' ' ' ILE . 2.0 p-90 -47.55 -26.13 1.34 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.953 0.406 . . . . 0.0 111.074 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.562 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 0.3 OUTLIER -114.63 157.75 42.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -91.09 -23.69 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.991 2.461 . . . . 0.0 114.023 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -154.34 6.65 0.3 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.562 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 2.9 m-85 -78.93 -43.08 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.224 0.535 . . . . 0.0 110.705 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.545 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.41 -58.06 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.622 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.68 -42.05 44.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.322 2.014 . . . . 0.0 111.583 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -81.75 -29.79 32.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.591 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.435 ' HB3' ' HA2' ' A' ' 536' ' ' GLY . . . -58.18 148.11 28.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.223 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -129.16 -35.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.594 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.421 ' O ' ' HZ2' ' A' ' 518' ' ' TRP . . . -114.76 27.57 8.66 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -142.35 -6.19 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.72 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -127.42 -41.99 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 120.368 0.128 . . . . 0.0 111.085 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.488 ' HB ' ' OE1' ' A' ' 523' ' ' GLU . 3.2 mp 34.45 -72.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.549 0.74 . . . . 0.0 112.551 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.72 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.5 mt-10 68.4 90.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.148 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.415 ' H ' ' HE2' ' A' ' 548' ' ' MET . . . 155.51 -15.33 0.47 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.182 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -129.4 -3.17 4.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.786 0.327 . . . . 0.0 111.684 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.461 ' HE1' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -81.08 80.37 7.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.173 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.457 ' CD2' ' HE1' ' A' ' 548' ' ' MET . 1.2 m170 -133.19 -68.7 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.589 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 167.44 66.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.405 ' CG ' HD22 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -88.7 -74.67 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.19 -179.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.93 20.61 9.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.93 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -122.99 -38.15 0.58 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.647 ' HG ' HD11 ' A' ' 555' ' ' ILE . 2.4 pp -83.15 -1.16 52.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.647 HD11 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.31 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.709 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.481 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -103.86 143.22 33.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.93 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 179.2 -72.55 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.133 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.458 ' HG ' ' HG3' ' A' ' 559' ' ' ARG . 1.3 pt? -144.44 -40.94 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.626 0.251 . . . . 0.0 111.321 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.458 ' HG3' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 176.03 32.87 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.324 0.583 . . . . 0.0 111.016 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.785 0.326 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.99 53.73 0.83 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.67 163.01 21.45 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.61 2.207 . . . . 0.0 112.33 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.29 105.65 13.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.627 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.7 m 63.41 122.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.557 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.4 m-80 -104.67 -52.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.875 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 512' ' ' ASN . 39.7 Cg_endo -104.02 5.71 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.019 3.146 . . . . 0.0 113.162 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.414 ' N ' HD12 ' A' ' 515' ' ' LEU . 19.4 m-80 -115.53 57.61 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.195 0.521 . . . . 0.0 109.791 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.445 HD22 ' CD2' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -121.73 -38.21 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.736 ' O ' ' O ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -164.23 -84.63 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.768 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.992 ' O ' ' N ' ' A' ' 519' ' ' THR . 1.4 m-85 -52.21 -137.79 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.69 ' HA ' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER 26.14 -63.17 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.992 ' N ' ' O ' ' A' ' 517' ' ' TYR . 9.2 t -70.13 -25.35 63.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.066 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.587 ' HB ' ' O ' ' A' ' 516' ' ' HIS . 0.4 OUTLIER -78.64 -63.93 1.29 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.554 ' N ' ' CG2' ' A' ' 520' ' ' THR . 7.6 pt20 -100.79 -153.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.83 31.75 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.69 ' HG3' ' HA ' ' A' ' 518' ' ' TRP . 1.7 mt-10 46.96 70.72 0.37 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.824 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 90.97 -25.15 14.84 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.895 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 52.47 11.95 0.21 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.55 16.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.749 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.467 ' H ' ' C ' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -57.88 -20.25 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.319 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 160.61 -46.0 0.4 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.924 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 3.4 mp 71.15 -34.79 0.31 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.18 -22.94 44.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.46 ' CE3' HG21 ' A' ' 532' ' ' ILE . 2.4 p-90 -47.63 -26.73 1.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.631 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -116.03 167.45 10.27 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.713 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.418 ' CD ' ' HB ' ' A' ' 532' ' ' ILE . 92.7 Cg_endo -95.39 -5.92 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.13 2.553 . . . . 0.0 113.812 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.52 ' CZ ' ' CE1' ' A' ' 535' ' ' PHE . 17.9 p90 -159.0 -28.95 0.07 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.631 ' HD1' ' HB ' ' A' ' 532' ' ' ILE . 16.4 m-85 -59.44 -26.14 64.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.72 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.424 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -115.53 -55.28 0.36 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.223 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 17.9 Cg_exo -67.33 -31.92 33.97 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.701 2.267 . . . . 0.0 112.224 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -93.31 -25.93 17.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.43 ' O ' ' CD1' ' A' ' 543' ' ' TYR . . . -64.63 131.35 46.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.63 -25.07 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.925 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.559 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.25 35.24 4.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.777 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.458 HG22 ' CG ' ' A' ' 517' ' ' TYR . 0.2 OUTLIER -148.36 -28.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -103.85 -43.97 5.17 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -178.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.594 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 34.44 -72.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.613 0.765 . . . . 0.0 112.497 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 18.2 mt-10 71.87 34.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.032 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.472 ' N ' ' HE2' ' A' ' 548' ' ' MET . . . -139.44 -3.62 1.58 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.016 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.476 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.4 pt? -143.04 -4.11 0.93 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.494 ' HB3' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -75.81 73.74 2.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.01 0.433 . . . . 0.0 111.602 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -132.78 27.79 4.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.229 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.56 101.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.626 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.404 ' NE2' HD13 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -133.43 -76.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.117 0.484 . . . . 0.0 110.721 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 11.9 t70 60.24 18.53 8.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.427 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -125.63 -34.61 0.64 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 555' ' ' ILE . 1.6 pp -88.24 6.19 38.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 0.0 111.045 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.592 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.56 -42.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.266 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.461 ' N ' HG12 ' A' ' 555' ' ' ILE . 4.8 t -107.44 101.28 10.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.352 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -149.3 -65.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.352 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.435 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 1.8 pt? -138.67 -48.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.563 0.22 . . . . 0.0 110.919 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.435 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.98 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.987 0.422 . . . . 0.0 111.448 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.422 ' NE2' HD21 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.822 0.344 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.7 58.48 0.2 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.34 167.57 25.89 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.584 2.189 . . . . 0.0 112.257 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -110.7 125.92 53.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.72 111.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.548 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.5 m-80 -103.88 -51.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.759 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.619 ' HD2' HG13 ' A' ' 555' ' ' ILE . 46.6 Cg_endo -105.41 14.97 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.241 3.294 . . . . 0.0 113.033 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -126.33 58.13 1.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.229 0.538 . . . . 0.0 109.899 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.433 ' N ' ' CD2' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -119.31 -54.37 2.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.858 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.632 ' HA ' ' CG2' ' A' ' 519' ' ' THR . 7.4 p-80 -174.75 -54.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.619 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.46 -10.85 0.45 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.694 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.85 -49.69 1.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.517 0.675 . . . . 0.0 109.869 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.632 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 14.7 t -60.35 -23.29 64.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.48 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -85.02 -56.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.629 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 4.2 pt20 -100.44 -161.31 0.86 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.043 0.449 . . . . 0.0 111.166 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.454 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -102.92 31.85 3.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.607 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.629 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.9 mp0 45.21 74.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.5 0.667 . . . . 0.0 109.933 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 91.38 -25.74 14.14 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.412 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 52.03 10.28 0.11 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.6 16.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.922 0.392 . . . . 0.0 110.54 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.474 ' H ' ' C ' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -55.65 -22.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.301 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 156.32 -38.08 0.59 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.266 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.543 ' O ' ' HD3' ' A' ' 537' ' ' PRO . 4.4 mp 70.39 -38.48 0.42 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.02 -24.62 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.498 ' CD1' HD13 ' A' ' 532' ' ' ILE . 1.9 p-90 -45.98 -27.47 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.564 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.498 HD13 ' CD1' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -113.04 165.71 12.6 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.917 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.08 -41.09 0.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.06 2.506 . . . . 0.0 113.232 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -156.31 6.08 0.19 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.4 OUTLIER -73.95 -26.97 60.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.051 0.453 . . . . 0.0 110.597 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -108.49 -55.09 0.59 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.785 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 23.9 Cg_exo -64.33 -37.98 37.09 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.621 2.214 . . . . 0.0 111.788 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -93.25 -5.47 49.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.163 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.435 ' CB ' HD12 ' A' ' 542' ' ' ILE . . . -51.73 -72.02 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.772 0.32 . . . . 0.0 110.963 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 70.89 -48.23 0.66 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.409 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -108.41 29.55 9.9 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.968 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.453 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -146.62 -33.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.436 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.701 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -95.36 -43.07 8.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.526 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.512 HD13 ' CH2' ' A' ' 518' ' ' TRP . 1.6 mp 37.77 -73.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.545 0.738 . . . . 0.0 112.345 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.701 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.9 mt-10 66.86 85.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.261 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 165.02 -22.13 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.91 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.471 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.3 pt? -133.87 -8.38 2.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.426 ' CE ' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -67.85 64.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 111.811 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.471 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.27 46.68 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.568 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 2.4 m-80 68.7 -66.29 0.25 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 49.53 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.901 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.7 m-20 59.89 20.06 9.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.187 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -133.17 -34.12 0.34 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.422 ' HG ' HD11 ' A' ' 555' ' ' ILE . 3.0 pp -86.96 8.32 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.326 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.619 HG13 ' HD2' ' A' ' 513' ' ' PRO . 0.1 OUTLIER -143.91 -42.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.159 0.504 . . . . 0.0 111.087 -178.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.491 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -108.16 93.47 4.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.19 -178.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -136.22 -65.82 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.358 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 2.2 pt? -134.96 -47.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.61 0.243 . . . . 0.0 111.005 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.457 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.1 OUTLIER 179.48 38.31 0.0 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.036 0.446 . . . . 0.0 111.395 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.403 ' NE2' HD23 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.008 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.726 0.298 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.445 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 15.2 mm100 -152.23 50.92 0.69 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 84.5 Cg_endo -77.6 139.27 17.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.437 2.092 . . . . 0.0 112.363 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 126.51 35.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.794 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 95.1 m 61.72 101.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.554 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.4 m-80 -99.04 -50.31 0.21 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.763 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.65 ' HB3' ' CZ3' ' A' ' 518' ' ' TRP . 38.3 Cg_endo -101.54 16.17 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.048 3.166 . . . . 0.0 112.593 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.418 ' HA ' ' HB ' ' A' ' 519' ' ' THR . 5.8 m-80 -119.91 54.4 1.02 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -99.11 -47.74 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.415 -178.23 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 11.1 p-80 -175.61 -52.76 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.586 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -61.55 -24.5 66.69 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.732 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -116.61 -39.8 3.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.181 0.515 . . . . 0.0 110.838 -177.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.545 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 5.5 t -57.89 -21.47 43.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.527 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.492 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -105.15 -67.12 0.93 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.087 0.47 . . . . 0.0 111.225 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.492 ' N ' ' CG2' ' A' ' 520' ' ' THR . 1.3 pt20 -99.88 -160.84 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.782 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.404 ' HB3' ' CB ' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -94.73 34.7 1.3 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.31 -179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 16.1 mt-10 60.69 20.09 10.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 98.38 32.84 5.89 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.165 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.488 ' HA ' HD12 ' A' ' 529' ' ' LEU . . . -117.34 3.63 12.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -92.29 18.3 8.5 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.901 0.381 . . . . 0.0 111.146 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.401 ' HB ' ' NE1' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -124.75 -53.4 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.658 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 150.52 -19.96 1.03 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.794 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.54 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 7.1 mp 72.98 -20.74 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.22 -20.93 47.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.175 0.512 . . . . 0.0 111.268 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.465 ' CD2' HG23 ' A' ' 532' ' ' ILE . 7.3 p-90 -69.07 -13.7 62.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.774 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 0.8 OUTLIER -126.26 142.74 43.64 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.063 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.92 -21.6 2.06 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.712 2.274 . . . . 0.0 113.935 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.428 ' HA ' ' CB ' ' A' ' 538' ' ' ALA . 9.7 p90 -150.82 6.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.559 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 22.7 m-85 -82.3 -39.54 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -112.55 -61.44 0.44 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.452 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.53 -39.69 74.17 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.392 2.062 . . . . 0.0 111.903 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.428 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -85.02 -37.12 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.285 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 543' ' ' TYR . . . -46.25 164.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.518 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -147.11 -43.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.55 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.99 23.25 21.77 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' A' ' 523' ' ' GLU . 0.1 OUTLIER -139.99 -18.52 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.463 0.173 . . . . 0.0 111.046 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.818 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -122.85 -3.08 8.69 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.533 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.691 ' O ' ' HG3' ' A' ' 545' ' ' GLU . 1.5 mp 4.69 -51.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.805 1.242 . . . . 0.0 114.044 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.818 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.6 pt-20 44.44 79.18 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.438 ' O ' ' CE1' ' A' ' 549' ' ' HIS . . . 172.79 -25.61 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.839 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.453 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.6 pt? -125.78 -12.23 6.57 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 71.94 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 111.174 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.453 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.8 OUTLIER -124.94 26.35 7.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.708 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 59.23 61.58 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.12 -70.94 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.578 . . . . 0.0 110.64 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 556' ' ' CYS . 1.1 m-20 63.2 19.28 11.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.092 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.52 -30.62 1.37 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.883 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.665 ' HG ' HD13 ' A' ' 555' ' ' ILE . 1.9 pp -88.79 2.23 53.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.756 0.313 . . . . 0.0 111.119 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.665 HD13 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -147.52 -40.95 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.293 0.568 . . . . 0.0 110.658 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.474 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.6 m -93.56 36.63 1.08 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.176 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.414 ' HA2' ' NE2' ' A' ' 560' ' ' GLN . . . 140.04 41.22 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.981 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.544 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 1.0 OUTLIER -95.78 -43.42 7.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.429 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.544 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 171.03 36.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.085 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.425 ' HG3' HD21 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.26 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.818 0.342 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -170.75 56.54 0.25 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.875 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.7 168.42 23.79 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.616 2.211 . . . . 0.0 112.35 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -125.34 127.41 46.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.655 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.66 98.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.559 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.551 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 3.5 m-80 -95.66 -50.58 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.878 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.584 ' HD2' HG13 ' A' ' 555' ' ' ILE . 57.7 Cg_endo -105.45 16.39 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.224 3.282 . . . . 0.0 113.04 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -123.76 57.91 1.17 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.561 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -117.43 -52.82 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.99 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.655 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 5.1 p-80 -176.97 -56.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.332 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.655 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.41 -13.52 0.6 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.716 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.07 -43.84 2.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.372 0.606 . . . . 0.0 110.037 -177.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.577 HG22 ' HA ' ' A' ' 516' ' ' HIS . 6.7 t -70.96 -22.06 62.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.804 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.34 -56.15 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.822 0.344 . . . . 0.0 111.601 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.547 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 6.2 pt20 -100.46 -157.85 0.63 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.445 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -102.67 32.72 3.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.317 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.547 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 4.3 mt-10 44.75 74.02 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.949 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.45 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.13 -24.81 20.07 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 54.1 9.99 0.26 Allowed 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.98 16.48 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 110.614 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.53 -24.24 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.296 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 158.55 -52.49 0.39 Allowed Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.176 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 3.4 mp 75.28 -21.4 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.799 0.44 . . . . 0.0 112.048 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.41 -26.42 41.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.241 0.543 . . . . 0.0 110.922 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.469 ' CD2' HG21 ' A' ' 532' ' ' ILE . 4.7 p-90 -63.03 -16.52 60.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.715 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.555 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 1.3 pt -126.06 135.69 27.45 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.022 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 1.2 Cg_endo -84.48 -20.43 3.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.957 2.438 . . . . 0.0 113.889 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.508 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 9.0 p90 -146.65 6.34 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.555 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 15.1 m-85 -87.72 -39.91 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.033 0.444 . . . . 0.0 110.793 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.464 ' N ' HD11 ' A' ' 532' ' ' ILE . . . -110.44 -60.54 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.506 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.94 -37.2 85.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.41 2.073 . . . . 0.0 111.576 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -93.18 -17.21 23.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.25 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.439 ' CB ' HD11 ' A' ' 542' ' ' ILE . . . -48.84 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.606 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 21.0 mt-10 76.72 -44.96 0.48 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.462 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -110.14 33.44 6.0 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.478 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -151.06 -33.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.138 0.494 . . . . 0.0 110.416 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.708 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -97.6 -37.75 9.81 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.162 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.545 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.0 OUTLIER 37.53 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.436 0.694 . . . . 0.0 112.567 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.708 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.1 mt-10 66.05 86.09 0.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.025 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 159.24 -16.7 0.24 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.369 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.446 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.3 pt? -129.6 -13.28 4.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.46 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -69.11 69.16 0.19 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.137 0.494 . . . . 0.0 111.299 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.446 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.8 OUTLIER -120.74 -53.18 2.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.71 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.412 ' O ' ' C ' ' A' ' 551' ' ' GLN . 22.8 t-20 -179.11 -57.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.425 ' NE2' HD13 ' A' ' 555' ' ' ILE . 0.0 OUTLIER 27.12 -91.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.408 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.95 15.72 9.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.035 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -127.51 -29.35 0.84 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.946 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.616 ' HG ' HD12 ' A' ' 555' ' ' ILE . 2.2 pp -80.97 1.65 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.616 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -141.49 -42.62 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.769 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.48 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.3 OUTLIER -107.15 98.63 8.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.199 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -136.81 -70.17 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.351 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 1.9 pt? -138.39 -48.07 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.44 0.162 . . . . 0.0 111.104 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.44 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.56 38.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.93 0.395 . . . . 0.0 111.504 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.102 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.797 0.332 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.441 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -155.07 52.8 0.75 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.134 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 97.7 Cg_endo -83.23 153.73 14.25 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.644 2.23 . . . . 0.0 112.459 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.11 114.59 9.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.524 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.3 m 60.78 107.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.167 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.557 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.3 m-80 -90.9 -51.08 0.32 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.733 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.654 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 74.5 Cg_endo -105.92 20.94 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.315 3.343 . . . . 0.0 112.623 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -118.35 51.99 1.05 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.501 0.667 . . . . 0.0 109.232 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -109.35 -56.75 2.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.133 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 7.5 p-80 -174.93 -57.14 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.712 0.291 . . . . 0.0 111.366 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.629 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -56.23 -15.63 4.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.08 -29.82 4.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.021 0.439 . . . . 0.0 111.325 -177.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 3.0 t -77.5 -20.43 54.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.288 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.84 -67.65 0.84 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.483 ' N ' ' CG2' ' A' ' 520' ' ' THR . 4.3 pt20 -99.9 -156.82 0.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.554 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 521' ' ' GLN . 0.7 OUTLIER -98.35 34.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.404 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.771 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 62.2 mt-10 56.93 34.08 24.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.547 0.689 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.402 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 80.14 32.36 35.79 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.311 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' A' ' 522' ' ' ASP . . . -117.88 1.96 12.13 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -91.56 19.49 6.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.449 HG12 ' CZ2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -124.27 -52.7 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.642 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.89 -18.45 1.09 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.986 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 6.8 mp 73.21 -25.6 0.19 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.27 -24.65 42.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.234 0.54 . . . . 0.0 111.433 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.512 ' CD2' HG22 ' A' ' 532' ' ' ILE . 5.9 p-90 -62.53 -16.02 53.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.852 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.575 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 1.1 pt -125.91 140.99 38.14 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.362 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -89.3 -18.88 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.867 2.378 . . . . 0.0 113.826 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.97 6.14 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.575 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 13.9 m-85 -86.03 -40.34 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.014 0.435 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.455 ' N ' HD12 ' A' ' 532' ' ' ILE . . . -112.96 -62.17 0.44 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.443 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -50.16 -38.88 51.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.211 1.94 . . . . 0.0 111.686 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -86.34 -31.24 21.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 543' ' ' TYR . . . -51.07 169.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.447 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -153.5 -41.01 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -113.25 33.37 5.6 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -149.66 -31.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.771 ' HA ' ' O ' ' A' ' 523' ' ' GLU . 0.3 OUTLIER -103.02 -44.77 5.13 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.451 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.516 HG12 ' CZ3' ' A' ' 518' ' ' TRP . 1.2 mp 42.09 -72.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 112.666 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.669 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.0 mm-40 69.34 29.08 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.406 ' N ' ' HE1' ' A' ' 548' ' ' MET . . . -139.6 -1.93 1.81 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.798 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.451 HD22 ' CG2' ' A' ' 544' ' ' ILE . 1.5 pt? -139.88 -10.17 1.17 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.428 ' HE3' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -70.19 66.58 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.45 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -119.31 24.49 10.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.388 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 65.35 64.29 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.65 -177.63 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.802 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -179.43 -22.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.346 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.4 32.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.411 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -85.53 -0.99 56.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.6 0.238 . . . . 0.0 111.526 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.646 HD11 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.28 -40.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 111.342 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.479 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.1 t -99.11 80.46 2.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.304 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -129.73 -67.43 0.11 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.465 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 1.8 pt? -137.6 -48.23 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.495 0.188 . . . . 0.0 111.093 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.427 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 178.27 38.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.061 0.457 . . . . 0.0 111.475 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.421 ' NE2' HD21 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.11 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.863 0.363 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.451 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 36.5 mt-30 -158.34 64.94 2.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.656 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 5.5 Cg_endo -87.42 139.52 5.04 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.306 2.67 . . . . 0.0 112.327 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.14 117.22 27.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.98 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 99.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.55 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.4 m-80 -100.8 -51.28 0.18 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.67 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.622 ' HD2' HG13 ' A' ' 555' ' ' ILE . 56.2 Cg_endo -104.46 17.84 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.293 3.329 . . . . 0.0 112.548 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.401 HD21 HG13 ' A' ' 555' ' ' ILE . 4.8 m-80 -121.24 57.46 1.0 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.446 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.3 -51.36 2.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.27 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.627 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.0 p-80 -176.89 -56.67 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.627 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -55.09 -16.17 2.75 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.731 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.29 -41.05 2.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.599 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.1 t -62.61 -27.62 69.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.463 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -88.33 -62.83 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.048 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.575 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 2.1 pt20 -99.84 -165.08 1.18 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.405 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . 2.9 m-20 -103.11 34.87 2.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.603 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.575 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 13.5 mt-10 45.56 31.5 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.534 0.683 . . . . 0.0 110.301 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 161.73 -30.32 0.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 57.54 12.6 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.88 15.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -70.55 -13.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.654 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 158.2 -57.36 0.35 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.863 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.458 HD21 ' HD3' ' A' ' 537' ' ' PRO . 0.1 OUTLIER 79.81 -27.91 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.96 -3.86 47.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.466 ' CE3' HG23 ' A' ' 532' ' ' ILE . 10.9 p-90 -81.75 -4.36 56.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.881 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.545 ' O ' ' HD2' ' A' ' 537' ' ' PRO . 1.0 OUTLIER -132.61 61.59 57.71 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.069 -177.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -37.44 -47.14 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.471 2.78 . . . . 0.0 114.075 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -113.73 6.31 16.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.519 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 11.3 t80 -114.06 -19.73 11.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.704 0.288 . . . . 0.0 111.532 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.5 ' HA3' HG13 ' A' ' 532' ' ' ILE . . . -113.49 -74.42 0.65 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.271 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.545 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 33.4 Cg_exo -61.73 -32.81 86.54 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.57 2.18 . . . . 0.0 111.209 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -90.72 -16.26 28.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.62 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.446 ' CB ' ' CD1' ' A' ' 542' ' ' ILE . . . -51.95 -58.41 6.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 70.78 -53.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -106.03 32.7 7.11 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.819 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.508 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -150.74 -30.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.678 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -100.48 -44.78 5.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.519 HD11 ' CH2' ' A' ' 518' ' ' TRP . 1.2 mp 40.65 -72.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.493 0.717 . . . . 0.0 112.62 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.8 mt-10 69.6 33.99 2.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.141 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.431 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -142.17 2.1 1.77 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.002 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.431 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.1 pt? -143.49 -8.89 0.75 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.463 ' HE2' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -76.95 74.39 3.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.075 0.464 . . . . 0.0 111.232 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.463 ' CD2' ' HE2' ' A' ' 548' ' ' MET . 0.0 OUTLIER -134.25 27.98 3.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.082 179.199 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.49 87.16 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.43 ' NE2' HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -115.71 -77.13 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.778 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.62 24.77 14.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.91 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.19 -34.47 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.919 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.591 ' HG ' HD11 ' A' ' 555' ' ' ILE . 2.3 pp -85.57 2.64 44.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 111.307 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.622 HG13 ' HD2' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -142.53 -42.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.481 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -114.2 87.56 2.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.057 -179.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -123.8 -69.02 0.22 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.418 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.413 ' HG ' ' HG3' ' A' ' 559' ' ' ARG . 1.1 pt? -142.66 -40.17 0.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.413 ' HG3' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 174.71 31.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.332 0.587 . . . . 0.0 111.179 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.449 ' NE2' ' H ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.945 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.758 0.313 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.86 60.96 0.18 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.694 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.86 -170.22 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.575 2.183 . . . . 0.0 112.339 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.97 123.41 23.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 59.27 92.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.56 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 2.7 m-80 -91.96 -50.88 0.3 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.457 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.628 ' HD2' HG13 ' A' ' 555' ' ' ILE . 57.6 Cg_endo -104.45 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.402 3.402 . . . . 0.0 112.397 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.413 HD21 HG13 ' A' ' 555' ' ' ILE . 3.9 m-80 -121.84 57.98 1.03 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.38 -48.31 3.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.307 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.638 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.4 p-80 -178.48 -56.94 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.797 0.332 . . . . 0.0 111.408 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.638 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -56.93 -16.33 6.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.711 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -124.23 -38.17 2.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.122 0.486 . . . . 0.0 110.639 -177.59 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.554 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.6 t -65.75 -24.52 66.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.298 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.573 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -90.29 -60.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.683 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 0.4 OUTLIER -100.39 -168.31 1.56 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.432 ' O ' ' HG2' ' A' ' 548' ' ' MET . 1.1 m-20 -103.25 31.4 4.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.393 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.683 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 4.1 mt-10 45.5 29.02 0.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 110.333 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.532 ' O ' HD13 ' A' ' 527' ' ' ILE . . . 152.96 -23.55 0.8 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.58 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.696 ' CB ' HD13 ' A' ' 527' ' ' ILE . . . 32.24 26.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.06 16.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.789 0.328 . . . . 0.0 111.544 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.696 HD13 ' CB ' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.17 -33.73 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.315 0.579 . . . . 0.0 110.034 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 166.66 -39.82 0.25 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.763 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 3.3 mp 72.23 -18.01 0.34 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.15 -19.2 51.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.293 0.568 . . . . 0.0 110.876 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.424 ' CD2' HG21 ' A' ' 532' ' ' ILE . 8.6 p-90 -74.96 -10.43 59.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.517 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -125.28 59.52 24.88 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.58 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -42.58 -41.6 8.1 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.071 2.514 . . . . 0.0 113.559 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -115.45 6.25 14.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.56 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 10.3 t80 -114.79 -24.36 8.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.443 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.446 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -112.39 -90.98 1.95 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.623 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 83.6 Cg_exo -42.93 -43.65 9.28 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.674 2.249 . . . . 0.0 112.017 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.3 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.48 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.415 ' O ' ' CD1' ' A' ' 543' ' ' TYR . . . -65.8 150.66 48.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.283 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -133.37 -32.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -117.25 30.5 6.23 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.414 HG23 ' CD2' ' A' ' 517' ' ' TYR . 0.1 OUTLIER -142.42 -31.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -105.5 -31.76 8.84 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.902 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.49 ' N ' ' CD1' ' A' ' 543' ' ' TYR . 2.5 mp 33.27 -71.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.637 0.775 . . . . 0.0 112.699 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 32.6 mt-10 70.8 35.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.256 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.446 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -141.1 0.3 1.78 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.727 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.457 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.5 pt? -146.92 -5.52 0.52 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.446 ' HE3' ' N ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -78.63 76.55 5.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.457 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -134.5 28.47 3.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.073 179.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.79 89.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.434 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.453 ' NE2' HD13 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -119.52 -78.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 67.43 23.41 9.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.632 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.47 -34.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.994 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.594 ' HG ' HD12 ' A' ' 555' ' ' ILE . 2.1 pp -81.99 1.24 36.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.628 HG13 ' HD2' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -140.69 -42.61 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.067 0.461 . . . . 0.0 110.816 -179.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.499 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -111.31 120.24 41.56 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.114 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -159.54 -70.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.39 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.424 HD21 ' NE2' ' A' ' 560' ' ' GLN . 1.9 pt? -135.79 -44.86 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.594 0.197 . . . . 0.0 111.464 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.48 38.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.066 0.46 . . . . 0.0 111.476 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.424 ' NE2' HD21 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.092 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.699 0.285 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.428 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 6.6 mt-30 -158.81 52.84 0.54 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.865 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 67.4 Cg_endo -73.96 125.6 10.0 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.64 2.227 . . . . 0.0 112.203 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.4 87.42 4.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.212 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 40.1 m 60.76 117.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.554 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 0.7 OUTLIER -106.78 -52.49 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.465 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.581 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 57.5 Cg_endo -106.51 16.93 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 124.304 3.336 . . . . 0.0 112.448 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -122.56 53.78 1.24 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.318 0.58 . . . . 0.0 109.812 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.437 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.54 -69.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.858 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.635 ' HA ' ' CG2' ' A' ' 519' ' ' THR . 8.5 p-80 -159.64 -55.2 0.06 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.369 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.602 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.92 -8.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -124.82 -44.47 1.94 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.548 0.689 . . . . 0.0 110.51 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.635 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 13.1 t -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.499 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.7 OUTLIER -82.51 -64.79 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.846 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.567 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 2.6 pt20 -99.89 -160.37 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.357 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.04 34.48 2.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.478 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.567 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.2 mt-10 44.55 34.46 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 140.66 -40.34 1.38 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.223 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 57.28 8.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.43 15.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 110.792 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.454 HD13 ' CZ2' ' A' ' 531' ' ' TRP . 0.3 OUTLIER -54.55 -24.54 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.539 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.589 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 172.52 -51.67 0.17 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 3.5 mp 77.99 -18.4 0.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.776 0.43 . . . . 0.0 111.986 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.8 45.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.417 0.627 . . . . 0.0 110.164 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.471 ' CD1' HG12 ' A' ' 532' ' ' ILE . 1.8 p-90 -66.07 -15.72 63.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.742 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.625 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -124.01 64.07 33.13 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.39 -36.56 17.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.897 2.398 . . . . 0.0 113.503 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -121.27 6.19 10.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.625 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 8.1 t80 -112.19 -26.46 8.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.648 0.261 . . . . 0.0 111.406 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.459 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -111.84 -90.88 1.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.585 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 82.0 Cg_exo -40.45 -44.01 4.22 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.915 2.41 . . . . 0.0 112.095 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -73.39 -35.3 65.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.425 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 543' ' ' TYR . . . -58.15 157.18 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.989 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.31 -34.08 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.478 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -117.67 36.73 3.56 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.69 -36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.226 0.536 . . . . 0.0 109.849 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.689 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -100.09 -33.94 10.26 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.21 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.506 ' CD1' ' CZ3' ' A' ' 518' ' ' TRP . 1.6 mp 32.31 -72.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.913 0.885 . . . . 0.0 113.025 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 543' ' ' TYR . 20.0 mt-10 68.85 96.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.176 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 140.93 -9.36 2.79 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.844 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.468 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.5 pt? -129.93 -1.66 4.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.516 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -72.62 85.26 1.17 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.468 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 1.6 m170 -130.79 -48.83 1.04 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.417 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 167.73 -73.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' A' ' 552' ' ' ASP . 0.0 OUTLIER 57.04 -152.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 551' ' ' GLN . 13.0 t70 110.49 21.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.105 0.962 . . . . 0.0 110.527 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -141.34 0.14 1.7 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.489 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.599 ' HG ' HD12 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -127.12 2.46 6.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.995 0.518 . . . . 0.0 110.332 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.599 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -147.1 -41.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.629 -178.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.6 t -118.06 134.83 54.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.971 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 51.13 65.65 2.97 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.153 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 559' ' ' ARG . 1.7 pt? -141.44 -44.81 0.37 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.686 0.279 . . . . 0.0 110.527 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 170.38 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.179 0.514 . . . . 0.0 110.708 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.222 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.777 0.323 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -174.56 66.94 0.28 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.08 175.03 10.41 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.918 2.412 . . . . 0.0 112.468 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.8 124.68 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.452 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 57.94 98.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.327 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.556 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.2 m-80 -101.83 -51.28 0.16 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.576 ' HB3' ' CZ3' ' A' ' 518' ' ' TRP . 48.4 Cg_endo -104.03 15.41 0.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.052 3.168 . . . . 0.0 113.122 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -125.61 59.16 1.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.237 0.542 . . . . 0.0 109.608 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.444 ' N ' ' CD2' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -119.45 -52.06 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.032 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.635 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.9 p-80 -176.63 -55.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.324 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.635 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.44 -13.54 0.96 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.74 -45.64 2.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.449 0.643 . . . . 0.0 110.156 -177.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 2.1 t -65.64 -25.84 67.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.656 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -80.94 -56.97 3.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.251 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.542 ' N ' ' CG2' ' A' ' 520' ' ' THR . 4.3 pt20 -100.68 -162.32 0.93 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.144 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.42 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -103.05 35.96 2.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.496 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.535 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 26.3 mt-10 43.9 73.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.097 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.501 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.73 -21.65 35.04 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.989 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 53.77 11.08 0.29 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.11 16.23 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.481 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 524' ' ' GLY . 0.5 OUTLIER -55.01 -22.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.261 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 157.61 -34.72 0.54 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.354 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 3.6 mt 69.29 -56.87 0.54 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 111.586 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.74 46.16 0.75 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.363 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.548 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 2.9 p-90 -120.28 -18.82 7.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.519 ' CD1' ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -108.63 159.47 30.79 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.055 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 18.5 Cg_endo -59.37 -48.57 13.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.6 2.2 . . . . 0.0 112.868 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -156.58 6.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 0.5 OUTLIER -72.5 -26.42 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.88 0.371 . . . . 0.0 111.081 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.472 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -108.4 -58.84 0.55 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.878 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.44 -35.6 76.34 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.389 2.059 . . . . 0.0 111.71 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -92.52 -12.14 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.381 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.427 ' O ' ' CD1' ' A' ' 543' ' ' TYR . . . -75.28 122.51 23.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.366 . . . . 0.0 111.503 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -124.18 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.499 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -120.08 35.27 3.85 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.404 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -146.99 -33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.074 0.464 . . . . 0.0 110.333 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.714 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -97.3 -40.02 8.95 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.733 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.5 mp 36.96 -72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.466 0.707 . . . . 0.0 112.364 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.714 ' N ' ' O ' ' A' ' 543' ' ' TYR . 25.1 mt-10 66.21 94.8 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.54 -4.75 1.51 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.998 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.447 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.4 pt? -128.59 -10.25 5.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.336 0.568 . . . . 0.0 112.369 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.487 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.73 78.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.908 0.385 . . . . 0.0 111.032 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 2.0 m170 -133.72 27.13 4.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.638 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 1.3 m120 54.21 63.74 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.355 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.19 -79.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.043 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.71 12.86 7.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.265 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -118.37 -34.61 1.09 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.592 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.647 ' HG ' HD12 ' A' ' 555' ' ' ILE . 2.1 pp -87.48 2.93 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.647 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.64 -40.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.275 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.473 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER -109.88 57.71 0.61 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.973 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -109.43 -62.22 0.53 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.148 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 1.8 pt? -143.12 -49.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.545 0.212 . . . . 0.0 111.131 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.439 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 176.28 34.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.204 0.526 . . . . 0.0 110.865 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.543 ' NE2' ' H ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.119 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.805 0.336 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.413 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 3.1 mt-30 -166.68 53.67 0.28 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 70.9 Cg_endo -74.37 125.55 9.73 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.609 2.206 . . . . 0.0 112.341 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 560' ' ' GLN . 0.1 OUTLIER -91.9 117.26 29.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.4 m 60.1 86.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.007 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.535 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 5.5 m-80 -83.37 -49.22 0.73 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.623 ' HD2' HG13 ' A' ' 555' ' ' ILE . 36.8 Cg_endo -102.2 16.05 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.256 3.304 . . . . 0.0 112.098 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -120.42 56.64 0.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.414 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -105.77 -48.0 3.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.302 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.625 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.2 p-80 -177.62 -56.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.353 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.625 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -57.11 -20.44 25.56 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -120.75 -41.23 2.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 0.0 110.999 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.585 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 7.4 t -57.2 -30.15 64.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.18 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.51 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -94.42 -70.11 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.891 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.521 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -99.75 -168.18 1.57 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.451 -178.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.93 22.17 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.904 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.521 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.9 mt-10 69.94 5.51 5.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.983 0.421 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.457 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 128.63 17.16 1.94 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.066 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -99.64 -6.1 27.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -89.17 18.99 4.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.821 0.343 . . . . 0.0 111.413 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.463 ' CD1' ' N ' ' A' ' 527' ' ' ILE . 0.0 OUTLIER -136.09 -50.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 -179.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 159.92 -27.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.755 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.432 HD21 ' HD3' ' A' ' 537' ' ' PRO . 0.0 OUTLIER 81.01 -28.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.8 -21.29 48.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.849 0.357 . . . . 0.0 111.869 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.489 ' CE3' HG22 ' A' ' 532' ' ' ILE . 3.0 p-90 -53.61 -24.59 14.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 110.587 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 536' ' ' GLY . 0.3 OUTLIER -115.52 119.34 38.11 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.271 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.442 ' HG2' ' CE2' ' A' ' 534' ' ' TYR . 74.9 Cg_endo -90.12 31.97 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.715 2.276 . . . . 0.0 114.19 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.488 ' CD1' ' N ' ' A' ' 535' ' ' PHE . 8.1 p90 172.2 -34.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 111.044 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.488 ' N ' ' CD1' ' A' ' 534' ' ' TYR . 2.3 t80 -71.89 -21.15 61.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.67 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -116.69 -71.46 0.45 Allowed Glycine 0 C--N 1.32 -0.344 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.34 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.432 ' HD3' HD21 ' A' ' 529' ' ' LEU . 51.2 Cg_exo -52.5 -39.46 74.42 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.485 2.123 . . . . 0.0 111.581 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 534' ' ' TYR . . . -91.84 -17.35 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.117 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.517 ' CB ' HD11 ' A' ' 542' ' ' ILE . . . -45.25 -52.01 10.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.873 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 2.0 mt-10 71.85 -58.91 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -103.96 26.13 24.16 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.348 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.0 OUTLIER -149.05 1.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 O-C-N 122.778 -0.248 . . . . 0.0 111.664 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.712 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.8 OUTLIER -129.33 -42.95 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.482 0.182 . . . . 0.0 110.725 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.454 HD11 ' N ' ' A' ' 544' ' ' ILE . 3.3 mp 34.34 -73.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.444 0.698 . . . . 0.0 112.554 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.712 ' N ' ' O ' ' A' ' 543' ' ' TYR . 20.8 mt-10 64.02 34.98 10.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.356 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -147.17 13.43 1.45 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.54 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -157.87 -17.86 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.407 ' HE1' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -70.07 63.14 0.22 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.407 ' CD2' ' HE1' ' A' ' 548' ' ' MET . 0.3 OUTLIER -113.78 -43.03 3.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.649 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 552' ' ' ASP . 0.9 OUTLIER 172.89 -75.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.403 ' HG2' HD23 ' A' ' 554' ' ' LEU . 0.0 OUTLIER 41.19 -85.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.368 179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.3 OUTLIER 63.65 18.27 10.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -123.79 -31.44 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.187 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.599 ' HG ' HD11 ' A' ' 555' ' ' ILE . 1.6 pp -77.52 -2.55 36.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.611 0.243 . . . . 0.0 111.305 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.623 HG13 ' HD2' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -141.91 -39.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.104 0.478 . . . . 0.0 110.897 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.509 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -115.13 66.84 0.69 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.417 -178.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.408 ' N ' ' NE2' ' A' ' 560' ' ' GLN . . . 167.69 -28.43 0.16 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.431 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.4 ' CD1' ' HD3' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -47.43 -62.51 1.4 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 111.37 -179.671 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.4 ' HD3' ' CD1' ' A' ' 558' ' ' LEU . 0.0 OUTLIER -171.33 34.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.356 0.598 . . . . 0.0 110.366 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.408 ' NE2' ' N ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.086 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.849 0.357 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 26.5 mt-30 -162.79 52.94 0.37 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 72.1 Cg_endo -76.74 106.03 2.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.596 2.197 . . . . 0.0 112.406 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.91 117.34 8.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.827 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 97.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.556 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 2.9 m-80 -94.84 -50.37 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.683 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.608 ' HD2' HG13 ' A' ' 555' ' ' ILE . 74.4 Cg_endo -107.13 16.88 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.374 3.383 . . . . 0.0 112.902 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.402 HD21 HG13 ' A' ' 555' ' ' ILE . 4.7 m-80 -119.22 56.62 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.676 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.87 -58.7 1.99 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.104 -179.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.649 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.5 p-80 -173.85 -56.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.482 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.649 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.18 -12.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.708 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -122.49 -40.57 2.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -177.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.598 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.0 t -74.4 -21.11 59.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.648 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.49 -56.5 3.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 0.0 111.538 -179.009 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.544 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 6.2 pt20 -100.45 -158.13 0.65 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.449 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 9.0 m-20 -102.72 32.84 3.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.544 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 4.7 mt-10 44.67 73.99 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.963 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.455 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.12 -24.58 21.16 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 527' ' ' ILE . . . 54.28 10.0 0.28 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.03 16.52 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.416 . . . . 0.0 110.539 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.467 ' H ' ' C ' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.97 -24.13 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.343 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 158.19 -52.68 0.4 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.328 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 3.8 mp 75.07 -22.18 0.27 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.868 0.467 . . . . 0.0 112.115 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.29 -24.82 42.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.162 0.506 . . . . 0.0 111.135 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.481 ' CD2' HG23 ' A' ' 532' ' ' ILE . 6.2 p-90 -64.27 -15.23 59.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.757 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.555 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 1.0 OUTLIER -126.31 139.27 34.12 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.191 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.91 -20.2 2.42 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.777 2.318 . . . . 0.0 113.892 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.0 p90 -148.21 6.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.555 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 18.6 m-85 -86.63 -40.49 15.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.027 0.441 . . . . 0.0 110.701 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.471 ' N ' HD11 ' A' ' 532' ' ' ILE . . . -110.3 -60.4 0.5 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.367 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.76 -37.55 84.52 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.346 2.031 . . . . 0.0 111.551 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.42 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -92.65 -17.54 24.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.174 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.432 ' CB ' ' CD1' ' A' ' 542' ' ' ILE . . . -49.29 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.517 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 22.8 mt-10 76.15 -44.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.441 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -110.2 32.41 6.69 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.655 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.475 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -149.95 -32.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.065 0.46 . . . . 0.0 110.543 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.728 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -98.2 -39.86 8.66 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.0 OUTLIER 36.14 -72.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.396 0.679 . . . . 0.0 112.538 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.728 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.9 mt-10 67.0 33.38 5.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.042 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -138.5 -3.75 1.79 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.886 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.503 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.7 pt? -144.72 -8.24 0.65 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.441 ' HE3' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -70.46 68.14 0.36 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.957 0.408 . . . . 0.0 111.859 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.503 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -133.16 34.04 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 43.9 t30 55.67 95.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.424 ' NE2' HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -125.45 -76.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.533 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.27 24.76 7.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.884 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.94 -35.75 0.38 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.057 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.593 ' HG ' HD11 ' A' ' 555' ' ' ILE . 2.5 pp -82.3 1.67 35.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 111.261 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.608 HG13 ' HD2' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -140.59 -42.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 110.872 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.496 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -111.77 118.31 35.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.994 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -152.04 -70.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.716 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 2.0 pt? -136.03 -48.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.632 0.216 . . . . 0.0 111.433 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.436 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER -178.65 37.92 0.0 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.964 0.412 . . . . 0.0 111.608 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.401 ' NE2' HD21 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.958 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.497 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 77.99 61.59 0.21 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.527 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 8.8 Cg_exo -73.85 78.96 2.38 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.964 2.443 . . . . 0.0 112.299 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -67.51 109.67 3.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.507 ' HA ' HD11 ' A' ' 555' ' ' ILE . 0.6 OUTLIER 63.62 98.36 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.556 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 2.6 m-80 -97.5 -50.8 0.22 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.604 ' HB3' ' CZ3' ' A' ' 518' ' ' TRP . 36.3 Cg_endo -101.93 16.37 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.921 3.08 . . . . 0.0 112.319 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.406 ' HA ' ' HB ' ' A' ' 519' ' ' THR . 5.4 m-80 -119.61 52.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -98.98 -48.63 4.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.354 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 8.5 p-80 -177.04 -53.04 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.586 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -60.17 -23.03 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.733 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -118.01 -39.48 3.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.0 110.959 -177.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.56 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 5.2 t -58.52 -27.78 64.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.542 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.496 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -97.8 -67.59 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.465 -179.135 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.496 ' N ' ' CG2' ' A' ' 520' ' ' THR . 0.0 OUTLIER -99.52 -168.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.771 -178.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.425 ' HB3' ' CB ' ' A' ' 525' ' ' ALA . 0.1 OUTLIER -87.23 24.26 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.883 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 16.9 mt-10 68.57 4.87 4.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.06 0.457 . . . . 0.0 111.073 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.413 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 123.7 22.62 2.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.966 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.425 ' CB ' ' HB3' ' A' ' 522' ' ' ASP . . . -110.28 4.4 20.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -93.16 12.67 23.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.859 0.361 . . . . 0.0 111.657 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.7 -45.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.292 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 150.85 -17.2 0.94 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.467 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.492 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.6 OUTLIER 73.72 -51.53 0.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 45.1 0.64 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.384 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 3.2 p-90 -119.87 -16.92 8.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.577 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.475 HD11 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.24 159.93 32.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.699 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 37.6 Cg_endo -66.3 -45.2 5.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.3 2.0 . . . . 0.0 112.491 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 533' ' ' PRO . 18.5 p90 -161.57 6.68 0.07 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.415 ' CE1' ' HG2' ' A' ' 533' ' ' PRO . 1.1 m-85 -66.0 -26.85 67.73 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.118 -0.364 . . . . 0.0 111.4 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.48 -63.5 0.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.609 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.409 ' HD3' HD22 ' A' ' 529' ' ' LEU . 51.2 Cg_exo -53.07 -39.3 80.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.356 2.038 . . . . 0.0 111.835 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -95.3 -4.58 45.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.533 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.519 ' CB ' HD13 ' A' ' 542' ' ' ILE . . . -54.15 -61.73 2.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 32.4 mt-10 72.61 -58.26 0.6 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -102.91 22.59 36.44 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.312 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -144.66 -5.84 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.711 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -125.53 -37.17 2.37 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.47 0.176 . . . . 0.0 111.131 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.485 HD13 ' CZ3' ' A' ' 518' ' ' TRP . 2.1 mp 36.7 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.471 0.708 . . . . 0.0 112.582 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 543' ' ' TYR . 36.9 mt-10 65.47 96.92 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.976 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.39 -8.27 1.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.709 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.408 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 2.1 pt? -128.15 -9.38 5.33 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.404 ' HG2' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -66.44 76.3 0.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 1.5 m170 -134.62 36.16 3.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.101 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.5 m-20 70.38 -64.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.151 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 42.66 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.963 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.1 OUTLIER 59.63 16.53 5.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -115.17 -34.79 1.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.69 -3.85 52.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.847 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.555 HD13 ' HD2' ' A' ' 513' ' ' PRO . 2.9 pp -145.19 -29.95 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.485 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.512 ' HB2' ' CD1' ' A' ' 555' ' ' ILE . 0.1 OUTLIER -118.63 49.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.145 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.401 ' HA2' ' NE2' ' A' ' 560' ' ' GLN . . . 153.76 44.02 0.02 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.43 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 2.2 pt? -122.46 -40.32 2.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 110.529 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.433 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER -178.17 35.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.39 0.614 . . . . 0.0 110.295 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.401 ' NE2' ' HA2' ' A' ' 557' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.117 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.8 0.333 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.452 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.3 OUTLIER -144.63 50.57 1.22 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.664 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 95.5 Cg_endo -81.76 104.59 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.594 2.196 . . . . 0.0 112.656 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.414 ' HA ' ' CG ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER -63.5 112.62 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.602 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.74 109.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.551 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 2.3 m-80 -97.03 -50.35 0.23 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.958 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.688 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 23.9 Cg_endo -99.86 -1.67 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.791 2.994 . . . . 0.0 113.208 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.592 ' N ' HD11 ' A' ' 515' ' ' LEU . 18.1 m-80 -106.06 66.2 0.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.592 HD11 ' N ' ' A' ' 514' ' ' ASN . 0.0 OUTLIER -133.27 -30.46 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.616 ' CD2' ' CD1' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -173.0 -78.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.616 ' CD1' ' CD2' ' A' ' 516' ' ' HIS . 0.4 OUTLIER -67.4 12.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -177.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.697 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -139.26 -39.57 0.48 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.305 0.574 . . . . 0.0 109.66 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 516' ' ' HIS . 0.8 OUTLIER -78.62 -13.17 59.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.379 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.5 OUTLIER -95.84 -59.76 1.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.626 0.251 . . . . 0.0 110.873 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.547 ' N ' ' CG2' ' A' ' 520' ' ' THR . 6.4 pt20 -100.7 -158.02 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.301 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.403 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 2.4 m-20 -103.02 34.27 2.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.857 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.487 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 20.9 mt-10 47.07 71.95 0.28 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 110.269 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.552 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.6 -19.47 47.62 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.117 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.457 ' C ' ' N ' ' A' ' 527' ' ' ILE . . . 54.24 11.35 0.38 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.55 16.2 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.023 0.44 . . . . 0.0 110.507 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 524' ' ' GLY . 0.3 OUTLIER -54.17 -22.96 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.482 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 162.15 -53.31 0.31 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.245 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.548 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 2.8 mp 75.51 -20.06 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.6 0.36 . . . . 0.0 111.813 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.5 -24.17 42.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.175 0.512 . . . . 0.0 111.106 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.49 ' CD2' HG22 ' A' ' 532' ' ' ILE . 7.1 p-90 -63.84 -14.37 52.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.846 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 535' ' ' PHE . 0.9 OUTLIER -125.62 140.23 35.98 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.164 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -87.42 -20.06 2.21 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.763 2.308 . . . . 0.0 113.982 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.505 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.56 6.24 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.55 ' HB2' ' CD1' ' A' ' 532' ' ' ILE . 18.6 m-85 -86.64 -38.49 17.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 110.93 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -113.73 -60.66 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.595 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.88 -40.07 76.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.434 2.089 . . . . 0.0 111.609 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -84.54 -27.71 27.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.727 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . . . . . . . . . . . -58.07 158.82 6.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.492 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -151.32 -34.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.307 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.54 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -115.44 34.72 4.66 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.489 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.448 HG23 ' CG ' ' A' ' 517' ' ' TYR . 0.3 OUTLIER -149.92 -33.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.044 0.45 . . . . 0.0 110.163 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -103.33 -44.68 5.09 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.235 -178.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.57 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 0.9 OUTLIER 42.4 -72.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.56 0.744 . . . . 0.0 112.755 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.665 ' N ' ' O ' ' A' ' 543' ' ' TYR . 0.4 OUTLIER 69.31 29.91 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.431 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -139.36 -5.7 1.28 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.092 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.462 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.3 pt? -138.94 -6.56 1.44 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.448 ' HB3' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -72.36 63.1 0.53 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 111.615 -178.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.462 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -119.08 26.04 9.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.466 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 58.9 80.98 0.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.427 ' NE2' HD13 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -108.57 -77.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 14.8 t70 63.24 15.27 8.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.358 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -121.89 -33.46 0.92 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.61 ' HG ' HD12 ' A' ' 555' ' ' ILE . 1.8 pp -87.84 5.49 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.61 HD12 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -146.35 -41.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t -107.96 48.96 0.83 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.114 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 146.49 40.39 0.04 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.458 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.547 HD23 ' HG3' ' A' ' 560' ' ' GLN . 1.7 pt? -110.06 -40.86 4.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.948 0.374 . . . . 0.0 110.407 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.472 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 176.37 35.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.349 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.547 ' HG3' HD23 ' A' ' 558' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.211 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.402 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -168.88 66.06 0.63 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 4.4 Cg_exo -77.29 122.91 6.32 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.009 2.473 . . . . 0.0 112.338 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.76 122.18 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.566 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.84 100.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.552 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 1.5 m-80 -103.19 -51.23 0.14 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.947 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.766 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 22.2 Cg_endo -100.11 -1.85 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.777 2.985 . . . . 0.0 113.259 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . 0.632 ' N ' HD11 ' A' ' 515' ' ' LEU . 13.1 m-80 -103.44 65.66 0.85 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.632 HD11 ' N ' ' A' ' 514' ' ' ASN . 0.0 OUTLIER -132.16 -22.64 2.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -178.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.606 ' CD2' ' CD1' ' A' ' 517' ' ' TYR . 0.0 OUTLIER 179.83 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.606 ' CD1' ' CD2' ' A' ' 516' ' ' HIS . 0.5 OUTLIER -62.48 7.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.296 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.766 ' HB2' ' O ' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -135.57 -40.23 0.71 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.369 0.604 . . . . 0.0 109.775 -178.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' THR . . . . . . . . . . . . . 7.2 t -80.17 -12.54 59.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.945 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.572 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -97.76 -62.38 1.26 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.685 0.278 . . . . 0.0 111.361 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.572 ' N ' ' CG2' ' A' ' 520' ' ' THR . 2.0 pt20 -100.45 -163.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.995 0.426 . . . . 0.0 111.208 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -102.89 32.32 3.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.44 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.462 ' HG3' ' HA ' ' A' ' 518' ' ' TRP . 3.9 mt-10 41.61 79.56 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.352 0.596 . . . . 0.0 110.097 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 526' ' ' ALA . . . 93.49 -14.93 64.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.934 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.677 ' CB ' HD11 ' A' ' 527' ' ' ILE . . . 28.66 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.56 16.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.677 HD11 ' CB ' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.22 -35.6 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 173.99 -38.58 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.134 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.32 -46.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -76.88 -20.04 56.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.3 p-90 -43.69 -29.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 0.0 111.083 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.514 HG22 ' CD2' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -104.71 157.56 33.89 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.319 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.434 ' HG2' ' CE1' ' A' ' 535' ' ' PHE . 36.4 Cg_endo -65.11 -44.09 10.21 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.426 2.084 . . . . 0.0 112.363 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -161.9 6.56 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.468 ' CD2' ' HB ' ' A' ' 532' ' ' ILE . 0.8 OUTLIER -63.98 -28.51 69.86 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.086 -0.384 . . . . 0.0 110.982 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.444 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -110.2 -57.83 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.988 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 75.8 Cg_exo -50.33 -46.71 27.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.47 2.114 . . . . 0.0 112.023 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -79.05 -25.8 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.462 ' O ' ' CD1' ' A' ' 543' ' ' TYR . . . -59.95 141.62 55.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -129.97 -26.13 2.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.56 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.28 38.26 2.96 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 544' ' ' ILE . 0.3 OUTLIER -150.26 -35.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.312 0.577 . . . . 0.0 109.951 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.682 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -103.29 -30.33 10.7 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.089 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.4 mp 33.95 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.789 0.835 . . . . 0.0 112.907 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 543' ' ' TYR . 29.1 mt-10 69.13 87.4 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.934 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 157.29 -19.73 0.4 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.152 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.417 ' HA ' ' NE2' ' A' ' 549' ' ' HIS . 1.4 pt? -127.7 -18.61 4.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 111.68 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.423 ' C ' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -58.36 102.85 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.172 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.423 ' CD2' ' C ' ' A' ' 548' ' ' MET . 0.4 OUTLIER -179.75 -64.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 178.73 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 175.33 108.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.823 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 -72.6 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.822 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 45.5 28.46 0.5 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.11 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.33 -35.33 0.42 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.639 ' HG ' HD11 ' A' ' 555' ' ' ILE . 1.5 pp -89.65 -4.54 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.735 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.639 HD11 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.74 -42.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.294 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.519 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER -115.48 58.37 0.73 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.334 -178.665 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -97.86 -55.63 1.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.554 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.492 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 2.5 pt? -147.09 -45.74 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.516 0.198 . . . . 0.0 110.886 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.492 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.91 37.6 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.947 0.403 . . . . 0.0 111.433 179.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.09 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.81 0.338 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.429 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 2.5 mt-30 -168.25 63.81 0.61 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 25.7 Cg_exo -62.89 97.32 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.666 2.244 . . . . 0.0 112.388 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.2 115.57 20.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.634 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 64.84 88.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.535 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 5.8 m-80 -87.74 -49.63 0.44 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.6 ' HD2' HG13 ' A' ' 555' ' ' ILE . 38.6 Cg_endo -102.67 17.51 0.24 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 124.229 3.286 . . . . 0.0 112.232 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -122.74 57.77 1.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.402 ' CD2' ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.99 -52.42 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.357 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.652 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.4 p-80 -175.76 -56.36 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.054 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.652 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.35 -14.83 1.32 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -179.155 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.37 -47.45 2.0 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.406 0.622 . . . . 0.0 110.04 -177.205 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.4 t -63.79 -26.15 68.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -81.43 -56.5 4.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.56 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.566 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 4.7 pt20 -100.54 -161.92 0.9 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.038 0.447 . . . . 0.0 111.283 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.427 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.2 m-20 -102.95 34.37 2.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.569 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.566 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 20.1 mt-10 43.56 77.28 0.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.854 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.47 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 93.72 -23.44 30.64 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.463 ' C ' ' N ' ' A' ' 527' ' ' ILE . . . 54.0 10.68 0.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.13 15.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.01 0.433 . . . . 0.0 110.644 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 524' ' ' GLY . 0.4 OUTLIER -55.21 -22.35 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.366 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 155.45 -48.36 0.49 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.999 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.553 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.1 mp 74.68 -47.02 0.62 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.833 0.453 . . . . 0.0 111.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.54 43.98 0.59 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.529 ' CE2' HD13 ' A' ' 532' ' ' ILE . 4.3 p-90 -121.87 -13.9 8.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.829 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.607 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -117.64 169.67 7.23 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.882 -179.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.481 ' CD ' ' HB ' ' A' ' 532' ' ' ILE . 75.9 Cg_endo -92.73 6.16 3.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.746 2.297 . . . . 0.0 113.318 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.503 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 28.3 p90 -176.83 -27.28 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.607 ' HD1' ' HB ' ' A' ' 532' ' ' ILE . 48.8 m-85 -59.48 -26.49 65.31 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.85 -0.531 . . . . 0.0 111.453 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.468 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -110.8 -65.6 0.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.059 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 42.3 Cg_exo -57.27 -39.0 93.29 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.587 2.191 . . . . 0.0 111.943 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -86.03 -18.38 32.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . . . . . . . . . . . -58.31 150.16 22.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.87 0.367 . . . . 0.0 111.184 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -157.71 -36.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -114.63 31.66 6.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.025 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.429 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -146.57 -33.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.084 0.468 . . . . 0.0 110.366 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -99.56 -36.4 9.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.044 -179.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 544' ' ' ILE . 1.4 mp 37.0 -73.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.465 0.706 . . . . 0.0 112.496 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.706 ' N ' ' O ' ' A' ' 543' ' ' TYR . 31.9 mt-10 65.85 36.82 5.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . 0.415 ' N ' ' HE1' ' A' ' 548' ' ' MET . . . -148.69 14.32 1.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.363 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.481 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.2 pt? -160.53 -14.91 0.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.488 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.86 64.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.416 . . . . 0.0 111.759 -178.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.62 33.07 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.437 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 58.15 86.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.449 ' NE2' HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -112.23 -77.84 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.037 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.78 11.5 8.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -117.29 -32.89 1.42 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.973 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.62 ' HG ' HD11 ' A' ' 555' ' ' ILE . 1.6 pp -82.76 -0.81 49.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.796 0.331 . . . . 0.0 111.238 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.62 HD11 ' HG ' ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.94 -40.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.876 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.488 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -110.97 54.52 0.67 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.298 -179.126 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 150.94 41.57 0.03 OUTLIER Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.353 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.435 HD22 ' HG3' ' A' ' 560' ' ' GLN . 2.4 pt? -124.82 -41.28 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.663 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.404 ' HD3' ' CD1' ' A' ' 558' ' ' LEU . 0.0 OUTLIER -175.41 34.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 0.0 110.787 179.502 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.435 ' HG3' HD22 ' A' ' 558' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.117 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' A' ' 508' ' ' GLN . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.667 0.27 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 507' ' ' ALA . 0.6 OUTLIER 84.51 69.92 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.189 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 -179.635 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -73.16 69.17 4.01 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.252 2.635 . . . . 0.0 111.002 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 560' ' ' GLN . 5.5 mptt -144.56 -173.76 4.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.374 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 42.91 61.32 2.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.179 0.514 . . . . 0.0 110.927 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.518 ' HB2' ' HD3' ' A' ' 513' ' ' PRO . 2.8 m-80 -89.55 -48.75 0.39 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.503 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.602 ' HD2' HG13 ' A' ' 555' ' ' ILE . 59.9 Cg_endo -103.67 20.59 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.245 3.297 . . . . 0.0 112.314 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -115.46 48.16 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 515' ' ' LEU . 0.0 OUTLIER -100.27 -55.24 2.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.256 -178.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.63 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.3 p-80 -175.48 -56.43 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.669 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.63 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -57.21 -20.18 25.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.336 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -119.05 -27.68 5.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.424 -177.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.549 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 1.6 t -76.97 -20.09 56.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.5 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -98.55 -70.87 0.71 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 110.539 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.581 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 0.7 OUTLIER -99.93 -160.98 0.83 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.095 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.19 30.83 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.218 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.581 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 20.3 mt-10 63.04 14.4 7.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.891 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 113.93 22.68 5.23 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.911 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.83 -3.62 38.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -84.86 22.42 1.37 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 110.968 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.497 HG13 ' CZ2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -132.73 -60.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.586 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.1 -21.8 1.25 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.41 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.9 mp 75.2 -20.31 0.35 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.06 -25.09 43.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.331 0.586 . . . . 0.0 111.023 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.498 ' CD2' HG21 ' A' ' 532' ' ' ILE . 7.2 p-90 -65.72 -18.51 65.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.029 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.498 HG21 ' CD2' ' A' ' 531' ' ' TRP . 1.6 pt -123.42 135.61 26.25 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.037 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.415 ' HG2' ' CD2' ' A' ' 534' ' ' TYR . 98.2 Cg_endo -87.63 -17.73 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.71 2.273 . . . . 0.0 113.604 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.61 ' O ' ' HB1' ' A' ' 538' ' ' ALA . 26.6 p90 -138.14 -26.08 0.94 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . 0.501 ' CE2' ' CZ ' ' A' ' 534' ' ' TYR . 98.3 m-85 -59.97 -43.14 95.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.986 -0.446 . . . . 0.0 111.564 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.462 ' N ' HD11 ' A' ' 532' ' ' ILE . . . -109.25 -60.92 0.52 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.987 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.426 ' HG2' ' O ' ' A' ' 532' ' ' ILE . 54.3 Cg_exo -51.7 -41.99 58.97 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.388 2.059 . . . . 0.0 111.813 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 534' ' ' TYR . . . -81.93 -31.08 31.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.633 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 543' ' ' TYR . . . -49.36 159.37 0.32 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -149.28 -44.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.72 25.18 17.76 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.095 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.486 ' CD1' ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -145.06 -4.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 -179.389 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.677 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.5 OUTLIER -129.57 -42.73 1.29 Allowed 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.316 -178.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' ILE . . . . . 0.477 HD12 ' CE3' ' A' ' 518' ' ' TRP . 3.4 mp 38.89 -73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 123.54 0.736 . . . . 0.0 112.712 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.677 ' N ' ' O ' ' A' ' 543' ' ' TYR . 2.0 mm-40 73.65 29.77 1.49 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.314 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.93 4.72 2.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.648 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.457 ' HA ' ' CE1' ' A' ' 549' ' ' HIS . 1.7 pt? -149.88 -16.22 0.26 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.479 ' HE3' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -69.46 65.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.938 0.399 . . . . 0.0 111.836 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.479 ' CD2' ' HE3' ' A' ' 548' ' ' MET . 0.0 OUTLIER -132.23 35.73 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.404 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 93.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.333 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.429 ' NE2' HD11 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -120.72 -76.44 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.216 0.531 . . . . 0.0 111.116 -179.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 3.5 t70 63.7 17.17 10.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.678 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . 0.428 ' HA2' ' HA3' ' A' ' 557' ' ' GLY . . . -123.77 -31.91 0.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.891 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.614 ' HG ' HD13 ' A' ' 555' ' ' ILE . 2.7 pp -90.03 8.38 32.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.088 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.614 HD13 ' HG ' ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.1 -44.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.545 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.48 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER -116.05 47.8 1.33 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.234 179.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.45 ' HA2' ' NE2' ' A' ' 560' ' ' GLN . . . -154.33 -35.15 0.03 OUTLIER Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.345 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.435 ' CD1' ' HD3' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -33.89 -50.56 0.37 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.849 0.324 . . . . 0.0 111.467 -179.544 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.435 ' HD3' ' CD1' ' A' ' 558' ' ' LEU . 0.0 OUTLIER -177.86 30.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.268 0.556 . . . . 0.0 111.168 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.529 ' HB3' ' CB ' ' A' ' 510' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.708 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.328 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.9 m 60.32 101.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.9 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.1 m120 -91.0 -51.44 0.31 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.08 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 61.5 Cg_endo -106.52 21.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.501 3.467 . . . . 0.0 112.406 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.637 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.7 m120 -118.8 51.18 1.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.9 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -105.59 -67.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.079 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.673 ' HA ' HG22 ' A' ' 519' ' ' THR . 2.5 p80 -161.51 -57.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.193 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.605 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -55.94 -9.61 0.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.698 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -123.23 -44.31 2.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.581 0.705 . . . . 0.0 110.563 -176.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 516' ' ' HIS . 12.1 t -63.15 -28.78 70.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.467 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.668 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.8 OUTLIER -84.57 -65.69 0.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.764 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.668 ' N ' HG22 ' A' ' 520' ' ' THR . 9.8 pt20 -99.99 -157.64 0.62 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.2 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 4.1 m-20 -100.62 36.64 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.233 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 8.3 mt-10 52.28 34.88 15.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.034 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.437 ' HA2' HD11 ' A' ' 527' ' ' ILE . . . 89.26 33.35 9.55 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.571 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.797 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -119.95 -5.47 10.07 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -90.79 15.69 10.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.795 0.331 . . . . 0.0 111.72 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.588 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.2 OUTLIER -129.65 -44.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.432 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 134.28 -17.63 4.27 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.637 HD11 ' HD2' ' A' ' 543' ' ' TYR . 2.9 tp 78.0 -51.61 0.5 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.67 47.13 0.71 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.107 0.48 . . . . 0.0 112.241 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.76 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.9 p-90 -122.5 -16.53 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.632 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.777 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -116.17 166.29 12.82 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.856 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 83.1 Cg_endo -94.04 2.39 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.835 2.357 . . . . 0.0 113.563 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.728 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 9.8 p90 -177.16 -21.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.777 ' HB2' HD12 ' A' ' 532' ' ' ILE . 60.9 m-85 -59.5 -30.93 68.91 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.91 -0.494 . . . . 0.0 111.67 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.565 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -111.37 -69.07 0.56 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.938 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -49.01 -40.22 40.83 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.603 2.202 . . . . 0.0 112.022 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.91 -31.6 31.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -52.82 158.09 1.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -141.57 -41.64 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -111.31 34.15 5.45 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.26 -35.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.101 0.476 . . . . 0.0 109.962 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.735 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -99.68 -29.13 12.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.182 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.813 HG21 HD22 ' A' ' 547' ' ' LEU . 2.5 mp 30.84 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.916 0.886 . . . . 0.0 112.95 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.735 ' N ' ' O ' ' A' ' 543' ' ' TYR . 7.4 mt-10 69.63 91.85 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.116 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 150.13 -9.6 0.84 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.875 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.813 HD22 HG21 ' A' ' 544' ' ' ILE . 2.7 pt? -128.14 -11.36 5.27 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.493 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -63.13 80.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.911 0.386 . . . . 0.0 110.7 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.4 ' N ' ' O ' ' A' ' 547' ' ' LEU . 5.4 m-70 -133.15 29.7 4.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.424 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 52.32 55.79 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.451 ' NE2' ' O ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.41 172.21 8.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.819 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.1 t70 179.17 31.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -134.87 -37.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -77.8 -3.89 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.616 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.909 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -144.03 -42.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.32 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t . . . . . 0 N--CA 1.449 -0.493 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.378 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.826 0.346 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.6 m 51.32 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.909 ' O ' HD21 ' A' ' 515' ' ' LEU . 5.6 m120 -93.52 -49.53 0.27 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.854 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.69 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 50.4 Cg_endo -102.69 17.42 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 124.339 3.359 . . . . 0.0 112.658 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.733 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.2 m120 -123.32 59.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.319 0.58 . . . . 0.0 109.914 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.909 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.18 -72.83 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.05 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 16.8 p80 -147.62 -56.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.771 ' C ' ' HD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -65.91 179.51 0.88 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.443 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.771 ' HD1' ' C ' ' A' ' 517' ' ' TYR . 0.1 OUTLIER 62.79 -44.99 0.2 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.239 0.472 . . . . 0.0 110.945 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 517' ' ' TYR . 8.9 t -94.37 -19.86 20.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.258 0.551 . . . . 0.0 109.829 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.69 HG22 ' N ' ' A' ' 521' ' ' GLN . 1.2 m -85.16 -78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.391 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.69 ' N ' HG22 ' A' ' 520' ' ' THR . 2.8 pt20 -100.51 -161.88 0.9 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.162 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.629 ' HB2' ' HB2' ' A' ' 526' ' ' ALA . 1.1 t0 -93.19 22.36 5.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.942 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.618 ' HG3' ' HA ' ' A' ' 518' ' ' TRP . 9.3 mt-10 48.31 75.84 0.13 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.546 0.689 . . . . 0.0 110.369 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 52.47 20.29 7.21 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.391 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 522' ' ' ASP . . . -106.69 -22.83 12.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.302 0.551 . . . . 0.0 111.832 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.785 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -87.3 20.98 2.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.974 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.785 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -133.81 -48.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.476 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 136.98 -11.95 3.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.108 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.879 HD11 ' CD2' ' A' ' 543' ' ' TYR . 3.2 mt 70.04 -56.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.88 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 46.23 0.73 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.412 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.601 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.4 p-90 -120.56 -18.29 7.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.664 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.601 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.1 160.37 30.26 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.259 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 27.1 Cg_endo -62.2 -47.1 10.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.875 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.767 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 37.1 p90 -155.33 6.26 0.23 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.518 ' HD2' HG21 ' A' ' 532' ' ' ILE . 0.9 OUTLIER -71.65 -26.48 62.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.044 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -108.47 -63.41 0.56 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.674 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.09 -41.88 39.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 111.661 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -78.02 -23.03 48.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.585 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 536' ' ' GLY . . . -51.59 161.64 0.48 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -163.69 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.575 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.443 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -109.01 29.59 9.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.875 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.674 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.42 -29.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 110.792 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.879 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.8 OUTLIER -98.68 -47.92 5.15 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.785 HG21 HD22 ' A' ' 547' ' ' LEU . 2.0 mp 36.85 -74.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.377 0.671 . . . . 0.0 112.442 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.693 ' N ' ' O ' ' A' ' 543' ' ' TYR . 22.6 mt-10 68.32 85.82 0.14 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.003 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 162.96 -17.32 0.14 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.551 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.785 HD22 HG21 ' A' ' 544' ' ' ILE . 1.9 pt? -134.68 -12.57 2.3 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.492 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -70.17 64.42 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.129 0.49 . . . . 0.0 111.473 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -116.36 -74.63 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.002 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.7 t30 175.47 73.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.402 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -99.11 -78.25 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.603 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.678 ' H ' HD11 ' A' ' 555' ' ' ILE . 6.7 t70 66.08 12.59 8.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.683 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.9 -31.77 1.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.711 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.934 HD12 HG23 ' A' ' 555' ' ' ILE . 1.5 pp -93.15 9.4 36.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.934 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.3 -42.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.468 -178.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.468 ' N ' HG12 ' A' ' 555' ' ' ILE . 5.2 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.351 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.715 0.293 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.503 ' O ' HD11 ' A' ' 515' ' ' LEU . 12.4 m 61.76 114.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.408 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.97 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.5 m120 -94.09 -50.83 0.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.77 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 86.5 Cg_endo -109.64 16.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.267 3.311 . . . . 0.0 113.32 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.832 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.4 m120 -118.62 53.18 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.17 0.51 . . . . 0.0 110.171 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.97 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -121.98 -62.73 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.956 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.637 ' HA ' ' CG2' ' A' ' 519' ' ' THR . 3.3 p80 -171.18 -56.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.578 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.637 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.53 -10.61 0.27 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.77 ' CE3' ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -123.61 -33.33 3.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.21 0.529 . . . . 0.0 110.462 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.637 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 8.9 t -82.87 -16.1 48.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.505 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.533 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -87.07 -56.8 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.716 0.294 . . . . 0.0 111.38 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 7.9 pt20 -100.45 -157.58 0.62 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.146 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 525' ' ' ALA . 5.3 m-20 -102.73 32.55 3.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.26 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.5 mt-10 45.33 69.69 0.42 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.907 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 93.59 -26.94 13.52 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.622 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.89 11.0 0.17 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.69 16.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.377 . . . . 0.0 110.769 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.622 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -56.08 -22.23 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.275 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.559 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 163.63 -34.01 0.29 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.805 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 543' ' ' TYR . 2.0 mt 67.91 -53.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.28 -21.68 60.54 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.601 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.9 p-90 -43.61 -29.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.016 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.587 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -103.71 152.09 38.87 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.574 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.56 -50.51 13.8 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.618 2.212 . . . . 0.0 112.281 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 42.6 p90 -157.97 6.45 0.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -62.59 -27.1 68.96 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.831 0.348 . . . . 0.0 110.766 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -107.84 -56.65 0.59 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.838 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 46.6 Cg_exo -56.27 -41.27 78.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.481 2.12 . . . . 0.0 111.937 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 534' ' ' TYR . . . -93.24 -7.92 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.219 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 1.119 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -53.1 -75.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 75.87 -43.59 0.49 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.512 ' C ' HD12 ' A' ' 542' ' ' ILE . . . -112.33 35.08 4.83 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.745 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 1.119 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -151.09 -33.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.992 0.425 . . . . 0.0 110.513 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.6 OUTLIER -94.96 -45.75 7.13 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.037 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.894 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 36.47 -73.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.627 0.771 . . . . 0.0 112.404 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 543' ' ' TYR . 19.9 mt-10 67.49 32.24 5.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.732 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -137.88 -7.86 1.31 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.87 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.894 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -137.67 -8.57 1.65 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.518 ' HE1' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.49 65.66 0.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 110.761 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.7 OUTLIER -111.49 -65.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.611 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 168.59 63.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.742 ' CB ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -115.61 -178.84 3.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.238 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 556' ' ' CYS . 2.9 p30 -179.2 -22.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.187 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -88.33 -29.05 20.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.309 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.932 HD12 HG23 ' A' ' 555' ' ' ILE . 1.2 pp -82.42 -2.77 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.669 0.271 . . . . 0.0 111.45 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.932 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.99 -41.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.996 0.427 . . . . 0.0 111.04 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.186 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.761 0.315 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.67 90.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.892 ' O ' HD21 ' A' ' 515' ' ' LEU . 7.8 m120 -87.39 -49.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.75 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.909 ' CG ' HG21 ' A' ' 555' ' ' ILE . 39.3 Cg_endo -102.08 16.7 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 124.195 3.263 . . . . 0.0 112.525 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.687 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.6 m120 -123.82 60.2 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.892 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -111.46 -46.15 3.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.31 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 1.9 p80 -177.59 -56.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.665 0.269 . . . . 0.0 111.514 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.71 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -56.18 -20.16 16.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.735 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.83 -44.03 2.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.186 0.517 . . . . 0.0 110.761 -177.353 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.601 HG22 ' CA ' ' A' ' 516' ' ' HIS . 9.3 t -53.84 -31.34 49.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.288 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.711 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.19 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.163 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.711 ' N ' HG22 ' A' ' 520' ' ' THR . 3.2 pt20 -99.64 -169.99 1.83 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.467 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.888 ' CB ' ' HB3' ' A' ' 525' ' ' ALA . 3.5 m-20 -88.19 21.39 2.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.9 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 34.2 mt-10 69.11 4.51 4.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.934 0.397 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 130.96 20.23 1.19 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.16 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.888 ' HB3' ' CB ' ' A' ' 522' ' ' ASP . . . -97.21 -25.26 15.35 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.744 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -84.45 23.19 1.15 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 111.412 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.744 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -131.67 -46.57 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.587 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 138.72 -12.9 3.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.04 -46.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -75.85 -20.25 58.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.746 ' CE2' HD13 ' A' ' 532' ' ' ILE . 2.0 p-90 -47.55 -26.13 1.34 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.953 0.406 . . . . 0.0 111.074 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.836 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.3 OUTLIER -114.63 157.75 42.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -91.09 -23.69 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.991 2.461 . . . . 0.0 114.023 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 8.6 p90 -154.34 6.65 0.3 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.836 ' HB2' HD12 ' A' ' 532' ' ' ILE . 2.9 m-85 -78.93 -43.08 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.224 0.535 . . . . 0.0 110.705 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.566 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.41 -58.06 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.622 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' A' ' 536' ' ' GLY . 77.8 Cg_exo -49.68 -42.05 44.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.322 2.014 . . . . 0.0 111.583 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.75 -29.79 32.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.591 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.18 148.11 28.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.223 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -129.16 -35.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.594 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.435 ' O ' ' HZ2' ' A' ' 518' ' ' TRP . . . -114.76 27.57 8.66 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.7 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -142.35 -6.19 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.72 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -127.42 -41.99 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 120.368 0.128 . . . . 0.0 111.085 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.563 HG21 HD22 ' A' ' 547' ' ' LEU . 3.2 mp 34.45 -72.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.549 0.74 . . . . 0.0 112.551 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.72 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.5 mt-10 68.4 90.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.148 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 155.51 -15.33 0.47 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.182 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.563 HD22 HG21 ' A' ' 544' ' ' ILE . 1.4 pt? -129.4 -3.17 4.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.786 0.327 . . . . 0.0 111.684 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.811 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -81.08 80.37 7.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.173 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -133.19 -68.7 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.589 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 167.44 66.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -74.67 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.19 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.93 20.61 9.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.93 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -122.99 -38.15 0.58 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.979 HD12 HG23 ' A' ' 555' ' ' ILE . 2.4 pp -83.15 -1.16 52.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.979 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.31 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.709 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.484 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.93 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.842 0.353 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.7 m 63.41 122.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.708 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.0 m120 -104.67 -52.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.875 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.563 ' HD3' ' HB2' ' A' ' 512' ' ' ASN . 39.7 Cg_endo -104.02 5.71 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.019 3.146 . . . . 0.0 113.162 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.709 ' C ' HD13 ' A' ' 515' ' ' LEU . 5.8 m120 -115.53 57.61 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.195 0.521 . . . . 0.0 109.791 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.745 ' H ' HD22 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -121.73 -38.21 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.736 ' O ' ' O ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -164.23 -84.63 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.768 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.992 ' O ' ' N ' ' A' ' 519' ' ' THR . 1.4 m-85 -52.21 -137.79 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.682 ' HA ' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER 26.14 -63.17 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.992 ' N ' ' O ' ' A' ' 517' ' ' TYR . 9.2 t -70.13 -25.35 63.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.066 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 516' ' ' HIS . 0.4 OUTLIER -78.64 -63.93 1.29 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.567 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 10.5 pt20 -100.79 -153.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.83 31.75 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.698 ' OE2' HD13 ' A' ' 544' ' ' ILE . 1.7 mt-10 46.96 70.72 0.37 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.824 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 90.97 -25.15 14.84 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.895 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.616 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.47 11.95 0.21 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.55 16.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.749 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.616 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -57.88 -20.25 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.319 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.57 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 160.61 -46.0 0.4 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.924 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.529 HD21 ' CD ' ' A' ' 545' ' ' GLU . 3.4 mp 71.15 -34.79 0.31 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.18 -22.94 44.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.591 ' CD2' HG23 ' A' ' 532' ' ' ILE . 2.4 p-90 -47.63 -26.73 1.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.675 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -116.03 167.45 10.27 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.713 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 92.7 Cg_endo -95.39 -5.92 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.13 2.553 . . . . 0.0 113.812 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 17.9 p90 -159.0 -28.95 0.07 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.675 ' HD1' ' HB ' ' A' ' 532' ' ' ILE . 16.4 m-85 -59.44 -26.14 64.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.72 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.406 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -115.53 -55.28 0.36 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.223 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 17.9 Cg_exo -67.33 -31.92 33.97 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.701 2.267 . . . . 0.0 112.224 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -93.31 -25.93 17.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.606 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -64.63 131.35 46.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.63 -25.07 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.925 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.559 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.25 35.24 4.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.777 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.65 HG23 ' CG ' ' A' ' 517' ' ' TYR . 0.2 OUTLIER -148.36 -28.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -103.85 -43.97 5.17 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 34.44 -72.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.613 0.765 . . . . 0.0 112.497 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 18.2 mt-10 71.87 34.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.032 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.44 -3.62 1.58 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.016 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.784 HD22 HG21 ' A' ' 544' ' ' ILE . 2.4 pt? -143.04 -4.11 0.93 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.538 ' HE1' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -75.81 73.74 2.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.01 0.433 . . . . 0.0 111.602 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.512 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -132.78 27.79 4.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.229 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.56 101.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.626 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -76.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.117 0.484 . . . . 0.0 110.721 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.528 ' H ' HD11 ' A' ' 555' ' ' ILE . 11.9 t70 60.24 18.53 8.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.427 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -125.63 -34.61 0.64 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -88.24 6.19 38.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 0.0 111.045 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.954 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.56 -42.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.266 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.467 ' N ' HG12 ' A' ' 555' ' ' ILE . 4.8 t . . . . . 0 N--CA 1.449 -0.481 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.352 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 9.1 mttm . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.792 0.33 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.72 111.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.968 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.0 m120 -103.88 -51.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.759 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.726 ' CG ' HG21 ' A' ' 555' ' ' ILE . 46.6 Cg_endo -105.41 14.97 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.241 3.294 . . . . 0.0 113.033 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.711 ' C ' HD13 ' A' ' 515' ' ' LEU . 4.9 m120 -126.33 58.13 1.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.229 0.538 . . . . 0.0 109.899 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.968 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -119.31 -54.37 2.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.858 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.675 ' HA ' HG22 ' A' ' 519' ' ' THR . 3.1 p80 -174.75 -54.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.619 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.46 -10.85 0.45 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.694 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.85 -49.69 1.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.517 0.675 . . . . 0.0 109.869 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 516' ' ' HIS . 14.7 t -60.35 -23.29 64.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.48 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -85.02 -56.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.127 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.669 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 8.4 pt20 -100.44 -161.31 0.86 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.043 0.449 . . . . 0.0 111.166 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.456 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -102.92 31.85 3.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.607 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.669 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.9 mp0 45.21 74.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.5 0.667 . . . . 0.0 109.933 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 91.38 -25.74 14.14 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.412 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.648 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.03 10.28 0.11 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.6 16.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.922 0.392 . . . . 0.0 110.54 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.689 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.4 OUTLIER -55.65 -22.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.301 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.52 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 156.32 -38.08 0.59 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.266 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.536 ' O ' ' HD3' ' A' ' 537' ' ' PRO . 4.4 mp 70.39 -38.48 0.42 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.02 -24.62 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.689 ' NE1' HD13 ' A' ' 527' ' ' ILE . 1.9 p-90 -45.98 -27.47 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.564 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.623 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -113.04 165.71 12.6 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.917 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.08 -41.09 0.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.06 2.506 . . . . 0.0 113.232 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.644 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 16.9 p90 -156.31 6.08 0.19 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.713 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -73.95 -26.97 60.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.051 0.453 . . . . 0.0 110.597 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.483 ' HA3' HD11 ' A' ' 532' ' ' ILE . . . -108.49 -55.09 0.59 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.785 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 23.9 Cg_exo -64.33 -37.98 37.09 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.621 2.214 . . . . 0.0 111.788 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -93.25 -5.47 49.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.163 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.912 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -51.73 -72.02 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.772 0.32 . . . . 0.0 110.963 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 70.89 -48.23 0.66 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.409 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -108.41 29.55 9.9 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.968 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.912 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -146.62 -33.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.436 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.701 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -95.36 -43.07 8.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.526 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.77 HD12 ' N ' ' A' ' 544' ' ' ILE . 1.6 mp 37.77 -73.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.545 0.738 . . . . 0.0 112.345 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.701 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.9 mt-10 66.86 85.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.261 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 165.02 -22.13 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.91 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.767 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -133.87 -8.38 2.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.426 ' CE ' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -67.85 64.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 111.811 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.27 46.68 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.568 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 2.4 m-80 68.7 -66.29 0.25 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.46 HE21 HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER 49.53 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.901 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.7 m-20 59.89 20.06 9.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.187 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -133.17 -34.12 0.34 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.916 HD12 HG23 ' A' ' 555' ' ' ILE . 3.0 pp -86.96 8.32 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.326 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.916 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -143.91 -42.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.159 0.504 . . . . 0.0 111.087 -178.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.494 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.19 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.787 0.327 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 95.1 m 61.72 101.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.764 ' O ' HD11 ' A' ' 515' ' ' LEU . 5.4 m120 -99.04 -50.31 0.21 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.763 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.832 ' CG ' HG21 ' A' ' 555' ' ' ILE . 38.3 Cg_endo -101.54 16.17 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.048 3.166 . . . . 0.0 112.593 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.538 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.4 m120 -119.91 54.4 1.02 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.809 HD23 ' HE1' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -99.11 -47.74 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.415 -178.23 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.597 ' N ' HG22 ' A' ' 519' ' ' THR . 5.9 p80 -175.61 -52.76 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.809 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -61.55 -24.5 66.69 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.329 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.732 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -116.61 -39.8 3.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.181 0.515 . . . . 0.0 110.838 -177.447 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 516' ' ' HIS . 5.5 t -57.89 -21.47 43.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.527 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.67 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -105.15 -67.12 0.93 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.087 0.47 . . . . 0.0 111.225 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.67 ' N ' HG22 ' A' ' 520' ' ' THR . 9.5 pt20 -99.88 -160.84 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.782 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.761 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -94.73 34.7 1.3 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.31 -179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.681 ' CD ' HD13 ' A' ' 544' ' ' ILE . 16.1 mt-10 60.69 20.09 10.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.547 ' C ' HD11 ' A' ' 527' ' ' ILE . . . 98.38 32.84 5.89 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.165 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.761 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -117.34 3.63 12.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -92.29 18.3 8.5 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.901 0.381 . . . . 0.0 111.146 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.1 OUTLIER -124.75 -53.4 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.658 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 150.52 -19.96 1.03 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.794 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.64 HD11 ' HA ' ' A' ' 525' ' ' ALA . 7.1 mp 72.98 -20.74 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.22 -20.93 47.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.175 0.512 . . . . 0.0 111.268 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.681 ' HE1' HD13 ' A' ' 527' ' ' ILE . 7.3 p-90 -69.07 -13.7 62.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.774 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.8 OUTLIER -126.26 142.74 43.64 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.063 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.92 -21.6 2.06 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.712 2.274 . . . . 0.0 113.935 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.425 ' HA ' ' CB ' ' A' ' 538' ' ' ALA . 9.7 p90 -150.82 6.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.877 ' HB2' HD12 ' A' ' 532' ' ' ILE . 22.7 m-85 -82.3 -39.54 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -112.55 -61.44 0.44 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.452 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.53 -39.69 74.17 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.392 2.062 . . . . 0.0 111.903 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -85.02 -37.12 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.285 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -46.25 164.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.518 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -147.11 -43.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.55 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.99 23.25 21.77 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.645 HG23 ' CD2' ' A' ' 517' ' ' TYR . 0.1 OUTLIER -139.99 -18.52 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.463 0.173 . . . . 0.0 111.046 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.818 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -122.85 -3.08 8.69 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.533 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.719 ' O ' ' HG3' ' A' ' 545' ' ' GLU . 1.5 mp 4.69 -51.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.805 1.242 . . . . 0.0 114.044 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.818 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.6 pt-20 44.44 79.18 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 546' ' ' GLY . . . . . 0.412 ' O ' ' CE1' ' A' ' 549' ' ' HIS . . . 172.79 -25.61 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.839 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.687 HD22 HG21 ' A' ' 544' ' ' ILE . 1.6 pt? -125.78 -12.23 6.57 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.424 ' HG3' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -68.01 71.94 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 111.174 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.412 ' CE1' ' O ' ' A' ' 546' ' ' GLY . 1.4 m-70 -124.94 26.35 7.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.708 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 59.23 61.58 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.403 ' OE1' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -87.12 -70.94 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.578 . . . . 0.0 110.64 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 556' ' ' CYS . 1.1 m-20 63.2 19.28 11.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.092 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.52 -30.62 1.37 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.883 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.977 HD12 HG23 ' A' ' 555' ' ' ILE . 1.9 pp -88.79 2.23 53.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.756 0.313 . . . . 0.0 111.119 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.977 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -147.52 -40.95 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.293 0.568 . . . . 0.0 110.658 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 552' ' ' ASP . 1.6 m . . . . . 0 N--CA 1.449 -0.486 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.176 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.825 0.345 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 514' ' ' ASN . 0.0 OUTLIER 59.66 98.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.559 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.958 ' O ' HD21 ' A' ' 515' ' ' LEU . 7.2 m120 -95.66 -50.58 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.878 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.809 ' CG ' HG21 ' A' ' 555' ' ' ILE . 57.7 Cg_endo -105.45 16.39 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.224 3.282 . . . . 0.0 113.04 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.727 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.7 m120 -123.76 57.91 1.17 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.561 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.958 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.43 -52.82 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.99 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.655 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 1.9 p80 -176.97 -56.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.332 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.655 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.41 -13.52 0.6 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.716 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.07 -43.84 2.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.372 0.606 . . . . 0.0 110.037 -177.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.528 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.7 t -70.96 -22.06 62.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.804 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.34 -56.15 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.822 0.344 . . . . 0.0 111.601 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.584 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 7.9 pt20 -100.46 -157.85 0.63 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.456 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -102.67 32.72 3.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.317 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.685 ' OE1' HD21 ' A' ' 547' ' ' LEU . 4.3 mt-10 44.75 74.02 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.949 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.442 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.13 -24.81 20.07 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.595 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.1 9.99 0.26 Allowed 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.98 16.48 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 110.614 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.595 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.53 -24.24 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.296 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.55 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 158.55 -52.49 0.39 Allowed Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.176 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.582 HD21 ' HD2' ' A' ' 543' ' ' TYR . 3.4 mp 75.28 -21.4 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.799 0.44 . . . . 0.0 112.048 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.41 -26.42 41.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.241 0.543 . . . . 0.0 110.922 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.593 ' CE2' HD13 ' A' ' 532' ' ' ILE . 4.7 p-90 -63.03 -16.52 60.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.715 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.874 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.3 pt -126.06 135.69 27.45 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.022 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 1.2 Cg_endo -84.48 -20.43 3.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.957 2.438 . . . . 0.0 113.889 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.508 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 9.0 p90 -146.65 6.34 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.934 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 15.1 m-85 -87.72 -39.91 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.033 0.444 . . . . 0.0 110.793 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -110.44 -60.54 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.506 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.94 -37.2 85.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.41 2.073 . . . . 0.0 111.576 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -93.18 -17.21 23.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.25 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.994 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -48.84 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.606 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 21.0 mt-10 76.72 -44.96 0.48 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.484 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -110.14 33.44 6.0 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.994 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -151.06 -33.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.138 0.494 . . . . 0.0 110.416 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.708 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -97.6 -37.75 9.81 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.162 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.937 HG21 HD22 ' A' ' 547' ' ' LEU . 1.0 OUTLIER 37.53 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.436 0.694 . . . . 0.0 112.567 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.708 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.1 mt-10 66.05 86.09 0.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.025 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 159.24 -16.7 0.24 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.369 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.937 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -129.6 -13.28 4.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.489 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -69.11 69.16 0.19 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.137 0.494 . . . . 0.0 111.299 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -120.74 -53.18 2.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.71 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.414 ' C ' ' HG3' ' A' ' 551' ' ' GLN . 22.8 t-20 -179.11 -57.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.491 ' OE1' HD11 ' A' ' 554' ' ' LEU . 0.0 OUTLIER 27.12 -91.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.408 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.443 ' OD1' ' ND2' ' A' ' 514' ' ' ASN . 0.4 OUTLIER 63.95 15.72 9.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.035 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -127.51 -29.35 0.84 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.946 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.934 HD12 HG23 ' A' ' 555' ' ' ILE . 2.2 pp -80.97 1.65 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.934 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -141.49 -42.62 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.769 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.53 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.199 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.726 0.298 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.3 m 60.78 107.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.167 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.902 ' O ' HD21 ' A' ' 515' ' ' LEU . 4.4 m120 -90.9 -51.08 0.32 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.733 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.675 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 74.5 Cg_endo -105.92 20.94 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.315 3.343 . . . . 0.0 112.623 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.655 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.5 m120 -118.35 51.99 1.05 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.501 0.667 . . . . 0.0 109.232 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.902 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -109.35 -56.75 2.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.133 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 3.2 p80 -174.93 -57.14 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.712 0.291 . . . . 0.0 111.366 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.629 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -56.23 -15.63 4.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.08 -29.82 4.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.021 0.439 . . . . 0.0 111.325 -177.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.625 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 3.0 t -77.5 -20.43 54.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.288 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.667 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.84 -67.65 0.84 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.667 ' N ' HG22 ' A' ' 520' ' ' THR . 8.3 pt20 -99.9 -156.82 0.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.554 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -98.35 34.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.404 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.842 ' OE1' HD13 ' A' ' 544' ' ' ILE . 62.2 mt-10 56.93 34.08 24.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.547 0.689 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.562 ' C ' HD11 ' A' ' 527' ' ' ILE . . . 80.14 32.36 35.79 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.311 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.545 ' HA ' HD11 ' A' ' 529' ' ' LEU . . . -117.88 1.96 12.13 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -91.56 19.49 6.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.692 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.1 OUTLIER -124.27 -52.7 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.642 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.89 -18.45 1.09 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.986 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.85 HD21 ' CD ' ' A' ' 545' ' ' GLU . 6.8 mp 73.21 -25.6 0.19 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.27 -24.65 42.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.234 0.54 . . . . 0.0 111.433 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.686 ' CE2' HD13 ' A' ' 532' ' ' ILE . 5.9 p-90 -62.53 -16.02 53.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.852 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.902 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.1 pt -125.91 140.99 38.14 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.362 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -89.3 -18.88 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.867 2.378 . . . . 0.0 113.826 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.97 6.14 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.902 ' HB2' HD12 ' A' ' 532' ' ' ILE . 13.9 m-85 -86.03 -40.34 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.014 0.435 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.4 ' H ' ' HD2' ' A' ' 537' ' ' PRO . . . -112.96 -62.17 0.44 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.443 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.4 ' HD2' ' H ' ' A' ' 536' ' ' GLY . 54.4 Cg_exo -50.16 -38.88 51.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.211 1.94 . . . . 0.0 111.686 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -86.34 -31.24 21.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -51.07 169.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.447 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -153.5 -41.01 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.488 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -113.25 33.37 5.6 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -149.66 -31.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.791 ' HA ' ' O ' ' A' ' 523' ' ' GLU . 0.3 OUTLIER -103.02 -44.77 5.13 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.451 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 1.037 HG21 HD22 ' A' ' 547' ' ' LEU . 1.2 mp 42.09 -72.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 112.666 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.85 ' CD ' HD21 ' A' ' 529' ' ' LEU . 3.0 mm-40 69.34 29.08 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.6 -1.93 1.81 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.798 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 1.037 HD22 HG21 ' A' ' 544' ' ' ILE . 1.5 pt? -139.88 -10.17 1.17 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.561 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.19 66.58 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -119.31 24.49 10.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.388 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 65.35 64.29 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.732 ' CB ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -110.65 -177.63 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.802 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 556' ' ' CYS . 18.3 p-10 -179.43 -22.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.346 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.4 32.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.411 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 551' ' ' GLN . 0.8 OUTLIER -85.53 -0.99 56.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.6 0.238 . . . . 0.0 111.526 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.756 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.1 OUTLIER -145.28 -40.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 111.342 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.1 t . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.304 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.87 0.367 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 99.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.962 ' O ' HD21 ' A' ' 515' ' ' LEU . 5.6 m120 -100.8 -51.28 0.18 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.67 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.879 ' CG ' HG21 ' A' ' 555' ' ' ILE . 56.2 Cg_endo -104.46 17.84 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.293 3.329 . . . . 0.0 112.548 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.705 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.9 m120 -121.24 57.46 1.0 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.962 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.3 -51.36 2.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.27 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.627 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 2.4 p80 -176.89 -56.67 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.668 ' CD2' HG23 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -55.09 -16.17 2.75 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.731 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.29 -41.05 2.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.1 t -62.61 -27.62 69.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.463 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.648 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -88.33 -62.83 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.048 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.648 ' N ' HG22 ' A' ' 520' ' ' THR . 9.0 pt20 -99.84 -165.08 1.18 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.405 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . 2.9 m-20 -103.11 34.87 2.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.603 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.625 ' OE1' HD13 ' A' ' 544' ' ' ILE . 13.5 mt-10 45.56 31.5 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.534 0.683 . . . . 0.0 110.301 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 161.73 -30.32 0.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 57.54 12.6 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.88 15.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.805 HG13 ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -70.55 -13.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.654 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.555 ' N ' HD12 ' A' ' 527' ' ' ILE . . . 158.2 -57.36 0.35 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.863 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.1 OUTLIER 79.81 -27.91 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.96 -3.86 47.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.595 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 10.9 p-90 -81.75 -4.36 56.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.881 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.595 HD13 ' CZ2' ' A' ' 531' ' ' TRP . 1.0 OUTLIER -132.61 61.59 57.71 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.069 -177.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -37.44 -47.14 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.471 2.78 . . . . 0.0 114.075 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.662 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 8.3 p90 -113.73 6.31 16.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.893 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 11.3 t80 -114.06 -19.73 11.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.704 0.288 . . . . 0.0 111.532 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.503 ' HA3' HG13 ' A' ' 532' ' ' ILE . . . -113.49 -74.42 0.65 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.271 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 33.4 Cg_exo -61.73 -32.81 86.54 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.57 2.18 . . . . 0.0 111.209 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -90.72 -16.26 28.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.62 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 1.014 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -51.95 -58.41 6.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 70.78 -53.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.508 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -106.03 32.7 7.11 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.819 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 1.014 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -150.74 -30.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.691 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.3 OUTLIER -100.48 -44.78 5.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.905 HG21 HD22 ' A' ' 547' ' ' LEU . 1.2 mp 40.65 -72.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.493 0.717 . . . . 0.0 112.62 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.8 mt-10 69.6 33.99 2.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.141 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -142.17 2.1 1.77 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.002 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.905 HD22 HG21 ' A' ' 544' ' ' ILE . 2.1 pt? -143.49 -8.89 0.75 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.469 ' HB3' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -76.95 74.39 3.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.075 0.464 . . . . 0.0 111.232 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.469 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -134.25 27.98 3.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.082 179.199 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.49 87.16 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.71 -77.13 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.778 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.459 ' OD2' ' ND2' ' A' ' 514' ' ' ASN . 0.8 OUTLIER 62.62 24.77 14.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.91 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.19 -34.47 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.919 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.957 HD12 HG23 ' A' ' 555' ' ' ILE . 2.3 pp -85.57 2.64 44.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 111.307 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.957 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.53 -42.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.057 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.83 0.348 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 59.27 92.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.899 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.3 m120 -91.96 -50.88 0.3 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.457 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.956 ' CG ' HG21 ' A' ' 555' ' ' ILE . 57.6 Cg_endo -104.45 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.402 3.402 . . . . 0.0 112.397 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.709 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.8 m120 -121.84 57.98 1.03 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.899 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.38 -48.31 3.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.307 -178.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.638 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 1.6 p80 -178.48 -56.94 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.797 0.332 . . . . 0.0 111.408 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.664 ' CD2' HG23 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -56.93 -16.33 6.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.711 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -124.23 -38.17 2.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.122 0.486 . . . . 0.0 110.639 -177.59 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.562 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.6 t -65.75 -24.52 66.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.298 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.573 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -90.29 -60.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.743 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 6.7 pt20 -100.39 -168.31 1.56 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 548' ' ' MET . 1.1 m-20 -103.25 31.4 4.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.393 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.743 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 4.1 mt-10 45.5 29.02 0.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 110.333 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 526' ' ' ALA . . . 152.96 -23.55 0.8 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.58 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 1.087 ' HB3' HD13 ' A' ' 527' ' ' ILE . . . 32.24 26.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.06 16.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.789 0.328 . . . . 0.0 111.544 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 1.087 HD13 ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.17 -33.73 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.315 0.579 . . . . 0.0 110.034 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 166.66 -39.82 0.25 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.763 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 529' ' ' LEU . 3.3 mp 72.23 -18.01 0.34 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.15 -19.2 51.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.293 0.568 . . . . 0.0 110.876 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.477 ' CD2' HG23 ' A' ' 532' ' ' ILE . 8.6 p-90 -74.96 -10.43 59.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.517 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -125.28 59.52 24.88 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.58 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -42.58 -41.6 8.1 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.071 2.514 . . . . 0.0 113.559 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 8.0 p90 -115.45 6.25 14.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 10.3 t80 -114.79 -24.36 8.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.443 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -112.39 -90.98 1.95 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.623 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 83.6 Cg_exo -42.93 -43.65 9.28 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.674 2.249 . . . . 0.0 112.017 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -73.34 -31.3 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.48 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.832 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -65.8 150.66 48.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.283 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -133.37 -32.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -117.25 30.5 6.23 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.832 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -142.42 -31.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -105.5 -31.76 8.84 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.902 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 547' ' ' LEU . 2.5 mp 33.27 -71.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.637 0.775 . . . . 0.0 112.699 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 32.6 mt-10 70.8 35.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.256 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -141.1 0.3 1.78 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.727 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 544' ' ' ILE . 2.5 pt? -146.92 -5.52 0.52 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 522' ' ' ASP . 0.0 OUTLIER -78.63 76.55 5.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.5 28.47 3.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.073 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.79 89.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.434 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.528 ' OE1' HD11 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -119.52 -78.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 67.43 23.41 9.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.632 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.47 -34.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.994 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.865 HD12 HG23 ' A' ' 555' ' ' ILE . 2.1 pp -81.99 1.24 36.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.956 HG21 ' CG ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -140.69 -42.61 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.067 0.461 . . . . 0.0 110.816 -179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.501 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.114 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.763 0.316 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 40.1 m 60.76 117.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.979 ' O ' HD21 ' A' ' 515' ' ' LEU . 4.3 m120 -106.78 -52.49 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.465 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.609 ' CD ' HG13 ' A' ' 555' ' ' ILE . 57.5 Cg_endo -106.51 16.93 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 124.304 3.336 . . . . 0.0 112.448 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.716 ' C ' HD13 ' A' ' 515' ' ' LEU . 5.1 m120 -122.56 53.78 1.24 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.318 0.58 . . . . 0.0 109.812 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.979 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.54 -69.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.858 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.758 ' HA ' HG22 ' A' ' 519' ' ' THR . 3.5 p80 -159.64 -55.2 0.06 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.369 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.602 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.92 -8.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -124.82 -44.47 1.94 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.548 0.689 . . . . 0.0 110.51 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 516' ' ' HIS . 13.1 t -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.7 OUTLIER -82.51 -64.79 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.846 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.654 ' N ' HG22 ' A' ' 520' ' ' THR . 9.1 pt20 -99.89 -160.37 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.357 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -103.04 34.48 2.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.478 -179.548 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.599 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.2 mt-10 44.55 34.46 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 140.66 -40.34 1.38 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.223 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.66 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 57.28 8.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.43 15.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 110.792 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.66 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -54.55 -24.54 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.539 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 172.52 -51.67 0.17 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.792 HD21 ' OE2' ' A' ' 545' ' ' GLU . 3.5 mp 77.99 -18.4 0.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.776 0.43 . . . . 0.0 111.986 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.8 45.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.417 0.627 . . . . 0.0 110.164 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.502 ' NE1' HD13 ' A' ' 527' ' ' ILE . 1.8 p-90 -66.07 -15.72 63.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.742 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -124.01 64.07 33.13 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -177.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.39 -36.56 17.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.897 2.398 . . . . 0.0 113.503 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.492 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 4.7 p90 -121.27 6.19 10.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.617 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 8.1 t80 -112.19 -26.46 8.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.648 0.261 . . . . 0.0 111.406 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -111.84 -90.88 1.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.585 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 82.0 Cg_exo -40.45 -44.01 4.22 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.915 2.41 . . . . 0.0 112.095 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -73.39 -35.3 65.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.425 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.876 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -58.15 157.18 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.989 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.31 -34.08 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.478 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.483 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -117.67 36.73 3.56 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.876 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -148.69 -36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.226 0.536 . . . . 0.0 109.849 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.689 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -100.09 -33.94 10.26 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.21 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.597 ' CG2' HD22 ' A' ' 547' ' ' LEU . 1.6 mp 32.31 -72.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.913 0.885 . . . . 0.0 113.025 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.792 ' OE2' HD21 ' A' ' 529' ' ' LEU . 20.0 mt-10 68.85 96.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.176 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 140.93 -9.36 2.79 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.844 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.669 HD11 ' HZ3' ' A' ' 518' ' ' TRP . 1.5 pt? -129.93 -1.66 4.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.599 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -72.62 85.26 1.17 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -130.79 -48.83 1.04 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.417 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 167.73 -73.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' A' ' 552' ' ' ASP . 0.0 OUTLIER 57.04 -152.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.667 ' H ' HD11 ' A' ' 555' ' ' ILE . 13.0 t70 110.49 21.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.105 0.962 . . . . 0.0 110.527 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -141.34 0.14 1.7 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.489 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.953 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -127.12 2.46 6.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.995 0.518 . . . . 0.0 110.332 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.953 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -147.1 -41.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.629 -178.584 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.537 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.6 t . . . . . 0 N--CA 1.449 -0.507 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.971 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.646 0.26 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 57.94 98.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.327 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.971 ' O ' HD21 ' A' ' 515' ' ' LEU . 4.9 m120 -101.83 -51.28 0.16 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.643 ' CG ' HG21 ' A' ' 555' ' ' ILE . 48.4 Cg_endo -104.03 15.41 0.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.052 3.168 . . . . 0.0 113.122 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.708 ' C ' HD13 ' A' ' 515' ' ' LEU . 4.1 m120 -125.61 59.16 1.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.237 0.542 . . . . 0.0 109.608 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.971 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -119.45 -52.06 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.032 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.635 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 3.0 p80 -176.63 -55.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.324 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.681 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -54.44 -13.54 0.96 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.74 -45.64 2.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.449 0.643 . . . . 0.0 110.156 -177.264 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 2.1 t -65.64 -25.84 67.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.656 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -80.94 -56.97 3.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.251 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 8.0 pt20 -100.68 -162.32 0.93 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.144 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.43 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -103.05 35.96 2.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.496 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.863 ' OE1' HD21 ' A' ' 547' ' ' LEU . 26.3 mt-10 43.9 73.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.097 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.494 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.73 -21.65 35.04 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.989 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.604 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 53.77 11.08 0.29 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.11 16.23 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.481 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.635 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.5 OUTLIER -55.01 -22.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.261 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.542 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 157.61 -34.72 0.54 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.354 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.781 HD11 ' CD2' ' A' ' 543' ' ' TYR . 3.6 mt 69.29 -56.87 0.54 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 111.586 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.74 46.16 0.75 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.363 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.635 ' NE1' HD13 ' A' ' 527' ' ' ILE . 2.9 p-90 -120.28 -18.82 7.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.528 HG21 ' HD2' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -108.63 159.47 30.79 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.055 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.463 ' HG2' ' CE1' ' A' ' 535' ' ' PHE . 18.5 Cg_endo -59.37 -48.57 13.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.6 2.2 . . . . 0.0 112.868 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.669 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 49.0 p90 -156.58 6.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.811 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.5 OUTLIER -72.5 -26.42 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.88 0.371 . . . . 0.0 111.081 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -108.4 -58.84 0.55 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.878 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.44 -35.6 76.34 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.389 2.059 . . . . 0.0 111.71 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -92.52 -12.14 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.381 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.816 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -75.28 122.51 23.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.366 . . . . 0.0 111.503 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -124.18 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.499 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -120.08 35.27 3.85 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.816 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -146.99 -33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.074 0.464 . . . . 0.0 110.333 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.781 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.3 OUTLIER -97.3 -40.02 8.95 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.733 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.889 HG21 HD22 ' A' ' 547' ' ' LEU . 1.5 mp 36.96 -72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.466 0.707 . . . . 0.0 112.364 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.714 ' N ' ' O ' ' A' ' 543' ' ' TYR . 25.1 mt-10 66.21 94.8 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.54 -4.75 1.51 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.998 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 544' ' ' ILE . 2.4 pt? -128.59 -10.25 5.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.336 0.568 . . . . 0.0 112.369 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.73 78.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.908 0.385 . . . . 0.0 111.032 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -133.72 27.13 4.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.638 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 1.3 m120 54.21 63.74 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.355 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.43 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -86.19 -79.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.043 -179.33 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.57 ' H ' HD11 ' A' ' 555' ' ' ILE . 0.5 OUTLIER 64.71 12.86 7.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.265 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -118.37 -34.61 1.09 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.592 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.997 HD12 HG23 ' A' ' 555' ' ' ILE . 2.1 pp -87.48 2.93 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.997 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.64 -40.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.275 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.973 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.844 0.354 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.4 m 60.1 86.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.007 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.827 ' O ' HD21 ' A' ' 515' ' ' LEU . 8.7 m120 -83.37 -49.22 0.73 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.95 ' CG ' HG21 ' A' ' 555' ' ' ILE . 36.8 Cg_endo -102.2 16.05 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.256 3.304 . . . . 0.0 112.098 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.623 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.4 m120 -120.42 56.64 0.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.827 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -105.77 -48.0 3.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.302 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.625 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 2.6 p80 -177.62 -56.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.353 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.712 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -57.11 -20.44 25.56 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -120.75 -41.23 2.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 0.0 110.999 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.596 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 7.4 t -57.2 -30.15 64.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.18 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.699 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -94.42 -70.11 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.891 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.699 ' N ' HG22 ' A' ' 520' ' ' THR . 3.6 pt20 -99.75 -168.18 1.57 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.451 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.846 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 3.7 m-20 -89.93 22.17 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.904 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.584 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.9 mt-10 69.94 5.51 5.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.983 0.421 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 128.63 17.16 1.94 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.066 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.846 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -99.64 -6.1 27.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.798 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -89.17 18.99 4.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.821 0.343 . . . . 0.0 111.413 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -136.09 -50.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 -179.339 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 159.92 -27.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.755 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.815 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 81.01 -28.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.8 -21.29 48.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.849 0.357 . . . . 0.0 111.869 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.805 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.0 p-90 -53.61 -24.59 14.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 110.587 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.805 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.3 OUTLIER -115.52 119.34 38.11 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.271 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.45 ' HG2' ' CE2' ' A' ' 534' ' ' TYR . 74.9 Cg_endo -90.12 31.97 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.715 2.276 . . . . 0.0 114.19 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.559 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 8.1 p90 172.2 -34.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 111.044 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.91 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 2.3 t80 -71.89 -21.15 61.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.67 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -116.69 -71.46 0.45 Allowed Glycine 0 C--N 1.32 -0.344 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.34 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HD3' HG13 ' A' ' 532' ' ' ILE . 51.2 Cg_exo -52.5 -39.46 74.42 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.485 2.123 . . . . 0.0 111.581 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -91.84 -17.35 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.117 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 1.018 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -45.25 -52.01 10.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.873 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 2.0 mt-10 71.85 -58.91 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.433 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -103.96 26.13 24.16 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.348 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 1.018 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -149.05 1.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 O-C-N 122.778 -0.248 . . . . 0.0 111.664 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.815 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.8 OUTLIER -129.33 -42.95 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.482 0.182 . . . . 0.0 110.725 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.994 HG21 HD22 ' A' ' 547' ' ' LEU . 3.3 mp 34.34 -73.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.444 0.698 . . . . 0.0 112.554 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.712 ' N ' ' O ' ' A' ' 543' ' ' TYR . 20.8 mt-10 64.02 34.98 10.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.356 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -147.17 13.43 1.45 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.54 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.994 HD22 HG21 ' A' ' 544' ' ' ILE . 1.1 pt? -157.87 -17.86 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.526 ' N ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -70.07 63.14 0.22 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.78 -43.03 3.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.649 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 552' ' ' ASP . 0.9 OUTLIER 172.89 -75.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.472 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER 41.19 -85.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.368 179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.3 OUTLIER 63.65 18.27 10.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -123.79 -31.44 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.187 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.957 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -77.52 -2.55 36.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.611 0.243 . . . . 0.0 111.305 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.957 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.91 -39.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.104 0.478 . . . . 0.0 110.897 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.504 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.417 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.877 0.37 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 97.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.987 ' O ' HD21 ' A' ' 515' ' ' LEU . 7.2 m120 -94.84 -50.37 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.683 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.848 ' CG ' HG21 ' A' ' 555' ' ' ILE . 74.4 Cg_endo -107.13 16.88 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.374 3.383 . . . . 0.0 112.902 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.796 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.8 m120 -119.22 56.62 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.676 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.87 -58.7 1.99 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.104 -179.118 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.649 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 2.6 p80 -173.85 -56.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.482 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.649 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.18 -12.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.708 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -122.49 -40.57 2.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -177.464 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.611 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.0 t -74.4 -21.11 59.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.648 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.49 -56.5 3.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 0.0 111.538 -179.009 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.589 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 7.7 pt20 -100.45 -158.13 0.65 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.46 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 9.0 m-20 -102.72 32.84 3.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.701 ' OE1' HD13 ' A' ' 544' ' ' ILE . 4.7 mt-10 44.67 73.99 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.963 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.449 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.12 -24.58 21.16 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.28 10.0 0.28 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.03 16.52 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.416 . . . . 0.0 110.539 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.598 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.97 -24.13 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.343 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.548 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 158.19 -52.68 0.4 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.328 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.609 HD21 ' CD2' ' A' ' 543' ' ' TYR . 3.8 mp 75.07 -22.18 0.27 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.868 0.467 . . . . 0.0 112.115 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.29 -24.82 42.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.162 0.506 . . . . 0.0 111.135 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.632 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 6.2 p-90 -64.27 -15.23 59.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.757 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.865 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.0 OUTLIER -126.31 139.27 34.12 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.191 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.91 -20.2 2.42 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.777 2.318 . . . . 0.0 113.892 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.0 p90 -148.21 6.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.936 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 18.6 m-85 -86.63 -40.49 15.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.027 0.441 . . . . 0.0 110.701 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -110.3 -60.4 0.5 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.367 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.76 -37.55 84.52 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.346 2.031 . . . . 0.0 111.551 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -92.65 -17.54 24.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.174 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 1.012 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -49.29 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.517 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 22.8 mt-10 76.15 -44.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.462 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -110.2 32.41 6.69 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.655 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 1.012 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -149.95 -32.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.065 0.46 . . . . 0.0 110.543 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.728 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -98.2 -39.86 8.66 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.958 HG21 HD22 ' A' ' 547' ' ' LEU . 1.0 OUTLIER 36.14 -72.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.396 0.679 . . . . 0.0 112.538 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.728 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.9 mt-10 67.0 33.38 5.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.042 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -138.5 -3.75 1.79 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.886 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.958 HD22 HG21 ' A' ' 544' ' ' ILE . 1.7 pt? -144.72 -8.24 0.65 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.467 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.46 68.14 0.36 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.957 0.408 . . . . 0.0 111.859 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -133.16 34.04 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.266 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 43.9 t30 55.67 95.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.655 ' OE1' HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -125.45 -76.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.27 24.76 7.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.884 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.94 -35.75 0.38 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.057 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 555' ' ' ILE . 2.5 pp -82.3 1.67 35.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 111.261 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.909 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -140.59 -42.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 110.872 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.499 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.994 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.845 0.355 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.473 ' HA ' HD13 ' A' ' 555' ' ' ILE . 0.6 OUTLIER 63.62 98.36 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.797 ' O ' HD21 ' A' ' 515' ' ' LEU . 7.3 m120 -97.5 -50.8 0.22 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.669 ' CG ' HG21 ' A' ' 555' ' ' ILE . 36.3 Cg_endo -101.93 16.37 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.921 3.08 . . . . 0.0 112.319 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.523 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.5 m120 -119.61 52.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -98.98 -48.63 4.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.354 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.0 p80 -177.04 -53.04 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.772 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -60.17 -23.03 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.733 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -118.01 -39.48 3.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.0 110.959 -177.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.576 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 5.2 t -58.52 -27.78 64.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.542 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.674 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -97.8 -67.59 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.465 -179.135 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.674 ' N ' HG22 ' A' ' 520' ' ' THR . 4.8 pt20 -99.52 -168.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.771 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.1 OUTLIER -87.23 24.26 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.883 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.662 ' OE2' HD21 ' A' ' 547' ' ' LEU . 16.9 mt-10 68.57 4.87 4.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.06 0.457 . . . . 0.0 111.073 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 123.7 22.62 2.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.966 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -110.28 4.4 20.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -93.16 12.67 23.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.859 0.361 . . . . 0.0 111.657 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.636 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -129.7 -45.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.292 -179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 150.85 -17.2 0.94 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.467 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.6 OUTLIER 73.72 -51.53 0.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 45.1 0.64 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.384 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.636 ' NE1' HD13 ' A' ' 527' ' ' ILE . 3.2 p-90 -119.87 -16.92 8.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.577 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.536 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.24 159.93 32.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.699 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 37.6 Cg_endo -66.3 -45.2 5.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.3 2.0 . . . . 0.0 112.491 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 18.5 p90 -161.57 6.68 0.07 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.865 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 1.1 m-85 -66.0 -26.85 67.73 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.118 -0.364 . . . . 0.0 111.4 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.48 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.48 -63.5 0.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.609 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.07 -39.3 80.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.356 2.038 . . . . 0.0 111.835 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 534' ' ' TYR . . . -95.3 -4.58 45.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.533 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.865 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -54.15 -61.73 2.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 32.4 mt-10 72.61 -58.26 0.6 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -102.91 22.59 36.44 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.312 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.862 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -144.66 -5.84 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.711 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -125.53 -37.17 2.37 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.47 0.176 . . . . 0.0 111.131 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.892 HG21 HD22 ' A' ' 547' ' ' LEU . 2.1 mp 36.7 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.471 0.708 . . . . 0.0 112.582 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 543' ' ' TYR . 36.9 mt-10 65.47 96.92 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.976 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.39 -8.27 1.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.709 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.892 HD22 HG21 ' A' ' 544' ' ' ILE . 2.1 pt? -128.15 -9.38 5.33 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.42 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.44 76.3 0.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.349 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -134.62 36.16 3.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.101 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.5 m-20 70.38 -64.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.151 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 42.66 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.963 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.1 OUTLIER 59.63 16.53 5.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -115.17 -34.79 1.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.697 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -80.69 -3.85 52.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.847 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 556' ' ' CYS . 2.9 pp -145.19 -29.95 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.485 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.731 ' N ' HD12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.145 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.902 0.382 . . . . 0.0 110.602 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.74 109.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.833 ' C ' HD11 ' A' ' 515' ' ' LEU . 6.7 m120 -97.03 -50.35 0.23 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.958 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 23.9 Cg_endo -99.86 -1.67 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.791 2.994 . . . . 0.0 113.208 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.811 ' C ' HD13 ' A' ' 515' ' ' LEU . 5.4 m120 -106.06 66.2 0.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.886 HD23 ' CE1' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -133.27 -30.46 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.886 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -173.0 -78.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.649 ' CB ' HG23 ' A' ' 542' ' ' ILE . 0.4 OUTLIER -67.4 12.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -177.692 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.697 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -139.26 -39.57 0.48 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.305 0.574 . . . . 0.0 109.66 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.537 HG22 ' N ' ' A' ' 516' ' ' HIS . 0.8 OUTLIER -78.62 -13.17 59.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.379 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.5 OUTLIER -95.84 -59.76 1.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.626 0.251 . . . . 0.0 110.873 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.547 ' N ' ' CG2' ' A' ' 520' ' ' THR . 9.3 pt20 -100.7 -158.02 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.301 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.418 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 2.4 m-20 -103.02 34.27 2.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.857 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.712 ' OE1' HD13 ' A' ' 544' ' ' ILE . 20.9 mt-10 47.07 71.95 0.28 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 110.269 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.6 -19.47 47.62 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.117 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.59 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.24 11.35 0.38 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.55 16.2 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.023 0.44 . . . . 0.0 110.507 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.59 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -54.17 -22.96 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.482 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.554 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 162.15 -53.31 0.31 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.245 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 2.8 mp 75.51 -20.06 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.6 0.36 . . . . 0.0 111.813 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.5 -24.17 42.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.175 0.512 . . . . 0.0 111.106 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.592 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 7.1 p-90 -63.84 -14.37 52.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.846 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.862 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.9 OUTLIER -125.62 140.23 35.98 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.164 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -87.42 -20.06 2.21 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.763 2.308 . . . . 0.0 113.982 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.505 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.56 6.24 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.862 ' HB2' HD12 ' A' ' 532' ' ' ILE . 18.6 m-85 -86.64 -38.49 17.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 110.93 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -113.73 -60.66 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.595 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.88 -40.07 76.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.434 2.089 . . . . 0.0 111.609 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -84.54 -27.71 27.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.727 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.768 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.07 158.82 6.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.492 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -151.32 -34.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.307 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.54 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -115.44 34.72 4.66 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.489 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.3 OUTLIER -149.92 -33.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.044 0.45 . . . . 0.0 110.163 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -103.33 -44.68 5.09 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.235 -178.852 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.995 HG21 HD22 ' A' ' 547' ' ' LEU . 0.9 OUTLIER 42.4 -72.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.56 0.744 . . . . 0.0 112.755 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.665 ' N ' ' O ' ' A' ' 543' ' ' TYR . 0.4 OUTLIER 69.31 29.91 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.36 -5.7 1.28 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.092 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.995 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -138.94 -6.56 1.44 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.474 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -72.36 63.1 0.53 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 111.615 -178.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -119.08 26.04 9.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.466 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 58.9 80.98 0.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.57 -77.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.784 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.518 ' H ' HD11 ' A' ' 555' ' ' ILE . 14.8 t70 63.24 15.27 8.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.358 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -121.89 -33.46 0.92 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.968 HD12 HG23 ' A' ' 555' ' ' ILE . 1.8 pp -87.84 5.49 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.968 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -146.35 -41.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.454 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.114 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.684 0.278 . . . . 0.0 110.566 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.84 100.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.85 ' C ' HD11 ' A' ' 515' ' ' LEU . 5.9 m120 -103.19 -51.23 0.14 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.947 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.814 ' CG ' HG21 ' A' ' 555' ' ' ILE . 22.2 Cg_endo -100.11 -1.85 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.777 2.985 . . . . 0.0 113.259 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.821 ' C ' HD13 ' A' ' 515' ' ' LEU . 3.8 m120 -103.44 65.66 0.85 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.957 HD23 ' CE1' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -132.16 -22.64 2.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -178.117 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.957 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER 179.83 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.564 ' CB ' HG23 ' A' ' 542' ' ' ILE . 0.5 OUTLIER -62.48 7.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.296 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.759 ' HB2' ' O ' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -135.57 -40.23 0.71 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.369 0.604 . . . . 0.0 109.775 -178.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.736 HG22 ' N ' ' A' ' 516' ' ' HIS . 7.2 t -80.17 -12.54 59.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.945 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.572 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -97.76 -62.38 1.26 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.685 0.278 . . . . 0.0 111.361 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.572 ' N ' ' CG2' ' A' ' 520' ' ' THR . 11.5 pt20 -100.45 -163.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.995 0.426 . . . . 0.0 111.208 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -102.89 32.32 3.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.44 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.785 ' OE1' HD13 ' A' ' 544' ' ' ILE . 3.9 mt-10 41.61 79.56 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.352 0.596 . . . . 0.0 110.097 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 526' ' ' ALA . . . 93.49 -14.93 64.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.934 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 527' ' ' ILE . . . 28.66 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.56 16.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 1.04 HD13 ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.22 -35.6 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 173.99 -38.58 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.134 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.32 -46.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -76.88 -20.04 56.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.3 p-90 -43.69 -29.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 0.0 111.083 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.531 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -104.71 157.56 33.89 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.319 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.458 ' HG2' ' CE1' ' A' ' 535' ' ' PHE . 36.4 Cg_endo -65.11 -44.09 10.21 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.426 2.084 . . . . 0.0 112.363 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 46.1 p90 -161.9 6.56 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.707 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.8 OUTLIER -63.98 -28.51 69.86 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.086 -0.384 . . . . 0.0 110.982 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.517 ' HA3' HD11 ' A' ' 532' ' ' ILE . . . -110.2 -57.83 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.988 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 75.8 Cg_exo -50.33 -46.71 27.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.47 2.114 . . . . 0.0 112.023 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -79.05 -25.8 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.933 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -59.95 141.62 55.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -129.97 -26.13 2.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.56 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.28 38.26 2.96 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.933 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.3 OUTLIER -150.26 -35.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.312 0.577 . . . . 0.0 109.951 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.682 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -103.29 -30.33 10.7 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.089 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.923 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 33.95 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.789 0.835 . . . . 0.0 112.907 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 543' ' ' TYR . 29.1 mt-10 69.13 87.4 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.934 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 157.29 -19.73 0.4 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.152 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.923 HD22 HG21 ' A' ' 544' ' ' ILE . 1.4 pt? -127.7 -18.61 4.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 111.68 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.441 ' HE3' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -58.36 102.85 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.172 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.438 ' NE2' ' HA ' ' A' ' 547' ' ' LEU . 0.4 OUTLIER -179.75 -64.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 178.73 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 175.33 108.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.823 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 -72.6 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.822 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 45.5 28.46 0.5 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.11 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.33 -35.33 0.42 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 1.017 HD12 HG23 ' A' ' 555' ' ' ILE . 1.5 pp -89.65 -4.54 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.735 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 1.017 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.74 -42.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.294 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.527 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.334 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.727 0.299 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 64.84 88.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.864 ' O ' HD21 ' A' ' 515' ' ' LEU . 8.4 m120 -87.74 -49.63 0.44 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.837 ' CG ' HG21 ' A' ' 555' ' ' ILE . 38.6 Cg_endo -102.67 17.51 0.24 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 124.229 3.286 . . . . 0.0 112.232 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.694 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.6 m120 -122.74 57.77 1.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.864 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.99 -52.42 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.357 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.652 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 1.6 p80 -175.76 -56.36 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.054 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.665 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -54.35 -14.83 1.32 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -179.155 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.37 -47.45 2.0 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.406 0.622 . . . . 0.0 110.04 -177.205 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 516' ' ' HIS . 6.4 t -63.79 -26.15 68.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -81.43 -56.5 4.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.56 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.609 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 8.5 pt20 -100.54 -161.92 0.9 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.038 0.447 . . . . 0.0 111.283 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.444 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.2 m-20 -102.95 34.37 2.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.569 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.759 ' OE1' HD21 ' A' ' 547' ' ' LEU . 20.1 mt-10 43.56 77.28 0.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.854 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 93.72 -23.44 30.64 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.0 10.68 0.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.13 15.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.01 0.433 . . . . 0.0 110.644 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.603 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -55.21 -22.35 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.366 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.558 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 155.45 -48.36 0.49 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.999 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.1 mp 74.68 -47.02 0.62 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.833 0.453 . . . . 0.0 111.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.54 43.98 0.59 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.572 ' CE2' HD13 ' A' ' 532' ' ' ILE . 4.3 p-90 -121.87 -13.9 8.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.829 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.65 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -117.64 169.67 7.23 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.882 -179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 75.9 Cg_endo -92.73 6.16 3.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.746 2.297 . . . . 0.0 113.318 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.635 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 28.3 p90 -176.83 -27.28 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.776 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 48.8 m-85 -59.48 -26.49 65.31 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.85 -0.531 . . . . 0.0 111.453 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.448 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -110.8 -65.6 0.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.059 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 42.3 Cg_exo -57.27 -39.0 93.29 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.587 2.191 . . . . 0.0 111.943 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -86.03 -18.38 32.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.31 150.16 22.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.87 0.367 . . . . 0.0 111.184 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -157.71 -36.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -114.63 31.66 6.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.025 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.626 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -146.57 -33.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.084 0.468 . . . . 0.0 110.366 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -99.56 -36.4 9.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.044 -179.161 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 1.046 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 37.0 -73.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.465 0.706 . . . . 0.0 112.496 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.706 ' N ' ' O ' ' A' ' 543' ' ' TYR . 31.9 mt-10 65.85 36.82 5.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 546' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -148.69 14.32 1.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.363 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 1.046 HD22 HG21 ' A' ' 544' ' ' ILE . 1.2 pt? -160.53 -14.91 0.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.86 64.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.416 . . . . 0.0 111.759 -178.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.522 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.62 33.07 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.437 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 58.15 86.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.512 ' CG ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -112.23 -77.84 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.037 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.78 11.5 8.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -117.29 -32.89 1.42 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.973 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 1.011 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -82.76 -0.81 49.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.796 0.331 . . . . 0.0 111.238 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 1.011 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.94 -40.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.876 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.298 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 556' ' ' CYS . 5.5 mptt . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.646 0.26 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 42.91 61.32 2.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.179 0.514 . . . . 0.0 110.927 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.812 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.8 m120 -89.55 -48.75 0.39 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.503 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.896 ' CG ' HG21 ' A' ' 555' ' ' ILE . 59.9 Cg_endo -103.67 20.59 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.245 3.297 . . . . 0.0 112.314 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 514' ' ' ASN . . . . . 0.583 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.7 m120 -115.46 48.16 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.812 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -100.27 -55.24 2.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.256 -178.665 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.63 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 2.6 p80 -175.48 -56.43 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.669 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.647 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -57.21 -20.18 25.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.336 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -119.05 -27.68 5.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.424 -177.449 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 1.6 t -76.97 -20.09 56.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.684 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -98.55 -70.87 0.71 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 110.539 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.684 ' N ' HG22 ' A' ' 520' ' ' THR . 7.9 pt20 -99.93 -160.98 0.83 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.095 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.85 ' CB ' ' HB3' ' A' ' 525' ' ' ALA . 5.2 m-20 -96.19 30.83 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.218 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.617 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 20.3 mt-10 63.04 14.4 7.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.891 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 113.93 22.68 5.23 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.911 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.85 ' HB3' ' CB ' ' A' ' 522' ' ' ASP . . . -97.83 -3.62 38.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.64 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -84.86 22.42 1.37 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 110.968 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.64 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -132.73 -60.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.1 -21.8 1.25 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.41 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.9 mp 75.2 -20.31 0.35 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.09 43.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.331 0.586 . . . . 0.0 111.023 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.729 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 7.2 p-90 -65.72 -18.51 65.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.029 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.6 pt -123.42 135.61 26.25 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.037 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.424 ' HG2' ' CD2' ' A' ' 534' ' ' TYR . 98.2 Cg_endo -87.63 -17.73 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.71 2.273 . . . . 0.0 113.604 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.642 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 26.6 p90 -138.14 -26.08 0.94 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 535' ' ' PHE . . . . . 0.825 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 98.3 m-85 -59.97 -43.14 95.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.986 -0.446 . . . . 0.0 111.564 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -109.25 -60.92 0.52 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.987 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 532' ' ' ILE . 54.3 Cg_exo -51.7 -41.99 58.97 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.388 2.059 . . . . 0.0 111.813 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.93 -31.08 31.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.633 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -49.36 159.37 0.32 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -149.28 -44.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.72 25.18 17.76 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.095 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -145.06 -4.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 -179.389 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.677 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.5 OUTLIER -129.57 -42.73 1.29 Allowed 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.316 -178.532 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 544' ' ' ILE . . . . . 0.959 HG21 HD22 ' A' ' 547' ' ' LEU . 3.4 mp 38.89 -73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 123.54 0.736 . . . . 0.0 112.712 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.677 ' N ' ' O ' ' A' ' 543' ' ' TYR . 2.0 mm-40 73.65 29.77 1.49 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.314 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.93 4.72 2.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.648 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.959 HD22 HG21 ' A' ' 544' ' ' ILE . 1.7 pt? -149.88 -16.22 0.26 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.604 ' HE2' ' HA ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -69.46 65.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.938 0.399 . . . . 0.0 111.836 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -132.23 35.73 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.404 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 93.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.333 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.444 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -120.72 -76.44 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.216 0.531 . . . . 0.0 111.116 -179.459 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.462 ' H ' HD11 ' A' ' 555' ' ' ILE . 3.5 t70 63.7 17.17 10.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.678 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -123.77 -31.91 0.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.891 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 555' ' ' ILE . 2.7 pp -90.03 8.38 32.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.088 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.954 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.1 -44.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.545 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.234 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.412 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -171.12 64.24 0.41 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 35.0 Cg_exo -59.79 173.36 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.592 2.194 . . . . 0.0 112.445 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.01 118.76 25.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.626 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.9 m 60.32 101.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.9 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.1 m120 -91.0 -51.44 0.31 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.08 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 61.5 Cg_endo -106.52 21.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.501 3.467 . . . . 0.0 112.406 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.637 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.7 m120 -118.8 51.18 1.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.9 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -105.59 -67.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.079 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.673 ' HA ' HG22 ' A' ' 519' ' ' THR . 2.5 p80 -161.51 -57.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.193 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.605 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -55.94 -9.61 0.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.698 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -123.23 -44.31 2.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.581 0.705 . . . . 0.0 110.563 -176.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 516' ' ' HIS . 12.1 t -63.15 -28.78 70.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.467 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.668 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.8 OUTLIER -84.57 -65.69 0.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.764 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.668 ' N ' HG22 ' A' ' 520' ' ' THR . 9.8 pt20 -99.99 -157.64 0.62 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.2 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 4.1 m-20 -100.62 36.64 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.233 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 8.3 mt-10 52.28 34.88 15.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.034 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.437 ' HA2' HD11 ' A' ' 527' ' ' ILE . . . 89.26 33.35 9.55 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.571 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.797 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -119.95 -5.47 10.07 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -90.79 15.69 10.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.795 0.331 . . . . 0.0 111.72 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.588 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.2 OUTLIER -129.65 -44.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.432 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 134.28 -17.63 4.27 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.637 HD11 ' HD2' ' A' ' 543' ' ' TYR . 2.9 tp 78.0 -51.61 0.5 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.67 47.13 0.71 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.107 0.48 . . . . 0.0 112.241 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.76 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.9 p-90 -122.5 -16.53 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.632 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.777 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -116.17 166.29 12.82 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.856 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 83.1 Cg_endo -94.04 2.39 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.835 2.357 . . . . 0.0 113.563 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.728 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 9.8 p90 -177.16 -21.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.777 ' HB2' HD12 ' A' ' 532' ' ' ILE . 60.9 m-85 -59.5 -30.93 68.91 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.91 -0.494 . . . . 0.0 111.67 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.565 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -111.37 -69.07 0.56 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.938 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -49.01 -40.22 40.83 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.603 2.202 . . . . 0.0 112.022 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.91 -31.6 31.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -52.82 158.09 1.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -141.57 -41.64 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -111.31 34.15 5.45 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.26 -35.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.101 0.476 . . . . 0.0 109.962 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.735 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -99.68 -29.13 12.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.182 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.813 HG21 HD22 ' A' ' 547' ' ' LEU . 2.5 mp 30.84 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.916 0.886 . . . . 0.0 112.95 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.735 ' N ' ' O ' ' A' ' 543' ' ' TYR . 7.4 mt-10 69.63 91.85 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.116 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 150.13 -9.6 0.84 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.875 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.813 HD22 HG21 ' A' ' 544' ' ' ILE . 2.7 pt? -128.14 -11.36 5.27 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.493 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -63.13 80.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.911 0.386 . . . . 0.0 110.7 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.4 ' N ' ' O ' ' A' ' 547' ' ' LEU . 5.4 m-70 -133.15 29.7 4.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.424 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 52.32 55.79 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.451 ' NE2' ' O ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.41 172.21 8.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.819 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.1 t70 179.17 31.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -134.87 -37.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -77.8 -3.89 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.616 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.909 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -144.03 -42.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.32 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t -113.61 60.55 0.66 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.378 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -99.65 -58.47 0.89 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.244 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 2.5 pt? -146.38 -46.07 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.463 0.173 . . . . 0.0 110.939 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.501 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 175.59 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 111.542 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.099 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.906 0.384 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 13.7 pt20 -165.68 53.97 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 84.3 Cg_endo -78.23 138.6 16.13 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.19 124.29 37.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.08 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.6 m 51.32 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.909 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.8 m-80 -93.52 -49.53 0.27 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.854 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.69 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 50.4 Cg_endo -102.69 17.42 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 124.339 3.359 . . . . 0.0 112.658 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.733 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.2 m120 -123.32 59.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.319 0.58 . . . . 0.0 109.914 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.909 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.18 -72.83 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.05 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 16.8 p80 -147.62 -56.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.771 ' C ' ' HD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -65.91 179.51 0.88 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.771 ' HD1' ' C ' ' A' ' 517' ' ' TYR . 0.1 OUTLIER 62.79 -44.99 0.2 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.239 0.472 . . . . 0.0 110.945 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 517' ' ' TYR . 8.9 t -94.37 -19.86 20.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.258 0.551 . . . . 0.0 109.829 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.69 HG22 ' N ' ' A' ' 521' ' ' GLN . 1.2 m -85.16 -78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.391 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.69 ' N ' HG22 ' A' ' 520' ' ' THR . 2.8 pt20 -100.51 -161.88 0.9 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.162 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.629 ' HB2' ' HB2' ' A' ' 526' ' ' ALA . 1.1 t0 -93.19 22.36 5.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.942 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.618 ' HG3' ' HA ' ' A' ' 518' ' ' TRP . 9.3 mt-10 48.31 75.84 0.13 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.546 0.689 . . . . 0.0 110.369 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 52.47 20.29 7.21 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.391 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 522' ' ' ASP . . . -106.69 -22.83 12.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.302 0.551 . . . . 0.0 111.832 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.785 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -87.3 20.98 2.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.974 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.785 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -133.81 -48.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.476 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 136.98 -11.95 3.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.108 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.879 HD11 ' CD2' ' A' ' 543' ' ' TYR . 3.2 mt 70.04 -56.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.88 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 46.23 0.73 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.412 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.601 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.4 p-90 -120.56 -18.29 7.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.664 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.601 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.1 160.37 30.26 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.259 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 27.1 Cg_endo -62.2 -47.1 10.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.875 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.767 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 37.1 p90 -155.33 6.26 0.23 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.518 ' HD2' HG21 ' A' ' 532' ' ' ILE . 0.9 OUTLIER -71.65 -26.48 62.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.044 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -108.47 -63.41 0.56 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.674 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.09 -41.88 39.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 111.661 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -78.02 -23.03 48.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.585 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 536' ' ' GLY . . . -51.59 161.64 0.48 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -163.69 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.575 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.443 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -109.01 29.59 9.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.875 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.674 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.42 -29.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 110.792 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.879 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.8 OUTLIER -98.68 -47.92 5.15 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.785 HG21 HD22 ' A' ' 547' ' ' LEU . 2.0 mp 36.85 -74.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.377 0.671 . . . . 0.0 112.442 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.693 ' N ' ' O ' ' A' ' 543' ' ' TYR . 22.6 mt-10 68.32 85.82 0.14 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.003 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 162.96 -17.32 0.14 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.551 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.785 HD22 HG21 ' A' ' 544' ' ' ILE . 1.9 pt? -134.68 -12.57 2.3 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.492 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -70.17 64.42 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.129 0.49 . . . . 0.0 111.473 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -116.36 -74.63 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.002 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.7 t30 175.47 73.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.402 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -99.11 -78.25 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.603 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.678 ' H ' HD11 ' A' ' 555' ' ' ILE . 6.7 t70 66.08 12.59 8.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.683 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.9 -31.77 1.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.711 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.934 HD12 HG23 ' A' ' 555' ' ' ILE . 1.5 pp -93.15 9.4 36.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.934 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.3 -42.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.468 -178.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.468 ' N ' HG12 ' A' ' 555' ' ' ILE . 5.2 t -105.43 114.46 28.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.351 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -160.22 -73.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.087 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 558' ' ' LEU . 1.2 pt? -141.67 -40.47 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 111.205 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.447 ' HG3' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 173.74 32.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.294 0.569 . . . . 0.0 110.893 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.566 ' NE2' ' H ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.063 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.808 0.337 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -172.38 56.49 0.22 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.04 147.84 24.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.588 2.192 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -72.89 116.75 13.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.655 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.503 ' O ' HD11 ' A' ' 515' ' ' LEU . 12.4 m 61.76 114.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.408 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.97 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.7 m-80 -94.09 -50.83 0.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.77 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 86.5 Cg_endo -109.64 16.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.267 3.311 . . . . 0.0 113.32 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.832 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.4 m120 -118.62 53.18 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.17 0.51 . . . . 0.0 110.171 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.97 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -121.98 -62.73 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.956 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.637 ' HA ' ' CG2' ' A' ' 519' ' ' THR . 3.3 p80 -171.18 -56.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.578 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.637 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.53 -10.61 0.27 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.77 ' CE3' ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -123.61 -33.33 3.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.21 0.529 . . . . 0.0 110.462 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.637 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 8.9 t -82.87 -16.1 48.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.505 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.533 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -87.07 -56.8 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.716 0.294 . . . . 0.0 111.38 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 7.9 pt20 -100.45 -157.58 0.62 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.146 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 525' ' ' ALA . 5.3 m-20 -102.73 32.55 3.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.26 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.5 mt-10 45.33 69.69 0.42 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.907 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 93.59 -26.94 13.52 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.622 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.89 11.0 0.17 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.69 16.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.377 . . . . 0.0 110.769 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.622 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -56.08 -22.23 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.275 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.559 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 163.63 -34.01 0.29 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.805 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 543' ' ' TYR . 2.0 mt 67.91 -53.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.28 -21.68 60.54 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.601 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.9 p-90 -43.61 -29.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.016 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.587 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -103.71 152.09 38.87 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.574 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.56 -50.51 13.8 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.618 2.212 . . . . 0.0 112.281 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 42.6 p90 -157.97 6.45 0.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -62.59 -27.1 68.96 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.831 0.348 . . . . 0.0 110.766 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -107.84 -56.65 0.59 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.838 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 46.6 Cg_exo -56.27 -41.27 78.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.481 2.12 . . . . 0.0 111.937 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 534' ' ' TYR . . . -93.24 -7.92 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.219 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 1.119 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -53.1 -75.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 75.87 -43.59 0.49 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.512 ' C ' HD12 ' A' ' 542' ' ' ILE . . . -112.33 35.08 4.83 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.745 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 1.119 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -151.09 -33.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.992 0.425 . . . . 0.0 110.513 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.6 OUTLIER -94.96 -45.75 7.13 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.037 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.894 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 36.47 -73.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.627 0.771 . . . . 0.0 112.404 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 543' ' ' TYR . 19.9 mt-10 67.49 32.24 5.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.732 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -137.88 -7.86 1.31 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.87 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.894 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -137.67 -8.57 1.65 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.518 ' HE1' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.49 65.66 0.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 110.761 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.7 OUTLIER -111.49 -65.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.611 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 168.59 63.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.742 ' CB ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -115.61 -178.84 3.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.238 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 556' ' ' CYS . 2.9 p30 -179.2 -22.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.187 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -88.33 -29.05 20.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.309 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.932 HD12 HG23 ' A' ' 555' ' ' ILE . 1.2 pp -82.42 -2.77 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.669 0.271 . . . . 0.0 111.45 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.932 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.99 -41.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.996 0.427 . . . . 0.0 111.04 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER -101.41 72.16 1.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.186 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -124.5 -67.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.541 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 558' ' ' LEU . 2.2 pt? -134.32 -48.16 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.522 0.201 . . . . 0.0 111.051 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.476 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.1 OUTLIER 178.81 37.7 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.032 0.444 . . . . 0.0 111.421 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.401 ' OE1' HD23 ' A' ' 558' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.013 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.832 0.348 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -169.87 56.09 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.727 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.87 -165.94 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.815 2.343 . . . . 0.0 112.496 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.8 118.4 15.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.67 90.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.892 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.0 m-80 -87.39 -49.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.75 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.909 ' CG ' HG21 ' A' ' 555' ' ' ILE . 39.3 Cg_endo -102.08 16.7 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 124.195 3.263 . . . . 0.0 112.525 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.687 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.6 m120 -123.82 60.2 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.892 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -111.46 -46.15 3.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.31 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 1.9 p80 -177.59 -56.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.665 0.269 . . . . 0.0 111.514 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.71 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -56.18 -20.16 16.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.735 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.83 -44.03 2.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.186 0.517 . . . . 0.0 110.761 -177.353 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.601 HG22 ' CA ' ' A' ' 516' ' ' HIS . 9.3 t -53.84 -31.34 49.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.288 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.711 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.19 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.163 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.711 ' N ' HG22 ' A' ' 520' ' ' THR . 3.2 pt20 -99.64 -169.99 1.83 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.467 -178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.888 ' CB ' ' HB3' ' A' ' 525' ' ' ALA . 3.5 m-20 -88.19 21.39 2.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.9 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 34.2 mt-10 69.11 4.51 4.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.934 0.397 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 130.96 20.23 1.19 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.16 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.888 ' HB3' ' CB ' ' A' ' 522' ' ' ASP . . . -97.21 -25.26 15.35 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.744 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -84.45 23.19 1.15 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 111.412 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.744 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -131.67 -46.57 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.587 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 138.72 -12.9 3.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.04 -46.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -75.85 -20.25 58.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.746 ' CE2' HD13 ' A' ' 532' ' ' ILE . 2.0 p-90 -47.55 -26.13 1.34 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.953 0.406 . . . . 0.0 111.074 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.836 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.3 OUTLIER -114.63 157.75 42.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -91.09 -23.69 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.991 2.461 . . . . 0.0 114.023 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 8.6 p90 -154.34 6.65 0.3 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.836 ' HB2' HD12 ' A' ' 532' ' ' ILE . 2.9 m-85 -78.93 -43.08 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.224 0.535 . . . . 0.0 110.705 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.566 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.41 -58.06 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.622 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' A' ' 536' ' ' GLY . 77.8 Cg_exo -49.68 -42.05 44.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.322 2.014 . . . . 0.0 111.583 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.75 -29.79 32.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.591 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.18 148.11 28.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.223 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -129.16 -35.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.594 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.435 ' O ' ' HZ2' ' A' ' 518' ' ' TRP . . . -114.76 27.57 8.66 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.7 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -142.35 -6.19 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.72 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -127.42 -41.99 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 120.368 0.128 . . . . 0.0 111.085 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.563 HG21 HD22 ' A' ' 547' ' ' LEU . 3.2 mp 34.45 -72.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.549 0.74 . . . . 0.0 112.551 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.72 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.5 mt-10 68.4 90.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.148 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 155.51 -15.33 0.47 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.182 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.563 HD22 HG21 ' A' ' 544' ' ' ILE . 1.4 pt? -129.4 -3.17 4.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.786 0.327 . . . . 0.0 111.684 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.811 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -81.08 80.37 7.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.173 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -133.19 -68.7 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.589 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 167.44 66.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -74.67 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.19 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.93 20.61 9.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.93 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -122.99 -38.15 0.58 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.979 HD12 HG23 ' A' ' 555' ' ' ILE . 2.4 pp -83.15 -1.16 52.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.979 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.31 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.709 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.484 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -103.86 143.22 33.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.93 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 179.2 -72.55 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.133 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.472 ' HG ' ' HG3' ' A' ' 559' ' ' ARG . 1.3 pt? -144.44 -40.94 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.626 0.251 . . . . 0.0 111.321 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.472 ' HG3' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 176.03 32.87 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.324 0.583 . . . . 0.0 111.016 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.458 ' NE2' ' H ' ' A' ' 560' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.0 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.785 0.326 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.41 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -155.99 53.73 0.83 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 84.2 Cg_endo -80.67 163.01 21.45 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.61 2.207 . . . . 0.0 112.33 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.29 105.65 13.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.627 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.7 m 63.41 122.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.708 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.4 m-80 -104.67 -52.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.875 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.563 ' HD3' ' HB2' ' A' ' 512' ' ' ASN . 39.7 Cg_endo -104.02 5.71 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.019 3.146 . . . . 0.0 113.162 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.709 ' C ' HD13 ' A' ' 515' ' ' LEU . 5.8 m120 -115.53 57.61 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.195 0.521 . . . . 0.0 109.791 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.745 ' H ' HD22 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -121.73 -38.21 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.736 ' O ' ' O ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -164.23 -84.63 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.768 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.992 ' O ' ' N ' ' A' ' 519' ' ' THR . 1.4 m-85 -52.21 -137.79 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.682 ' HA ' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER 26.14 -63.17 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.992 ' N ' ' O ' ' A' ' 517' ' ' TYR . 9.2 t -70.13 -25.35 63.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.066 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 516' ' ' HIS . 0.4 OUTLIER -78.64 -63.93 1.29 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.567 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 10.5 pt20 -100.79 -153.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.83 31.75 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.698 ' OE2' HD13 ' A' ' 544' ' ' ILE . 1.7 mt-10 46.96 70.72 0.37 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.824 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 90.97 -25.15 14.84 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.895 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.616 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.47 11.95 0.21 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.55 16.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.749 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.616 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -57.88 -20.25 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.319 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.57 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 160.61 -46.0 0.4 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.924 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.529 HD21 ' CD ' ' A' ' 545' ' ' GLU . 3.4 mp 71.15 -34.79 0.31 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.18 -22.94 44.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.591 ' CD2' HG23 ' A' ' 532' ' ' ILE . 2.4 p-90 -47.63 -26.73 1.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.675 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -116.03 167.45 10.27 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.713 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 92.7 Cg_endo -95.39 -5.92 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.13 2.553 . . . . 0.0 113.812 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 17.9 p90 -159.0 -28.95 0.07 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.675 ' HD1' ' HB ' ' A' ' 532' ' ' ILE . 16.4 m-85 -59.44 -26.14 64.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.72 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.406 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -115.53 -55.28 0.36 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.223 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 17.9 Cg_exo -67.33 -31.92 33.97 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.701 2.267 . . . . 0.0 112.224 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -93.31 -25.93 17.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.606 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -64.63 131.35 46.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.63 -25.07 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.925 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.559 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.25 35.24 4.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.777 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.65 HG23 ' CG ' ' A' ' 517' ' ' TYR . 0.2 OUTLIER -148.36 -28.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -103.85 -43.97 5.17 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -178.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 34.44 -72.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.613 0.765 . . . . 0.0 112.497 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 18.2 mt-10 71.87 34.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.032 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.44 -3.62 1.58 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.016 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.784 HD22 HG21 ' A' ' 544' ' ' ILE . 2.4 pt? -143.04 -4.11 0.93 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.538 ' HE1' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -75.81 73.74 2.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.01 0.433 . . . . 0.0 111.602 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.512 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -132.78 27.79 4.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.229 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.56 101.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.626 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -76.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.117 0.484 . . . . 0.0 110.721 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.528 ' H ' HD11 ' A' ' 555' ' ' ILE . 11.9 t70 60.24 18.53 8.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.427 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -125.63 -34.61 0.64 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -88.24 6.19 38.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 0.0 111.045 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.954 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.56 -42.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.266 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.467 ' N ' HG12 ' A' ' 555' ' ' ILE . 4.8 t -107.44 101.28 10.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.352 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -149.3 -65.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.352 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.674 HD23 ' H ' ' A' ' 558' ' ' LEU . 1.8 pt? -138.67 -48.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.563 0.22 . . . . 0.0 110.919 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.451 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.98 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.987 0.422 . . . . 0.0 111.448 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.171 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.822 0.344 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.7 58.48 0.2 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.34 167.57 25.89 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.584 2.189 . . . . 0.0 112.257 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -110.7 125.92 53.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.72 111.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.968 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.0 m120 -103.88 -51.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.759 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.726 ' CG ' HG21 ' A' ' 555' ' ' ILE . 46.6 Cg_endo -105.41 14.97 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.241 3.294 . . . . 0.0 113.033 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.711 ' C ' HD13 ' A' ' 515' ' ' LEU . 4.9 m120 -126.33 58.13 1.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.229 0.538 . . . . 0.0 109.899 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.968 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -119.31 -54.37 2.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.858 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.675 ' HA ' HG22 ' A' ' 519' ' ' THR . 3.1 p80 -174.75 -54.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.619 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.46 -10.85 0.45 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.694 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.85 -49.69 1.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.517 0.675 . . . . 0.0 109.869 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 516' ' ' HIS . 14.7 t -60.35 -23.29 64.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.48 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -85.02 -56.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.127 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.669 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 8.4 pt20 -100.44 -161.31 0.86 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.043 0.449 . . . . 0.0 111.166 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.456 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -102.92 31.85 3.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.607 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.669 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.9 mp0 45.21 74.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.5 0.667 . . . . 0.0 109.933 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 91.38 -25.74 14.14 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.412 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.648 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.03 10.28 0.11 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.6 16.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.922 0.392 . . . . 0.0 110.54 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.689 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.4 OUTLIER -55.65 -22.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.301 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.52 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 156.32 -38.08 0.59 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.266 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.536 ' O ' ' HD3' ' A' ' 537' ' ' PRO . 4.4 mp 70.39 -38.48 0.42 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.02 -24.62 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.689 ' NE1' HD13 ' A' ' 527' ' ' ILE . 1.9 p-90 -45.98 -27.47 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.564 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.623 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -113.04 165.71 12.6 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.917 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.08 -41.09 0.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.06 2.506 . . . . 0.0 113.232 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.644 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 16.9 p90 -156.31 6.08 0.19 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.713 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -73.95 -26.97 60.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.051 0.453 . . . . 0.0 110.597 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.483 ' HA3' HD11 ' A' ' 532' ' ' ILE . . . -108.49 -55.09 0.59 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.785 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 23.9 Cg_exo -64.33 -37.98 37.09 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.621 2.214 . . . . 0.0 111.788 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -93.25 -5.47 49.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.163 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.912 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -51.73 -72.02 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.772 0.32 . . . . 0.0 110.963 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 70.89 -48.23 0.66 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.409 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -108.41 29.55 9.9 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.968 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.912 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -146.62 -33.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.436 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.701 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -95.36 -43.07 8.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.526 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.77 HD12 ' N ' ' A' ' 544' ' ' ILE . 1.6 mp 37.77 -73.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.545 0.738 . . . . 0.0 112.345 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.701 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.9 mt-10 66.86 85.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.261 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 165.02 -22.13 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.91 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.767 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -133.87 -8.38 2.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.426 ' CE ' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -67.85 64.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 111.811 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.27 46.68 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.568 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 2.4 m-80 68.7 -66.29 0.25 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.46 HE21 HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER 49.53 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.901 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.7 m-20 59.89 20.06 9.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.187 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -133.17 -34.12 0.34 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.916 HD12 HG23 ' A' ' 555' ' ' ILE . 3.0 pp -86.96 8.32 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.326 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.916 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -143.91 -42.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.159 0.504 . . . . 0.0 111.087 -178.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.494 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -108.16 93.47 4.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.19 -178.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -136.22 -65.82 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.358 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 558' ' ' LEU . 2.2 pt? -134.96 -47.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.61 0.243 . . . . 0.0 111.005 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.472 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.1 OUTLIER 179.48 38.31 0.0 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.036 0.446 . . . . 0.0 111.395 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.423 ' OE1' HD23 ' A' ' 558' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.008 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.726 0.298 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.445 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 15.2 mm100 -152.23 50.92 0.69 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 84.5 Cg_endo -77.6 139.27 17.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.437 2.092 . . . . 0.0 112.363 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 126.51 35.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.794 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 95.1 m 61.72 101.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.764 ' O ' HD11 ' A' ' 515' ' ' LEU . 1.4 m-80 -99.04 -50.31 0.21 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.763 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.832 ' CG ' HG21 ' A' ' 555' ' ' ILE . 38.3 Cg_endo -101.54 16.17 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.048 3.166 . . . . 0.0 112.593 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.538 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.4 m120 -119.91 54.4 1.02 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.809 HD23 ' HE1' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -99.11 -47.74 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.415 -178.23 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.597 ' N ' HG22 ' A' ' 519' ' ' THR . 5.9 p80 -175.61 -52.76 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.809 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -61.55 -24.5 66.69 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.329 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.732 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -116.61 -39.8 3.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.181 0.515 . . . . 0.0 110.838 -177.447 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 516' ' ' HIS . 5.5 t -57.89 -21.47 43.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.527 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.67 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -105.15 -67.12 0.93 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.087 0.47 . . . . 0.0 111.225 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.67 ' N ' HG22 ' A' ' 520' ' ' THR . 9.5 pt20 -99.88 -160.84 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.782 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.761 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -94.73 34.7 1.3 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.31 -179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.681 ' CD ' HD13 ' A' ' 544' ' ' ILE . 16.1 mt-10 60.69 20.09 10.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.547 ' C ' HD11 ' A' ' 527' ' ' ILE . . . 98.38 32.84 5.89 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.165 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.761 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -117.34 3.63 12.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -92.29 18.3 8.5 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.901 0.381 . . . . 0.0 111.146 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.1 OUTLIER -124.75 -53.4 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.658 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 150.52 -19.96 1.03 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.794 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.64 HD11 ' HA ' ' A' ' 525' ' ' ALA . 7.1 mp 72.98 -20.74 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.22 -20.93 47.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.175 0.512 . . . . 0.0 111.268 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.681 ' HE1' HD13 ' A' ' 527' ' ' ILE . 7.3 p-90 -69.07 -13.7 62.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.774 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.8 OUTLIER -126.26 142.74 43.64 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.063 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.92 -21.6 2.06 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.712 2.274 . . . . 0.0 113.935 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.425 ' HA ' ' CB ' ' A' ' 538' ' ' ALA . 9.7 p90 -150.82 6.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.877 ' HB2' HD12 ' A' ' 532' ' ' ILE . 22.7 m-85 -82.3 -39.54 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -112.55 -61.44 0.44 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.452 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.53 -39.69 74.17 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.392 2.062 . . . . 0.0 111.903 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -85.02 -37.12 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.285 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -46.25 164.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.518 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -147.11 -43.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.55 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.99 23.25 21.77 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.645 HG23 ' CD2' ' A' ' 517' ' ' TYR . 0.1 OUTLIER -139.99 -18.52 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.463 0.173 . . . . 0.0 111.046 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.818 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -122.85 -3.08 8.69 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.533 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.719 ' O ' ' HG3' ' A' ' 545' ' ' GLU . 1.5 mp 4.69 -51.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.805 1.242 . . . . 0.0 114.044 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.818 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.6 pt-20 44.44 79.18 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.412 ' O ' ' CE1' ' A' ' 549' ' ' HIS . . . 172.79 -25.61 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.839 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.687 HD22 HG21 ' A' ' 544' ' ' ILE . 1.6 pt? -125.78 -12.23 6.57 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.424 ' HG3' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -68.01 71.94 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 111.174 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.412 ' CE1' ' O ' ' A' ' 546' ' ' GLY . 1.4 m-70 -124.94 26.35 7.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.708 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 59.23 61.58 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.403 ' OE1' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -87.12 -70.94 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.578 . . . . 0.0 110.64 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 556' ' ' CYS . 1.1 m-20 63.2 19.28 11.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.092 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.52 -30.62 1.37 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.883 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.977 HD12 HG23 ' A' ' 555' ' ' ILE . 1.9 pp -88.79 2.23 53.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.756 0.313 . . . . 0.0 111.119 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.977 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -147.52 -40.95 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.293 0.568 . . . . 0.0 110.658 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 552' ' ' ASP . 1.6 m -93.56 36.63 1.08 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.176 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.408 ' HA2' ' NE2' ' A' ' 560' ' ' GLN . . . 140.04 41.22 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.981 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.632 HD22 ' HA ' ' A' ' 555' ' ' ILE . 1.0 OUTLIER -95.78 -43.42 7.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.429 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.569 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 171.03 36.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.085 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.529 ' HG3' HD23 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.26 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.818 0.342 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -170.75 56.54 0.25 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.875 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.7 168.42 23.79 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.616 2.211 . . . . 0.0 112.35 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -125.34 127.41 46.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.655 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 514' ' ' ASN . 0.0 OUTLIER 59.66 98.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.559 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.958 ' O ' HD21 ' A' ' 515' ' ' LEU . 7.2 m120 -95.66 -50.58 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.878 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.809 ' CG ' HG21 ' A' ' 555' ' ' ILE . 57.7 Cg_endo -105.45 16.39 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.224 3.282 . . . . 0.0 113.04 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.727 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.7 m120 -123.76 57.91 1.17 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.561 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.958 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.43 -52.82 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.99 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.655 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 1.9 p80 -176.97 -56.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.332 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.655 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.41 -13.52 0.6 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.716 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.07 -43.84 2.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.372 0.606 . . . . 0.0 110.037 -177.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.528 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.7 t -70.96 -22.06 62.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.804 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.34 -56.15 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.822 0.344 . . . . 0.0 111.601 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.584 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 7.9 pt20 -100.46 -157.85 0.63 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.456 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -102.67 32.72 3.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.317 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.685 ' OE1' HD21 ' A' ' 547' ' ' LEU . 4.3 mt-10 44.75 74.02 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.949 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.442 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.13 -24.81 20.07 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.595 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.1 9.99 0.26 Allowed 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.98 16.48 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 110.614 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.595 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.53 -24.24 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.296 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.55 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 158.55 -52.49 0.39 Allowed Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.176 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.582 HD21 ' HD2' ' A' ' 543' ' ' TYR . 3.4 mp 75.28 -21.4 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.799 0.44 . . . . 0.0 112.048 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.41 -26.42 41.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.241 0.543 . . . . 0.0 110.922 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.593 ' CE2' HD13 ' A' ' 532' ' ' ILE . 4.7 p-90 -63.03 -16.52 60.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.715 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.874 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.3 pt -126.06 135.69 27.45 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.022 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 1.2 Cg_endo -84.48 -20.43 3.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.957 2.438 . . . . 0.0 113.889 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.508 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 9.0 p90 -146.65 6.34 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.934 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 15.1 m-85 -87.72 -39.91 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.033 0.444 . . . . 0.0 110.793 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -110.44 -60.54 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.506 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.94 -37.2 85.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.41 2.073 . . . . 0.0 111.576 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -93.18 -17.21 23.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.25 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.994 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -48.84 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.606 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 21.0 mt-10 76.72 -44.96 0.48 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.484 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -110.14 33.44 6.0 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.994 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -151.06 -33.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.138 0.494 . . . . 0.0 110.416 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.708 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -97.6 -37.75 9.81 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.162 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.937 HG21 HD22 ' A' ' 547' ' ' LEU . 1.0 OUTLIER 37.53 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.436 0.694 . . . . 0.0 112.567 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.708 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.1 mt-10 66.05 86.09 0.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.025 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 159.24 -16.7 0.24 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.369 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.937 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -129.6 -13.28 4.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.489 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -69.11 69.16 0.19 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.137 0.494 . . . . 0.0 111.299 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -120.74 -53.18 2.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.71 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.414 ' C ' ' HG3' ' A' ' 551' ' ' GLN . 22.8 t-20 -179.11 -57.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.491 ' OE1' HD11 ' A' ' 554' ' ' LEU . 0.0 OUTLIER 27.12 -91.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.408 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.443 ' OD1' ' ND2' ' A' ' 514' ' ' ASN . 0.4 OUTLIER 63.95 15.72 9.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.035 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -127.51 -29.35 0.84 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.946 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.934 HD12 HG23 ' A' ' 555' ' ' ILE . 2.2 pp -80.97 1.65 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.934 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -141.49 -42.62 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.769 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.3 OUTLIER -107.15 98.63 8.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.199 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -136.81 -70.17 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.351 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.673 HD23 ' H ' ' A' ' 558' ' ' LEU . 1.9 pt? -138.39 -48.07 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.44 0.162 . . . . 0.0 111.104 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.458 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.56 38.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.93 0.395 . . . . 0.0 111.504 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.102 -179.82 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.797 0.332 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.461 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -155.07 52.8 0.75 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.134 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 97.7 Cg_endo -83.23 153.73 14.25 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.644 2.23 . . . . 0.0 112.459 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.11 114.59 9.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.524 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.3 m 60.78 107.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.167 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.902 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.3 m-80 -90.9 -51.08 0.32 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.733 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.675 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 74.5 Cg_endo -105.92 20.94 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.315 3.343 . . . . 0.0 112.623 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.655 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.5 m120 -118.35 51.99 1.05 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.501 0.667 . . . . 0.0 109.232 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.902 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -109.35 -56.75 2.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.133 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 3.2 p80 -174.93 -57.14 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.712 0.291 . . . . 0.0 111.366 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.629 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -56.23 -15.63 4.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.08 -29.82 4.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.021 0.439 . . . . 0.0 111.325 -177.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.625 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 3.0 t -77.5 -20.43 54.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.288 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.667 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.84 -67.65 0.84 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.667 ' N ' HG22 ' A' ' 520' ' ' THR . 8.3 pt20 -99.9 -156.82 0.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.554 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -98.35 34.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.404 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.842 ' OE1' HD13 ' A' ' 544' ' ' ILE . 62.2 mt-10 56.93 34.08 24.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.547 0.689 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.562 ' C ' HD11 ' A' ' 527' ' ' ILE . . . 80.14 32.36 35.79 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.311 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.545 ' HA ' HD11 ' A' ' 529' ' ' LEU . . . -117.88 1.96 12.13 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -91.56 19.49 6.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.692 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.1 OUTLIER -124.27 -52.7 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.642 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.89 -18.45 1.09 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.986 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.85 HD21 ' CD ' ' A' ' 545' ' ' GLU . 6.8 mp 73.21 -25.6 0.19 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.27 -24.65 42.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.234 0.54 . . . . 0.0 111.433 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.686 ' CE2' HD13 ' A' ' 532' ' ' ILE . 5.9 p-90 -62.53 -16.02 53.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.852 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.902 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.1 pt -125.91 140.99 38.14 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.362 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -89.3 -18.88 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.867 2.378 . . . . 0.0 113.826 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.97 6.14 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.902 ' HB2' HD12 ' A' ' 532' ' ' ILE . 13.9 m-85 -86.03 -40.34 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.014 0.435 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.4 ' H ' ' HD2' ' A' ' 537' ' ' PRO . . . -112.96 -62.17 0.44 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.443 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.4 ' HD2' ' H ' ' A' ' 536' ' ' GLY . 54.4 Cg_exo -50.16 -38.88 51.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.211 1.94 . . . . 0.0 111.686 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -86.34 -31.24 21.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -51.07 169.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.447 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -153.5 -41.01 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.488 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -113.25 33.37 5.6 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -149.66 -31.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.791 ' HA ' ' O ' ' A' ' 523' ' ' GLU . 0.3 OUTLIER -103.02 -44.77 5.13 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.451 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 1.037 HG21 HD22 ' A' ' 547' ' ' LEU . 1.2 mp 42.09 -72.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 112.666 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.85 ' CD ' HD21 ' A' ' 529' ' ' LEU . 3.0 mm-40 69.34 29.08 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.6 -1.93 1.81 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.798 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 1.037 HD22 HG21 ' A' ' 544' ' ' ILE . 1.5 pt? -139.88 -10.17 1.17 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.561 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.19 66.58 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -119.31 24.49 10.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.388 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 65.35 64.29 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.732 ' CB ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -110.65 -177.63 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.802 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 556' ' ' CYS . 18.3 p-10 -179.43 -22.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.346 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.4 32.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.411 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 551' ' ' GLN . 0.8 OUTLIER -85.53 -0.99 56.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.6 0.238 . . . . 0.0 111.526 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.756 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.1 OUTLIER -145.28 -40.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 111.342 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.1 t -99.11 80.46 2.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.304 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -129.73 -67.43 0.11 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.465 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.676 HD23 ' H ' ' A' ' 558' ' ' LEU . 1.8 pt? -137.6 -48.23 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.495 0.188 . . . . 0.0 111.093 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.445 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 178.27 38.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.061 0.457 . . . . 0.0 111.475 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.11 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.863 0.363 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.445 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 60.4 mt-30 -158.34 64.94 2.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.656 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 5.5 Cg_endo -87.42 139.52 5.04 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.306 2.67 . . . . 0.0 112.327 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.14 117.22 27.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.98 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 99.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.962 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.4 m-80 -100.8 -51.28 0.18 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.67 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.879 ' CG ' HG21 ' A' ' 555' ' ' ILE . 56.2 Cg_endo -104.46 17.84 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.293 3.329 . . . . 0.0 112.548 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.705 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.9 m120 -121.24 57.46 1.0 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.962 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.3 -51.36 2.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.27 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.627 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 2.4 p80 -176.89 -56.67 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.668 ' CD2' HG23 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -55.09 -16.17 2.75 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.731 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.29 -41.05 2.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.1 t -62.61 -27.62 69.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.463 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.648 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -88.33 -62.83 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.048 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.648 ' N ' HG22 ' A' ' 520' ' ' THR . 9.0 pt20 -99.84 -165.08 1.18 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.405 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . 2.9 m-20 -103.11 34.87 2.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.603 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.625 ' OE1' HD13 ' A' ' 544' ' ' ILE . 13.5 mt-10 45.56 31.5 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.534 0.683 . . . . 0.0 110.301 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 161.73 -30.32 0.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 57.54 12.6 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.88 15.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.805 HG13 ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -70.55 -13.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.654 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.555 ' N ' HD12 ' A' ' 527' ' ' ILE . . . 158.2 -57.36 0.35 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.863 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.1 OUTLIER 79.81 -27.91 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.96 -3.86 47.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.595 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 10.9 p-90 -81.75 -4.36 56.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.881 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.595 HD13 ' CZ2' ' A' ' 531' ' ' TRP . 1.0 OUTLIER -132.61 61.59 57.71 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.069 -177.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -37.44 -47.14 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.471 2.78 . . . . 0.0 114.075 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.662 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 8.3 p90 -113.73 6.31 16.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.893 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 11.3 t80 -114.06 -19.73 11.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.704 0.288 . . . . 0.0 111.532 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.503 ' HA3' HG13 ' A' ' 532' ' ' ILE . . . -113.49 -74.42 0.65 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.271 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 33.4 Cg_exo -61.73 -32.81 86.54 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.57 2.18 . . . . 0.0 111.209 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -90.72 -16.26 28.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.62 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 1.014 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -51.95 -58.41 6.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 70.78 -53.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.508 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -106.03 32.7 7.11 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.819 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 1.014 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -150.74 -30.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.691 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.3 OUTLIER -100.48 -44.78 5.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.905 HG21 HD22 ' A' ' 547' ' ' LEU . 1.2 mp 40.65 -72.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.493 0.717 . . . . 0.0 112.62 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.8 mt-10 69.6 33.99 2.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.141 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -142.17 2.1 1.77 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.002 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.905 HD22 HG21 ' A' ' 544' ' ' ILE . 2.1 pt? -143.49 -8.89 0.75 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.469 ' HB3' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -76.95 74.39 3.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.075 0.464 . . . . 0.0 111.232 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.469 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -134.25 27.98 3.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.082 179.199 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.49 87.16 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.71 -77.13 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.778 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.459 ' OD2' ' ND2' ' A' ' 514' ' ' ASN . 0.8 OUTLIER 62.62 24.77 14.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.91 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.19 -34.47 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.919 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.957 HD12 HG23 ' A' ' 555' ' ' ILE . 2.3 pp -85.57 2.64 44.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 111.307 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.957 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.53 -42.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -114.2 87.56 2.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.057 -179.209 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -123.8 -69.02 0.22 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.418 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.429 ' HG ' ' HG3' ' A' ' 559' ' ' ARG . 1.1 pt? -142.66 -40.17 0.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.429 ' HG3' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 174.71 31.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.332 0.587 . . . . 0.0 111.179 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.945 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.758 0.313 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.86 60.96 0.18 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.694 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.86 -170.22 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.575 2.183 . . . . 0.0 112.339 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.97 123.41 23.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 59.27 92.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.899 ' O ' HD21 ' A' ' 515' ' ' LEU . 2.7 m-80 -91.96 -50.88 0.3 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.457 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.956 ' CG ' HG21 ' A' ' 555' ' ' ILE . 57.6 Cg_endo -104.45 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.402 3.402 . . . . 0.0 112.397 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.709 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.8 m120 -121.84 57.98 1.03 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.899 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.38 -48.31 3.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.307 -178.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.638 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 1.6 p80 -178.48 -56.94 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.797 0.332 . . . . 0.0 111.408 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.664 ' CD2' HG23 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -56.93 -16.33 6.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.711 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -124.23 -38.17 2.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.122 0.486 . . . . 0.0 110.639 -177.59 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.562 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.6 t -65.75 -24.52 66.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.298 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.573 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -90.29 -60.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.743 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 6.7 pt20 -100.39 -168.31 1.56 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 548' ' ' MET . 1.1 m-20 -103.25 31.4 4.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.393 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.743 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 4.1 mt-10 45.5 29.02 0.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 110.333 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 526' ' ' ALA . . . 152.96 -23.55 0.8 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.58 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 1.087 ' HB3' HD13 ' A' ' 527' ' ' ILE . . . 32.24 26.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.06 16.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.789 0.328 . . . . 0.0 111.544 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 1.087 HD13 ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.17 -33.73 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.315 0.579 . . . . 0.0 110.034 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 166.66 -39.82 0.25 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.763 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 529' ' ' LEU . 3.3 mp 72.23 -18.01 0.34 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.15 -19.2 51.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.293 0.568 . . . . 0.0 110.876 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.477 ' CD2' HG23 ' A' ' 532' ' ' ILE . 8.6 p-90 -74.96 -10.43 59.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.517 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -125.28 59.52 24.88 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.58 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -42.58 -41.6 8.1 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.071 2.514 . . . . 0.0 113.559 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 8.0 p90 -115.45 6.25 14.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 10.3 t80 -114.79 -24.36 8.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.443 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -112.39 -90.98 1.95 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.623 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 83.6 Cg_exo -42.93 -43.65 9.28 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.674 2.249 . . . . 0.0 112.017 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -73.34 -31.3 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.48 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.832 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -65.8 150.66 48.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.283 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -133.37 -32.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -117.25 30.5 6.23 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.832 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -142.42 -31.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -105.5 -31.76 8.84 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.902 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 547' ' ' LEU . 2.5 mp 33.27 -71.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.637 0.775 . . . . 0.0 112.699 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 32.6 mt-10 70.8 35.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.256 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -141.1 0.3 1.78 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.727 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 544' ' ' ILE . 2.5 pt? -146.92 -5.52 0.52 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 522' ' ' ASP . 0.0 OUTLIER -78.63 76.55 5.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.5 28.47 3.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.073 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.79 89.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.434 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.528 ' OE1' HD11 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -119.52 -78.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 67.43 23.41 9.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.632 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.47 -34.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.994 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.865 HD12 HG23 ' A' ' 555' ' ' ILE . 2.1 pp -81.99 1.24 36.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.956 HG21 ' CG ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -140.69 -42.61 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.067 0.461 . . . . 0.0 110.816 -179.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.501 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -111.31 120.24 41.56 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.114 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -159.54 -70.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.39 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 558' ' ' LEU . 1.9 pt? -135.79 -44.86 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.594 0.197 . . . . 0.0 111.464 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.44 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.48 38.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.066 0.46 . . . . 0.0 111.476 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.092 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.699 0.285 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.428 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 6.6 mt-30 -158.81 52.84 0.54 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.865 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.483 ' CB ' HD22 ' A' ' 512' ' ' ASN . 67.4 Cg_endo -73.96 125.6 10.0 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.64 2.227 . . . . 0.0 112.203 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.4 ' HA ' ' OE1' ' A' ' 560' ' ' GLN . 0.1 OUTLIER -78.4 87.42 4.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.212 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 40.1 m 60.76 117.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.979 ' O ' HD21 ' A' ' 515' ' ' LEU . 4.3 m120 -106.78 -52.49 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.465 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.609 ' CD ' HG13 ' A' ' 555' ' ' ILE . 57.5 Cg_endo -106.51 16.93 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 124.304 3.336 . . . . 0.0 112.448 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.716 ' C ' HD13 ' A' ' 515' ' ' LEU . 5.1 m120 -122.56 53.78 1.24 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.318 0.58 . . . . 0.0 109.812 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.979 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.54 -69.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.858 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.758 ' HA ' HG22 ' A' ' 519' ' ' THR . 3.5 p80 -159.64 -55.2 0.06 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.369 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.602 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.92 -8.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -124.82 -44.47 1.94 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.548 0.689 . . . . 0.0 110.51 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 516' ' ' HIS . 13.1 t -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.7 OUTLIER -82.51 -64.79 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.846 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.654 ' N ' HG22 ' A' ' 520' ' ' THR . 9.1 pt20 -99.89 -160.37 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.357 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -103.04 34.48 2.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.478 -179.548 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.599 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.2 mt-10 44.55 34.46 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 140.66 -40.34 1.38 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.223 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.66 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 57.28 8.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.43 15.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 110.792 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.66 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -54.55 -24.54 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.539 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 172.52 -51.67 0.17 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.792 HD21 ' OE2' ' A' ' 545' ' ' GLU . 3.5 mp 77.99 -18.4 0.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.776 0.43 . . . . 0.0 111.986 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.8 45.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.417 0.627 . . . . 0.0 110.164 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.502 ' NE1' HD13 ' A' ' 527' ' ' ILE . 1.8 p-90 -66.07 -15.72 63.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.742 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -124.01 64.07 33.13 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -177.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.39 -36.56 17.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.897 2.398 . . . . 0.0 113.503 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.492 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 4.7 p90 -121.27 6.19 10.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.617 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 8.1 t80 -112.19 -26.46 8.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.648 0.261 . . . . 0.0 111.406 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -111.84 -90.88 1.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.585 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 82.0 Cg_exo -40.45 -44.01 4.22 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.915 2.41 . . . . 0.0 112.095 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -73.39 -35.3 65.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.425 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.876 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -58.15 157.18 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.989 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.31 -34.08 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.478 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.483 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -117.67 36.73 3.56 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.876 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -148.69 -36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.226 0.536 . . . . 0.0 109.849 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.689 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -100.09 -33.94 10.26 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.21 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.597 ' CG2' HD22 ' A' ' 547' ' ' LEU . 1.6 mp 32.31 -72.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.913 0.885 . . . . 0.0 113.025 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.792 ' OE2' HD21 ' A' ' 529' ' ' LEU . 20.0 mt-10 68.85 96.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.176 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 140.93 -9.36 2.79 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.844 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.669 HD11 ' HZ3' ' A' ' 518' ' ' TRP . 1.5 pt? -129.93 -1.66 4.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.599 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -72.62 85.26 1.17 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -130.79 -48.83 1.04 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.417 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 167.73 -73.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' A' ' 552' ' ' ASP . 0.0 OUTLIER 57.04 -152.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.667 ' H ' HD11 ' A' ' 555' ' ' ILE . 13.0 t70 110.49 21.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.105 0.962 . . . . 0.0 110.527 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -141.34 0.14 1.7 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.489 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.953 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -127.12 2.46 6.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.995 0.518 . . . . 0.0 110.332 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.953 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -147.1 -41.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.629 -178.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.537 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.6 t -118.06 134.83 54.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.971 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 51.13 65.65 2.97 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.153 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.522 HD12 ' HD3' ' A' ' 559' ' ' ARG . 1.7 pt? -141.44 -44.81 0.37 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.686 0.279 . . . . 0.0 110.527 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.522 ' HD3' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 170.38 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.179 0.514 . . . . 0.0 110.708 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 510' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.222 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.777 0.323 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -174.56 66.94 0.28 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.08 175.03 10.41 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.918 2.412 . . . . 0.0 112.468 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.8 124.68 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.452 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 57.94 98.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.327 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.971 ' O ' HD21 ' A' ' 515' ' ' LEU . 4.9 m120 -101.83 -51.28 0.16 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.643 ' CG ' HG21 ' A' ' 555' ' ' ILE . 48.4 Cg_endo -104.03 15.41 0.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.052 3.168 . . . . 0.0 113.122 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.708 ' C ' HD13 ' A' ' 515' ' ' LEU . 4.1 m120 -125.61 59.16 1.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.237 0.542 . . . . 0.0 109.608 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.971 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -119.45 -52.06 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.032 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.635 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 3.0 p80 -176.63 -55.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.324 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.681 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -54.44 -13.54 0.96 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.74 -45.64 2.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.449 0.643 . . . . 0.0 110.156 -177.264 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 2.1 t -65.64 -25.84 67.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.656 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -80.94 -56.97 3.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.251 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 8.0 pt20 -100.68 -162.32 0.93 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.144 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.43 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -103.05 35.96 2.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.496 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.863 ' OE1' HD21 ' A' ' 547' ' ' LEU . 26.3 mt-10 43.9 73.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.097 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.494 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.73 -21.65 35.04 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.989 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.604 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 53.77 11.08 0.29 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.11 16.23 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.481 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.635 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.5 OUTLIER -55.01 -22.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.261 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.542 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 157.61 -34.72 0.54 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.354 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.781 HD11 ' CD2' ' A' ' 543' ' ' TYR . 3.6 mt 69.29 -56.87 0.54 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 111.586 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.74 46.16 0.75 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.363 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.635 ' NE1' HD13 ' A' ' 527' ' ' ILE . 2.9 p-90 -120.28 -18.82 7.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.528 HG21 ' HD2' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -108.63 159.47 30.79 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.055 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.463 ' HG2' ' CE1' ' A' ' 535' ' ' PHE . 18.5 Cg_endo -59.37 -48.57 13.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.6 2.2 . . . . 0.0 112.868 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.669 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 49.0 p90 -156.58 6.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.811 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.5 OUTLIER -72.5 -26.42 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.88 0.371 . . . . 0.0 111.081 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -108.4 -58.84 0.55 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.878 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.44 -35.6 76.34 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.389 2.059 . . . . 0.0 111.71 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -92.52 -12.14 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.381 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.816 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -75.28 122.51 23.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.366 . . . . 0.0 111.503 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -124.18 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.499 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -120.08 35.27 3.85 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.816 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -146.99 -33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.074 0.464 . . . . 0.0 110.333 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.781 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.3 OUTLIER -97.3 -40.02 8.95 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.733 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.889 HG21 HD22 ' A' ' 547' ' ' LEU . 1.5 mp 36.96 -72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.466 0.707 . . . . 0.0 112.364 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.714 ' N ' ' O ' ' A' ' 543' ' ' TYR . 25.1 mt-10 66.21 94.8 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.54 -4.75 1.51 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.998 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 544' ' ' ILE . 2.4 pt? -128.59 -10.25 5.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.336 0.568 . . . . 0.0 112.369 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.73 78.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.908 0.385 . . . . 0.0 111.032 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -133.72 27.13 4.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.638 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 1.3 m120 54.21 63.74 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.355 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.43 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -86.19 -79.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.043 -179.33 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.57 ' H ' HD11 ' A' ' 555' ' ' ILE . 0.5 OUTLIER 64.71 12.86 7.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.265 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -118.37 -34.61 1.09 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.592 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.997 HD12 HG23 ' A' ' 555' ' ' ILE . 2.1 pp -87.48 2.93 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.997 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.64 -40.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.275 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER -109.88 57.71 0.61 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.973 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -109.43 -62.22 0.53 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.148 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 558' ' ' LEU . 1.8 pt? -143.12 -49.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.545 0.212 . . . . 0.0 111.131 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.455 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 176.28 34.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.204 0.526 . . . . 0.0 110.865 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.62 ' NE2' ' H ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.119 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.805 0.336 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.413 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 11.4 mt-30 -166.68 53.67 0.28 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 70.9 Cg_endo -74.37 125.55 9.73 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.609 2.206 . . . . 0.0 112.341 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 560' ' ' GLN . 0.1 OUTLIER -91.9 117.26 29.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.4 m 60.1 86.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.007 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.827 ' O ' HD21 ' A' ' 515' ' ' LEU . 5.5 m-80 -83.37 -49.22 0.73 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.95 ' CG ' HG21 ' A' ' 555' ' ' ILE . 36.8 Cg_endo -102.2 16.05 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.256 3.304 . . . . 0.0 112.098 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.623 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.4 m120 -120.42 56.64 0.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.827 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -105.77 -48.0 3.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.302 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.625 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 2.6 p80 -177.62 -56.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.353 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.712 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -57.11 -20.44 25.56 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -120.75 -41.23 2.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 0.0 110.999 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.596 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 7.4 t -57.2 -30.15 64.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.18 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.699 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -94.42 -70.11 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.891 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.699 ' N ' HG22 ' A' ' 520' ' ' THR . 3.6 pt20 -99.75 -168.18 1.57 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.451 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.846 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 3.7 m-20 -89.93 22.17 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.904 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.584 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.9 mt-10 69.94 5.51 5.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.983 0.421 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 128.63 17.16 1.94 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.066 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.846 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -99.64 -6.1 27.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.798 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -89.17 18.99 4.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.821 0.343 . . . . 0.0 111.413 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -136.09 -50.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 -179.339 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 159.92 -27.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.755 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.815 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 81.01 -28.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.8 -21.29 48.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.849 0.357 . . . . 0.0 111.869 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.805 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.0 p-90 -53.61 -24.59 14.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 110.587 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.805 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.3 OUTLIER -115.52 119.34 38.11 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.271 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.45 ' HG2' ' CE2' ' A' ' 534' ' ' TYR . 74.9 Cg_endo -90.12 31.97 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.715 2.276 . . . . 0.0 114.19 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.559 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 8.1 p90 172.2 -34.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 111.044 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.91 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 2.3 t80 -71.89 -21.15 61.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.67 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -116.69 -71.46 0.45 Allowed Glycine 0 C--N 1.32 -0.344 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.34 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HD3' HG13 ' A' ' 532' ' ' ILE . 51.2 Cg_exo -52.5 -39.46 74.42 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.485 2.123 . . . . 0.0 111.581 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -91.84 -17.35 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.117 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 1.018 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -45.25 -52.01 10.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.873 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 2.0 mt-10 71.85 -58.91 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.433 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -103.96 26.13 24.16 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.348 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 1.018 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -149.05 1.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 O-C-N 122.778 -0.248 . . . . 0.0 111.664 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.815 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.8 OUTLIER -129.33 -42.95 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.482 0.182 . . . . 0.0 110.725 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.994 HG21 HD22 ' A' ' 547' ' ' LEU . 3.3 mp 34.34 -73.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.444 0.698 . . . . 0.0 112.554 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.712 ' N ' ' O ' ' A' ' 543' ' ' TYR . 20.8 mt-10 64.02 34.98 10.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.356 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -147.17 13.43 1.45 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.54 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.994 HD22 HG21 ' A' ' 544' ' ' ILE . 1.1 pt? -157.87 -17.86 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.526 ' N ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -70.07 63.14 0.22 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.78 -43.03 3.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.649 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 552' ' ' ASP . 0.9 OUTLIER 172.89 -75.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.472 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER 41.19 -85.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.368 179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.3 OUTLIER 63.65 18.27 10.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -123.79 -31.44 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.187 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.957 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -77.52 -2.55 36.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.611 0.243 . . . . 0.0 111.305 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.957 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.91 -39.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.104 0.478 . . . . 0.0 110.897 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.504 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -115.13 66.84 0.69 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.417 -178.7 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 167.69 -28.43 0.16 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.431 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.74 HD12 ' HD3' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -47.43 -62.51 1.4 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 111.37 -179.671 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.74 ' HD3' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -171.33 34.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.356 0.598 . . . . 0.0 110.366 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 510' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.086 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.849 0.357 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 26.5 mt-30 -162.79 52.94 0.37 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 72.1 Cg_endo -76.74 106.03 2.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.596 2.197 . . . . 0.0 112.406 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.91 117.34 8.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.827 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 97.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.987 ' O ' HD21 ' A' ' 515' ' ' LEU . 2.9 m-80 -94.84 -50.37 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.683 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.848 ' CG ' HG21 ' A' ' 555' ' ' ILE . 74.4 Cg_endo -107.13 16.88 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.374 3.383 . . . . 0.0 112.902 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.796 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.8 m120 -119.22 56.62 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.676 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.87 -58.7 1.99 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.104 -179.118 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.649 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 2.6 p80 -173.85 -56.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.482 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.649 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.18 -12.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.708 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -122.49 -40.57 2.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -177.464 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.611 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.0 t -74.4 -21.11 59.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.648 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.49 -56.5 3.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 0.0 111.538 -179.009 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.589 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 7.7 pt20 -100.45 -158.13 0.65 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.46 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 9.0 m-20 -102.72 32.84 3.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.701 ' OE1' HD13 ' A' ' 544' ' ' ILE . 4.7 mt-10 44.67 73.99 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.963 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.449 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.12 -24.58 21.16 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.28 10.0 0.28 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.03 16.52 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.416 . . . . 0.0 110.539 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.598 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.97 -24.13 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.343 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.548 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 158.19 -52.68 0.4 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.328 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.609 HD21 ' CD2' ' A' ' 543' ' ' TYR . 3.8 mp 75.07 -22.18 0.27 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.868 0.467 . . . . 0.0 112.115 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.29 -24.82 42.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.162 0.506 . . . . 0.0 111.135 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.632 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 6.2 p-90 -64.27 -15.23 59.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.757 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.865 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.0 OUTLIER -126.31 139.27 34.12 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.191 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.91 -20.2 2.42 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.777 2.318 . . . . 0.0 113.892 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.0 p90 -148.21 6.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.936 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 18.6 m-85 -86.63 -40.49 15.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.027 0.441 . . . . 0.0 110.701 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -110.3 -60.4 0.5 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.367 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.76 -37.55 84.52 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.346 2.031 . . . . 0.0 111.551 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -92.65 -17.54 24.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.174 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 1.012 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -49.29 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.517 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 22.8 mt-10 76.15 -44.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.462 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -110.2 32.41 6.69 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.655 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 1.012 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -149.95 -32.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.065 0.46 . . . . 0.0 110.543 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.728 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -98.2 -39.86 8.66 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.958 HG21 HD22 ' A' ' 547' ' ' LEU . 1.0 OUTLIER 36.14 -72.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.396 0.679 . . . . 0.0 112.538 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.728 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.9 mt-10 67.0 33.38 5.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.042 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -138.5 -3.75 1.79 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.886 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.958 HD22 HG21 ' A' ' 544' ' ' ILE . 1.7 pt? -144.72 -8.24 0.65 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.467 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.46 68.14 0.36 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.957 0.408 . . . . 0.0 111.859 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -133.16 34.04 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.266 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 43.9 t30 55.67 95.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.655 ' OE1' HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -125.45 -76.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.533 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.27 24.76 7.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.884 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.94 -35.75 0.38 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.057 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 555' ' ' ILE . 2.5 pp -82.3 1.67 35.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 111.261 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.909 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -140.59 -42.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 110.872 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.499 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -111.77 118.31 35.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.994 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -152.04 -70.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.716 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.673 HD23 ' H ' ' A' ' 558' ' ' LEU . 2.0 pt? -136.03 -48.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.632 0.216 . . . . 0.0 111.433 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.656 HH11 HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -178.65 37.92 0.0 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.964 0.412 . . . . 0.0 111.608 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 508' ' ' GLN . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.5 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 1.6 tp60 77.99 61.59 0.21 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.527 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 8.8 Cg_exo -73.85 78.96 2.38 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.964 2.443 . . . . 0.0 112.299 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -67.51 109.67 3.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.473 ' HA ' HD13 ' A' ' 555' ' ' ILE . 0.6 OUTLIER 63.62 98.36 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.797 ' O ' HD21 ' A' ' 515' ' ' LEU . 2.6 m-80 -97.5 -50.8 0.22 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.669 ' CG ' HG21 ' A' ' 555' ' ' ILE . 36.3 Cg_endo -101.93 16.37 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.921 3.08 . . . . 0.0 112.319 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.523 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.5 m120 -119.61 52.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -98.98 -48.63 4.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.354 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.0 p80 -177.04 -53.04 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.772 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -60.17 -23.03 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.733 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -118.01 -39.48 3.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.0 110.959 -177.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.576 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 5.2 t -58.52 -27.78 64.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.542 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.674 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -97.8 -67.59 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.465 -179.135 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.674 ' N ' HG22 ' A' ' 520' ' ' THR . 4.8 pt20 -99.52 -168.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.771 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.1 OUTLIER -87.23 24.26 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.883 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.662 ' OE2' HD21 ' A' ' 547' ' ' LEU . 16.9 mt-10 68.57 4.87 4.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.06 0.457 . . . . 0.0 111.073 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 123.7 22.62 2.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.966 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -110.28 4.4 20.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -93.16 12.67 23.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.859 0.361 . . . . 0.0 111.657 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.636 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -129.7 -45.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.292 -179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 150.85 -17.2 0.94 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.467 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.6 OUTLIER 73.72 -51.53 0.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 45.1 0.64 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.384 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.636 ' NE1' HD13 ' A' ' 527' ' ' ILE . 3.2 p-90 -119.87 -16.92 8.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.577 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.536 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.24 159.93 32.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.699 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 37.6 Cg_endo -66.3 -45.2 5.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.3 2.0 . . . . 0.0 112.491 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 18.5 p90 -161.57 6.68 0.07 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.865 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 1.1 m-85 -66.0 -26.85 67.73 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.118 -0.364 . . . . 0.0 111.4 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.48 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.48 -63.5 0.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.609 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.07 -39.3 80.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.356 2.038 . . . . 0.0 111.835 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 534' ' ' TYR . . . -95.3 -4.58 45.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.533 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.865 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -54.15 -61.73 2.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 32.4 mt-10 72.61 -58.26 0.6 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -102.91 22.59 36.44 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.312 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.862 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -144.66 -5.84 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.711 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -125.53 -37.17 2.37 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.47 0.176 . . . . 0.0 111.131 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.892 HG21 HD22 ' A' ' 547' ' ' LEU . 2.1 mp 36.7 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.471 0.708 . . . . 0.0 112.582 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 543' ' ' TYR . 36.9 mt-10 65.47 96.92 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.976 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.39 -8.27 1.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.709 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.892 HD22 HG21 ' A' ' 544' ' ' ILE . 2.1 pt? -128.15 -9.38 5.33 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.42 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.44 76.3 0.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.349 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -134.62 36.16 3.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.101 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.5 m-20 70.38 -64.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.151 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 42.66 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.963 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.1 OUTLIER 59.63 16.53 5.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -115.17 -34.79 1.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.697 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -80.69 -3.85 52.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.847 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 556' ' ' CYS . 2.9 pp -145.19 -29.95 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.485 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.731 ' N ' HD12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -118.63 49.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.145 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 153.76 44.02 0.02 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.43 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 558' ' ' LEU . 2.2 pt? -122.46 -40.32 2.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 110.529 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.45 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER -178.17 35.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.39 0.614 . . . . 0.0 110.295 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.117 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.8 0.333 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.472 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 7.9 mm-40 -144.63 50.57 1.22 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.664 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 95.5 Cg_endo -81.76 104.59 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.594 2.196 . . . . 0.0 112.656 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.425 ' HA ' ' CG ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER -63.5 112.62 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.602 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.74 109.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.833 ' C ' HD11 ' A' ' 515' ' ' LEU . 2.3 m-80 -97.03 -50.35 0.23 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.958 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 23.9 Cg_endo -99.86 -1.67 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.791 2.994 . . . . 0.0 113.208 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.811 ' C ' HD13 ' A' ' 515' ' ' LEU . 5.4 m120 -106.06 66.2 0.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.886 HD23 ' CE1' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -133.27 -30.46 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.886 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -173.0 -78.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.649 ' CB ' HG23 ' A' ' 542' ' ' ILE . 0.4 OUTLIER -67.4 12.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -177.692 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.697 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -139.26 -39.57 0.48 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.305 0.574 . . . . 0.0 109.66 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.537 HG22 ' N ' ' A' ' 516' ' ' HIS . 0.8 OUTLIER -78.62 -13.17 59.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.379 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.5 OUTLIER -95.84 -59.76 1.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.626 0.251 . . . . 0.0 110.873 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.547 ' N ' ' CG2' ' A' ' 520' ' ' THR . 9.3 pt20 -100.7 -158.02 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.301 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.418 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 2.4 m-20 -103.02 34.27 2.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.857 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.712 ' OE1' HD13 ' A' ' 544' ' ' ILE . 20.9 mt-10 47.07 71.95 0.28 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 110.269 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.6 -19.47 47.62 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.117 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.59 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.24 11.35 0.38 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.55 16.2 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.023 0.44 . . . . 0.0 110.507 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.59 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -54.17 -22.96 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.482 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.554 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 162.15 -53.31 0.31 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.245 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 2.8 mp 75.51 -20.06 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.6 0.36 . . . . 0.0 111.813 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.5 -24.17 42.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.175 0.512 . . . . 0.0 111.106 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.592 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 7.1 p-90 -63.84 -14.37 52.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.846 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.862 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.9 OUTLIER -125.62 140.23 35.98 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.164 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -87.42 -20.06 2.21 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.763 2.308 . . . . 0.0 113.982 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.505 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.56 6.24 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.862 ' HB2' HD12 ' A' ' 532' ' ' ILE . 18.6 m-85 -86.64 -38.49 17.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 110.93 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -113.73 -60.66 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.595 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.88 -40.07 76.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.434 2.089 . . . . 0.0 111.609 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -84.54 -27.71 27.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.727 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.768 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.07 158.82 6.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.492 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -151.32 -34.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.307 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.54 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -115.44 34.72 4.66 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.489 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.3 OUTLIER -149.92 -33.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.044 0.45 . . . . 0.0 110.163 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -103.33 -44.68 5.09 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.235 -178.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.995 HG21 HD22 ' A' ' 547' ' ' LEU . 0.9 OUTLIER 42.4 -72.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.56 0.744 . . . . 0.0 112.755 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.665 ' N ' ' O ' ' A' ' 543' ' ' TYR . 0.4 OUTLIER 69.31 29.91 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.36 -5.7 1.28 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.092 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.995 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -138.94 -6.56 1.44 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.474 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -72.36 63.1 0.53 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 111.615 -178.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -119.08 26.04 9.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.466 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 58.9 80.98 0.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.57 -77.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.784 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.518 ' H ' HD11 ' A' ' 555' ' ' ILE . 14.8 t70 63.24 15.27 8.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.358 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -121.89 -33.46 0.92 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.968 HD12 HG23 ' A' ' 555' ' ' ILE . 1.8 pp -87.84 5.49 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.968 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -146.35 -41.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.454 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t -107.96 48.96 0.83 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.114 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 146.49 40.39 0.04 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.458 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 558' ' ' LEU . 1.7 pt? -110.06 -40.86 4.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.948 0.374 . . . . 0.0 110.407 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.556 ' HD3' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 176.37 35.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.349 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.425 ' CG ' ' HA ' ' A' ' 510' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.211 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.404 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -168.88 66.06 0.63 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 4.4 Cg_exo -77.29 122.91 6.32 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.009 2.473 . . . . 0.0 112.338 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.76 122.18 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.566 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.84 100.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.85 ' C ' HD11 ' A' ' 515' ' ' LEU . 1.5 m-80 -103.19 -51.23 0.14 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.947 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.814 ' CG ' HG21 ' A' ' 555' ' ' ILE . 22.2 Cg_endo -100.11 -1.85 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.777 2.985 . . . . 0.0 113.259 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.821 ' C ' HD13 ' A' ' 515' ' ' LEU . 3.8 m120 -103.44 65.66 0.85 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.957 HD23 ' CE1' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -132.16 -22.64 2.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -178.117 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.957 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER 179.83 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.564 ' CB ' HG23 ' A' ' 542' ' ' ILE . 0.5 OUTLIER -62.48 7.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.296 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.759 ' HB2' ' O ' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -135.57 -40.23 0.71 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.369 0.604 . . . . 0.0 109.775 -178.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.736 HG22 ' N ' ' A' ' 516' ' ' HIS . 7.2 t -80.17 -12.54 59.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.945 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.572 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -97.76 -62.38 1.26 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.685 0.278 . . . . 0.0 111.361 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.572 ' N ' ' CG2' ' A' ' 520' ' ' THR . 11.5 pt20 -100.45 -163.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.995 0.426 . . . . 0.0 111.208 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -102.89 32.32 3.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.44 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.785 ' OE1' HD13 ' A' ' 544' ' ' ILE . 3.9 mt-10 41.61 79.56 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.352 0.596 . . . . 0.0 110.097 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 526' ' ' ALA . . . 93.49 -14.93 64.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.934 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 527' ' ' ILE . . . 28.66 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.56 16.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 1.04 HD13 ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.22 -35.6 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 173.99 -38.58 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.134 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.32 -46.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -76.88 -20.04 56.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.3 p-90 -43.69 -29.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 0.0 111.083 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.531 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -104.71 157.56 33.89 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.319 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.458 ' HG2' ' CE1' ' A' ' 535' ' ' PHE . 36.4 Cg_endo -65.11 -44.09 10.21 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.426 2.084 . . . . 0.0 112.363 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 46.1 p90 -161.9 6.56 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.707 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.8 OUTLIER -63.98 -28.51 69.86 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.086 -0.384 . . . . 0.0 110.982 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.517 ' HA3' HD11 ' A' ' 532' ' ' ILE . . . -110.2 -57.83 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.988 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 75.8 Cg_exo -50.33 -46.71 27.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.47 2.114 . . . . 0.0 112.023 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -79.05 -25.8 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.933 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -59.95 141.62 55.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -129.97 -26.13 2.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.56 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.28 38.26 2.96 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.933 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.3 OUTLIER -150.26 -35.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.312 0.577 . . . . 0.0 109.951 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.682 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -103.29 -30.33 10.7 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.089 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.923 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 33.95 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.789 0.835 . . . . 0.0 112.907 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 543' ' ' TYR . 29.1 mt-10 69.13 87.4 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.934 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 157.29 -19.73 0.4 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.152 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.923 HD22 HG21 ' A' ' 544' ' ' ILE . 1.4 pt? -127.7 -18.61 4.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 111.68 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.441 ' HE3' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -58.36 102.85 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.172 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.438 ' NE2' ' HA ' ' A' ' 547' ' ' LEU . 0.4 OUTLIER -179.75 -64.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 178.73 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 175.33 108.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.823 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 -72.6 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.822 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 45.5 28.46 0.5 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.11 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.33 -35.33 0.42 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 1.017 HD12 HG23 ' A' ' 555' ' ' ILE . 1.5 pp -89.65 -4.54 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.735 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 1.017 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.74 -42.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.294 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.527 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER -115.48 58.37 0.73 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.334 -178.665 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -97.86 -55.63 1.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.554 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 2.5 pt? -147.09 -45.74 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.516 0.198 . . . . 0.0 110.886 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.51 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.91 37.6 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.947 0.403 . . . . 0.0 111.433 179.835 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.508 ' OE1' HD23 ' A' ' 558' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.09 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.81 0.338 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.435 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 2.5 mt-30 -168.25 63.81 0.61 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 25.7 Cg_exo -62.89 97.32 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.666 2.244 . . . . 0.0 112.388 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.2 115.57 20.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.634 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 64.84 88.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.864 ' O ' HD21 ' A' ' 515' ' ' LEU . 5.8 m-80 -87.74 -49.63 0.44 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.837 ' CG ' HG21 ' A' ' 555' ' ' ILE . 38.6 Cg_endo -102.67 17.51 0.24 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 124.229 3.286 . . . . 0.0 112.232 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.694 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.6 m120 -122.74 57.77 1.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.864 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.99 -52.42 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.357 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.652 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 1.6 p80 -175.76 -56.36 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.054 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.665 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -54.35 -14.83 1.32 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -179.155 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.37 -47.45 2.0 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.406 0.622 . . . . 0.0 110.04 -177.205 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 516' ' ' HIS . 6.4 t -63.79 -26.15 68.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -81.43 -56.5 4.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.56 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.609 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 8.5 pt20 -100.54 -161.92 0.9 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.038 0.447 . . . . 0.0 111.283 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.444 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.2 m-20 -102.95 34.37 2.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.569 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.759 ' OE1' HD21 ' A' ' 547' ' ' LEU . 20.1 mt-10 43.56 77.28 0.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.854 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 93.72 -23.44 30.64 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.0 10.68 0.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.13 15.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.01 0.433 . . . . 0.0 110.644 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.603 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -55.21 -22.35 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.366 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.558 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 155.45 -48.36 0.49 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.999 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.1 mp 74.68 -47.02 0.62 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.833 0.453 . . . . 0.0 111.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.54 43.98 0.59 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.572 ' CE2' HD13 ' A' ' 532' ' ' ILE . 4.3 p-90 -121.87 -13.9 8.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.829 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.65 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -117.64 169.67 7.23 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.882 -179.792 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 75.9 Cg_endo -92.73 6.16 3.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.746 2.297 . . . . 0.0 113.318 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.635 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 28.3 p90 -176.83 -27.28 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.776 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 48.8 m-85 -59.48 -26.49 65.31 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.85 -0.531 . . . . 0.0 111.453 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.448 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -110.8 -65.6 0.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.059 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 42.3 Cg_exo -57.27 -39.0 93.29 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.587 2.191 . . . . 0.0 111.943 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -86.03 -18.38 32.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.31 150.16 22.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.87 0.367 . . . . 0.0 111.184 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -157.71 -36.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -114.63 31.66 6.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.025 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.626 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -146.57 -33.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.084 0.468 . . . . 0.0 110.366 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -99.56 -36.4 9.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.044 -179.161 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 1.046 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 37.0 -73.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.465 0.706 . . . . 0.0 112.496 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.706 ' N ' ' O ' ' A' ' 543' ' ' TYR . 31.9 mt-10 65.85 36.82 5.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 546' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -148.69 14.32 1.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.363 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 1.046 HD22 HG21 ' A' ' 544' ' ' ILE . 1.2 pt? -160.53 -14.91 0.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.86 64.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.416 . . . . 0.0 111.759 -178.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.522 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.62 33.07 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.437 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 58.15 86.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.512 ' CG ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -112.23 -77.84 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.037 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.78 11.5 8.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -117.29 -32.89 1.42 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.973 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 1.011 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -82.76 -0.81 49.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.796 0.331 . . . . 0.0 111.238 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 1.011 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.94 -40.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.876 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -110.97 54.52 0.67 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.298 -179.126 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 150.94 41.57 0.03 OUTLIER Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.353 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 558' ' ' LEU . 2.4 pt? -124.82 -41.28 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.663 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.431 ' HD3' ' CD1' ' A' ' 558' ' ' LEU . 0.0 OUTLIER -175.41 34.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 0.0 110.787 179.502 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.117 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' A' ' 508' ' ' GLN . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.667 0.27 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 507' ' ' ALA . 6.1 mm-40 84.51 69.92 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.189 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.407 ' HD3' ' H ' ' A' ' 508' ' ' GLN . 8.8 Cg_exo -73.16 69.17 4.01 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.252 2.635 . . . . 0.0 111.002 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.588 ' HG3' HD11 ' A' ' 558' ' ' LEU . 5.5 mptt -144.56 -173.76 4.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.374 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 42.91 61.32 2.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.179 0.514 . . . . 0.0 110.927 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.812 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.8 m120 -89.55 -48.75 0.39 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.503 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.896 ' CG ' HG21 ' A' ' 555' ' ' ILE . 59.9 Cg_endo -103.67 20.59 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.245 3.297 . . . . 0.0 112.314 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 514' ' ' ASN . . . . . 0.583 ' C ' HD13 ' A' ' 515' ' ' LEU . 1.7 m120 -115.46 48.16 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.812 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -100.27 -55.24 2.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.256 -178.665 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.63 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 2.6 p80 -175.48 -56.43 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.669 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.647 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -57.21 -20.18 25.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.336 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -119.05 -27.68 5.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.424 -177.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 1.6 t -76.97 -20.09 56.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.684 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -98.55 -70.87 0.71 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 110.539 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.684 ' N ' HG22 ' A' ' 520' ' ' THR . 7.9 pt20 -99.93 -160.98 0.83 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.095 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.85 ' CB ' ' HB3' ' A' ' 525' ' ' ALA . 5.2 m-20 -96.19 30.83 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.218 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.617 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 20.3 mt-10 63.04 14.4 7.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.891 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 113.93 22.68 5.23 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.911 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.85 ' HB3' ' CB ' ' A' ' 522' ' ' ASP . . . -97.83 -3.62 38.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.64 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -84.86 22.42 1.37 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 110.968 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.64 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -132.73 -60.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.1 -21.8 1.25 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.41 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.9 mp 75.2 -20.31 0.35 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.09 43.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.331 0.586 . . . . 0.0 111.023 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.729 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 7.2 p-90 -65.72 -18.51 65.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.029 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.6 pt -123.42 135.61 26.25 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.037 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.424 ' HG2' ' CD2' ' A' ' 534' ' ' TYR . 98.2 Cg_endo -87.63 -17.73 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.71 2.273 . . . . 0.0 113.604 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.642 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 26.6 p90 -138.14 -26.08 0.94 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 535' ' ' PHE . . . . . 0.825 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 98.3 m-85 -59.97 -43.14 95.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.986 -0.446 . . . . 0.0 111.564 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -109.25 -60.92 0.52 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.987 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 532' ' ' ILE . 54.3 Cg_exo -51.7 -41.99 58.97 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.388 2.059 . . . . 0.0 111.813 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.93 -31.08 31.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.633 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -49.36 159.37 0.32 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -149.28 -44.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.72 25.18 17.76 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.095 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -145.06 -4.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 -179.389 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.677 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.5 OUTLIER -129.57 -42.73 1.29 Allowed 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.316 -178.532 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 544' ' ' ILE . . . . . 0.959 HG21 HD22 ' A' ' 547' ' ' LEU . 3.4 mp 38.89 -73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 123.54 0.736 . . . . 0.0 112.712 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.677 ' N ' ' O ' ' A' ' 543' ' ' TYR . 2.0 mm-40 73.65 29.77 1.49 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.314 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.93 4.72 2.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.648 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.959 HD22 HG21 ' A' ' 544' ' ' ILE . 1.7 pt? -149.88 -16.22 0.26 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.604 ' HE2' ' HA ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -69.46 65.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.938 0.399 . . . . 0.0 111.836 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -132.23 35.73 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.404 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 93.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.333 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.444 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -120.72 -76.44 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.216 0.531 . . . . 0.0 111.116 -179.459 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.462 ' H ' HD11 ' A' ' 555' ' ' ILE . 3.5 t70 63.7 17.17 10.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.678 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.443 ' HA2' ' HA3' ' A' ' 557' ' ' GLY . . . -123.77 -31.91 0.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.891 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 555' ' ' ILE . 2.7 pp -90.03 8.38 32.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.088 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.954 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.1 -44.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.545 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER -116.05 47.8 1.33 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.234 179.257 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.443 ' HA3' ' HA2' ' A' ' 553' ' ' GLY . . . -154.33 -35.15 0.03 OUTLIER Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.345 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.759 HD12 ' HD3' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -33.89 -50.56 0.37 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.849 0.324 . . . . 0.0 111.467 -179.544 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.759 ' HD3' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -177.86 30.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.268 0.556 . . . . 0.0 111.168 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.542 ' HB3' ' CB ' ' A' ' 510' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.708 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.328 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.9 m 60.32 101.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.9 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.5 m-80 -91.0 -51.44 0.31 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.08 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 61.5 Cg_endo -106.52 21.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.501 3.467 . . . . 0.0 112.406 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.637 ' C ' HD13 ' A' ' 515' ' ' LEU . 4.0 m-80 -118.8 51.18 1.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.9 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -105.59 -67.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.079 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.673 ' HA ' HG22 ' A' ' 519' ' ' THR . 6.0 p-80 -161.51 -57.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.193 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.605 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -55.94 -9.61 0.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.698 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -123.23 -44.31 2.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.581 0.705 . . . . 0.0 110.563 -176.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 516' ' ' HIS . 12.1 t -63.15 -28.78 70.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.467 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.668 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.8 OUTLIER -84.57 -65.69 0.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.764 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.668 ' N ' HG22 ' A' ' 520' ' ' THR . 3.5 pt20 -99.99 -157.64 0.62 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.2 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 4.1 m-20 -100.62 36.64 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.233 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 8.3 mt-10 52.28 34.88 15.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.034 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.518 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 89.26 33.35 9.55 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.571 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.797 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -119.95 -5.47 10.07 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -90.79 15.69 10.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.795 0.331 . . . . 0.0 111.72 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.588 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.2 OUTLIER -129.65 -44.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.432 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 134.28 -17.63 4.27 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.637 HD11 ' HD2' ' A' ' 543' ' ' TYR . 2.9 tp 78.0 -51.61 0.5 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.67 47.13 0.71 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.107 0.48 . . . . 0.0 112.241 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.76 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.9 p-90 -122.5 -16.53 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.632 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.777 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -116.17 166.29 12.82 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.856 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 83.1 Cg_endo -94.04 2.39 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.835 2.357 . . . . 0.0 113.563 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.728 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 9.8 p90 -177.16 -21.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.777 ' HB2' HD12 ' A' ' 532' ' ' ILE . 60.9 m-85 -59.5 -30.93 68.91 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.91 -0.494 . . . . 0.0 111.67 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.565 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -111.37 -69.07 0.56 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.938 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -49.01 -40.22 40.83 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.603 2.202 . . . . 0.0 112.022 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.91 -31.6 31.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -52.82 158.09 1.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -141.57 -41.64 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -111.31 34.15 5.45 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.26 -35.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.101 0.476 . . . . 0.0 109.962 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.735 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -99.68 -29.13 12.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.182 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.813 HG21 HD22 ' A' ' 547' ' ' LEU . 2.5 mp 30.84 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.916 0.886 . . . . 0.0 112.95 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.735 ' N ' ' O ' ' A' ' 543' ' ' TYR . 7.4 mt-10 69.63 91.85 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.116 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 150.13 -9.6 0.84 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.875 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.813 HD22 HG21 ' A' ' 544' ' ' ILE . 2.7 pt? -128.14 -11.36 5.27 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.493 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -63.13 80.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.911 0.386 . . . . 0.0 110.7 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 4.1 m170 -133.15 29.7 4.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.424 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 52.32 55.79 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.41 ' HB3' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -96.41 172.21 8.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.819 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.1 t70 179.17 31.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -134.87 -37.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -77.8 -3.89 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.616 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.909 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -144.03 -42.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.32 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t . . . . . 0 N--CA 1.449 -0.493 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.378 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.826 0.346 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.6 m 51.32 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.909 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.8 m-80 -93.52 -49.53 0.27 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.854 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.69 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 50.4 Cg_endo -102.69 17.42 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 124.339 3.359 . . . . 0.0 112.658 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.733 ' C ' HD13 ' A' ' 515' ' ' LEU . 5.8 m-80 -123.32 59.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.319 0.58 . . . . 0.0 109.914 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.909 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.18 -72.83 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.05 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 22.9 p-80 -147.62 -56.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.771 ' C ' ' HD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -65.91 179.51 0.88 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.771 ' HD1' ' C ' ' A' ' 517' ' ' TYR . 0.1 OUTLIER 62.79 -44.99 0.2 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.239 0.472 . . . . 0.0 110.945 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 517' ' ' TYR . 8.9 t -94.37 -19.86 20.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.258 0.551 . . . . 0.0 109.829 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.69 HG22 ' N ' ' A' ' 521' ' ' GLN . 1.2 m -85.16 -78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.391 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.69 ' N ' HG22 ' A' ' 520' ' ' THR . 0.0 OUTLIER -100.51 -161.88 0.9 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.162 -179.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.629 ' HB2' ' HB2' ' A' ' 526' ' ' ALA . 1.1 t0 -93.19 22.36 5.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.942 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.618 ' HG3' ' HA ' ' A' ' 518' ' ' TRP . 9.3 mt-10 48.31 75.84 0.13 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.546 0.689 . . . . 0.0 110.369 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.456 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 52.47 20.29 7.21 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.391 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 522' ' ' ASP . . . -106.69 -22.83 12.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.302 0.551 . . . . 0.0 111.832 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.785 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -87.3 20.98 2.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.974 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.785 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -133.81 -48.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.476 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 136.98 -11.95 3.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.108 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.879 HD11 ' CD2' ' A' ' 543' ' ' TYR . 3.2 mt 70.04 -56.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.88 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 46.23 0.73 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.412 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.601 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.4 p-90 -120.56 -18.29 7.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.664 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.601 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.1 160.37 30.26 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.259 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 27.1 Cg_endo -62.2 -47.1 10.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.875 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.767 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 37.1 p90 -155.33 6.26 0.23 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.518 ' HD2' HG21 ' A' ' 532' ' ' ILE . 0.9 OUTLIER -71.65 -26.48 62.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.044 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -108.47 -63.41 0.56 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.674 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.09 -41.88 39.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 111.661 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -78.02 -23.03 48.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.585 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 536' ' ' GLY . . . -51.59 161.64 0.48 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -163.69 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.575 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.443 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -109.01 29.59 9.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.875 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.674 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.42 -29.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 110.792 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.879 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.8 OUTLIER -98.68 -47.92 5.15 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.785 HG21 HD22 ' A' ' 547' ' ' LEU . 2.0 mp 36.85 -74.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.377 0.671 . . . . 0.0 112.442 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.693 ' N ' ' O ' ' A' ' 543' ' ' TYR . 22.6 mt-10 68.32 85.82 0.14 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.003 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 162.96 -17.32 0.14 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.551 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.785 HD22 HG21 ' A' ' 544' ' ' ILE . 1.9 pt? -134.68 -12.57 2.3 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.492 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -70.17 64.42 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.129 0.49 . . . . 0.0 111.473 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.465 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -116.36 -74.63 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.002 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.7 t30 175.47 73.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.402 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -99.11 -78.25 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.603 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.678 ' H ' HD11 ' A' ' 555' ' ' ILE . 6.7 t70 66.08 12.59 8.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.683 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.9 -31.77 1.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.711 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.934 HD12 HG23 ' A' ' 555' ' ' ILE . 1.5 pp -93.15 9.4 36.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.934 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.3 -42.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.468 -178.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.468 ' N ' HG12 ' A' ' 555' ' ' ILE . 5.2 t . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.351 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 18.6 mttt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.715 0.293 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.503 ' O ' HD11 ' A' ' 515' ' ' LEU . 12.4 m 61.76 114.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.408 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.97 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.7 m-80 -94.09 -50.83 0.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.77 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 86.5 Cg_endo -109.64 16.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.267 3.311 . . . . 0.0 113.32 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.832 ' C ' HD13 ' A' ' 515' ' ' LEU . 8.3 m-80 -118.62 53.18 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.17 0.51 . . . . 0.0 110.171 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.97 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -121.98 -62.73 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.956 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.637 ' HA ' ' CG2' ' A' ' 519' ' ' THR . 7.9 p-80 -171.18 -56.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.578 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.637 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.53 -10.61 0.27 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.77 ' CE3' ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -123.61 -33.33 3.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.21 0.529 . . . . 0.0 110.462 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.637 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 8.9 t -82.87 -16.1 48.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.505 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.533 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -87.07 -56.8 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.716 0.294 . . . . 0.0 111.38 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 5.6 pt20 -100.45 -157.58 0.62 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.146 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 525' ' ' ALA . 5.3 m-20 -102.73 32.55 3.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.26 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.5 mt-10 45.33 69.69 0.42 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.907 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 93.59 -26.94 13.52 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.622 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.89 11.0 0.17 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.69 16.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.377 . . . . 0.0 110.769 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.622 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -56.08 -22.23 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.275 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.559 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 163.63 -34.01 0.29 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.805 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 543' ' ' TYR . 2.0 mt 67.91 -53.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.28 -21.68 60.54 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.601 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.9 p-90 -43.61 -29.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.016 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.587 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -103.71 152.09 38.87 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.574 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.56 -50.51 13.8 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.618 2.212 . . . . 0.0 112.281 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 42.6 p90 -157.97 6.45 0.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -62.59 -27.1 68.96 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.831 0.348 . . . . 0.0 110.766 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -107.84 -56.65 0.59 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.838 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 46.6 Cg_exo -56.27 -41.27 78.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.481 2.12 . . . . 0.0 111.937 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 534' ' ' TYR . . . -93.24 -7.92 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.219 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 1.119 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -53.1 -75.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 75.87 -43.59 0.49 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.512 ' C ' HD12 ' A' ' 542' ' ' ILE . . . -112.33 35.08 4.83 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.745 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 1.119 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -151.09 -33.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.992 0.425 . . . . 0.0 110.513 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.6 OUTLIER -94.96 -45.75 7.13 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.037 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.894 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 36.47 -73.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.627 0.771 . . . . 0.0 112.404 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 543' ' ' TYR . 19.9 mt-10 67.49 32.24 5.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.732 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -137.88 -7.86 1.31 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.87 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.894 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -137.67 -8.57 1.65 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.518 ' HE1' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.49 65.66 0.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 110.761 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.7 OUTLIER -111.49 -65.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.611 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 168.59 63.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.742 ' CB ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -115.61 -178.84 3.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.238 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 556' ' ' CYS . 2.9 p30 -179.2 -22.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.187 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -88.33 -29.05 20.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.309 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.932 HD12 HG23 ' A' ' 555' ' ' ILE . 1.2 pp -82.42 -2.77 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.669 0.271 . . . . 0.0 111.45 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.932 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.99 -41.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.996 0.427 . . . . 0.0 111.04 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.186 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.761 0.315 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.67 90.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.892 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.0 m-80 -87.39 -49.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.75 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.909 ' CG ' HG21 ' A' ' 555' ' ' ILE . 39.3 Cg_endo -102.08 16.7 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 124.195 3.263 . . . . 0.0 112.525 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.687 ' C ' HD13 ' A' ' 515' ' ' LEU . 8.5 m-80 -123.82 60.2 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.892 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -111.46 -46.15 3.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.31 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.9 p-80 -177.59 -56.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.665 0.269 . . . . 0.0 111.514 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.71 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -56.18 -20.16 16.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.735 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.83 -44.03 2.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.186 0.517 . . . . 0.0 110.761 -177.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.601 HG22 ' CA ' ' A' ' 516' ' ' HIS . 9.3 t -53.84 -31.34 49.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.288 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.711 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.19 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.163 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.756 HE22 HD11 ' A' ' 527' ' ' ILE . 0.0 OUTLIER -99.64 -169.99 1.83 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.467 -178.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.888 ' CB ' ' HB3' ' A' ' 525' ' ' ALA . 3.5 m-20 -88.19 21.39 2.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.9 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 34.2 mt-10 69.11 4.51 4.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.934 0.397 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.499 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 130.96 20.23 1.19 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.16 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.888 ' HB3' ' CB ' ' A' ' 522' ' ' ASP . . . -97.21 -25.26 15.35 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.744 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -84.45 23.19 1.15 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 111.412 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.756 HD11 HE22 ' A' ' 521' ' ' GLN . 0.0 OUTLIER -131.67 -46.57 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.587 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 138.72 -12.9 3.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.04 -46.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -75.85 -20.25 58.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.746 ' CE2' HD13 ' A' ' 532' ' ' ILE . 2.0 p-90 -47.55 -26.13 1.34 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.953 0.406 . . . . 0.0 111.074 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.836 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.3 OUTLIER -114.63 157.75 42.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -91.09 -23.69 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.991 2.461 . . . . 0.0 114.023 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 8.6 p90 -154.34 6.65 0.3 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.836 ' HB2' HD12 ' A' ' 532' ' ' ILE . 2.9 m-85 -78.93 -43.08 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.224 0.535 . . . . 0.0 110.705 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.566 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.41 -58.06 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.622 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' A' ' 536' ' ' GLY . 77.8 Cg_exo -49.68 -42.05 44.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.322 2.014 . . . . 0.0 111.583 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.75 -29.79 32.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.591 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.18 148.11 28.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.223 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -129.16 -35.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.594 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.435 ' O ' ' HZ2' ' A' ' 518' ' ' TRP . . . -114.76 27.57 8.66 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.7 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -142.35 -6.19 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.72 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -127.42 -41.99 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 120.368 0.128 . . . . 0.0 111.085 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.563 HG21 HD22 ' A' ' 547' ' ' LEU . 3.2 mp 34.45 -72.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.549 0.74 . . . . 0.0 112.551 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.72 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.5 mt-10 68.4 90.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.148 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 155.51 -15.33 0.47 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.182 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.563 HD22 HG21 ' A' ' 544' ' ' ILE . 1.4 pt? -129.4 -3.17 4.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.786 0.327 . . . . 0.0 111.684 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.762 ' N ' ' HE2' ' A' ' 548' ' ' MET . 0.0 OUTLIER -81.08 80.37 7.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.173 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -133.19 -68.7 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.589 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 167.44 66.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -74.67 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.19 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.93 20.61 9.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.93 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -122.99 -38.15 0.58 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.979 HD12 HG23 ' A' ' 555' ' ' ILE . 2.4 pp -83.15 -1.16 52.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.979 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.31 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.709 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.484 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.498 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.93 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.842 0.353 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.7 m 63.41 122.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.708 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.4 m-80 -104.67 -52.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.875 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.563 ' HD3' ' HB2' ' A' ' 512' ' ' ASN . 39.7 Cg_endo -104.02 5.71 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.019 3.146 . . . . 0.0 113.162 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.709 ' C ' HD13 ' A' ' 515' ' ' LEU . 19.4 m-80 -115.53 57.61 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.195 0.521 . . . . 0.0 109.791 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.745 ' H ' HD22 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -121.73 -38.21 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.736 ' O ' ' O ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -164.23 -84.63 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.768 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.992 ' O ' ' N ' ' A' ' 519' ' ' THR . 1.4 m-85 -52.21 -137.79 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.682 ' HA ' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER 26.14 -63.17 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.992 ' N ' ' O ' ' A' ' 517' ' ' TYR . 9.2 t -70.13 -25.35 63.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.066 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 516' ' ' HIS . 0.4 OUTLIER -78.64 -63.93 1.29 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.567 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 7.6 pt20 -100.79 -153.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.83 31.75 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.698 ' OE2' HD13 ' A' ' 544' ' ' ILE . 1.7 mt-10 46.96 70.72 0.37 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.824 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 90.97 -25.15 14.84 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.895 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.616 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.47 11.95 0.21 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.55 16.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.749 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.616 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -57.88 -20.25 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.319 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.57 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 160.61 -46.0 0.4 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.924 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.529 HD21 ' CD ' ' A' ' 545' ' ' GLU . 3.4 mp 71.15 -34.79 0.31 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.18 -22.94 44.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.591 ' CD2' HG23 ' A' ' 532' ' ' ILE . 2.4 p-90 -47.63 -26.73 1.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.675 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -116.03 167.45 10.27 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.713 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 92.7 Cg_endo -95.39 -5.92 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.13 2.553 . . . . 0.0 113.812 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 17.9 p90 -159.0 -28.95 0.07 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.675 ' HD1' ' HB ' ' A' ' 532' ' ' ILE . 16.4 m-85 -59.44 -26.14 64.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.72 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.406 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -115.53 -55.28 0.36 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.223 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 17.9 Cg_exo -67.33 -31.92 33.97 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.701 2.267 . . . . 0.0 112.224 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -93.31 -25.93 17.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.606 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -64.63 131.35 46.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.63 -25.07 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.925 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.559 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.25 35.24 4.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.777 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.65 HG23 ' CG ' ' A' ' 517' ' ' TYR . 0.2 OUTLIER -148.36 -28.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -103.85 -43.97 5.17 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 34.44 -72.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.613 0.765 . . . . 0.0 112.497 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 18.2 mt-10 71.87 34.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.032 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.44 -3.62 1.58 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.016 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.784 HD22 HG21 ' A' ' 544' ' ' ILE . 2.4 pt? -143.04 -4.11 0.93 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.538 ' HE1' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -75.81 73.74 2.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.01 0.433 . . . . 0.0 111.602 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.512 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -132.78 27.79 4.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.229 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.56 101.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.626 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -76.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.117 0.484 . . . . 0.0 110.721 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.528 ' H ' HD11 ' A' ' 555' ' ' ILE . 11.9 t70 60.24 18.53 8.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.427 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -125.63 -34.61 0.64 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -88.24 6.19 38.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 0.0 111.045 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.954 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.56 -42.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.266 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.467 ' N ' HG12 ' A' ' 555' ' ' ILE . 4.8 t . . . . . 0 N--CA 1.449 -0.481 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.352 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 9.1 mttm . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.792 0.33 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.72 111.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.968 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.5 m-80 -103.88 -51.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.759 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.726 ' CG ' HG21 ' A' ' 555' ' ' ILE . 46.6 Cg_endo -105.41 14.97 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.241 3.294 . . . . 0.0 113.033 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.711 ' C ' HD13 ' A' ' 515' ' ' LEU . 16.6 m-80 -126.33 58.13 1.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.229 0.538 . . . . 0.0 109.899 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.968 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -119.31 -54.37 2.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.858 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.675 ' HA ' HG22 ' A' ' 519' ' ' THR . 7.4 p-80 -174.75 -54.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.619 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.46 -10.85 0.45 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.694 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.85 -49.69 1.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.517 0.675 . . . . 0.0 109.869 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 516' ' ' HIS . 14.7 t -60.35 -23.29 64.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.48 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -85.02 -56.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.669 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 4.2 pt20 -100.44 -161.31 0.86 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.043 0.449 . . . . 0.0 111.166 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.456 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -102.92 31.85 3.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.607 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.669 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.9 mp0 45.21 74.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.5 0.667 . . . . 0.0 109.933 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 91.38 -25.74 14.14 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.412 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.648 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.03 10.28 0.11 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.6 16.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.922 0.392 . . . . 0.0 110.54 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.689 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.4 OUTLIER -55.65 -22.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.301 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.52 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 156.32 -38.08 0.59 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.266 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.536 ' O ' ' HD3' ' A' ' 537' ' ' PRO . 4.4 mp 70.39 -38.48 0.42 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.02 -24.62 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.689 ' NE1' HD13 ' A' ' 527' ' ' ILE . 1.9 p-90 -45.98 -27.47 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.564 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.623 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -113.04 165.71 12.6 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.917 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.08 -41.09 0.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.06 2.506 . . . . 0.0 113.232 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.644 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 16.9 p90 -156.31 6.08 0.19 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.713 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -73.95 -26.97 60.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.051 0.453 . . . . 0.0 110.597 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.483 ' HA3' HD11 ' A' ' 532' ' ' ILE . . . -108.49 -55.09 0.59 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.785 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 23.9 Cg_exo -64.33 -37.98 37.09 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.621 2.214 . . . . 0.0 111.788 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -93.25 -5.47 49.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.163 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.912 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -51.73 -72.02 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.772 0.32 . . . . 0.0 110.963 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 70.89 -48.23 0.66 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.409 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -108.41 29.55 9.9 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.968 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.912 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -146.62 -33.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.436 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.701 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -95.36 -43.07 8.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.526 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.77 HD12 ' N ' ' A' ' 544' ' ' ILE . 1.6 mp 37.77 -73.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.545 0.738 . . . . 0.0 112.345 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.701 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.9 mt-10 66.86 85.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.261 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 165.02 -22.13 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.91 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.767 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -133.87 -8.38 2.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.426 ' CE ' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -67.85 64.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 111.811 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.27 46.68 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.568 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 2.4 m-80 68.7 -66.29 0.25 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.46 HE21 HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER 49.53 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.901 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.7 m-20 59.89 20.06 9.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.187 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -133.17 -34.12 0.34 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.916 HD12 HG23 ' A' ' 555' ' ' ILE . 3.0 pp -86.96 8.32 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.326 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.916 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -143.91 -42.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.159 0.504 . . . . 0.0 111.087 -178.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.494 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.487 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.19 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.787 0.327 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 95.1 m 61.72 101.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.764 ' O ' HD11 ' A' ' 515' ' ' LEU . 1.4 m-80 -99.04 -50.31 0.21 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.763 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.832 ' CG ' HG21 ' A' ' 555' ' ' ILE . 38.3 Cg_endo -101.54 16.17 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.048 3.166 . . . . 0.0 112.593 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.538 ' C ' HD13 ' A' ' 515' ' ' LEU . 5.8 m-80 -119.91 54.4 1.02 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.809 HD23 ' HE1' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -99.11 -47.74 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.415 -178.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.597 ' N ' HG22 ' A' ' 519' ' ' THR . 11.1 p-80 -175.61 -52.76 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.809 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -61.55 -24.5 66.69 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.732 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -116.61 -39.8 3.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.181 0.515 . . . . 0.0 110.838 -177.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 516' ' ' HIS . 5.5 t -57.89 -21.47 43.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.527 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.67 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -105.15 -67.12 0.93 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.087 0.47 . . . . 0.0 111.225 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.67 ' N ' HG22 ' A' ' 520' ' ' THR . 1.3 pt20 -99.88 -160.84 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.782 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.761 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -94.73 34.7 1.3 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.31 -179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.681 ' CD ' HD13 ' A' ' 544' ' ' ILE . 16.1 mt-10 60.69 20.09 10.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.547 ' C ' HD11 ' A' ' 527' ' ' ILE . . . 98.38 32.84 5.89 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.165 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.761 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -117.34 3.63 12.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -92.29 18.3 8.5 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.901 0.381 . . . . 0.0 111.146 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.1 OUTLIER -124.75 -53.4 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.658 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 150.52 -19.96 1.03 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.794 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.64 HD11 ' HA ' ' A' ' 525' ' ' ALA . 7.1 mp 72.98 -20.74 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.22 -20.93 47.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.175 0.512 . . . . 0.0 111.268 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.681 ' HE1' HD13 ' A' ' 527' ' ' ILE . 7.3 p-90 -69.07 -13.7 62.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.774 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.8 OUTLIER -126.26 142.74 43.64 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.063 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.92 -21.6 2.06 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.712 2.274 . . . . 0.0 113.935 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.425 ' HA ' ' CB ' ' A' ' 538' ' ' ALA . 9.7 p90 -150.82 6.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.877 ' HB2' HD12 ' A' ' 532' ' ' ILE . 22.7 m-85 -82.3 -39.54 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -112.55 -61.44 0.44 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.452 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.53 -39.69 74.17 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.392 2.062 . . . . 0.0 111.903 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -85.02 -37.12 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.285 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -46.25 164.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.518 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -147.11 -43.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.55 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.99 23.25 21.77 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.645 HG23 ' CD2' ' A' ' 517' ' ' TYR . 0.1 OUTLIER -139.99 -18.52 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.463 0.173 . . . . 0.0 111.046 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.818 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -122.85 -3.08 8.69 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.533 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.719 ' O ' ' HG3' ' A' ' 545' ' ' GLU . 1.5 mp 4.69 -51.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.805 1.242 . . . . 0.0 114.044 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.818 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.6 pt-20 44.44 79.18 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . 0.479 ' N ' ' HE2' ' A' ' 548' ' ' MET . . . 172.79 -25.61 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.839 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.687 HD22 HG21 ' A' ' 544' ' ' ILE . 1.6 pt? -125.78 -12.23 6.57 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.479 ' HE2' ' N ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -68.01 71.94 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 111.174 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.8 OUTLIER -124.94 26.35 7.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.708 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 59.23 61.58 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.403 ' OE1' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -87.12 -70.94 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.578 . . . . 0.0 110.64 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 556' ' ' CYS . 1.1 m-20 63.2 19.28 11.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.092 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.52 -30.62 1.37 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.883 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.977 HD12 HG23 ' A' ' 555' ' ' ILE . 1.9 pp -88.79 2.23 53.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.756 0.313 . . . . 0.0 111.119 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.977 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -147.52 -40.95 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.293 0.568 . . . . 0.0 110.658 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 552' ' ' ASP . 1.6 m . . . . . 0 N--CA 1.449 -0.486 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.176 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.825 0.345 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 514' ' ' ASN . 0.0 OUTLIER 59.66 98.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.559 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.958 ' O ' HD21 ' A' ' 515' ' ' LEU . 3.5 m-80 -95.66 -50.58 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.878 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.809 ' CG ' HG21 ' A' ' 555' ' ' ILE . 57.7 Cg_endo -105.45 16.39 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.224 3.282 . . . . 0.0 113.04 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.727 ' C ' HD13 ' A' ' 515' ' ' LEU . 9.1 m-80 -123.76 57.91 1.17 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.561 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.958 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.43 -52.82 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.99 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.655 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 5.1 p-80 -176.97 -56.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.332 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.655 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.41 -13.52 0.6 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.716 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.07 -43.84 2.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.372 0.606 . . . . 0.0 110.037 -177.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.528 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.7 t -70.96 -22.06 62.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.804 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.34 -56.15 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.822 0.344 . . . . 0.0 111.601 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.584 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 6.2 pt20 -100.46 -157.85 0.63 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.456 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -102.67 32.72 3.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.317 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.685 ' OE1' HD21 ' A' ' 547' ' ' LEU . 4.3 mt-10 44.75 74.02 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.949 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.442 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.13 -24.81 20.07 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.595 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.1 9.99 0.26 Allowed 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.98 16.48 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 110.614 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.595 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.53 -24.24 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.296 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.55 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 158.55 -52.49 0.39 Allowed Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.176 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.582 HD21 ' HD2' ' A' ' 543' ' ' TYR . 3.4 mp 75.28 -21.4 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.799 0.44 . . . . 0.0 112.048 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.41 -26.42 41.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.241 0.543 . . . . 0.0 110.922 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.593 ' CE2' HD13 ' A' ' 532' ' ' ILE . 4.7 p-90 -63.03 -16.52 60.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.715 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.874 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.3 pt -126.06 135.69 27.45 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.022 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 1.2 Cg_endo -84.48 -20.43 3.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.957 2.438 . . . . 0.0 113.889 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.508 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 9.0 p90 -146.65 6.34 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.934 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 15.1 m-85 -87.72 -39.91 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.033 0.444 . . . . 0.0 110.793 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -110.44 -60.54 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.506 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.94 -37.2 85.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.41 2.073 . . . . 0.0 111.576 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -93.18 -17.21 23.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.25 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.994 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -48.84 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.606 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 21.0 mt-10 76.72 -44.96 0.48 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.484 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -110.14 33.44 6.0 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.994 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -151.06 -33.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.138 0.494 . . . . 0.0 110.416 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.708 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -97.6 -37.75 9.81 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.162 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.937 HG21 HD22 ' A' ' 547' ' ' LEU . 1.0 OUTLIER 37.53 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.436 0.694 . . . . 0.0 112.567 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.708 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.1 mt-10 66.05 86.09 0.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.025 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 159.24 -16.7 0.24 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.369 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.937 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -129.6 -13.28 4.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.489 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -69.11 69.16 0.19 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.137 0.494 . . . . 0.0 111.299 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.47 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.8 OUTLIER -120.74 -53.18 2.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.71 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.414 ' C ' ' HG3' ' A' ' 551' ' ' GLN . 22.8 t-20 -179.11 -57.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.491 ' OE1' HD11 ' A' ' 554' ' ' LEU . 0.0 OUTLIER 27.12 -91.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.408 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.409 ' HA ' HD11 ' A' ' 555' ' ' ILE . 0.4 OUTLIER 63.95 15.72 9.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.035 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -127.51 -29.35 0.84 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.946 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.934 HD12 HG23 ' A' ' 555' ' ' ILE . 2.2 pp -80.97 1.65 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.934 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -141.49 -42.62 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.769 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.53 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.199 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.726 0.298 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.3 m 60.78 107.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.167 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.902 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.3 m-80 -90.9 -51.08 0.32 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.733 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.675 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 74.5 Cg_endo -105.92 20.94 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.315 3.343 . . . . 0.0 112.623 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.655 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.0 m-80 -118.35 51.99 1.05 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.501 0.667 . . . . 0.0 109.232 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.902 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -109.35 -56.75 2.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.133 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 7.5 p-80 -174.93 -57.14 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.712 0.291 . . . . 0.0 111.366 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.629 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -56.23 -15.63 4.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.08 -29.82 4.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.021 0.439 . . . . 0.0 111.325 -177.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.625 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 3.0 t -77.5 -20.43 54.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.288 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.667 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.84 -67.65 0.84 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.667 ' N ' HG22 ' A' ' 520' ' ' THR . 4.3 pt20 -99.9 -156.82 0.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.554 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -98.35 34.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.404 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.842 ' OE1' HD13 ' A' ' 544' ' ' ILE . 62.2 mt-10 56.93 34.08 24.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.547 0.689 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.562 ' C ' HD11 ' A' ' 527' ' ' ILE . . . 80.14 32.36 35.79 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.311 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.545 ' HA ' HD11 ' A' ' 529' ' ' LEU . . . -117.88 1.96 12.13 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -91.56 19.49 6.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.692 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.1 OUTLIER -124.27 -52.7 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.642 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.89 -18.45 1.09 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.986 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.85 HD21 ' CD ' ' A' ' 545' ' ' GLU . 6.8 mp 73.21 -25.6 0.19 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.27 -24.65 42.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.234 0.54 . . . . 0.0 111.433 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.686 ' CE2' HD13 ' A' ' 532' ' ' ILE . 5.9 p-90 -62.53 -16.02 53.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.852 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.902 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.1 pt -125.91 140.99 38.14 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.362 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -89.3 -18.88 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.867 2.378 . . . . 0.0 113.826 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.97 6.14 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.902 ' HB2' HD12 ' A' ' 532' ' ' ILE . 13.9 m-85 -86.03 -40.34 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.014 0.435 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.4 ' H ' ' HD2' ' A' ' 537' ' ' PRO . . . -112.96 -62.17 0.44 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.443 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.4 ' HD2' ' H ' ' A' ' 536' ' ' GLY . 54.4 Cg_exo -50.16 -38.88 51.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.211 1.94 . . . . 0.0 111.686 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -86.34 -31.24 21.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -51.07 169.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.447 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -153.5 -41.01 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.488 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -113.25 33.37 5.6 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -149.66 -31.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.791 ' HA ' ' O ' ' A' ' 523' ' ' GLU . 0.3 OUTLIER -103.02 -44.77 5.13 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.451 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 1.037 HG21 HD22 ' A' ' 547' ' ' LEU . 1.2 mp 42.09 -72.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 112.666 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.85 ' CD ' HD21 ' A' ' 529' ' ' LEU . 3.0 mm-40 69.34 29.08 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.6 -1.93 1.81 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.798 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 1.037 HD22 HG21 ' A' ' 544' ' ' ILE . 1.5 pt? -139.88 -10.17 1.17 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.561 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.19 66.58 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -119.31 24.49 10.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.388 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 65.35 64.29 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.732 ' CB ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -110.65 -177.63 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.802 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 556' ' ' CYS . 18.3 p-10 -179.43 -22.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.346 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.4 32.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.411 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 551' ' ' GLN . 0.8 OUTLIER -85.53 -0.99 56.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.6 0.238 . . . . 0.0 111.526 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.756 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.1 OUTLIER -145.28 -40.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 111.342 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.1 t . . . . . 0 C--N 1.325 -0.487 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.304 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.87 0.367 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 99.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.962 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.4 m-80 -100.8 -51.28 0.18 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.67 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.879 ' CG ' HG21 ' A' ' 555' ' ' ILE . 56.2 Cg_endo -104.46 17.84 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.293 3.329 . . . . 0.0 112.548 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.705 ' C ' HD13 ' A' ' 515' ' ' LEU . 4.8 m-80 -121.24 57.46 1.0 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.962 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.3 -51.36 2.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.27 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.627 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.0 p-80 -176.89 -56.67 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.668 ' CD2' HG23 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -55.09 -16.17 2.75 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.731 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.29 -41.05 2.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.1 t -62.61 -27.62 69.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.463 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.648 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -88.33 -62.83 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.048 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.648 ' N ' HG22 ' A' ' 520' ' ' THR . 2.1 pt20 -99.84 -165.08 1.18 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.405 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . 2.9 m-20 -103.11 34.87 2.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.603 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.625 ' OE1' HD13 ' A' ' 544' ' ' ILE . 13.5 mt-10 45.56 31.5 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.534 0.683 . . . . 0.0 110.301 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 161.73 -30.32 0.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 57.54 12.6 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.88 15.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.805 HG13 ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -70.55 -13.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.654 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.555 ' N ' HD12 ' A' ' 527' ' ' ILE . . . 158.2 -57.36 0.35 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.863 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.1 OUTLIER 79.81 -27.91 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.96 -3.86 47.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.595 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 10.9 p-90 -81.75 -4.36 56.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.881 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.595 HD13 ' CZ2' ' A' ' 531' ' ' TRP . 1.0 OUTLIER -132.61 61.59 57.71 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.069 -177.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -37.44 -47.14 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.471 2.78 . . . . 0.0 114.075 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.662 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 8.3 p90 -113.73 6.31 16.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.893 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 11.3 t80 -114.06 -19.73 11.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.704 0.288 . . . . 0.0 111.532 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.503 ' HA3' HG13 ' A' ' 532' ' ' ILE . . . -113.49 -74.42 0.65 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.271 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 33.4 Cg_exo -61.73 -32.81 86.54 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.57 2.18 . . . . 0.0 111.209 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -90.72 -16.26 28.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.62 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 1.014 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -51.95 -58.41 6.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 70.78 -53.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.508 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -106.03 32.7 7.11 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.819 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 1.014 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -150.74 -30.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.691 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.3 OUTLIER -100.48 -44.78 5.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.905 HG21 HD22 ' A' ' 547' ' ' LEU . 1.2 mp 40.65 -72.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.493 0.717 . . . . 0.0 112.62 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.8 mt-10 69.6 33.99 2.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.141 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -142.17 2.1 1.77 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.002 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.905 HD22 HG21 ' A' ' 544' ' ' ILE . 2.1 pt? -143.49 -8.89 0.75 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.469 ' HB3' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -76.95 74.39 3.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.075 0.464 . . . . 0.0 111.232 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.469 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -134.25 27.98 3.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.082 179.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.49 87.16 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.71 -77.13 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.778 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.62 24.77 14.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.91 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.19 -34.47 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.919 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.957 HD12 HG23 ' A' ' 555' ' ' ILE . 2.3 pp -85.57 2.64 44.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 111.307 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.957 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.53 -42.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.057 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.83 0.348 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 59.27 92.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.899 ' O ' HD21 ' A' ' 515' ' ' LEU . 2.7 m-80 -91.96 -50.88 0.3 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.457 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.956 ' CG ' HG21 ' A' ' 555' ' ' ILE . 57.6 Cg_endo -104.45 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.402 3.402 . . . . 0.0 112.397 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.709 ' C ' HD13 ' A' ' 515' ' ' LEU . 3.9 m-80 -121.84 57.98 1.03 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.899 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.38 -48.31 3.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.307 -178.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.638 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.4 p-80 -178.48 -56.94 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.797 0.332 . . . . 0.0 111.408 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.664 ' CD2' HG23 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -56.93 -16.33 6.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.711 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -124.23 -38.17 2.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.122 0.486 . . . . 0.0 110.639 -177.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.562 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.6 t -65.75 -24.52 66.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.298 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.573 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -90.29 -60.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.743 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 0.4 OUTLIER -100.39 -168.31 1.56 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 548' ' ' MET . 1.1 m-20 -103.25 31.4 4.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.393 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.743 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 4.1 mt-10 45.5 29.02 0.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 110.333 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 526' ' ' ALA . . . 152.96 -23.55 0.8 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.58 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 1.087 ' HB3' HD13 ' A' ' 527' ' ' ILE . . . 32.24 26.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.06 16.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.789 0.328 . . . . 0.0 111.544 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 1.087 HD13 ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.17 -33.73 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.315 0.579 . . . . 0.0 110.034 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 166.66 -39.82 0.25 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.763 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 529' ' ' LEU . 3.3 mp 72.23 -18.01 0.34 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.15 -19.2 51.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.293 0.568 . . . . 0.0 110.876 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.477 ' CD2' HG23 ' A' ' 532' ' ' ILE . 8.6 p-90 -74.96 -10.43 59.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.517 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -125.28 59.52 24.88 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.58 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -42.58 -41.6 8.1 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.071 2.514 . . . . 0.0 113.559 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 8.0 p90 -115.45 6.25 14.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 10.3 t80 -114.79 -24.36 8.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.443 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -112.39 -90.98 1.95 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.623 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 83.6 Cg_exo -42.93 -43.65 9.28 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.674 2.249 . . . . 0.0 112.017 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -73.34 -31.3 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.48 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.832 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -65.8 150.66 48.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.283 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -133.37 -32.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -117.25 30.5 6.23 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.832 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -142.42 -31.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -105.5 -31.76 8.84 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.902 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 547' ' ' LEU . 2.5 mp 33.27 -71.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.637 0.775 . . . . 0.0 112.699 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 32.6 mt-10 70.8 35.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.256 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -141.1 0.3 1.78 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.727 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 544' ' ' ILE . 2.5 pt? -146.92 -5.52 0.52 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.46 ' HE1' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -78.63 76.55 5.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -134.5 28.47 3.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.073 179.128 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.79 89.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.434 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.528 ' OE1' HD11 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -119.52 -78.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 67.43 23.41 9.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.632 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.47 -34.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.994 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.865 HD12 HG23 ' A' ' 555' ' ' ILE . 2.1 pp -81.99 1.24 36.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.956 HG21 ' CG ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -140.69 -42.61 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.067 0.461 . . . . 0.0 110.816 -179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.501 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.114 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.763 0.316 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 40.1 m 60.76 117.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.979 ' O ' HD21 ' A' ' 515' ' ' LEU . 0.7 OUTLIER -106.78 -52.49 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.465 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.609 ' CD ' HG13 ' A' ' 555' ' ' ILE . 57.5 Cg_endo -106.51 16.93 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 124.304 3.336 . . . . 0.0 112.448 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.716 ' C ' HD13 ' A' ' 515' ' ' LEU . 17.2 m-80 -122.56 53.78 1.24 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.318 0.58 . . . . 0.0 109.812 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.979 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.54 -69.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.858 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.758 ' HA ' HG22 ' A' ' 519' ' ' THR . 8.5 p-80 -159.64 -55.2 0.06 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.369 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.602 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.92 -8.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -124.82 -44.47 1.94 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.548 0.689 . . . . 0.0 110.51 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 516' ' ' HIS . 13.1 t -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.7 OUTLIER -82.51 -64.79 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.846 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.654 ' N ' HG22 ' A' ' 520' ' ' THR . 2.6 pt20 -99.89 -160.37 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.357 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -103.04 34.48 2.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.478 -179.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.599 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.2 mt-10 44.55 34.46 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.404 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 140.66 -40.34 1.38 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.223 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.66 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 57.28 8.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.43 15.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 110.792 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.66 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -54.55 -24.54 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.539 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 172.52 -51.67 0.17 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.792 HD21 ' OE2' ' A' ' 545' ' ' GLU . 3.5 mp 77.99 -18.4 0.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.776 0.43 . . . . 0.0 111.986 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.8 45.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.417 0.627 . . . . 0.0 110.164 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.502 ' NE1' HD13 ' A' ' 527' ' ' ILE . 1.8 p-90 -66.07 -15.72 63.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.742 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -124.01 64.07 33.13 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -177.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.39 -36.56 17.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.897 2.398 . . . . 0.0 113.503 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.492 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 4.7 p90 -121.27 6.19 10.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.617 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 8.1 t80 -112.19 -26.46 8.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.648 0.261 . . . . 0.0 111.406 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -111.84 -90.88 1.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.585 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 82.0 Cg_exo -40.45 -44.01 4.22 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.915 2.41 . . . . 0.0 112.095 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -73.39 -35.3 65.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.425 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.876 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -58.15 157.18 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.989 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.31 -34.08 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.478 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.483 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -117.67 36.73 3.56 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.876 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -148.69 -36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.226 0.536 . . . . 0.0 109.849 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.689 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -100.09 -33.94 10.26 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.21 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.597 ' CG2' HD22 ' A' ' 547' ' ' LEU . 1.6 mp 32.31 -72.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.913 0.885 . . . . 0.0 113.025 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.792 ' OE2' HD21 ' A' ' 529' ' ' LEU . 20.0 mt-10 68.85 96.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.176 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 140.93 -9.36 2.79 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.844 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.669 HD11 ' HZ3' ' A' ' 518' ' ' TRP . 1.5 pt? -129.93 -1.66 4.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.599 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -72.62 85.26 1.17 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 1.6 m170 -130.79 -48.83 1.04 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.417 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 167.73 -73.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' A' ' 552' ' ' ASP . 0.0 OUTLIER 57.04 -152.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.667 ' H ' HD11 ' A' ' 555' ' ' ILE . 13.0 t70 110.49 21.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.105 0.962 . . . . 0.0 110.527 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -141.34 0.14 1.7 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.489 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.953 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -127.12 2.46 6.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.995 0.518 . . . . 0.0 110.332 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.953 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -147.1 -41.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.629 -178.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.537 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.6 t . . . . . 0 N--CA 1.449 -0.507 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.971 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.646 0.26 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 57.94 98.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.327 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.971 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.2 m-80 -101.83 -51.28 0.16 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.643 ' CG ' HG21 ' A' ' 555' ' ' ILE . 48.4 Cg_endo -104.03 15.41 0.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.052 3.168 . . . . 0.0 113.122 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.708 ' C ' HD13 ' A' ' 515' ' ' LEU . 13.8 m-80 -125.61 59.16 1.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.237 0.542 . . . . 0.0 109.608 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.971 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -119.45 -52.06 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.032 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.635 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.9 p-80 -176.63 -55.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.324 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.681 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -54.44 -13.54 0.96 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.74 -45.64 2.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.449 0.643 . . . . 0.0 110.156 -177.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 2.1 t -65.64 -25.84 67.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.656 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -80.94 -56.97 3.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.251 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 4.3 pt20 -100.68 -162.32 0.93 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.144 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.43 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -103.05 35.96 2.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.496 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.863 ' OE1' HD21 ' A' ' 547' ' ' LEU . 26.3 mt-10 43.9 73.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.097 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.494 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.73 -21.65 35.04 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.989 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.604 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 53.77 11.08 0.29 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.11 16.23 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.481 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.635 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.5 OUTLIER -55.01 -22.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.261 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.542 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 157.61 -34.72 0.54 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.354 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.781 HD11 ' CD2' ' A' ' 543' ' ' TYR . 3.6 mt 69.29 -56.87 0.54 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 111.586 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.74 46.16 0.75 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.363 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.635 ' NE1' HD13 ' A' ' 527' ' ' ILE . 2.9 p-90 -120.28 -18.82 7.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.528 HG21 ' HD2' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -108.63 159.47 30.79 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.055 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.463 ' HG2' ' CE1' ' A' ' 535' ' ' PHE . 18.5 Cg_endo -59.37 -48.57 13.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.6 2.2 . . . . 0.0 112.868 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.669 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 49.0 p90 -156.58 6.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.811 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.5 OUTLIER -72.5 -26.42 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.88 0.371 . . . . 0.0 111.081 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -108.4 -58.84 0.55 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.878 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.44 -35.6 76.34 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.389 2.059 . . . . 0.0 111.71 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -92.52 -12.14 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.381 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.816 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -75.28 122.51 23.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.366 . . . . 0.0 111.503 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -124.18 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.499 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -120.08 35.27 3.85 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.816 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -146.99 -33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.074 0.464 . . . . 0.0 110.333 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.781 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.3 OUTLIER -97.3 -40.02 8.95 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.733 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.889 HG21 HD22 ' A' ' 547' ' ' LEU . 1.5 mp 36.96 -72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.466 0.707 . . . . 0.0 112.364 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.714 ' N ' ' O ' ' A' ' 543' ' ' TYR . 25.1 mt-10 66.21 94.8 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.54 -4.75 1.51 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.998 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 544' ' ' ILE . 2.4 pt? -128.59 -10.25 5.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.336 0.568 . . . . 0.0 112.369 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.73 78.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.908 0.385 . . . . 0.0 111.032 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 2.0 m170 -133.72 27.13 4.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.638 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 1.3 m120 54.21 63.74 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.355 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.43 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -86.19 -79.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.043 -179.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.57 ' H ' HD11 ' A' ' 555' ' ' ILE . 0.5 OUTLIER 64.71 12.86 7.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.265 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -118.37 -34.61 1.09 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.592 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.997 HD12 HG23 ' A' ' 555' ' ' ILE . 2.1 pp -87.48 2.93 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.997 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.64 -40.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.275 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.973 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.844 0.354 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.4 m 60.1 86.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.007 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.827 ' O ' HD21 ' A' ' 515' ' ' LEU . 5.5 m-80 -83.37 -49.22 0.73 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.95 ' CG ' HG21 ' A' ' 555' ' ' ILE . 36.8 Cg_endo -102.2 16.05 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.256 3.304 . . . . 0.0 112.098 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.623 ' C ' HD13 ' A' ' 515' ' ' LEU . 6.8 m-80 -120.42 56.64 0.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.827 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -105.77 -48.0 3.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.302 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.625 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.2 p-80 -177.62 -56.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.353 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.712 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -57.11 -20.44 25.56 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -120.75 -41.23 2.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 0.0 110.999 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.596 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 7.4 t -57.2 -30.15 64.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.18 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.699 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -94.42 -70.11 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.891 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.699 ' N ' HG22 ' A' ' 520' ' ' THR . 0.0 OUTLIER -99.75 -168.18 1.57 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.451 -178.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.846 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 3.7 m-20 -89.93 22.17 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.904 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.584 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.9 mt-10 69.94 5.51 5.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.983 0.421 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.499 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 128.63 17.16 1.94 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.066 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.846 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -99.64 -6.1 27.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.798 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -89.17 18.99 4.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.821 0.343 . . . . 0.0 111.413 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -136.09 -50.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 -179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 159.92 -27.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.755 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.815 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 81.01 -28.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.8 -21.29 48.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.849 0.357 . . . . 0.0 111.869 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.805 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.0 p-90 -53.61 -24.59 14.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 110.587 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.805 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.3 OUTLIER -115.52 119.34 38.11 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.271 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.45 ' HG2' ' CE2' ' A' ' 534' ' ' TYR . 74.9 Cg_endo -90.12 31.97 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.715 2.276 . . . . 0.0 114.19 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.559 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 8.1 p90 172.2 -34.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 111.044 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.91 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 2.3 t80 -71.89 -21.15 61.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.67 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -116.69 -71.46 0.45 Allowed Glycine 0 C--N 1.32 -0.344 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.34 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HD3' HG13 ' A' ' 532' ' ' ILE . 51.2 Cg_exo -52.5 -39.46 74.42 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.485 2.123 . . . . 0.0 111.581 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -91.84 -17.35 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.117 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 1.018 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -45.25 -52.01 10.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.873 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 2.0 mt-10 71.85 -58.91 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.433 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -103.96 26.13 24.16 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.348 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 1.018 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -149.05 1.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 O-C-N 122.778 -0.248 . . . . 0.0 111.664 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.815 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.8 OUTLIER -129.33 -42.95 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.482 0.182 . . . . 0.0 110.725 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.994 HG21 HD22 ' A' ' 547' ' ' LEU . 3.3 mp 34.34 -73.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.444 0.698 . . . . 0.0 112.554 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.712 ' N ' ' O ' ' A' ' 543' ' ' TYR . 20.8 mt-10 64.02 34.98 10.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.356 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -147.17 13.43 1.45 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.54 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.994 HD22 HG21 ' A' ' 544' ' ' ILE . 1.1 pt? -157.87 -17.86 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.526 ' N ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -70.07 63.14 0.22 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.78 -43.03 3.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.649 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 552' ' ' ASP . 0.9 OUTLIER 172.89 -75.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.472 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER 41.19 -85.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.368 179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.3 OUTLIER 63.65 18.27 10.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -123.79 -31.44 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.187 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.957 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -77.52 -2.55 36.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.611 0.243 . . . . 0.0 111.305 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.957 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.91 -39.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.104 0.478 . . . . 0.0 110.897 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.504 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.417 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.877 0.37 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 97.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.987 ' O ' HD21 ' A' ' 515' ' ' LEU . 2.9 m-80 -94.84 -50.37 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.683 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.848 ' CG ' HG21 ' A' ' 555' ' ' ILE . 74.4 Cg_endo -107.13 16.88 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.374 3.383 . . . . 0.0 112.902 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.796 ' C ' HD13 ' A' ' 515' ' ' LEU . 4.7 m-80 -119.22 56.62 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.676 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.87 -58.7 1.99 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.104 -179.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.649 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.5 p-80 -173.85 -56.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.482 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.649 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.18 -12.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.708 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -122.49 -40.57 2.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -177.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.611 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.0 t -74.4 -21.11 59.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.648 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.49 -56.5 3.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 0.0 111.538 -179.009 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.589 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 6.2 pt20 -100.45 -158.13 0.65 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.46 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 9.0 m-20 -102.72 32.84 3.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.701 ' OE1' HD13 ' A' ' 544' ' ' ILE . 4.7 mt-10 44.67 73.99 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.963 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.449 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.12 -24.58 21.16 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.28 10.0 0.28 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.03 16.52 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.416 . . . . 0.0 110.539 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.598 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.97 -24.13 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.343 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.548 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 158.19 -52.68 0.4 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.328 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.609 HD21 ' CD2' ' A' ' 543' ' ' TYR . 3.8 mp 75.07 -22.18 0.27 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.868 0.467 . . . . 0.0 112.115 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.29 -24.82 42.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.162 0.506 . . . . 0.0 111.135 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.632 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 6.2 p-90 -64.27 -15.23 59.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.757 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.865 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.0 OUTLIER -126.31 139.27 34.12 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.191 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.91 -20.2 2.42 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.777 2.318 . . . . 0.0 113.892 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.0 p90 -148.21 6.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.936 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 18.6 m-85 -86.63 -40.49 15.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.027 0.441 . . . . 0.0 110.701 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -110.3 -60.4 0.5 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.367 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.76 -37.55 84.52 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.346 2.031 . . . . 0.0 111.551 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -92.65 -17.54 24.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.174 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 1.012 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -49.29 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.517 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 22.8 mt-10 76.15 -44.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.462 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -110.2 32.41 6.69 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.655 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 1.012 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -149.95 -32.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.065 0.46 . . . . 0.0 110.543 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.728 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -98.2 -39.86 8.66 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.958 HG21 HD22 ' A' ' 547' ' ' LEU . 1.0 OUTLIER 36.14 -72.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.396 0.679 . . . . 0.0 112.538 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.728 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.9 mt-10 67.0 33.38 5.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.042 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -138.5 -3.75 1.79 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.886 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.958 HD22 HG21 ' A' ' 544' ' ' ILE . 1.7 pt? -144.72 -8.24 0.65 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.467 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.46 68.14 0.36 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.957 0.408 . . . . 0.0 111.859 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -133.16 34.04 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 43.9 t30 55.67 95.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.655 ' OE1' HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -125.45 -76.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.27 24.76 7.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.884 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.94 -35.75 0.38 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.057 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 555' ' ' ILE . 2.5 pp -82.3 1.67 35.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 111.261 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.909 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -140.59 -42.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 110.872 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.499 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.994 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.845 0.355 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.473 ' HA ' HD13 ' A' ' 555' ' ' ILE . 0.6 OUTLIER 63.62 98.36 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.797 ' O ' HD21 ' A' ' 515' ' ' LEU . 2.6 m-80 -97.5 -50.8 0.22 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.669 ' CG ' HG21 ' A' ' 555' ' ' ILE . 36.3 Cg_endo -101.93 16.37 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.921 3.08 . . . . 0.0 112.319 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.524 ' ND2' HD11 ' A' ' 555' ' ' ILE . 5.4 m-80 -119.61 52.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -98.98 -48.63 4.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.354 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 8.5 p-80 -177.04 -53.04 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.772 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -60.17 -23.03 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.733 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -118.01 -39.48 3.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.0 110.959 -177.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.576 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 5.2 t -58.52 -27.78 64.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.542 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.674 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -97.8 -67.59 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.465 -179.135 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.674 ' N ' HG22 ' A' ' 520' ' ' THR . 0.0 OUTLIER -99.52 -168.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.771 -178.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.1 OUTLIER -87.23 24.26 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.883 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.662 ' OE2' HD21 ' A' ' 547' ' ' LEU . 16.9 mt-10 68.57 4.87 4.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.06 0.457 . . . . 0.0 111.073 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.46 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 123.7 22.62 2.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.966 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -110.28 4.4 20.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -93.16 12.67 23.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.859 0.361 . . . . 0.0 111.657 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.636 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -129.7 -45.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.292 -179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 150.85 -17.2 0.94 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.467 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.6 OUTLIER 73.72 -51.53 0.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 45.1 0.64 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.384 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.636 ' NE1' HD13 ' A' ' 527' ' ' ILE . 3.2 p-90 -119.87 -16.92 8.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.577 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.536 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.24 159.93 32.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.699 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 37.6 Cg_endo -66.3 -45.2 5.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.3 2.0 . . . . 0.0 112.491 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 18.5 p90 -161.57 6.68 0.07 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.865 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 1.1 m-85 -66.0 -26.85 67.73 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.118 -0.364 . . . . 0.0 111.4 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.48 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.48 -63.5 0.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.609 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.07 -39.3 80.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.356 2.038 . . . . 0.0 111.835 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 534' ' ' TYR . . . -95.3 -4.58 45.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.533 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.865 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -54.15 -61.73 2.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 32.4 mt-10 72.61 -58.26 0.6 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -102.91 22.59 36.44 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.312 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.862 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -144.66 -5.84 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.711 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -125.53 -37.17 2.37 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.47 0.176 . . . . 0.0 111.131 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.892 HG21 HD22 ' A' ' 547' ' ' LEU . 2.1 mp 36.7 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.471 0.708 . . . . 0.0 112.582 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 543' ' ' TYR . 36.9 mt-10 65.47 96.92 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.976 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.39 -8.27 1.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.709 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.892 HD22 HG21 ' A' ' 544' ' ' ILE . 2.1 pt? -128.15 -9.38 5.33 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.42 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.44 76.3 0.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.438 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 1.5 m170 -134.62 36.16 3.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.101 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.5 m-20 70.38 -64.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.151 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 42.66 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.963 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.1 OUTLIER 59.63 16.53 5.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -115.17 -34.79 1.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.697 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -80.69 -3.85 52.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.847 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 556' ' ' CYS . 2.9 pp -145.19 -29.95 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.485 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.731 ' N ' HD12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.145 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.902 0.382 . . . . 0.0 110.602 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.74 109.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.833 ' C ' HD11 ' A' ' 515' ' ' LEU . 2.3 m-80 -97.03 -50.35 0.23 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.958 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 23.9 Cg_endo -99.86 -1.67 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.791 2.994 . . . . 0.0 113.208 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.811 ' C ' HD13 ' A' ' 515' ' ' LEU . 18.1 m-80 -106.06 66.2 0.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.854 HD23 ' CD2' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -133.27 -30.46 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.854 ' CD2' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -173.0 -78.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.649 ' CB ' HG23 ' A' ' 542' ' ' ILE . 0.4 OUTLIER -67.4 12.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -177.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.697 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -139.26 -39.57 0.48 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.305 0.574 . . . . 0.0 109.66 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.537 HG22 ' N ' ' A' ' 516' ' ' HIS . 0.8 OUTLIER -78.62 -13.17 59.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.379 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.5 OUTLIER -95.84 -59.76 1.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.626 0.251 . . . . 0.0 110.873 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.547 ' N ' ' CG2' ' A' ' 520' ' ' THR . 6.4 pt20 -100.7 -158.02 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.301 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.418 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 2.4 m-20 -103.02 34.27 2.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.857 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.712 ' OE1' HD13 ' A' ' 544' ' ' ILE . 20.9 mt-10 47.07 71.95 0.28 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 110.269 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.6 -19.47 47.62 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.117 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.59 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.24 11.35 0.38 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.55 16.2 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.023 0.44 . . . . 0.0 110.507 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.59 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -54.17 -22.96 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.482 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.554 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 162.15 -53.31 0.31 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.245 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 2.8 mp 75.51 -20.06 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.6 0.36 . . . . 0.0 111.813 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.5 -24.17 42.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.175 0.512 . . . . 0.0 111.106 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.592 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 7.1 p-90 -63.84 -14.37 52.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.846 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.862 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.9 OUTLIER -125.62 140.23 35.98 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.164 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -87.42 -20.06 2.21 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.763 2.308 . . . . 0.0 113.982 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.505 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.56 6.24 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.862 ' HB2' HD12 ' A' ' 532' ' ' ILE . 18.6 m-85 -86.64 -38.49 17.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 110.93 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -113.73 -60.66 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.595 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.88 -40.07 76.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.434 2.089 . . . . 0.0 111.609 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -84.54 -27.71 27.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.727 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.768 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.07 158.82 6.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.492 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -151.32 -34.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.307 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.54 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -115.44 34.72 4.66 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.489 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.3 OUTLIER -149.92 -33.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.044 0.45 . . . . 0.0 110.163 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -103.33 -44.68 5.09 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.235 -178.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.995 HG21 HD22 ' A' ' 547' ' ' LEU . 0.9 OUTLIER 42.4 -72.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.56 0.744 . . . . 0.0 112.755 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.665 ' N ' ' O ' ' A' ' 543' ' ' TYR . 0.4 OUTLIER 69.31 29.91 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.36 -5.7 1.28 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.092 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.995 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -138.94 -6.56 1.44 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.474 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -72.36 63.1 0.53 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 111.615 -178.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -119.08 26.04 9.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.466 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 58.9 80.98 0.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.57 -77.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.784 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.518 ' H ' HD11 ' A' ' 555' ' ' ILE . 14.8 t70 63.24 15.27 8.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.358 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -121.89 -33.46 0.92 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.968 HD12 HG23 ' A' ' 555' ' ' ILE . 1.8 pp -87.84 5.49 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.968 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -146.35 -41.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.454 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.114 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.684 0.278 . . . . 0.0 110.566 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.84 100.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.85 ' C ' HD11 ' A' ' 515' ' ' LEU . 1.5 m-80 -103.19 -51.23 0.14 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.947 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.814 ' CG ' HG21 ' A' ' 555' ' ' ILE . 22.2 Cg_endo -100.11 -1.85 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.777 2.985 . . . . 0.0 113.259 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.821 ' C ' HD13 ' A' ' 515' ' ' LEU . 13.1 m-80 -103.44 65.66 0.85 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.85 HD11 ' C ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -132.16 -22.64 2.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -178.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.794 ' CD2' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER 179.83 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.606 ' CD1' ' CD2' ' A' ' 516' ' ' HIS . 0.5 OUTLIER -62.48 7.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.296 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.759 ' HB2' ' O ' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -135.57 -40.23 0.71 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.369 0.604 . . . . 0.0 109.775 -178.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.736 HG22 ' N ' ' A' ' 516' ' ' HIS . 7.2 t -80.17 -12.54 59.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.945 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.572 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -97.76 -62.38 1.26 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.685 0.278 . . . . 0.0 111.361 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.572 ' N ' ' CG2' ' A' ' 520' ' ' THR . 2.0 pt20 -100.45 -163.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.995 0.426 . . . . 0.0 111.208 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -102.89 32.32 3.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.44 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.785 ' OE1' HD13 ' A' ' 544' ' ' ILE . 3.9 mt-10 41.61 79.56 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.352 0.596 . . . . 0.0 110.097 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 526' ' ' ALA . . . 93.49 -14.93 64.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.934 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 527' ' ' ILE . . . 28.66 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.56 16.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 1.04 HD13 ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.22 -35.6 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 173.99 -38.58 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.134 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.32 -46.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -76.88 -20.04 56.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.3 p-90 -43.69 -29.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 0.0 111.083 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.531 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -104.71 157.56 33.89 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.319 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.458 ' HG2' ' CE1' ' A' ' 535' ' ' PHE . 36.4 Cg_endo -65.11 -44.09 10.21 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.426 2.084 . . . . 0.0 112.363 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 46.1 p90 -161.9 6.56 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.707 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.8 OUTLIER -63.98 -28.51 69.86 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.086 -0.384 . . . . 0.0 110.982 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.517 ' HA3' HD11 ' A' ' 532' ' ' ILE . . . -110.2 -57.83 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.988 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 75.8 Cg_exo -50.33 -46.71 27.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.47 2.114 . . . . 0.0 112.023 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -79.05 -25.8 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.933 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -59.95 141.62 55.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -129.97 -26.13 2.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.56 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.28 38.26 2.96 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.933 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.3 OUTLIER -150.26 -35.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.312 0.577 . . . . 0.0 109.951 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.682 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -103.29 -30.33 10.7 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.089 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.923 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 33.95 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.789 0.835 . . . . 0.0 112.907 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 543' ' ' TYR . 29.1 mt-10 69.13 87.4 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.934 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 157.29 -19.73 0.4 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.152 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.923 HD22 HG21 ' A' ' 544' ' ' ILE . 1.4 pt? -127.7 -18.61 4.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 111.68 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.441 ' HE3' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -58.36 102.85 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.172 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.438 ' NE2' ' HA ' ' A' ' 547' ' ' LEU . 0.4 OUTLIER -179.75 -64.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 178.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 175.33 108.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.823 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 -72.6 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.822 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 45.5 28.46 0.5 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.11 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.33 -35.33 0.42 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 1.017 HD12 HG23 ' A' ' 555' ' ' ILE . 1.5 pp -89.65 -4.54 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.735 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 1.017 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.74 -42.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.294 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.527 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.334 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.727 0.299 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 64.84 88.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.864 ' O ' HD21 ' A' ' 515' ' ' LEU . 5.8 m-80 -87.74 -49.63 0.44 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.837 ' CG ' HG21 ' A' ' 555' ' ' ILE . 38.6 Cg_endo -102.67 17.51 0.24 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 124.229 3.286 . . . . 0.0 112.232 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.694 ' C ' HD13 ' A' ' 515' ' ' LEU . 8.6 m-80 -122.74 57.77 1.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.864 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.99 -52.42 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.357 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.652 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.4 p-80 -175.76 -56.36 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.054 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.665 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -54.35 -14.83 1.32 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -179.155 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.37 -47.45 2.0 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.406 0.622 . . . . 0.0 110.04 -177.205 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 516' ' ' HIS . 6.4 t -63.79 -26.15 68.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -81.43 -56.5 4.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.56 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.609 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 4.7 pt20 -100.54 -161.92 0.9 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.038 0.447 . . . . 0.0 111.283 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.444 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.2 m-20 -102.95 34.37 2.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.569 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.759 ' OE1' HD21 ' A' ' 547' ' ' LEU . 20.1 mt-10 43.56 77.28 0.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.854 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 93.72 -23.44 30.64 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.0 10.68 0.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.13 15.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.01 0.433 . . . . 0.0 110.644 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.603 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -55.21 -22.35 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.366 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.558 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 155.45 -48.36 0.49 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.999 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.1 mp 74.68 -47.02 0.62 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.833 0.453 . . . . 0.0 111.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.54 43.98 0.59 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.572 ' CE2' HD13 ' A' ' 532' ' ' ILE . 4.3 p-90 -121.87 -13.9 8.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.829 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.65 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -117.64 169.67 7.23 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.882 -179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 75.9 Cg_endo -92.73 6.16 3.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.746 2.297 . . . . 0.0 113.318 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.635 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 28.3 p90 -176.83 -27.28 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.776 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 48.8 m-85 -59.48 -26.49 65.31 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.85 -0.531 . . . . 0.0 111.453 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.448 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -110.8 -65.6 0.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.059 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 42.3 Cg_exo -57.27 -39.0 93.29 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.587 2.191 . . . . 0.0 111.943 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -86.03 -18.38 32.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.31 150.16 22.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.87 0.367 . . . . 0.0 111.184 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -157.71 -36.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -114.63 31.66 6.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.025 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.626 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -146.57 -33.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.084 0.468 . . . . 0.0 110.366 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -99.56 -36.4 9.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.044 -179.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 1.046 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 37.0 -73.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.465 0.706 . . . . 0.0 112.496 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.706 ' N ' ' O ' ' A' ' 543' ' ' TYR . 31.9 mt-10 65.85 36.82 5.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -148.69 14.32 1.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.363 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 1.046 HD22 HG21 ' A' ' 544' ' ' ILE . 1.2 pt? -160.53 -14.91 0.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.86 64.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.416 . . . . 0.0 111.759 -178.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.522 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.62 33.07 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.437 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 58.15 86.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.512 ' CG ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -112.23 -77.84 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.037 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.78 11.5 8.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -117.29 -32.89 1.42 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.973 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 1.011 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -82.76 -0.81 49.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.796 0.331 . . . . 0.0 111.238 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 1.011 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.94 -40.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.876 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.298 -179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.482 ' HB3' ' HA ' ' A' ' 556' ' ' CYS . 5.5 mptt . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.646 0.26 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 42.91 61.32 2.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.179 0.514 . . . . 0.0 110.927 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.812 ' O ' HD21 ' A' ' 515' ' ' LEU . 2.8 m-80 -89.55 -48.75 0.39 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.503 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.896 ' CG ' HG21 ' A' ' 555' ' ' ILE . 59.9 Cg_endo -103.67 20.59 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.245 3.297 . . . . 0.0 112.314 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . 0.583 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.3 m-80 -115.46 48.16 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.812 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -100.27 -55.24 2.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.256 -178.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.63 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.3 p-80 -175.48 -56.43 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.669 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.647 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -57.21 -20.18 25.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -119.05 -27.68 5.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.424 -177.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 1.6 t -76.97 -20.09 56.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.684 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -98.55 -70.87 0.71 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 110.539 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.684 ' N ' HG22 ' A' ' 520' ' ' THR . 0.7 OUTLIER -99.93 -160.98 0.83 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.095 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.85 ' CB ' ' HB3' ' A' ' 525' ' ' ALA . 5.2 m-20 -96.19 30.83 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.218 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.617 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 20.3 mt-10 63.04 14.4 7.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.891 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.457 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 113.93 22.68 5.23 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.911 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.85 ' HB3' ' CB ' ' A' ' 522' ' ' ASP . . . -97.83 -3.62 38.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.64 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -84.86 22.42 1.37 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 110.968 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.64 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -132.73 -60.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.1 -21.8 1.25 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.41 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.9 mp 75.2 -20.31 0.35 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.09 43.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.331 0.586 . . . . 0.0 111.023 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.729 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 7.2 p-90 -65.72 -18.51 65.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.029 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.6 pt -123.42 135.61 26.25 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.037 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.424 ' HG2' ' CD2' ' A' ' 534' ' ' TYR . 98.2 Cg_endo -87.63 -17.73 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.71 2.273 . . . . 0.0 113.604 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.642 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 26.6 p90 -138.14 -26.08 0.94 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . 0.825 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 98.3 m-85 -59.97 -43.14 95.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.986 -0.446 . . . . 0.0 111.564 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -109.25 -60.92 0.52 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.987 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 532' ' ' ILE . 54.3 Cg_exo -51.7 -41.99 58.97 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.388 2.059 . . . . 0.0 111.813 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.93 -31.08 31.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.633 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -49.36 159.37 0.32 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -149.28 -44.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.72 25.18 17.76 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.095 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -145.06 -4.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 -179.389 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.677 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.5 OUTLIER -129.57 -42.73 1.29 Allowed 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.316 -178.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' ILE . . . . . 0.959 HG21 HD22 ' A' ' 547' ' ' LEU . 3.4 mp 38.89 -73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 123.54 0.736 . . . . 0.0 112.712 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.677 ' N ' ' O ' ' A' ' 543' ' ' TYR . 2.0 mm-40 73.65 29.77 1.49 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.314 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.93 4.72 2.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.648 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.959 HD22 HG21 ' A' ' 544' ' ' ILE . 1.7 pt? -149.88 -16.22 0.26 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.604 ' HE2' ' HA ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -69.46 65.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.938 0.399 . . . . 0.0 111.836 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -132.23 35.73 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.404 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 93.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.333 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.444 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -120.72 -76.44 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.216 0.531 . . . . 0.0 111.116 -179.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.462 ' H ' HD11 ' A' ' 555' ' ' ILE . 3.5 t70 63.7 17.17 10.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.678 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -123.77 -31.91 0.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.891 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 555' ' ' ILE . 2.7 pp -90.03 8.38 32.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.088 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.954 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.1 -44.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.545 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.642 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.234 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.412 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -171.12 64.24 0.41 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 35.0 Cg_exo -59.79 173.36 1.71 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.592 2.194 . . . . 0.0 112.445 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.01 118.76 25.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.626 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.9 m 60.32 101.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.593 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.9 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.5 m-80 -91.0 -51.44 0.31 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.08 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 61.5 Cg_endo -106.52 21.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.501 3.467 . . . . 0.0 112.406 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.637 ' C ' HD13 ' A' ' 515' ' ' LEU . 4.0 m-80 -118.8 51.18 1.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.9 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -105.59 -67.37 0.92 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.079 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.673 ' HA ' HG22 ' A' ' 519' ' ' THR . 6.0 p-80 -161.51 -57.05 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.193 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.605 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -55.94 -9.61 0.62 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.698 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -123.23 -44.31 2.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.581 0.705 . . . . 0.0 110.563 -176.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.673 HG22 ' HA ' ' A' ' 516' ' ' HIS . 12.1 t -63.15 -28.78 70.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.467 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.668 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.8 OUTLIER -84.57 -65.69 0.98 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.764 -179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.668 ' N ' HG22 ' A' ' 520' ' ' THR . 3.5 pt20 -99.99 -157.64 0.62 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.2 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.797 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 4.1 m-20 -100.62 36.64 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.233 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 543' ' ' TYR . 8.3 mt-10 52.28 34.88 15.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.034 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.518 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 89.26 33.35 9.55 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.571 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.797 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -119.95 -5.47 10.07 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -90.79 15.69 10.71 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.795 0.331 . . . . 0.0 111.72 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.588 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.2 OUTLIER -129.65 -44.71 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.432 -179.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 134.28 -17.63 4.27 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.552 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.637 HD11 ' HD2' ' A' ' 543' ' ' TYR . 2.9 tp 78.0 -51.61 0.5 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.67 47.13 0.71 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.107 0.48 . . . . 0.0 112.241 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.76 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.9 p-90 -122.5 -16.53 7.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.632 179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.777 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -116.17 166.29 12.82 Favored Pre-proline 0 N--CA 1.454 -0.262 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.856 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 83.1 Cg_endo -94.04 2.39 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.835 2.357 . . . . 0.0 113.563 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.728 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 9.8 p90 -177.16 -21.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.777 ' HB2' HD12 ' A' ' 532' ' ' ILE . 60.9 m-85 -59.5 -30.93 68.91 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.91 -0.494 . . . . 0.0 111.67 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.565 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -111.37 -69.07 0.56 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.938 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -49.01 -40.22 40.83 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.603 2.202 . . . . 0.0 112.022 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.91 -31.6 31.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -52.82 158.09 1.47 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -141.57 -41.64 0.37 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -111.31 34.15 5.45 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.637 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.26 -35.4 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.101 0.476 . . . . 0.0 109.962 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.735 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -99.68 -29.13 12.84 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.182 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.813 HG21 HD22 ' A' ' 547' ' ' LEU . 2.5 mp 30.84 -71.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.916 0.886 . . . . 0.0 112.95 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.735 ' N ' ' O ' ' A' ' 543' ' ' TYR . 7.4 mt-10 69.63 91.85 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.116 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 150.13 -9.6 0.84 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.875 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.813 HD22 HG21 ' A' ' 544' ' ' ILE . 2.7 pt? -128.14 -11.36 5.27 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.493 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -63.13 80.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.911 0.386 . . . . 0.0 110.7 -179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 4.1 m170 -133.15 29.7 4.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.424 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 52.32 55.79 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.734 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.41 ' HB3' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -96.41 172.21 8.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.819 -179.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 21.1 t70 179.17 31.09 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.787 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -134.87 -37.82 0.2 Allowed Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -77.8 -3.89 43.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.188 -0.506 . . . . 0.0 110.616 178.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.909 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -144.03 -42.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 111.32 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t -113.61 60.55 0.66 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.378 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -99.65 -58.47 0.89 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.244 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.501 ' HG ' ' N ' ' A' ' 559' ' ' ARG . 2.5 pt? -146.38 -46.07 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.463 0.173 . . . . 0.0 110.939 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.501 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 175.59 37.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.011 0.434 . . . . 0.0 111.542 179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.408 ' NE2' HD23 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.906 0.384 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 5.2 pt20 -165.68 53.97 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 84.3 Cg_endo -78.23 138.6 16.13 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.674 2.249 . . . . 0.0 112.31 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.19 124.29 37.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.08 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.6 m 51.32 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.909 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.8 m-80 -93.52 -49.53 0.27 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.854 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.69 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 50.4 Cg_endo -102.69 17.42 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 124.339 3.359 . . . . 0.0 112.658 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.733 ' C ' HD13 ' A' ' 515' ' ' LEU . 5.8 m-80 -123.32 59.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.319 0.58 . . . . 0.0 109.914 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.909 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.18 -72.83 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.05 -179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.601 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 22.9 p-80 -147.62 -56.04 0.23 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.771 ' C ' ' HD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -65.91 179.51 0.88 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.771 ' HD1' ' C ' ' A' ' 517' ' ' TYR . 0.1 OUTLIER 62.79 -44.99 0.2 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 118.239 0.472 . . . . 0.0 110.945 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 517' ' ' TYR . 8.9 t -94.37 -19.86 20.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.258 0.551 . . . . 0.0 109.829 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.69 HG22 ' N ' ' A' ' 521' ' ' GLN . 1.2 m -85.16 -78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.391 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.69 ' N ' HG22 ' A' ' 520' ' ' THR . 0.0 OUTLIER -100.51 -161.88 0.9 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.162 -179.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.629 ' HB2' ' HB2' ' A' ' 526' ' ' ALA . 1.1 t0 -93.19 22.36 5.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.942 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.618 ' HG3' ' HA ' ' A' ' 518' ' ' TRP . 9.3 mt-10 48.31 75.84 0.13 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.546 0.689 . . . . 0.0 110.369 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.456 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 52.47 20.29 7.21 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.391 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 522' ' ' ASP . . . -106.69 -22.83 12.62 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 117.302 0.551 . . . . 0.0 111.832 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.785 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -87.3 20.98 2.57 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 120.993 0.425 . . . . 0.0 110.974 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.785 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -133.81 -48.23 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.476 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 136.98 -11.95 3.9 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.108 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.879 HD11 ' CD2' ' A' ' 543' ' ' TYR . 3.2 mt 70.04 -56.37 0.58 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.047 0.451 . . . . 0.0 111.88 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 46.23 0.73 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.412 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.601 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.4 p-90 -120.56 -18.29 7.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.664 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.601 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.1 160.37 30.26 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.259 -179.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 27.1 Cg_endo -62.2 -47.1 10.83 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.528 2.152 . . . . 0.0 112.875 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.767 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 37.1 p90 -155.33 6.26 0.23 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.051 0.759 . . . . 0.0 113.051 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.518 ' HD2' HG21 ' A' ' 532' ' ' ILE . 0.9 OUTLIER -71.65 -26.48 62.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.946 0.403 . . . . 0.0 111.044 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -108.47 -63.41 0.56 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.674 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.09 -41.88 39.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.465 2.11 . . . . 0.0 111.661 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -78.02 -23.03 48.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.585 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 536' ' ' GLY . . . -51.59 161.64 0.48 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -163.69 -42.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.575 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.443 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -109.01 29.59 9.57 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.875 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.674 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -148.42 -29.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 110.792 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.879 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.8 OUTLIER -98.68 -47.92 5.15 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 -179.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.785 HG21 HD22 ' A' ' 547' ' ' LEU . 2.0 mp 36.85 -74.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.377 0.671 . . . . 0.0 112.442 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.693 ' N ' ' O ' ' A' ' 543' ' ' TYR . 22.6 mt-10 68.32 85.82 0.14 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.003 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 162.96 -17.32 0.14 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.551 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.785 HD22 HG21 ' A' ' 544' ' ' ILE . 1.9 pt? -134.68 -12.57 2.3 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.492 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -70.17 64.42 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.129 0.49 . . . . 0.0 111.473 -179.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.465 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.2 OUTLIER -116.36 -74.63 0.6 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.002 179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.7 t30 175.47 73.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 110.757 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.402 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -99.11 -78.25 0.5 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.603 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.678 ' H ' HD11 ' A' ' 555' ' ' ILE . 6.7 t70 66.08 12.59 8.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.683 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.9 -31.77 1.17 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.711 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.934 HD12 HG23 ' A' ' 555' ' ' ILE . 1.5 pp -93.15 9.4 36.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.828 0.347 . . . . 0.0 111.028 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.934 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.3 -42.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.468 -178.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.468 ' N ' HG12 ' A' ' 555' ' ' ILE . 5.2 t -105.43 114.46 28.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.351 -178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -160.22 -73.55 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.087 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.448 HD23 ' N ' ' A' ' 558' ' ' LEU . 1.2 pt? -141.67 -40.47 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 0.0 111.205 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.447 ' HG3' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 173.74 32.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.294 0.569 . . . . 0.0 110.893 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.566 ' NE2' ' H ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.063 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.808 0.337 . . . . 0.0 111.05 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -172.38 56.49 0.22 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.04 147.84 24.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.588 2.192 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -72.89 116.75 13.77 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.655 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.503 ' O ' HD11 ' A' ' 515' ' ' LEU . 12.4 m 61.76 114.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.408 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.97 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.7 m-80 -94.09 -50.83 0.26 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.675 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.77 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 86.5 Cg_endo -109.64 16.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 124.267 3.311 . . . . 0.0 113.32 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.832 ' C ' HD13 ' A' ' 515' ' ' LEU . 8.3 m-80 -118.62 53.18 1.0 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.17 0.51 . . . . 0.0 110.171 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.97 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -121.98 -62.73 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.956 -179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.637 ' HA ' ' CG2' ' A' ' 519' ' ' THR . 7.9 p-80 -171.18 -56.0 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.578 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.637 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.53 -10.61 0.27 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -178.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.77 ' CE3' ' HB3' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -123.61 -33.33 3.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.21 0.529 . . . . 0.0 110.462 -177.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.637 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 8.9 t -82.87 -16.1 48.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.505 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.533 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -87.07 -56.8 3.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.716 0.294 . . . . 0.0 111.38 -179.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 5.6 pt20 -100.45 -157.58 0.62 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.146 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 525' ' ' ALA . 5.3 m-20 -102.73 32.55 3.59 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.26 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.5 mt-10 45.33 69.69 0.42 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.907 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 93.59 -26.94 13.52 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.622 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.89 11.0 0.17 Allowed 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.69 16.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.891 0.377 . . . . 0.0 110.769 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.622 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -56.08 -22.23 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.275 -179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.559 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 163.63 -34.01 0.29 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.805 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 543' ' ' TYR . 2.0 mt 67.91 -53.96 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -73.28 -21.68 60.54 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.601 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.9 p-90 -43.61 -29.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.864 0.364 . . . . 0.0 111.016 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.587 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -103.71 152.09 38.87 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.574 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.56 -50.51 13.8 Favored 'Trans proline' 0 N--CA 1.465 -0.197 0 C-N-CA 122.618 2.212 . . . . 0.0 112.281 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 42.6 p90 -157.97 6.45 0.13 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.919 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -62.59 -27.1 68.96 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.831 0.348 . . . . 0.0 110.766 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -107.84 -56.65 0.59 Allowed Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.838 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 46.6 Cg_exo -56.27 -41.27 78.31 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.481 2.12 . . . . 0.0 111.937 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 534' ' ' TYR . . . -93.24 -7.92 43.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.219 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 1.119 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -53.1 -75.87 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.29 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 75.87 -43.59 0.49 Allowed 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.512 ' C ' HD12 ' A' ' 542' ' ' ILE . . . -112.33 35.08 4.83 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.745 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 1.119 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -151.09 -33.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.992 0.425 . . . . 0.0 110.513 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.6 OUTLIER -94.96 -45.75 7.13 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.037 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.894 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 36.47 -73.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.627 0.771 . . . . 0.0 112.404 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 543' ' ' TYR . 19.9 mt-10 67.49 32.24 5.82 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.732 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -137.88 -7.86 1.31 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.87 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.894 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -137.67 -8.57 1.65 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.518 ' HE1' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.49 65.66 0.3 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.228 0.537 . . . . 0.0 110.761 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.7 OUTLIER -111.49 -65.33 1.18 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.611 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 168.59 63.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.742 ' CB ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -115.61 -178.84 3.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.238 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 556' ' ' CYS . 2.9 p30 -179.2 -22.39 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.187 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -88.33 -29.05 20.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.309 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.932 HD12 HG23 ' A' ' 555' ' ' ILE . 1.2 pp -82.42 -2.77 54.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.669 0.271 . . . . 0.0 111.45 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.932 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.99 -41.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.996 0.427 . . . . 0.0 111.04 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER -101.41 72.16 1.4 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.186 -178.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -124.5 -67.69 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.541 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 558' ' ' LEU . 2.2 pt? -134.32 -48.16 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.522 0.201 . . . . 0.0 111.051 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.476 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.1 OUTLIER 178.81 37.7 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.032 0.444 . . . . 0.0 111.421 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.547 ' NE2' HD23 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.013 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.832 0.348 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -169.87 56.09 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.727 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.87 -165.94 0.37 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.815 2.343 . . . . 0.0 112.496 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.8 118.4 15.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.67 90.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.549 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.892 ' O ' HD21 ' A' ' 515' ' ' LEU . 6.0 m-80 -87.39 -49.51 0.45 Allowed Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.75 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.909 ' CG ' HG21 ' A' ' 555' ' ' ILE . 39.3 Cg_endo -102.08 16.7 0.28 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 124.195 3.263 . . . . 0.0 112.525 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.687 ' C ' HD13 ' A' ' 515' ' ' LEU . 8.5 m-80 -123.82 60.2 1.11 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.892 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -111.46 -46.15 3.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.31 -178.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.9 p-80 -177.59 -56.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.665 0.269 . . . . 0.0 111.514 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.71 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -56.18 -20.16 16.69 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.735 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.83 -44.03 2.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.186 0.517 . . . . 0.0 110.761 -177.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.601 HG22 ' CA ' ' A' ' 516' ' ' HIS . 9.3 t -53.84 -31.34 49.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.288 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.711 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.19 -68.49 0.8 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.163 -179.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.756 HE22 HD11 ' A' ' 527' ' ' ILE . 0.0 OUTLIER -99.64 -169.99 1.83 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.467 -178.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.888 ' CB ' ' HB3' ' A' ' 525' ' ' ALA . 3.5 m-20 -88.19 21.39 2.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.9 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 34.2 mt-10 69.11 4.51 4.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.934 0.397 . . . . 0.0 111.224 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.499 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 130.96 20.23 1.19 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.16 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.888 ' HB3' ' CB ' ' A' ' 522' ' ' ASP . . . -97.21 -25.26 15.35 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.744 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -84.45 23.19 1.15 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 120.826 0.346 . . . . 0.0 111.412 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.756 HD11 HE22 ' A' ' 521' ' ' GLN . 0.0 OUTLIER -131.67 -46.57 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.587 -179.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 138.72 -12.9 3.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.927 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.04 -46.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -75.85 -20.25 58.27 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.746 ' CE2' HD13 ' A' ' 532' ' ' ILE . 2.0 p-90 -47.55 -26.13 1.34 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.953 0.406 . . . . 0.0 111.074 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.836 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.3 OUTLIER -114.63 157.75 42.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -91.09 -23.69 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.991 2.461 . . . . 0.0 114.023 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 8.6 p90 -154.34 6.65 0.3 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.836 ' HB2' HD12 ' A' ' 532' ' ' ILE . 2.9 m-85 -78.93 -43.08 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.224 0.535 . . . . 0.0 110.705 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.566 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.41 -58.06 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.622 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' A' ' 536' ' ' GLY . 77.8 Cg_exo -49.68 -42.05 44.13 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.322 2.014 . . . . 0.0 111.583 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.75 -29.79 32.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.591 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.766 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.18 148.11 28.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.223 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -129.16 -35.73 1.79 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.594 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.435 ' O ' ' HZ2' ' A' ' 518' ' ' TRP . . . -114.76 27.57 8.66 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.937 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.7 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -142.35 -6.19 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.478 0.177 . . . . 0.0 111.478 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.72 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -127.42 -41.99 1.69 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 120.368 0.128 . . . . 0.0 111.085 -178.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.563 HG21 HD22 ' A' ' 547' ' ' LEU . 3.2 mp 34.45 -72.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.549 0.74 . . . . 0.0 112.551 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.72 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.5 mt-10 68.4 90.47 0.1 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.148 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 155.51 -15.33 0.47 Allowed Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.182 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.563 HD22 HG21 ' A' ' 544' ' ' ILE . 1.4 pt? -129.4 -3.17 4.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.786 0.327 . . . . 0.0 111.684 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.762 ' N ' ' HE2' ' A' ' 548' ' ' MET . 0.0 OUTLIER -81.08 80.37 7.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.173 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -133.19 -68.7 0.58 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.589 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 167.44 66.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -74.67 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.19 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.93 20.61 9.62 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.93 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -122.99 -38.15 0.58 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.979 HD12 HG23 ' A' ' 555' ' ' ILE . 2.4 pp -83.15 -1.16 52.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.979 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.31 -40.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.709 -179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.484 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -103.86 143.22 33.12 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.93 -179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 179.2 -72.55 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.133 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.472 ' HG ' ' HG3' ' A' ' 559' ' ' ARG . 1.3 pt? -144.44 -40.94 0.26 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.626 0.251 . . . . 0.0 111.321 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.472 ' HG3' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 176.03 32.87 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.324 0.583 . . . . 0.0 111.016 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.458 ' NE2' ' H ' ' A' ' 560' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.0 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.785 0.326 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.41 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -155.99 53.73 0.83 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.063 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 84.2 Cg_endo -80.67 163.01 21.45 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.61 2.207 . . . . 0.0 112.33 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.29 105.65 13.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.627 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 3.7 m 63.41 122.1 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.708 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.4 m-80 -104.67 -52.3 0.11 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.875 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.563 ' HD3' ' HB2' ' A' ' 512' ' ' ASN . 39.7 Cg_endo -104.02 5.71 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 124.019 3.146 . . . . 0.0 113.162 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.709 ' C ' HD13 ' A' ' 515' ' ' LEU . 19.4 m-80 -115.53 57.61 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.195 0.521 . . . . 0.0 109.791 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.745 ' H ' HD22 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -121.73 -38.21 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.552 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.736 ' O ' ' O ' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -164.23 -84.63 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.768 -178.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.992 ' O ' ' N ' ' A' ' 519' ' ' THR . 1.4 m-85 -52.21 -137.79 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.682 ' HA ' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER 26.14 -63.17 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 177.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.992 ' N ' ' O ' ' A' ' 517' ' ' TYR . 9.2 t -70.13 -25.35 63.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.066 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.603 ' HB ' ' O ' ' A' ' 516' ' ' HIS . 0.4 OUTLIER -78.64 -63.93 1.29 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.567 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 7.6 pt20 -100.79 -153.51 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.821 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.83 31.75 4.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.09 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.698 ' OE2' HD13 ' A' ' 544' ' ' ILE . 1.7 mt-10 46.96 70.72 0.37 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.824 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 90.97 -25.15 14.84 Favored Glycine 0 N--CA 1.441 -0.998 0 C-N-CA 120.334 -0.936 . . . . 0.0 110.895 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.616 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.47 11.95 0.21 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.55 16.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.009 0.433 . . . . 0.0 110.749 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.616 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.5 OUTLIER -57.88 -20.25 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.319 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.57 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 160.61 -46.0 0.4 Allowed Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.924 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.529 HD21 ' CD ' ' A' ' 545' ' ' GLU . 3.4 mp 71.15 -34.79 0.31 Allowed 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.18 -22.94 44.26 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.591 ' CD2' HG23 ' A' ' 532' ' ' ILE . 2.4 p-90 -47.63 -26.73 1.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.074 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.675 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.1 OUTLIER -116.03 167.45 10.27 Favored Pre-proline 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.713 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 92.7 Cg_endo -95.39 -5.92 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.13 2.553 . . . . 0.0 113.812 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.55 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 17.9 p90 -159.0 -28.95 0.07 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.675 ' HD1' ' HB ' ' A' ' 532' ' ' ILE . 16.4 m-85 -59.44 -26.14 64.95 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.72 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.406 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -115.53 -55.28 0.36 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.223 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 17.9 Cg_exo -67.33 -31.92 33.97 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.701 2.267 . . . . 0.0 112.224 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -93.31 -25.93 17.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.133 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.606 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -64.63 131.35 46.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.339 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.63 -25.07 2.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.925 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.559 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.25 35.24 4.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.116 -0.564 . . . . 0.0 111.777 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.65 HG23 ' CG ' ' A' ' 517' ' ' TYR . 0.2 OUTLIER -148.36 -28.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.782 0.325 . . . . 0.0 110.894 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -103.85 -43.97 5.17 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.002 -178.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 544' ' ' ILE . 0.7 OUTLIER 34.44 -72.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 123.613 0.765 . . . . 0.0 112.497 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 18.2 mt-10 71.87 34.29 1.55 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.032 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.44 -3.62 1.58 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 115.531 -0.759 . . . . 0.0 113.016 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.784 HD22 HG21 ' A' ' 544' ' ' ILE . 2.4 pt? -143.04 -4.11 0.93 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.538 ' HE1' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -75.81 73.74 2.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.01 0.433 . . . . 0.0 111.602 -179.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.512 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -132.78 27.79 4.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.229 179.01 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.56 101.42 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.626 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -76.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.117 0.484 . . . . 0.0 110.721 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.528 ' H ' HD11 ' A' ' 555' ' ' ILE . 11.9 t70 60.24 18.53 8.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.427 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -125.63 -34.61 0.64 Allowed Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -88.24 6.19 38.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.809 0.338 . . . . 0.0 111.045 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.954 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.56 -42.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.266 -178.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.467 ' N ' HG12 ' A' ' 555' ' ' ILE . 4.8 t -107.44 101.28 10.64 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.352 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -149.3 -65.27 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.352 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.674 HD23 ' H ' ' A' ' 558' ' ' LEU . 1.8 pt? -138.67 -48.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.563 0.22 . . . . 0.0 110.919 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.451 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.98 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.987 0.422 . . . . 0.0 111.448 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.498 ' NE2' HD23 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.171 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.822 0.344 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.7 58.48 0.2 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.838 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.34 167.57 25.89 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.584 2.189 . . . . 0.0 112.257 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -110.7 125.92 53.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.801 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.72 111.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.968 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.5 m-80 -103.88 -51.78 0.12 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.759 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.726 ' CG ' HG21 ' A' ' 555' ' ' ILE . 46.6 Cg_endo -105.41 14.97 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 124.241 3.294 . . . . 0.0 113.033 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.711 ' C ' HD13 ' A' ' 515' ' ' LEU . 16.6 m-80 -126.33 58.13 1.38 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.229 0.538 . . . . 0.0 109.899 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.968 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -119.31 -54.37 2.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.858 -179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.675 ' HA ' HG22 ' A' ' 519' ' ' THR . 7.4 p-80 -174.75 -54.47 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.287 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.619 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.46 -10.85 0.45 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.694 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.85 -49.69 1.85 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.517 0.675 . . . . 0.0 109.869 -177.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 516' ' ' HIS . 14.7 t -60.35 -23.29 64.15 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.48 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -85.02 -56.51 3.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.778 0.323 . . . . 0.0 111.485 -179.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.669 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 4.2 pt20 -100.44 -161.31 0.86 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.043 0.449 . . . . 0.0 111.166 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.456 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -102.92 31.85 3.98 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.607 -179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.669 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.9 mp0 45.21 74.77 0.12 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.5 0.667 . . . . 0.0 109.933 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 91.38 -25.74 14.14 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.412 -177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.648 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 52.03 10.28 0.11 Allowed 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.6 16.4 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.922 0.392 . . . . 0.0 110.54 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.689 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.4 OUTLIER -55.65 -22.08 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.301 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.52 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 156.32 -38.08 0.59 Allowed Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.41 -0.9 . . . . 0.0 113.266 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.536 ' O ' ' HD3' ' A' ' 537' ' ' PRO . 4.4 mp 70.39 -38.48 0.42 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.02 -24.62 43.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.689 ' NE1' HD13 ' A' ' 527' ' ' ILE . 1.9 p-90 -45.98 -27.47 0.92 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.564 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.623 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.1 OUTLIER -113.04 165.71 12.6 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.917 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.08 -41.09 0.7 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 123.06 2.506 . . . . 0.0 113.232 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.644 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 16.9 p90 -156.31 6.08 0.19 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.713 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -73.95 -26.97 60.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.051 0.453 . . . . 0.0 110.597 179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.483 ' HA3' HD11 ' A' ' 532' ' ' ILE . . . -108.49 -55.09 0.59 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.785 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 23.9 Cg_exo -64.33 -37.98 37.09 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.621 2.214 . . . . 0.0 111.788 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -93.25 -5.47 49.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.163 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.912 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -51.73 -72.02 0.06 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.772 0.32 . . . . 0.0 110.963 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 70.89 -48.23 0.66 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.409 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -108.41 29.55 9.9 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.968 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.912 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -146.62 -33.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.436 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.701 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -95.36 -43.07 8.19 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.526 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.77 HD12 ' N ' ' A' ' 544' ' ' ILE . 1.6 mp 37.77 -73.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 123.545 0.738 . . . . 0.0 112.345 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.701 ' N ' ' O ' ' A' ' 543' ' ' TYR . 26.9 mt-10 66.86 85.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.261 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 165.02 -22.13 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.91 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.767 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -133.87 -8.38 2.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.426 ' CE ' ' CD2' ' A' ' 549' ' ' HIS . 0.0 OUTLIER -67.85 64.84 0.09 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 111.811 -178.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.497 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.27 46.68 2.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.568 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 2.4 m-80 68.7 -66.29 0.25 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.46 HE21 HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER 49.53 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.901 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.7 m-20 59.89 20.06 9.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.187 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -133.17 -34.12 0.34 Allowed Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.916 HD12 HG23 ' A' ' 555' ' ' ILE . 3.0 pp -86.96 8.32 23.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.796 0.332 . . . . 0.0 111.326 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.916 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -143.91 -42.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.159 0.504 . . . . 0.0 111.087 -178.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.494 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -108.16 93.47 4.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.19 -178.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -136.22 -65.82 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.358 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 558' ' ' LEU . 2.2 pt? -134.96 -47.41 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.61 0.243 . . . . 0.0 111.005 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.472 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.1 OUTLIER 179.48 38.31 0.0 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.036 0.446 . . . . 0.0 111.395 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.573 ' NE2' HD23 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.008 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.726 0.298 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.445 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 15.2 mm100 -152.23 50.92 0.69 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 84.5 Cg_endo -77.6 139.27 17.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.437 2.092 . . . . 0.0 112.363 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.67 126.51 35.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.794 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 95.1 m 61.72 101.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.764 ' O ' HD11 ' A' ' 515' ' ' LEU . 1.4 m-80 -99.04 -50.31 0.21 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.763 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.832 ' CG ' HG21 ' A' ' 555' ' ' ILE . 38.3 Cg_endo -101.54 16.17 0.32 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 124.048 3.166 . . . . 0.0 112.593 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.538 ' C ' HD13 ' A' ' 515' ' ' LEU . 5.8 m-80 -119.91 54.4 1.02 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.809 HD23 ' HE1' ' A' ' 517' ' ' TYR . 0.0 OUTLIER -99.11 -47.74 5.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.415 -178.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.597 ' N ' HG22 ' A' ' 519' ' ' THR . 11.1 p-80 -175.61 -52.76 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.809 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -61.55 -24.5 66.69 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 -178.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.732 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -116.61 -39.8 3.28 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.181 0.515 . . . . 0.0 110.838 -177.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 516' ' ' HIS . 5.5 t -57.89 -21.47 43.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.527 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.67 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -105.15 -67.12 0.93 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.087 0.47 . . . . 0.0 111.225 -179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.67 ' N ' HG22 ' A' ' 520' ' ' THR . 1.3 pt20 -99.88 -160.84 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.782 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.761 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -94.73 34.7 1.3 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.31 -179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.681 ' CD ' HD13 ' A' ' 544' ' ' ILE . 16.1 mt-10 60.69 20.09 10.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.547 ' C ' HD11 ' A' ' 527' ' ' ILE . . . 98.38 32.84 5.89 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.445 -0.883 . . . . 0.0 111.165 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.761 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -117.34 3.63 12.56 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -92.29 18.3 8.5 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 120.901 0.381 . . . . 0.0 111.146 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.1 OUTLIER -124.75 -53.4 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.658 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 150.52 -19.96 1.03 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.794 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.64 HD11 ' HA ' ' A' ' 525' ' ' ALA . 7.1 mp 72.98 -20.74 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.22 -20.93 47.05 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.175 0.512 . . . . 0.0 111.268 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.681 ' HE1' HD13 ' A' ' 527' ' ' ILE . 7.3 p-90 -69.07 -13.7 62.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.774 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.877 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.8 OUTLIER -126.26 142.74 43.64 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.063 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -86.92 -21.6 2.06 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.712 2.274 . . . . 0.0 113.935 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.425 ' HA ' ' CB ' ' A' ' 538' ' ' ALA . 9.7 p90 -150.82 6.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.877 ' HB2' HD12 ' A' ' 532' ' ' ILE . 22.7 m-85 -82.3 -39.54 22.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.916 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -112.55 -61.44 0.44 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.452 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.53 -39.69 74.17 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.392 2.062 . . . . 0.0 111.903 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -85.02 -37.12 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.285 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -46.25 164.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.518 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -147.11 -43.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.55 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.99 23.25 21.77 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.789 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.645 HG23 ' CD2' ' A' ' 517' ' ' TYR . 0.1 OUTLIER -139.99 -18.52 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.463 0.173 . . . . 0.0 111.046 -179.62 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.818 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -122.85 -3.08 8.69 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.533 -179.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.719 ' O ' ' HG3' ' A' ' 545' ' ' GLU . 1.5 mp 4.69 -51.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.805 1.242 . . . . 0.0 114.044 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.818 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.6 pt-20 44.44 79.18 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.011 0.434 . . . . 0.0 111.414 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.479 ' N ' ' HE2' ' A' ' 548' ' ' MET . . . 172.79 -25.61 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.839 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.687 HD22 HG21 ' A' ' 544' ' ' ILE . 1.6 pt? -125.78 -12.23 6.57 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.479 ' HE2' ' N ' ' A' ' 546' ' ' GLY . 0.0 OUTLIER -68.01 71.94 0.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.164 0.507 . . . . 0.0 111.174 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.8 OUTLIER -124.94 26.35 7.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.708 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 59.23 61.58 2.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.403 ' OE1' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -87.12 -70.94 0.58 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.313 0.578 . . . . 0.0 110.64 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 556' ' ' CYS . 1.1 m-20 63.2 19.28 11.57 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.092 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -120.52 -30.62 1.37 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.883 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.977 HD12 HG23 ' A' ' 555' ' ' ILE . 1.9 pp -88.79 2.23 53.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.756 0.313 . . . . 0.0 111.119 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.977 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -147.52 -40.95 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.293 0.568 . . . . 0.0 110.658 -179.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 552' ' ' ASP . 1.6 m -93.56 36.63 1.08 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.176 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.408 ' HA2' ' NE2' ' A' ' 560' ' ' GLN . . . 140.04 41.22 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.344 -0.931 . . . . 0.0 112.981 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.632 HD22 ' HA ' ' A' ' 555' ' ' ILE . 1.0 OUTLIER -95.78 -43.42 7.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.429 179.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.569 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 171.03 36.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.085 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.529 ' HG3' HD23 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.992 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.26 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.818 0.342 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -170.75 56.54 0.25 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.875 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.7 168.42 23.79 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.616 2.211 . . . . 0.0 112.35 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -125.34 127.41 46.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.655 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 514' ' ' ASN . 0.0 OUTLIER 59.66 98.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.559 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.958 ' O ' HD21 ' A' ' 515' ' ' LEU . 3.5 m-80 -95.66 -50.58 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.878 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.809 ' CG ' HG21 ' A' ' 555' ' ' ILE . 57.7 Cg_endo -105.45 16.39 0.16 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.224 3.282 . . . . 0.0 113.04 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.727 ' C ' HD13 ' A' ' 515' ' ' LEU . 9.1 m-80 -123.76 57.91 1.17 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.561 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.958 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.43 -52.82 2.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.99 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.655 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 5.1 p-80 -176.97 -56.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.332 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.655 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.41 -13.52 0.6 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.716 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.07 -43.84 2.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.372 0.606 . . . . 0.0 110.037 -177.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.528 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.7 t -70.96 -22.06 62.26 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.804 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.34 -56.15 4.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.822 0.344 . . . . 0.0 111.601 -178.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.584 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 6.2 pt20 -100.46 -157.85 0.63 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.456 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -102.67 32.72 3.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.317 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.685 ' OE1' HD21 ' A' ' 547' ' ' LEU . 4.3 mt-10 44.75 74.02 0.14 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.949 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.442 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.13 -24.81 20.07 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.595 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.1 9.99 0.26 Allowed 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.98 16.48 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 121.031 0.443 . . . . 0.0 110.614 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.595 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.53 -24.24 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.296 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.55 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 158.55 -52.49 0.39 Allowed Glycine 0 CA--C 1.517 0.208 0 C-N-CA 120.379 -0.915 . . . . 0.0 113.176 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.582 HD21 ' HD2' ' A' ' 543' ' ' TYR . 3.4 mp 75.28 -21.4 0.3 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.799 0.44 . . . . 0.0 112.048 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.41 -26.42 41.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.241 0.543 . . . . 0.0 110.922 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.593 ' CE2' HD13 ' A' ' 532' ' ' ILE . 4.7 p-90 -63.03 -16.52 60.11 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.715 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.874 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.3 pt -126.06 135.69 27.45 Favored Pre-proline 0 N--CA 1.445 -0.69 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.022 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 532' ' ' ILE . 1.2 Cg_endo -84.48 -20.43 3.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.957 2.438 . . . . 0.0 113.889 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.508 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 9.0 p90 -146.65 6.34 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.934 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 15.1 m-85 -87.72 -39.91 14.55 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.033 0.444 . . . . 0.0 110.793 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -110.44 -60.54 0.49 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.506 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.94 -37.2 85.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.41 2.073 . . . . 0.0 111.576 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -93.18 -17.21 23.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.25 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.994 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -48.84 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.606 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 21.0 mt-10 76.72 -44.96 0.48 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.484 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -110.14 33.44 6.0 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.994 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -151.06 -33.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.138 0.494 . . . . 0.0 110.416 -179.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.708 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -97.6 -37.75 9.81 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.162 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.937 HG21 HD22 ' A' ' 547' ' ' LEU . 1.0 OUTLIER 37.53 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 123.436 0.694 . . . . 0.0 112.567 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.708 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.1 mt-10 66.05 86.09 0.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.025 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 159.24 -16.7 0.24 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.146 -0.934 . . . . 0.0 112.369 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.937 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -129.6 -13.28 4.29 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.489 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -69.11 69.16 0.19 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.137 0.494 . . . . 0.0 111.299 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.47 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.8 OUTLIER -120.74 -53.18 2.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.71 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.414 ' C ' ' HG3' ' A' ' 551' ' ' GLN . 22.8 t-20 -179.11 -57.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.448 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.491 ' OE1' HD11 ' A' ' 554' ' ' LEU . 0.0 OUTLIER 27.12 -91.84 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.408 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.409 ' HA ' HD11 ' A' ' 555' ' ' ILE . 0.4 OUTLIER 63.95 15.72 9.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.035 -179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -127.51 -29.35 0.84 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.143 -0.551 . . . . 0.0 111.946 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.934 HD12 HG23 ' A' ' 555' ' ' ILE . 2.2 pp -80.97 1.65 30.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.794 0.33 . . . . 0.0 111.197 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.934 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -141.49 -42.62 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.769 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.3 OUTLIER -107.15 98.63 8.25 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.199 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -136.81 -70.17 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.351 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.673 HD23 ' H ' ' A' ' 558' ' ' LEU . 1.9 pt? -138.39 -48.07 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.44 0.162 . . . . 0.0 111.104 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.458 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.56 38.25 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.93 0.395 . . . . 0.0 111.504 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.102 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.797 0.332 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.461 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -155.07 52.8 0.75 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.134 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 97.7 Cg_endo -83.23 153.73 14.25 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.644 2.23 . . . . 0.0 112.459 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.11 114.59 9.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.524 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 5.3 m 60.78 107.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.167 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.902 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.3 m-80 -90.9 -51.08 0.32 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.733 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.675 ' HB3' ' CE3' ' A' ' 518' ' ' TRP . 74.5 Cg_endo -105.92 20.94 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 124.315 3.343 . . . . 0.0 112.623 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.655 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.0 m-80 -118.35 51.99 1.05 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.501 0.667 . . . . 0.0 109.232 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.902 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -109.35 -56.75 2.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.133 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.629 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 7.5 p-80 -174.93 -57.14 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.712 0.291 . . . . 0.0 111.366 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.629 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -56.23 -15.63 4.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.723 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -121.08 -29.82 4.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.021 0.439 . . . . 0.0 111.325 -177.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.625 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 3.0 t -77.5 -20.43 54.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.288 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.667 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -93.84 -67.65 0.84 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.742 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.667 ' N ' HG22 ' A' ' 520' ' ' THR . 4.3 pt20 -99.9 -156.82 0.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.554 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.7 OUTLIER -98.35 34.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.404 -179.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.842 ' OE1' HD13 ' A' ' 544' ' ' ILE . 62.2 mt-10 56.93 34.08 24.28 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.547 0.689 . . . . 0.0 110.282 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.562 ' C ' HD11 ' A' ' 527' ' ' ILE . . . 80.14 32.36 35.79 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.311 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.545 ' HA ' HD11 ' A' ' 529' ' ' LEU . . . -117.88 1.96 12.13 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -91.56 19.49 6.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.692 ' H ' HD12 ' A' ' 527' ' ' ILE . 0.1 OUTLIER -124.27 -52.7 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.642 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.89 -18.45 1.09 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.986 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.85 HD21 ' CD ' ' A' ' 545' ' ' GLU . 6.8 mp 73.21 -25.6 0.19 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.27 -24.65 42.8 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.234 0.54 . . . . 0.0 111.433 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.686 ' CE2' HD13 ' A' ' 532' ' ' ILE . 5.9 p-90 -62.53 -16.02 53.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.852 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.902 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.1 pt -125.91 140.99 38.14 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.362 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -89.3 -18.88 1.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.867 2.378 . . . . 0.0 113.826 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.97 6.14 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.902 ' HB2' HD12 ' A' ' 532' ' ' ILE . 13.9 m-85 -86.03 -40.34 15.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.014 0.435 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.4 ' H ' ' HD2' ' A' ' 537' ' ' PRO . . . -112.96 -62.17 0.44 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.443 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.4 ' HD2' ' H ' ' A' ' 536' ' ' GLY . 54.4 Cg_exo -50.16 -38.88 51.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.211 1.94 . . . . 0.0 111.686 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.411 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -86.34 -31.24 21.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.945 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -51.07 169.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.447 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -153.5 -41.01 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.328 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.488 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -113.25 33.37 5.6 Favored Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 179.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.665 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -149.66 -31.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.818 0.342 . . . . 0.0 110.414 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.791 ' HA ' ' O ' ' A' ' 523' ' ' GLU . 0.3 OUTLIER -103.02 -44.77 5.13 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.451 -178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 1.037 HG21 HD22 ' A' ' 547' ' ' LEU . 1.2 mp 42.09 -72.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 123.426 0.69 . . . . 0.0 112.666 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.85 ' CD ' HD21 ' A' ' 529' ' ' LEU . 3.0 mm-40 69.34 29.08 4.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.919 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.6 -1.93 1.81 Allowed Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.798 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 1.037 HD22 HG21 ' A' ' 544' ' ' ILE . 1.5 pt? -139.88 -10.17 1.17 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.561 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.19 66.58 0.29 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.482 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.1 OUTLIER -119.31 24.49 10.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.388 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 65.35 64.29 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.973 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.732 ' CB ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -110.65 -177.63 3.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.802 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 556' ' ' CYS . 18.3 p-10 -179.43 -22.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.346 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.4 32.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.411 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.732 HD21 ' CB ' ' A' ' 551' ' ' GLN . 0.8 OUTLIER -85.53 -0.99 56.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.6 0.238 . . . . 0.0 111.526 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.756 HD13 ' N ' ' A' ' 555' ' ' ILE . 0.1 OUTLIER -145.28 -40.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.02 0.438 . . . . 0.0 111.342 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.485 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.1 t -99.11 80.46 2.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.304 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -129.73 -67.43 0.11 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.465 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.676 HD23 ' H ' ' A' ' 558' ' ' LEU . 1.8 pt? -137.6 -48.23 0.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.495 0.188 . . . . 0.0 111.093 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.445 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 178.27 38.43 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.061 0.457 . . . . 0.0 111.475 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.505 ' NE2' HD23 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.11 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.863 0.363 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.445 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 36.5 mt-30 -158.34 64.94 2.97 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.656 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 5.5 Cg_endo -87.42 139.52 5.04 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.306 2.67 . . . . 0.0 112.327 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.14 117.22 27.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.98 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 99.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.962 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.4 m-80 -100.8 -51.28 0.18 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.67 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.879 ' CG ' HG21 ' A' ' 555' ' ' ILE . 56.2 Cg_endo -104.46 17.84 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.293 3.329 . . . . 0.0 112.548 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.705 ' C ' HD13 ' A' ' 515' ' ' LEU . 4.8 m-80 -121.24 57.46 1.0 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.962 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.3 -51.36 2.85 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.27 -178.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.627 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.0 p-80 -176.89 -56.67 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.446 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.668 ' CD2' HG23 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -55.09 -16.17 2.75 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.731 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.29 -41.05 2.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.215 0.531 . . . . 0.0 110.714 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.613 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.1 t -62.61 -27.62 69.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.463 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.648 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -88.33 -62.83 1.4 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.048 -179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.648 ' N ' HG22 ' A' ' 520' ' ' THR . 2.1 pt20 -99.84 -165.08 1.18 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.405 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 525' ' ' ALA . 2.9 m-20 -103.11 34.87 2.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.603 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.625 ' OE1' HD13 ' A' ' 544' ' ' ILE . 13.5 mt-10 45.56 31.5 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.534 0.683 . . . . 0.0 110.301 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 161.73 -30.32 0.31 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.645 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 57.54 12.6 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 46.88 15.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 120.95 0.405 . . . . 0.0 111.203 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.805 HG13 ' HB3' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -70.55 -13.22 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.654 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.555 ' N ' HD12 ' A' ' 527' ' ' ILE . . . 158.2 -57.36 0.35 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.863 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.691 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.1 OUTLIER 79.81 -27.91 0.15 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.96 -3.86 47.02 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.595 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 10.9 p-90 -81.75 -4.36 56.12 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.881 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.595 HD13 ' CZ2' ' A' ' 531' ' ' TRP . 1.0 OUTLIER -132.61 61.59 57.71 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.069 -177.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -37.44 -47.14 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.471 2.78 . . . . 0.0 114.075 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.662 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 8.3 p90 -113.73 6.31 16.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.893 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 11.3 t80 -114.06 -19.73 11.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.704 0.288 . . . . 0.0 111.532 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.503 ' HA3' HG13 ' A' ' 532' ' ' ILE . . . -113.49 -74.42 0.65 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.271 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 33.4 Cg_exo -61.73 -32.81 86.54 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.57 2.18 . . . . 0.0 111.209 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -90.72 -16.26 28.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.62 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 1.014 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -51.95 -58.41 6.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.22 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 70.78 -53.13 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.508 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -106.03 32.7 7.11 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.819 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 1.014 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -150.74 -30.79 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.864 0.364 . . . . 0.0 110.587 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.691 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.3 OUTLIER -100.48 -44.78 5.77 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -178.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.905 HG21 HD22 ' A' ' 547' ' ' LEU . 1.2 mp 40.65 -72.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 123.493 0.717 . . . . 0.0 112.62 179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.678 ' N ' ' O ' ' A' ' 543' ' ' TYR . 3.8 mt-10 69.6 33.99 2.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.141 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -142.17 2.1 1.77 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.002 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.905 HD22 HG21 ' A' ' 544' ' ' ILE . 2.1 pt? -143.49 -8.89 0.75 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.469 ' HB3' ' HG3' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -76.95 74.39 3.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.075 0.464 . . . . 0.0 111.232 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.469 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -134.25 27.98 3.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.082 179.199 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 7.5 m120 62.49 87.16 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.424 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.71 -77.13 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.778 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.62 24.77 14.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.91 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.19 -34.47 0.46 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.062 -0.59 . . . . 0.0 111.919 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.957 HD12 HG23 ' A' ' 555' ' ' ILE . 2.3 pp -85.57 2.64 44.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 111.307 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.957 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.53 -42.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 -179.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -114.2 87.56 2.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.057 -179.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -123.8 -69.02 0.22 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.418 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.429 ' HG ' ' HG3' ' A' ' 559' ' ' ARG . 1.1 pt? -142.66 -40.17 0.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.429 ' HG3' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 174.71 31.4 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.332 0.587 . . . . 0.0 111.179 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.504 ' NE2' ' H ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.945 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.758 0.313 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.86 60.96 0.18 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.694 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.86 -170.22 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.575 2.183 . . . . 0.0 112.339 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.97 123.41 23.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 59.27 92.55 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.738 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.899 ' O ' HD21 ' A' ' 515' ' ' LEU . 2.7 m-80 -91.96 -50.88 0.3 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.457 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.956 ' CG ' HG21 ' A' ' 555' ' ' ILE . 57.6 Cg_endo -104.45 18.8 0.16 Allowed 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 124.402 3.402 . . . . 0.0 112.397 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.709 ' C ' HD13 ' A' ' 515' ' ' LEU . 3.9 m-80 -121.84 57.98 1.03 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.899 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.38 -48.31 3.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.307 -178.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.638 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.4 p-80 -178.48 -56.94 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 120.797 0.332 . . . . 0.0 111.408 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.664 ' CD2' HG23 ' A' ' 542' ' ' ILE . 0.0 OUTLIER -56.93 -16.33 6.64 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.711 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -124.23 -38.17 2.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.122 0.486 . . . . 0.0 110.639 -177.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.562 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 6.6 t -65.75 -24.52 66.97 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.298 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.573 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -90.29 -60.98 1.78 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.831 -179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.743 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 0.4 OUTLIER -100.39 -168.31 1.56 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.168 0.509 . . . . 0.0 110.954 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 548' ' ' MET . 1.1 m-20 -103.25 31.4 4.32 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.393 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.743 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 4.1 mt-10 45.5 29.02 0.56 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.357 0.599 . . . . 0.0 110.333 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 526' ' ' ALA . . . 152.96 -23.55 0.8 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.58 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 1.087 ' HB3' HD13 ' A' ' 527' ' ' ILE . . . 32.24 26.7 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.06 16.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.789 0.328 . . . . 0.0 111.544 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 1.087 HD13 ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.17 -33.73 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.315 0.579 . . . . 0.0 110.034 179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 166.66 -39.82 0.25 Allowed Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.294 -0.867 . . . . 0.0 112.763 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 529' ' ' LEU . 3.3 mp 72.23 -18.01 0.34 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 528' ' ' GLY . . . -79.15 -19.2 51.61 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.293 0.568 . . . . 0.0 110.876 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.477 ' CD2' HG23 ' A' ' 532' ' ' ILE . 8.6 p-90 -74.96 -10.43 59.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.517 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -125.28 59.52 24.88 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.58 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -42.58 -41.6 8.1 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.071 2.514 . . . . 0.0 113.559 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 8.0 p90 -115.45 6.25 14.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 10.3 t80 -114.79 -24.36 8.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.692 0.282 . . . . 0.0 111.443 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -112.39 -90.98 1.95 Allowed Glycine 0 CA--C 1.518 0.224 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.623 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 83.6 Cg_exo -42.93 -43.65 9.28 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.674 2.249 . . . . 0.0 112.017 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.517 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -73.34 -31.3 63.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.48 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.832 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -65.8 150.66 48.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.283 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -133.37 -32.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.772 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -117.25 30.5 6.23 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.832 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -142.42 -31.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.03 0.443 . . . . 0.0 110.364 -179.534 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.729 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -105.5 -31.76 8.84 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.902 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 547' ' ' LEU . 2.5 mp 33.27 -71.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 123.637 0.775 . . . . 0.0 112.699 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.729 ' N ' ' O ' ' A' ' 543' ' ' TYR . 32.6 mt-10 70.8 35.85 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.256 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -141.1 0.3 1.78 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.727 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 544' ' ' ILE . 2.5 pt? -146.92 -5.52 0.52 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.46 ' HE1' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -78.63 76.55 5.13 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.075 0.464 . . . . 0.0 111.32 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -134.5 28.47 3.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.073 179.128 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 60.79 89.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.434 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.528 ' OE1' HD11 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -119.52 -78.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.069 -179.598 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 67.43 23.41 9.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.632 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.47 -34.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.128 -0.558 . . . . 0.0 111.994 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.865 HD12 HG23 ' A' ' 555' ' ' ILE . 2.1 pp -81.99 1.24 36.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 0.0 111.219 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.956 HG21 ' CG ' ' A' ' 513' ' ' PRO . 0.2 OUTLIER -140.69 -42.61 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.067 0.461 . . . . 0.0 110.816 -179.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.501 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -111.31 120.24 41.56 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.114 -179.111 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -159.54 -70.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.39 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.525 HD23 ' N ' ' A' ' 558' ' ' LEU . 1.9 pt? -135.79 -44.86 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.594 0.197 . . . . 0.0 111.464 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.44 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.48 38.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.066 0.46 . . . . 0.0 111.476 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.092 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.699 0.285 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.428 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 6.6 mt-30 -158.81 52.84 0.54 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.865 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 67.4 Cg_endo -73.96 125.6 10.0 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.64 2.227 . . . . 0.0 112.203 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.4 ' HA ' ' OE1' ' A' ' 560' ' ' GLN . 0.1 OUTLIER -78.4 87.42 4.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.212 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 40.1 m 60.76 117.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.841 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.979 ' O ' HD21 ' A' ' 515' ' ' LEU . 0.7 OUTLIER -106.78 -52.49 0.09 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.465 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.609 ' CD ' HG13 ' A' ' 555' ' ' ILE . 57.5 Cg_endo -106.51 16.93 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 124.304 3.336 . . . . 0.0 112.448 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.716 ' C ' HD13 ' A' ' 515' ' ' LEU . 17.2 m-80 -122.56 53.78 1.24 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.318 0.58 . . . . 0.0 109.812 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.979 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.54 -69.58 0.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.858 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.758 ' HA ' HG22 ' A' ' 519' ' ' THR . 8.5 p-80 -159.64 -55.2 0.06 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.369 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.602 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -54.92 -8.79 0.29 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.696 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -124.82 -44.47 1.94 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.548 0.689 . . . . 0.0 110.51 -177.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.758 HG22 ' HA ' ' A' ' 516' ' ' HIS . 13.1 t -61.88 -30.27 70.75 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.291 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.7 OUTLIER -82.51 -64.79 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.846 -179.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.654 ' N ' HG22 ' A' ' 520' ' ' THR . 2.6 pt20 -99.89 -160.37 0.8 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.357 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 525' ' ' ALA . 1.0 OUTLIER -103.04 34.48 2.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.478 -179.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.599 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 2.2 mt-10 44.55 34.46 1.12 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.404 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 140.66 -40.34 1.38 Allowed Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.223 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.66 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 57.28 8.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.43 15.97 0.06 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.928 0.394 . . . . 0.0 110.792 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.66 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -54.55 -24.54 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.539 -179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 172.52 -51.67 0.17 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.333 -0.937 . . . . 0.0 113.372 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.792 HD21 ' OE2' ' A' ' 545' ' ' GLU . 3.5 mp 77.99 -18.4 0.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 122.776 0.43 . . . . 0.0 111.986 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.8 45.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.417 0.627 . . . . 0.0 110.164 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.502 ' NE1' HD13 ' A' ' 527' ' ' ILE . 1.8 p-90 -66.07 -15.72 63.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.742 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 535' ' ' PHE . 2.2 pt -124.01 64.07 33.13 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.006 -177.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -46.39 -36.56 17.96 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.897 2.398 . . . . 0.0 113.503 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.492 ' HA ' ' HB3' ' A' ' 538' ' ' ALA . 4.7 p90 -121.27 6.19 10.21 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.617 ' HB3' ' HB ' ' A' ' 532' ' ' ILE . 8.1 t80 -112.19 -26.46 8.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.648 0.261 . . . . 0.0 111.406 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.477 ' HA3' ' CD1' ' A' ' 532' ' ' ILE . . . -111.84 -90.88 1.98 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.585 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 532' ' ' ILE . 82.0 Cg_exo -40.45 -44.01 4.22 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.915 2.41 . . . . 0.0 112.095 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.492 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -73.39 -35.3 65.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.425 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.876 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -58.15 157.18 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.989 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -134.31 -34.08 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.478 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.483 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -117.67 36.73 3.56 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.876 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -148.69 -36.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.226 0.536 . . . . 0.0 109.849 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.689 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -100.09 -33.94 10.26 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.21 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.597 ' CG2' HD22 ' A' ' 547' ' ' LEU . 1.6 mp 32.31 -72.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.913 0.885 . . . . 0.0 113.025 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.792 ' OE2' HD21 ' A' ' 529' ' ' LEU . 20.0 mt-10 68.85 96.73 0.06 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.176 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 140.93 -9.36 2.79 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.844 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.669 HD11 ' HZ3' ' A' ' 518' ' ' TRP . 1.5 pt? -129.93 -1.66 4.69 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.599 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -72.62 85.26 1.17 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.569 -178.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 1.6 m170 -130.79 -48.83 1.04 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.417 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 167.73 -73.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.042 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' A' ' 552' ' ' ASP . 0.0 OUTLIER 57.04 -152.28 0.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.667 ' H ' HD11 ' A' ' 555' ' ' ILE . 13.0 t70 110.49 21.59 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.105 0.962 . . . . 0.0 110.527 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -141.34 0.14 1.7 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.489 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.953 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -127.12 2.46 6.47 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.995 0.518 . . . . 0.0 110.332 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.953 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -147.1 -41.13 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.629 -178.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.537 ' N ' HG12 ' A' ' 555' ' ' ILE . 1.6 t -118.06 134.83 54.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.971 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 51.13 65.65 2.97 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.153 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.522 HD12 ' HD3' ' A' ' 559' ' ' ARG . 1.7 pt? -141.44 -44.81 0.37 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.686 0.279 . . . . 0.0 110.527 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.522 ' HD3' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 170.38 35.78 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.179 0.514 . . . . 0.0 110.708 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 510' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.222 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.777 0.323 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -174.56 66.94 0.28 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.883 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.08 175.03 10.41 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.918 2.412 . . . . 0.0 112.468 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.8 124.68 43.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.452 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 57.94 98.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.327 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.971 ' O ' HD21 ' A' ' 515' ' ' LEU . 1.2 m-80 -101.83 -51.28 0.16 Allowed Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.643 ' CG ' HG21 ' A' ' 555' ' ' ILE . 48.4 Cg_endo -104.03 15.41 0.22 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 124.052 3.168 . . . . 0.0 113.122 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.708 ' C ' HD13 ' A' ' 515' ' ' LEU . 13.8 m-80 -125.61 59.16 1.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.237 0.542 . . . . 0.0 109.608 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.971 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -119.45 -52.06 2.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.032 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.635 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.9 p-80 -176.63 -55.9 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.324 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.681 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -54.44 -13.54 0.96 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.714 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.74 -45.64 2.03 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.449 0.643 . . . . 0.0 110.156 -177.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 2.1 t -65.64 -25.84 67.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.656 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.542 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -80.94 -56.97 3.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.251 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.576 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 4.3 pt20 -100.68 -162.32 0.93 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.041 0.448 . . . . 0.0 111.144 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.43 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.4 m-20 -103.05 35.96 2.37 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.496 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.863 ' OE1' HD21 ' A' ' 547' ' ' LEU . 26.3 mt-10 43.9 73.93 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.097 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.494 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.73 -21.65 35.04 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.989 -177.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.604 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 53.77 11.08 0.29 Allowed 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.11 16.23 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.011 0.434 . . . . 0.0 110.481 -178.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.635 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.5 OUTLIER -55.01 -22.33 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.261 -179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.542 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 157.61 -34.72 0.54 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.354 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.781 HD11 ' CD2' ' A' ' 543' ' ' TYR . 3.6 mt 69.29 -56.87 0.54 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 111.586 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.74 46.16 0.75 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.363 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.635 ' NE1' HD13 ' A' ' 527' ' ' ILE . 2.9 p-90 -120.28 -18.82 7.87 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.528 HG21 ' HD2' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -108.63 159.47 30.79 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.055 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.463 ' HG2' ' CE1' ' A' ' 535' ' ' PHE . 18.5 Cg_endo -59.37 -48.57 13.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.6 2.2 . . . . 0.0 112.868 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.669 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 49.0 p90 -156.58 6.35 0.18 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.811 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.5 OUTLIER -72.5 -26.42 61.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.88 0.371 . . . . 0.0 111.081 -179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -108.4 -58.84 0.55 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.878 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.44 -35.6 76.34 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.389 2.059 . . . . 0.0 111.71 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -92.52 -12.14 32.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.381 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.816 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -75.28 122.51 23.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.87 0.366 . . . . 0.0 111.503 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -124.18 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.499 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -120.08 35.27 3.85 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.816 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -146.99 -33.51 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.074 0.464 . . . . 0.0 110.333 -179.694 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.781 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.3 OUTLIER -97.3 -40.02 8.95 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.733 -179.512 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.889 HG21 HD22 ' A' ' 547' ' ' LEU . 1.5 mp 36.96 -72.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 123.466 0.707 . . . . 0.0 112.364 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.714 ' N ' ' O ' ' A' ' 543' ' ' TYR . 25.1 mt-10 66.21 94.8 0.06 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.854 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.54 -4.75 1.51 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.998 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 544' ' ' ILE . 2.4 pt? -128.59 -10.25 5.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 117.336 0.568 . . . . 0.0 112.369 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.504 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.73 78.41 0.2 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.908 0.385 . . . . 0.0 111.032 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 2.0 m170 -133.72 27.13 4.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.638 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 1.3 m120 54.21 63.74 2.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.355 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.43 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -86.19 -79.24 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.043 -179.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.57 ' H ' HD11 ' A' ' 555' ' ' ILE . 0.5 OUTLIER 64.71 12.86 7.95 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.265 -179.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -118.37 -34.61 1.09 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.592 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.997 HD12 HG23 ' A' ' 555' ' ' ILE . 2.1 pp -87.48 2.93 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.818 0.342 . . . . 0.0 111.021 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.997 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -145.64 -40.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.275 -179.24 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.475 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER -109.88 57.71 0.61 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.973 -179.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -109.43 -62.22 0.53 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.148 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 558' ' ' LEU . 1.8 pt? -143.12 -49.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.545 0.212 . . . . 0.0 111.131 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.455 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 176.28 34.08 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.204 0.526 . . . . 0.0 110.865 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.62 ' NE2' ' H ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.119 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.805 0.336 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.413 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 3.1 mt-30 -166.68 53.67 0.28 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.413 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 70.9 Cg_endo -74.37 125.55 9.73 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.609 2.206 . . . . 0.0 112.341 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 560' ' ' GLN . 0.1 OUTLIER -91.9 117.26 29.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.4 m 60.1 86.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.007 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.827 ' O ' HD21 ' A' ' 515' ' ' LEU . 5.5 m-80 -83.37 -49.22 0.73 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.971 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.95 ' CG ' HG21 ' A' ' 555' ' ' ILE . 36.8 Cg_endo -102.2 16.05 0.29 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 124.256 3.304 . . . . 0.0 112.098 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.623 ' C ' HD13 ' A' ' 515' ' ' LEU . 6.8 m-80 -120.42 56.64 0.98 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.827 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -105.77 -48.0 3.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.302 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.625 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.2 p-80 -177.62 -56.0 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.353 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.712 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -57.11 -20.44 25.56 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -120.75 -41.23 2.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.224 0.535 . . . . 0.0 110.999 -177.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.596 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 7.4 t -57.2 -30.15 64.3 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.18 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.699 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -94.42 -70.11 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.891 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.699 ' N ' HG22 ' A' ' 520' ' ' THR . 0.0 OUTLIER -99.75 -168.18 1.57 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.451 -178.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.846 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 3.7 m-20 -89.93 22.17 3.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.904 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.584 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 3.9 mt-10 69.94 5.51 5.3 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.983 0.421 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.499 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 128.63 17.16 1.94 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.066 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.846 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -99.64 -6.1 27.83 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.798 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -89.17 18.99 4.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.821 0.343 . . . . 0.0 111.413 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.798 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -136.09 -50.77 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.765 -179.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 159.92 -27.6 0.35 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.755 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.815 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.0 OUTLIER 81.01 -28.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -78.8 -21.29 48.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.849 0.357 . . . . 0.0 111.869 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.805 ' CE2' HD13 ' A' ' 532' ' ' ILE . 3.0 p-90 -53.61 -24.59 14.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 110.587 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.805 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.3 OUTLIER -115.52 119.34 38.11 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.271 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.45 ' HG2' ' CE2' ' A' ' 534' ' ' TYR . 74.9 Cg_endo -90.12 31.97 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.715 2.276 . . . . 0.0 114.19 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.559 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 8.1 p90 172.2 -34.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.303 0.573 . . . . 0.0 111.044 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.91 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 2.3 t80 -71.89 -21.15 61.69 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.67 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 532' ' ' ILE . . . -116.69 -71.46 0.45 Allowed Glycine 0 C--N 1.32 -0.344 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.34 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HD3' HG13 ' A' ' 532' ' ' ILE . 51.2 Cg_exo -52.5 -39.46 74.42 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.485 2.123 . . . . 0.0 111.581 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -91.84 -17.35 25.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.117 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 1.018 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -45.25 -52.01 10.11 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.873 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 2.0 mt-10 71.85 -58.91 0.57 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.433 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -103.96 26.13 24.16 Favored Glycine 0 C--O 1.228 -0.233 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.348 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 1.018 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -149.05 1.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 O-C-N 122.778 -0.248 . . . . 0.0 111.664 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.815 ' CD2' HD11 ' A' ' 529' ' ' LEU . 0.8 OUTLIER -129.33 -42.95 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 120.482 0.182 . . . . 0.0 110.725 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.994 HG21 HD22 ' A' ' 547' ' ' LEU . 3.3 mp 34.34 -73.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.444 0.698 . . . . 0.0 112.554 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.712 ' N ' ' O ' ' A' ' 543' ' ' TYR . 20.8 mt-10 64.02 34.98 10.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.356 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -147.17 13.43 1.45 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.54 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.994 HD22 HG21 ' A' ' 544' ' ' ILE . 1.1 pt? -157.87 -17.86 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.526 ' N ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -70.07 63.14 0.22 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.036 0.446 . . . . 0.0 111.26 -179.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.78 -43.03 3.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.649 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 552' ' ' ASP . 0.9 OUTLIER 172.89 -75.68 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.248 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.472 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER 41.19 -85.82 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.368 179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.3 OUTLIER 63.65 18.27 10.99 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.788 -179.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -123.79 -31.44 0.95 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.187 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.957 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -77.52 -2.55 36.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.611 0.243 . . . . 0.0 111.305 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.957 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.91 -39.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.104 0.478 . . . . 0.0 110.897 -179.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.504 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -115.13 66.84 0.69 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.417 -178.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.408 ' N ' ' NE2' ' A' ' 560' ' ' GLN . . . 167.69 -28.43 0.16 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.431 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.74 HD12 ' HD3' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -47.43 -62.51 1.4 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 111.37 -179.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.74 ' HD3' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -171.33 34.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.356 0.598 . . . . 0.0 110.366 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.408 ' NE2' ' N ' ' A' ' 557' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.086 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.849 0.357 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.415 ' N ' ' CD ' ' A' ' 509' ' ' PRO . 26.5 mt-30 -162.79 52.94 0.37 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 508' ' ' GLN . 72.1 Cg_endo -76.74 106.03 2.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.596 2.197 . . . . 0.0 112.406 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.91 117.34 8.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.827 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 97.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.792 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.987 ' O ' HD21 ' A' ' 515' ' ' LEU . 2.9 m-80 -94.84 -50.37 0.25 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.683 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.848 ' CG ' HG21 ' A' ' 555' ' ' ILE . 74.4 Cg_endo -107.13 16.88 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 124.374 3.383 . . . . 0.0 112.902 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.796 ' C ' HD13 ' A' ' 515' ' ' LEU . 4.7 m-80 -119.22 56.62 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.291 0.567 . . . . 0.0 109.676 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -117.87 -58.7 1.99 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.104 -179.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.649 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.5 p-80 -173.85 -56.37 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.482 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.649 ' N ' ' CG ' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -53.18 -12.4 0.37 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.708 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -122.49 -40.57 2.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.337 0.589 . . . . 0.0 110.179 -177.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.611 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 9.0 t -74.4 -21.11 59.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.648 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.537 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -82.49 -56.5 3.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.798 0.332 . . . . 0.0 111.538 -179.009 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.589 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 6.2 pt20 -100.45 -158.13 0.65 Allowed 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.113 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.46 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 9.0 m-20 -102.72 32.84 3.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.362 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.701 ' OE1' HD13 ' A' ' 544' ' ' ILE . 4.7 mt-10 44.67 73.99 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.963 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.449 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 92.12 -24.58 21.16 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.28 10.0 0.28 Allowed 'General case' 0 CA--C 1.517 -0.314 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.03 16.52 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.416 . . . . 0.0 110.539 -178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.598 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -52.97 -24.13 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.343 -179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.548 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 158.19 -52.68 0.4 Allowed Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.328 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.609 HD21 ' CD2' ' A' ' 543' ' ' TYR . 3.8 mp 75.07 -22.18 0.27 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 122.868 0.467 . . . . 0.0 112.115 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.29 -24.82 42.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.162 0.506 . . . . 0.0 111.135 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.632 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 6.2 p-90 -64.27 -15.23 59.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.757 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.865 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.0 OUTLIER -126.31 139.27 34.12 Favored Pre-proline 0 N--CA 1.446 -0.671 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.191 -178.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.91 -20.2 2.42 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.777 2.318 . . . . 0.0 113.892 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.515 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.0 p90 -148.21 6.11 0.76 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.936 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 18.6 m-85 -86.63 -40.49 15.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.027 0.441 . . . . 0.0 110.701 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -110.3 -60.4 0.5 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.367 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.76 -37.55 84.52 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.346 2.031 . . . . 0.0 111.551 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 534' ' ' TYR . . . -92.65 -17.54 24.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.174 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 1.012 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -49.29 -78.81 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.517 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 22.8 mt-10 76.15 -44.62 0.5 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.462 ' N ' HD12 ' A' ' 542' ' ' ILE . . . -110.2 32.41 6.69 Favored Glycine 0 C--O 1.23 -0.144 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.655 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 1.012 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -149.95 -32.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.065 0.46 . . . . 0.0 110.543 -179.761 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.728 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -98.2 -39.86 8.66 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -179.085 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.958 HG21 HD22 ' A' ' 547' ' ' LEU . 1.0 OUTLIER 36.14 -72.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.396 0.679 . . . . 0.0 112.538 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.728 ' N ' ' O ' ' A' ' 543' ' ' TYR . 30.9 mt-10 67.0 33.38 5.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.042 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -138.5 -3.75 1.79 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.886 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.958 HD22 HG21 ' A' ' 544' ' ' ILE . 1.7 pt? -144.72 -8.24 0.65 Allowed 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.467 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -70.46 68.14 0.36 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.957 0.408 . . . . 0.0 111.859 -178.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.541 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -133.16 34.04 3.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.718 179.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 43.9 t30 55.67 95.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.637 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.655 ' OE1' HD12 ' A' ' 555' ' ' ILE . 0.0 OUTLIER -125.45 -76.12 0.59 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.936 -179.533 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.27 24.76 7.34 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.884 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.94 -35.75 0.38 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.057 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.909 HD12 HG23 ' A' ' 555' ' ' ILE . 2.5 pp -82.3 1.67 35.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.726 0.298 . . . . 0.0 111.261 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.909 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -140.59 -42.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 110.872 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.499 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -111.77 118.31 35.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.994 -179.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -152.04 -70.75 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.716 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.673 HD23 ' H ' ' A' ' 558' ' ' LEU . 2.0 pt? -136.03 -48.17 0.67 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.632 0.216 . . . . 0.0 111.433 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.656 HH11 HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -178.65 37.92 0.0 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.964 0.412 . . . . 0.0 111.608 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.51 ' NE2' HD23 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.958 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 508' ' ' GLN . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.714 0.292 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.5 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 77.99 61.59 0.21 Allowed Pre-proline 0 N--CA 1.462 0.174 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.527 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 8.8 Cg_exo -73.85 78.96 2.38 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.964 2.443 . . . . 0.0 112.299 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -67.51 109.67 3.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.473 ' HA ' HD13 ' A' ' 555' ' ' ILE . 0.6 OUTLIER 63.62 98.36 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.81 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.797 ' O ' HD21 ' A' ' 515' ' ' LEU . 2.6 m-80 -97.5 -50.8 0.22 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.675 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.669 ' CG ' HG21 ' A' ' 555' ' ' ILE . 36.3 Cg_endo -101.93 16.37 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.921 3.08 . . . . 0.0 112.319 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.524 ' ND2' HD11 ' A' ' 555' ' ' ILE . 5.4 m-80 -119.61 52.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -98.98 -48.63 4.81 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.79 -1.096 . . . . 0.0 111.354 -178.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.586 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 8.5 p-80 -177.04 -53.04 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.671 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.772 ' HE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -60.17 -23.03 63.63 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.733 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -118.01 -39.48 3.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.0 110.959 -177.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.576 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 5.2 t -58.52 -27.78 64.82 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.542 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.674 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -97.8 -67.59 0.84 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.465 -179.135 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.674 ' N ' HG22 ' A' ' 520' ' ' THR . 0.0 OUTLIER -99.52 -168.28 1.59 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.771 -178.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.794 ' HB3' ' HB3' ' A' ' 525' ' ' ALA . 0.1 OUTLIER -87.23 24.26 1.63 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.883 -179.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.662 ' OE2' HD21 ' A' ' 547' ' ' LEU . 16.9 mt-10 68.57 4.87 4.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.06 0.457 . . . . 0.0 111.073 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.46 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 123.7 22.62 2.21 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.966 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.794 ' HB3' ' HB3' ' A' ' 522' ' ' ASP . . . -110.28 4.4 20.82 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -93.16 12.67 23.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.859 0.361 . . . . 0.0 111.657 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.636 HD13 ' NE1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -129.7 -45.4 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.292 -179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 150.85 -17.2 0.94 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.467 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.625 HD11 ' CD2' ' A' ' 543' ' ' TYR . 0.6 OUTLIER 73.72 -51.53 0.7 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.48 45.1 0.64 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.384 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.636 ' NE1' HD13 ' A' ' 527' ' ' ILE . 3.2 p-90 -119.87 -16.92 8.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.577 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.536 HD13 ' CE2' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -112.24 159.93 32.03 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.699 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 37.6 Cg_endo -66.3 -45.2 5.68 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.3 2.0 . . . . 0.0 112.491 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 538' ' ' ALA . 18.5 p90 -161.57 6.68 0.07 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.865 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 1.1 m-85 -66.0 -26.85 67.73 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.118 -0.364 . . . . 0.0 111.4 -179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.48 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -108.48 -63.5 0.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.609 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.07 -39.3 80.22 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.356 2.038 . . . . 0.0 111.835 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 534' ' ' TYR . . . -95.3 -4.58 45.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.533 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.865 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -54.15 -61.73 2.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.448 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 539' ' ' ALA . 32.4 mt-10 72.61 -58.26 0.6 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -102.91 22.59 36.44 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.312 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.862 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.0 OUTLIER -144.66 -5.84 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.711 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -125.53 -37.17 2.37 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 120.47 0.176 . . . . 0.0 111.131 -178.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.892 HG21 HD22 ' A' ' 547' ' ' LEU . 2.1 mp 36.7 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.471 0.708 . . . . 0.0 112.582 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.711 ' N ' ' O ' ' A' ' 543' ' ' TYR . 36.9 mt-10 65.47 96.92 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.976 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 144.39 -8.27 1.85 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.709 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.892 HD22 HG21 ' A' ' 544' ' ' ILE . 2.1 pt? -128.15 -9.38 5.33 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.42 ' HE2' ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.44 76.3 0.1 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.991 0.424 . . . . 0.0 111.066 -179.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.438 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 1.5 m170 -134.62 36.16 3.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.101 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.5 m-20 70.38 -64.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.151 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 42.66 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.963 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 550' ' ' ASN . 0.1 OUTLIER 59.63 16.53 5.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.006 -179.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -115.17 -34.79 1.42 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.697 HD12 HG23 ' A' ' 555' ' ' ILE . 0.8 OUTLIER -80.69 -3.85 52.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.46 -0.37 . . . . 0.0 110.847 179.276 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 556' ' ' CYS . 2.9 pp -145.19 -29.95 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.485 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.731 ' N ' HD12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -118.63 49.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.145 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 153.76 44.02 0.02 OUTLIER Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.243 -0.98 . . . . 0.0 113.43 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 558' ' ' LEU . 2.2 pt? -122.46 -40.32 2.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 110.529 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.45 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER -178.17 35.65 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.39 0.614 . . . . 0.0 110.295 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.117 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.8 0.333 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.472 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.3 OUTLIER -144.63 50.57 1.22 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.664 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 95.5 Cg_endo -81.76 104.59 1.45 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.594 2.196 . . . . 0.0 112.656 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.425 ' HA ' ' CG ' ' A' ' 560' ' ' GLN . 0.0 OUTLIER -63.5 112.62 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.602 179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.8 m 63.74 109.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.18 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.833 ' C ' HD11 ' A' ' 515' ' ' LEU . 2.3 m-80 -97.03 -50.35 0.23 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.958 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.684 ' O ' ' HB2' ' A' ' 518' ' ' TRP . 23.9 Cg_endo -99.86 -1.67 0.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 123.791 2.994 . . . . 0.0 113.208 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.811 ' C ' HD13 ' A' ' 515' ' ' LEU . 18.1 m-80 -106.06 66.2 0.71 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.854 HD23 ' CD2' ' A' ' 516' ' ' HIS . 0.0 OUTLIER -133.27 -30.46 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.354 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.854 ' CD2' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -173.0 -78.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.649 ' CB ' HG23 ' A' ' 542' ' ' ILE . 0.4 OUTLIER -67.4 12.05 0.1 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -177.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.697 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -139.26 -39.57 0.48 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.305 0.574 . . . . 0.0 109.66 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.537 HG22 ' N ' ' A' ' 516' ' ' HIS . 0.8 OUTLIER -78.62 -13.17 59.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.379 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.5 OUTLIER -95.84 -59.76 1.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.626 0.251 . . . . 0.0 110.873 179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.547 ' N ' ' CG2' ' A' ' 520' ' ' THR . 6.4 pt20 -100.7 -158.02 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.301 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.418 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 2.4 m-20 -103.02 34.27 2.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.857 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.712 ' OE1' HD13 ' A' ' 544' ' ' ILE . 20.9 mt-10 47.07 71.95 0.28 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.293 0.568 . . . . 0.0 110.269 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 91.6 -19.47 47.62 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.117 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.59 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.24 11.35 0.38 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.55 16.2 0.06 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 121.023 0.44 . . . . 0.0 110.507 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.59 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.3 OUTLIER -54.17 -22.96 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.482 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.554 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 162.15 -53.31 0.31 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.367 -0.92 . . . . 0.0 113.245 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 2.8 mp 75.51 -20.06 0.37 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 122.6 0.36 . . . . 0.0 111.813 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.5 -24.17 42.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.175 0.512 . . . . 0.0 111.106 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.592 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 7.1 p-90 -63.84 -14.37 52.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.846 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.862 HD12 ' HB2' ' A' ' 535' ' ' PHE . 0.9 OUTLIER -125.62 140.23 35.98 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.164 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -87.42 -20.06 2.21 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.763 2.308 . . . . 0.0 113.982 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.505 ' CE1' ' CE1' ' A' ' 535' ' ' PHE . 10.2 p90 -148.56 6.24 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.862 ' HB2' HD12 ' A' ' 532' ' ' ILE . 18.6 m-85 -86.64 -38.49 17.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.418 . . . . 0.0 110.93 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -113.73 -60.66 0.4 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.595 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.88 -40.07 76.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.434 2.089 . . . . 0.0 111.609 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.416 ' CB ' ' HA ' ' A' ' 534' ' ' TYR . . . -84.54 -27.71 27.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.727 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.768 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.07 158.82 6.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.492 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -151.32 -34.11 0.15 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.307 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.54 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -115.44 34.72 4.66 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.489 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.3 OUTLIER -149.92 -33.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.044 0.45 . . . . 0.0 110.163 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.3 OUTLIER -103.33 -44.68 5.09 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.235 -178.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.995 HG21 HD22 ' A' ' 547' ' ' LEU . 0.9 OUTLIER 42.4 -72.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 123.56 0.744 . . . . 0.0 112.755 178.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.665 ' N ' ' O ' ' A' ' 543' ' ' TYR . 0.4 OUTLIER 69.31 29.91 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.98 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.36 -5.7 1.28 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.092 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.995 HD22 HG21 ' A' ' 544' ' ' ILE . 1.3 pt? -138.94 -6.56 1.44 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.474 ' HE2' ' C ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -72.36 63.1 0.53 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.998 0.428 . . . . 0.0 111.615 -178.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.495 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -119.08 26.04 9.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.466 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 58.9 80.98 0.17 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.713 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.57 -77.44 0.6 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.784 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.518 ' H ' HD11 ' A' ' 555' ' ' ILE . 14.8 t70 63.24 15.27 8.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.358 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -121.89 -33.46 0.92 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.73 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.968 HD12 HG23 ' A' ' 555' ' ' ILE . 1.8 pp -87.84 5.49 40.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.89 0.376 . . . . 0.0 111.03 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.968 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -146.35 -41.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 -179.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.454 ' N ' HG12 ' A' ' 555' ' ' ILE . 6.5 t -107.96 48.96 0.83 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.114 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 146.49 40.39 0.04 OUTLIER Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.458 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 558' ' ' LEU . 1.7 pt? -110.06 -40.86 4.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.948 0.374 . . . . 0.0 110.407 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.556 ' HD3' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 176.37 35.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.349 179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.425 ' CG ' ' HA ' ' A' ' 510' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.211 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.404 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -168.88 66.06 0.63 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 4.4 Cg_exo -77.29 122.91 6.32 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.009 2.473 . . . . 0.0 112.338 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.76 122.18 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.566 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 60.84 100.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.615 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.85 ' C ' HD11 ' A' ' 515' ' ' LEU . 1.5 m-80 -103.19 -51.23 0.14 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.947 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.814 ' CG ' HG21 ' A' ' 555' ' ' ILE . 22.2 Cg_endo -100.11 -1.85 0.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.777 2.985 . . . . 0.0 113.259 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.821 ' C ' HD13 ' A' ' 515' ' ' LEU . 13.1 m-80 -103.44 65.66 0.85 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.85 HD11 ' C ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -132.16 -22.64 2.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -178.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.794 ' CD2' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER 179.83 -82.95 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.606 ' CD1' ' CD2' ' A' ' 516' ' ' HIS . 0.5 OUTLIER -62.48 7.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.296 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.759 ' HB2' ' O ' ' A' ' 513' ' ' PRO . 0.0 OUTLIER -135.57 -40.23 0.71 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.369 0.604 . . . . 0.0 109.775 -178.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.736 HG22 ' N ' ' A' ' 516' ' ' HIS . 7.2 t -80.17 -12.54 59.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.945 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.572 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.4 OUTLIER -97.76 -62.38 1.26 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.685 0.278 . . . . 0.0 111.361 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.572 ' N ' ' CG2' ' A' ' 520' ' ' THR . 2.0 pt20 -100.45 -163.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.995 0.426 . . . . 0.0 111.208 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -102.89 32.32 3.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.44 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.785 ' OE1' HD13 ' A' ' 544' ' ' ILE . 3.9 mt-10 41.61 79.56 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.352 0.596 . . . . 0.0 110.097 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 526' ' ' ALA . . . 93.49 -14.93 64.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.934 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 1.04 ' HB3' HD13 ' A' ' 527' ' ' ILE . . . 28.66 28.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 524' ' ' GLY . . . 42.56 16.22 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.936 0.398 . . . . 0.0 111.522 -178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 1.04 HD13 ' HB3' ' A' ' 525' ' ' ALA . 0.0 OUTLIER -58.22 -35.6 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.209 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . 173.99 -38.58 0.13 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.134 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 531' ' ' TRP . 0.2 OUTLIER 69.32 -46.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -76.88 -20.04 56.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.539 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 1.3 p-90 -43.69 -29.63 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.882 0.372 . . . . 0.0 111.083 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.531 HG23 ' CD2' ' A' ' 531' ' ' TRP . 0.2 OUTLIER -104.71 157.56 33.89 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.319 -179.733 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.458 ' HG2' ' CE1' ' A' ' 535' ' ' PHE . 36.4 Cg_endo -65.11 -44.09 10.21 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.426 2.084 . . . . 0.0 112.363 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 46.1 p90 -161.9 6.56 0.06 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.707 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 0.8 OUTLIER -63.98 -28.51 69.86 Favored 'General case' 0 C--N 1.333 -0.152 0 O-C-N 122.086 -0.384 . . . . 0.0 110.982 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.517 ' HA3' HD11 ' A' ' 532' ' ' ILE . . . -110.2 -57.83 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.988 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 75.8 Cg_exo -50.33 -46.71 27.6 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.47 2.114 . . . . 0.0 112.023 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -79.05 -25.8 43.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.933 ' HB1' HD13 ' A' ' 542' ' ' ILE . . . -59.95 141.62 55.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.229 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -129.97 -26.13 2.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.627 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.56 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -118.28 38.26 2.96 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.301 -0.719 . . . . 0.0 111.301 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.933 HD13 ' HB1' ' A' ' 539' ' ' ALA . 0.3 OUTLIER -150.26 -35.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.312 0.577 . . . . 0.0 109.951 -179.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.682 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -103.29 -30.33 10.7 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.089 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.923 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 33.95 -73.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.789 0.835 . . . . 0.0 112.907 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.682 ' N ' ' O ' ' A' ' 543' ' ' TYR . 29.1 mt-10 69.13 87.4 0.12 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.934 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 157.29 -19.73 0.4 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.152 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.923 HD22 HG21 ' A' ' 544' ' ' ILE . 1.4 pt? -127.7 -18.61 4.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 111.68 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.441 ' HE3' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -58.36 102.85 0.12 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.172 -179.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.438 ' NE2' ' HA ' ' A' ' 547' ' ' LEU . 0.4 OUTLIER -179.75 -64.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.974 178.73 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 175.33 108.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.823 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 -72.6 0.58 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.085 0.469 . . . . 0.0 110.822 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 45.5 28.46 0.5 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.11 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -130.33 -35.33 0.42 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 1.017 HD12 HG23 ' A' ' 555' ' ' ILE . 1.5 pp -89.65 -4.54 57.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.347 -0.426 . . . . 0.0 110.735 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 1.017 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -141.74 -42.58 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.294 -179.2 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.527 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.5 OUTLIER -115.48 58.37 0.73 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.334 -178.665 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -97.86 -55.63 1.13 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.554 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.661 HD23 ' NE2' ' A' ' 560' ' ' GLN . 2.5 pt? -147.09 -45.74 0.18 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.516 0.198 . . . . 0.0 110.886 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.51 ' N ' ' HG ' ' A' ' 558' ' ' LEU . 0.0 OUTLIER 177.91 37.6 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.947 0.403 . . . . 0.0 111.433 179.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.661 ' NE2' HD23 ' A' ' 558' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.09 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.81 0.338 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.435 ' N ' ' HD3' ' A' ' 509' ' ' PRO . 2.5 mt-30 -168.25 63.81 0.61 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.849 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 508' ' ' GLN . 25.7 Cg_exo -62.89 97.32 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.666 2.244 . . . . 0.0 112.388 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.2 115.57 20.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.634 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 64.84 88.95 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.854 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.864 ' O ' HD21 ' A' ' 515' ' ' LEU . 5.8 m-80 -87.74 -49.63 0.44 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.837 ' CG ' HG21 ' A' ' 555' ' ' ILE . 38.6 Cg_endo -102.67 17.51 0.24 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 124.229 3.286 . . . . 0.0 112.232 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.694 ' C ' HD13 ' A' ' 515' ' ' LEU . 8.6 m-80 -122.74 57.77 1.1 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.864 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -112.99 -52.42 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.357 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.652 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 4.4 p-80 -175.76 -56.36 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.054 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.665 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -54.35 -14.83 1.32 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -179.155 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.705 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -123.37 -47.45 2.0 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.406 0.622 . . . . 0.0 110.04 -177.205 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.596 HG22 ' N ' ' A' ' 516' ' ' HIS . 6.4 t -63.79 -26.15 68.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.711 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.545 ' CG2' ' N ' ' A' ' 521' ' ' GLN . 0.6 OUTLIER -81.43 -56.5 4.0 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.56 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.609 ' HG3' ' H ' ' A' ' 523' ' ' GLU . 4.7 pt20 -100.54 -161.92 0.9 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.038 0.447 . . . . 0.0 111.283 -178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.444 ' CB ' ' HA ' ' A' ' 525' ' ' ALA . 1.2 m-20 -102.95 34.37 2.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.569 -179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.759 ' OE1' HD21 ' A' ' 547' ' ' LEU . 20.1 mt-10 43.56 77.28 0.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.854 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.462 ' O ' HG13 ' A' ' 527' ' ' ILE . . . 93.72 -23.44 30.64 Favored Glycine 0 N--CA 1.44 -1.04 0 N-CA-C 110.709 -0.957 . . . . 0.0 110.709 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 527' ' ' ILE . . . 54.0 10.68 0.29 Allowed 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . 47.13 15.99 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.01 0.433 . . . . 0.0 110.644 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.603 HG13 ' HB3' ' A' ' 525' ' ' ALA . 0.4 OUTLIER -55.21 -22.35 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.366 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.558 ' H ' HD12 ' A' ' 527' ' ' ILE . . . 155.45 -48.36 0.49 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.999 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.1 mp 74.68 -47.02 0.62 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.833 0.453 . . . . 0.0 111.72 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.54 43.98 0.59 Allowed 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.572 ' CE2' HD13 ' A' ' 532' ' ' ILE . 4.3 p-90 -121.87 -13.9 8.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.829 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.65 ' HB ' ' HD1' ' A' ' 535' ' ' PHE . 0.0 OUTLIER -117.64 169.67 7.23 Favored Pre-proline 0 N--CA 1.454 -0.272 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.882 -179.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 532' ' ' ILE . 75.9 Cg_endo -92.73 6.16 3.17 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.746 2.297 . . . . 0.0 113.318 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.635 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 28.3 p90 -176.83 -27.28 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.776 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 48.8 m-85 -59.48 -26.49 65.31 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.85 -0.531 . . . . 0.0 111.453 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.448 ' H ' HG13 ' A' ' 532' ' ' ILE . . . -110.8 -65.6 0.53 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.558 -0.829 . . . . 0.0 113.059 -179.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 529' ' ' LEU . 42.3 Cg_exo -57.27 -39.0 93.29 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.587 2.191 . . . . 0.0 111.943 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -86.03 -18.38 32.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.21 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.776 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -58.31 150.16 22.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.87 0.367 . . . . 0.0 111.184 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -157.71 -36.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 518' ' ' TRP . . . -114.63 31.66 6.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.025 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.626 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -146.57 -33.3 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.084 0.468 . . . . 0.0 110.366 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.706 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.2 OUTLIER -99.56 -36.4 9.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.044 -179.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 1.046 HG21 HD22 ' A' ' 547' ' ' LEU . 1.4 mp 37.0 -73.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.465 0.706 . . . . 0.0 112.496 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.706 ' N ' ' O ' ' A' ' 543' ' ' TYR . 31.9 mt-10 65.85 36.82 5.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.246 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 548' ' ' MET . . . -148.69 14.32 1.2 Allowed Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.363 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 1.046 HD22 HG21 ' A' ' 544' ' ' ILE . 1.2 pt? -160.53 -14.91 0.05 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.529 ' HG2' ' HB2' ' A' ' 523' ' ' GLU . 0.0 OUTLIER -67.86 64.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.416 . . . . 0.0 111.759 -178.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.522 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -127.62 33.07 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.437 179.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 58.15 86.03 0.08 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.582 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.512 ' CG ' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -112.23 -77.84 0.58 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.037 -179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 68.78 11.5 8.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . -117.29 -32.89 1.42 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.973 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 1.011 HD12 HG23 ' A' ' 555' ' ' ILE . 1.6 pp -82.76 -0.81 49.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.796 0.331 . . . . 0.0 111.238 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 1.011 HG23 HD12 ' A' ' 554' ' ' LEU . 0.2 OUTLIER -142.94 -40.29 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.122 0.487 . . . . 0.0 110.876 -179.378 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.1 OUTLIER -110.97 54.52 0.67 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.298 -179.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . 150.94 41.57 0.03 OUTLIER Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.227 -0.987 . . . . 0.0 113.353 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 558' ' ' LEU . 2.4 pt? -124.82 -41.28 2.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.663 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.431 ' HD3' ' CD1' ' A' ' 558' ' ' LEU . 0.0 OUTLIER -175.41 34.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.274 0.559 . . . . 0.0 110.787 179.502 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.117 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.418 ' O ' ' CB ' ' A' ' 508' ' ' GLN . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.667 0.27 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 507' ' ' ALA . 0.6 OUTLIER 84.51 69.92 0.09 OUTLIER Pre-proline 0 N--CA 1.463 0.189 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 -179.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.407 ' HD3' ' H ' ' A' ' 508' ' ' GLN . 8.8 Cg_exo -73.16 69.17 4.01 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.252 2.635 . . . . 0.0 111.002 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.588 ' HG3' HD11 ' A' ' 558' ' ' LEU . 5.5 mptt -144.56 -173.76 4.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.374 -178.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 42.91 61.32 2.16 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.179 0.514 . . . . 0.0 110.927 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.812 ' O ' HD21 ' A' ' 515' ' ' LEU . 2.8 m-80 -89.55 -48.75 0.39 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.503 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.896 ' CG ' HG21 ' A' ' 555' ' ' ILE . 59.9 Cg_endo -103.67 20.59 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 124.245 3.297 . . . . 0.0 112.314 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . 0.583 ' C ' HD13 ' A' ' 515' ' ' LEU . 2.3 m-80 -115.46 48.16 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.812 HD21 ' O ' ' A' ' 512' ' ' ASN . 0.0 OUTLIER -100.27 -55.24 2.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.256 -178.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.63 ' CG ' ' N ' ' A' ' 517' ' ' TYR . 6.3 p-80 -175.48 -56.43 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.669 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.647 ' CE1' HD23 ' A' ' 515' ' ' LEU . 0.0 OUTLIER -57.21 -20.18 25.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.336 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -119.05 -27.68 5.67 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.424 -177.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 516' ' ' HIS . 1.6 t -76.97 -20.09 56.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.684 HG22 ' N ' ' A' ' 521' ' ' GLN . 0.9 OUTLIER -98.55 -70.87 0.71 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.087 0.47 . . . . 0.0 110.539 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.684 ' N ' HG22 ' A' ' 520' ' ' THR . 0.7 OUTLIER -99.93 -160.98 0.83 Allowed 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.095 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.85 ' CB ' ' HB3' ' A' ' 525' ' ' ALA . 5.2 m-20 -96.19 30.83 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.218 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.617 ' H ' ' HG3' ' A' ' 521' ' ' GLN . 20.3 mt-10 63.04 14.4 7.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.891 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.457 ' H ' ' NE2' ' A' ' 521' ' ' GLN . . . 113.93 22.68 5.23 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.911 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.85 ' HB3' ' CB ' ' A' ' 522' ' ' ASP . . . -97.83 -3.62 38.4 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.64 ' C ' HD13 ' A' ' 527' ' ' ILE . . . -84.86 22.42 1.37 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.853 0.359 . . . . 0.0 110.968 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.64 HD13 ' C ' ' A' ' 526' ' ' ALA . 0.0 OUTLIER -132.73 -60.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.58 ' O ' ' HB2' ' A' ' 529' ' ' LEU . . . 149.1 -21.8 1.25 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.41 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 528' ' ' GLY . 4.9 mp 75.2 -20.31 0.35 Allowed 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . . . . . . . . . . . -79.06 -25.09 43.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.331 0.586 . . . . 0.0 111.023 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.729 ' CZ2' HD13 ' A' ' 532' ' ' ILE . 7.2 p-90 -65.72 -18.51 65.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.029 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' A' ' 535' ' ' PHE . 1.6 pt -123.42 135.61 26.25 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.037 -179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.424 ' HG2' ' CD2' ' A' ' 534' ' ' TYR . 98.2 Cg_endo -87.63 -17.73 2.68 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.71 2.273 . . . . 0.0 113.604 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.642 ' O ' ' HB3' ' A' ' 538' ' ' ALA . 26.6 p90 -138.14 -26.08 0.94 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . 0.825 ' O ' ' HB2' ' A' ' 539' ' ' ALA . 98.3 m-85 -59.97 -43.14 95.28 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.986 -0.446 . . . . 0.0 111.564 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -109.25 -60.92 0.52 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.987 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 532' ' ' ILE . 54.3 Cg_exo -51.7 -41.99 58.97 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.388 2.059 . . . . 0.0 111.813 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 534' ' ' TYR . . . -81.93 -31.08 31.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.633 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.825 ' HB2' ' O ' ' A' ' 535' ' ' PHE . . . -49.36 159.37 0.32 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.9 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -149.28 -44.33 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.981 0.419 . . . . 0.0 110.731 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -109.72 25.18 17.76 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.095 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 542' ' ' ILE . 0.1 OUTLIER -145.06 -4.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 111.603 0.224 . . . . 0.0 111.603 -179.389 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.677 ' O ' ' N ' ' A' ' 545' ' ' GLU . 0.5 OUTLIER -129.57 -42.73 1.29 Allowed 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 121.173 -0.211 . . . . 0.0 111.316 -178.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' ILE . . . . . 0.959 HG21 HD22 ' A' ' 547' ' ' LEU . 3.4 mp 38.89 -73.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 123.54 0.736 . . . . 0.0 112.712 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.677 ' N ' ' O ' ' A' ' 543' ' ' TYR . 2.0 mm-40 73.65 29.77 1.49 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.314 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . -139.93 4.72 2.7 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.648 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.959 HD22 HG21 ' A' ' 544' ' ' ILE . 1.7 pt? -149.88 -16.22 0.26 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.604 ' HE2' ' HA ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -69.46 65.73 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.938 0.399 . . . . 0.0 111.836 -178.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -132.23 35.73 3.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.404 179.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.14 93.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.333 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.444 ' HG2' HD21 ' A' ' 554' ' ' LEU . 0.0 OUTLIER -120.72 -76.44 0.58 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.216 0.531 . . . . 0.0 111.116 -179.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.462 ' H ' HD11 ' A' ' 555' ' ' ILE . 3.5 t70 63.7 17.17 10.26 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.678 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.443 ' HA2' ' HA3' ' A' ' 557' ' ' GLY . . . -123.77 -31.91 0.92 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.891 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.954 HD12 HG23 ' A' ' 555' ' ' ILE . 2.7 pp -90.03 8.38 32.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.088 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.954 HG23 HD12 ' A' ' 554' ' ' LEU . 0.1 OUTLIER -148.1 -44.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.545 -179.301 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 555' ' ' ILE . 0.6 OUTLIER -116.05 47.8 1.33 Allowed 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.234 179.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.448 ' HA2' ' NE2' ' A' ' 560' ' ' GLN . . . -154.33 -35.15 0.03 OUTLIER Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.345 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.759 HD12 ' HD3' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -33.89 -50.56 0.37 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.849 0.324 . . . . 0.0 111.467 -179.544 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.759 ' HD3' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -177.86 30.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.268 0.556 . . . . 0.0 111.168 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.542 ' HB3' ' CB ' ' A' ' 510' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.161 -0.923 . . . . 0.0 110.708 179.877 . . . . . . . . 2 2 . 1 stop_ save_